{"nodes":[{"data":{"id":"Protein_bb03ec1e2744ad7c66fc37d4ec02ee5f","class":"macromolecule","label":"RPE65","parent":"plasma_membrane","clonemarker":false,"stateVariables":[{"id":"Protein_bb03ec1e2744ad7c66fc37d4ec02ee5f.info.1","class":"state variable","state":{"variable":"C330","value":"Pal"}},{"id":"Protein_bb03ec1e2744ad7c66fc37d4ec02ee5f.state.2","class":"state variable","state":{"variable":"C329","value":"Pal"}},{"id":"Protein_bb03ec1e2744ad7c66fc37d4ec02ee5f.info.3","class":"state variable","state":{"variable":"C231","value":"Pal"}}],"unitsOfInformation":[],"bbox":{"x":958.6776,"y":470.88007,"w":85,"h":25},"metadata":[["bp:displayName","RPE65"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005886"],["bp:db","gene ontology"]]],["bp:term","plasma membrane"],["bp:term","Cell Membrane"],["bp:term","Cell membrane"]]],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00115"],["bp:db","protein modification ontology"]]],["bp:term","S-palmitoyl-L-cysteine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29639"],["bp:featureLocation",[["bp:sequencePosition","330"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29640"]]]]],["bp:feature",[["bp:modificationType",null],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29637"],["bp:featureLocation",[["bp:sequencePosition","329"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29638"]]]]],["bp:feature",[["bp:modificationType",null],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29635"],["bp:featureLocation",[["bp:sequencePosition","231"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29636"]]]]],["bp:entityReference_http://identifiers.org/uniprot/Q16518",[["bp:modificationType",null],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29635"],["bp:featureLocation",[["bp:sequencePosition","231"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29636"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29632"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29632"]]}},{"data":{"id":"Protein_c88bfbd9fb33de98774d62d2ffe2dfb5","class":"macromolecule","label":"RDH12","parent":"plasma_membrane","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":830.82886,"y":434.78882,"w":48,"h":25},"metadata":[["bp:displayName","RDH12"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005886"],["bp:db","gene ontology"]]],["bp:term","plasma membrane"],["bp:term","Cell Membrane"],["bp:term","Cell membrane"]]],["bp:entityReference_http://identifiers.org/uniprot/Q96NR8",[["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_Q96NR8"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_Q96NR8"]]],["bp:standardName","Retinol dehydrogenase 12"],["bp:xref",[["bp:id","Q96NR8"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","RDH12"],["bp:db","hgnc symbol"]]],["bp:organism",[["bp:relationshipType",null],["bp:id","RDH12"],["bp:db","hgnc symbol"]]],["bp:displayName","RDH12_HUMAN"],["bp:name","All-trans and 9-cis retinol dehydrogenase"],["bp:name","Short chain dehydrogenase/reductase family 7C member 2"],["bp:name","RDH12"],["bp:name","SDR7C2"],["bp:name","1.1.1.-"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_689656"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#ProteinReference94159"],["bp:comment","FUNCTION: Exhibits an oxidoreductive catalytic activity towardsretinoids. Most efficient as an NADPH-dependent retinal reductase.Displays high activity toward 9-cis and all-trans-retinol. Alsoinvolved in the metabolism of short-chain aldehydes. No steroiddehydrogenase activity detected. Might be the key enzyme in theformation of 11-cis-retinal from 11-cis-retinol duringregeneration of the cone visual pigments.{ECO:0000269|PubMed:12226107}.TISSUE SPECIFICITY: Widely expressed, mostly in eye, kidney,brain, skeletal muscle and stomach.DISEASE: Leber congenital amaurosis 13 (LCA13) [MIM:612712]: Asevere dystrophy of the retina, typically becoming evident in thefirst years of life. Visual function is usually poor and oftenaccompanied by nystagmus, sluggish or near-absent pupillaryresponses, photophobia, high hyperopia and keratoconus.{ECO:0000269|PubMed:15258582, ECO:0000269|PubMed:15322982}.Note=The disease is caused by mutations affecting the generepresented in this entry.DISEASE: Retinitis pigmentosa 53 (RP53) [MIM:612712]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:19140180,ECO:0000269|PubMed:19956407}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the short-chain dehydrogenases/reductases(SDR) family. {ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_145226"],["bp:comment","RDH12_HUMAN Reviewed; 316 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29621"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]}},{"data":{"id":"Complex_df144db5664a3420707d4ed04b7742e9","class":"complex","label":"Na + (4 Units)","parent":"extracellular_region","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":962.16095,"y":1161.4985,"w":52,"h":24},"metadata":[["bp:displayName","Na + (4 Units)"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","Na+"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26708",[["bp:standardName","sodium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26708"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","Na"],["bp:displayName","sodium atom"],["bp:name","natrium"],["bp:name","[Na]"],["bp:name","Natrium"],["bp:name","11Na"],["bp:name","sodio"],["bp:name","Na"],["bp:molecularWeight","22.99"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d012964"],["bp:comment","has_role CHEBI:75772"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29781"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_12975"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/Na"]]]]],["bp:name","Na +"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29879"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29880"],["bp:stoichiometricCoefficient","4.0"]]],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:component",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29878"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29878"]]}},{"data":{"id":"SmallMolecule_fd7520e2f13316ef6b449851a6ea06dd_Complex_df144db5664a3420707d4ed04b7742e9","class":"simple chemical","label":"Na+","parent":"Complex_df144db5664a3420707d4ed04b7742e9","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":962.16095,"y":1161.4985,"w":48,"h":20},"metadata":[["bp:displayName","Na+"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26708",[["bp:standardName","sodium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26708"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","Na"],["bp:displayName","sodium atom"],["bp:name","natrium"],["bp:name","[Na]"],["bp:name","Natrium"],["bp:name","11Na"],["bp:name","sodio"],["bp:name","Na"],["bp:molecularWeight","22.99"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d012964"],["bp:comment","has_role CHEBI:75772"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29781"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_12975"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/Na"]]]]],["bp:name","Na +"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29879"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]}},{"data":{"id":"SmallMolecule_0caf25f6eb33df1ed0f36474e15b1ef1","class":"simple chemical","label":"Ca2+","parent":"extracellular_region","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":864.53906,"y":1080.8026,"w":48,"h":20},"metadata":[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]}},{"data":{"id":"SmallMolecule_3e76e616ad0dd87d938b5196e8753edf","class":"simple chemical","label":"K +","parent":"extracellular_region","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":834.6185,"y":1186.237,"w":48,"h":20},"metadata":[["bp:displayName","K +"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26216",[["bp:standardName","potassium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26216"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:33937"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","K"],["bp:displayName","potassium atom"],["bp:name","19K"],["bp:name","kalium"],["bp:name","[K]"],["bp:name","K"],["bp:name","Kalium"],["bp:name","potasio"],["bp:molecularWeight","39.0983"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29788"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB01345"],["bp:comment","has_role CHEBI:75772"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d011188"],["bp:comment","has_role CHEBI:33937"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/K"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29790"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]}},{"data":{"id":"SmallMolecule_6658a8720996f04f3b8cd03be7a2ec3e","class":"simple chemical","label":"Na +","parent":"extracellular_region","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":769.4022,"y":1091.6389,"w":48,"h":20},"metadata":[["bp:displayName","Na +"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26708",[["bp:standardName","sodium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26708"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","Na"],["bp:displayName","sodium atom"],["bp:name","natrium"],["bp:name","[Na]"],["bp:name","Natrium"],["bp:name","11Na"],["bp:name","sodio"],["bp:name","Na"],["bp:molecularWeight","22.99"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d012964"],["bp:comment","has_role CHEBI:75772"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29781"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_12975"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/Na"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29780"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]}},{"data":{"id":"ComplexAssembly_2b3b817d306cb30db5b3e6f7ef58e9dc_LEFT_TO_RIGHT","class":"process","label":"","parent":"cytoplasm","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":1089.1067,"y":707.7139,"w":15,"h":15},"metadata":[["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005737"],["bp:db","gene ontology"]]],["bp:term","cytoplasm"],["bp:term","Cytoplasm"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_8257"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29613"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:feature","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29614"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:feature","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29614"],["bp:stoichiometricCoefficient","1.0"]]],["bp:xref",[["bp:physicalEntity",[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:feature","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29614"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:feature","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29614"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:feature","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29614"],["bp:stoichiometricCoefficient","1.0"]]],["bp:right",[["bp:physicalEntity",[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:feature","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29614"],["bp:stoichiometricCoefficient","1.0"]]],["bp:right",[["bp:physicalEntity",[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:feature","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29614"],["bp:stoichiometricCoefficient","1.0"]]],["bp:spontaneous","true"],["bp:left","true"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29593"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29593"]]}},{"data":{"id":"Transport_70c6d41ad671622a441a872527127014_LEFT_TO_RIGHT","class":"process","label":"","parent":"cytoplasm","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":985.2838,"y":821.20526,"w":15,"h":15},"metadata":[["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005737"],["bp:db","gene ontology"]]],["bp:term","cytoplasm"],["bp:term","Cytoplasm"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_8257"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72467"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72466"],["bp:stoichiometricCoefficient","1.0"]]],["bp:xref",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72466"],["bp:stoichiometricCoefficient","1.0"]]],["bp:xref",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72466"],["bp:stoichiometricCoefficient","1.0"]]],["bp:xref",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72466"],["bp:stoichiometricCoefficient","1.0"]]],["bp:xref",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72466"],["bp:stoichiometricCoefficient","1.0"]]],["bp:xref",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72466"],["bp:stoichiometricCoefficient","1.0"]]],["bp:xref",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72466"],["bp:stoichiometricCoefficient","1.0"]]],["bp:xref",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72466"],["bp:stoichiometricCoefficient","1.0"]]],["bp:xref",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72466"],["bp:stoichiometricCoefficient","1.0"]]],["bp:xref",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72466"],["bp:stoichiometricCoefficient","1.0"]]],["bp:xref",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72466"],["bp:stoichiometricCoefficient","1.0"]]],["bp:xref",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72466"],["bp:stoichiometricCoefficient","1.0"]]],["bp:xref",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72466"],["bp:stoichiometricCoefficient","1.0"]]],["bp:xref",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72466"],["bp:stoichiometricCoefficient","1.0"]]],["bp:xref",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72466"],["bp:stoichiometricCoefficient","1.0"]]],["bp:xref",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72466"],["bp:stoichiometricCoefficient","1.0"]]],["bp:xref",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72466"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72466"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72466"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72466"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72466"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72466"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72466"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72466"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72466"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72466"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72466"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72466"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72466"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72466"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72466"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72466"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72466"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72466"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72466"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72466"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72466"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72466"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72466"],["bp:stoichiometricCoefficient","1.0"]]],["bp:right",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72466"],["bp:stoichiometricCoefficient","1.0"]]],["bp:left",[["bp:physicalEntity",[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[["bp:xref",[["bp:id","GO:0005576"],["bp:db","gene ontology"]]],["bp:term","extracellular region"],["bp:term","extracellular"],["bp:term","Extracellular"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_14787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72466"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_72465"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_72465"]]}},{"data":{"id":"Transport_fbd1a94ea3d89a1f5eee593d21370775_LEFT_TO_RIGHT","class":"process","label":"","parent":"cytoplasm","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":1181.177,"y":957.3943,"w":15,"h":15},"metadata":[["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","Na + (4 Units)"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","Na+"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26708",[["bp:standardName","sodium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26708"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","Na"],["bp:displayName","sodium atom"],["bp:name","natrium"],["bp:name","[Na]"],["bp:name","Natrium"],["bp:name","11Na"],["bp:name","sodio"],["bp:name","Na"],["bp:molecularWeight","22.99"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d012964"],["bp:comment","has_role CHEBI:75772"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29781"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_12975"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/Na"]]]]],["bp:name","Na +"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29879"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29882"],["bp:stoichiometricCoefficient","4.0"]]],["bp:cellularLocation",[["bp:physicalEntity",[["bp:displayName","Na+"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26708",[["bp:standardName","sodium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26708"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","Na"],["bp:displayName","sodium atom"],["bp:name","natrium"],["bp:name","[Na]"],["bp:name","Natrium"],["bp:name","11Na"],["bp:name","sodio"],["bp:name","Na"],["bp:molecularWeight","22.99"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d012964"],["bp:comment","has_role CHEBI:75772"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29781"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_12975"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/Na"]]]]],["bp:name","Na +"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29879"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29882"],["bp:stoichiometricCoefficient","4.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","Na+"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26708",[["bp:standardName","sodium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26708"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","Na"],["bp:displayName","sodium atom"],["bp:name","natrium"],["bp:name","[Na]"],["bp:name","Natrium"],["bp:name","11Na"],["bp:name","sodio"],["bp:name","Na"],["bp:molecularWeight","22.99"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d012964"],["bp:comment","has_role CHEBI:75772"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29781"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_12975"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/Na"]]]]],["bp:name","Na +"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29879"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29882"],["bp:stoichiometricCoefficient","4.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29881"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29881"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29884"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","Na + (4 Units)"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","Na+"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26708",[["bp:standardName","sodium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26708"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","Na"],["bp:displayName","sodium atom"],["bp:name","natrium"],["bp:name","[Na]"],["bp:name","Natrium"],["bp:name","11Na"],["bp:name","sodio"],["bp:name","Na"],["bp:molecularWeight","22.99"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d012964"],["bp:comment","has_role CHEBI:75772"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29781"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_12975"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/Na"]]]]],["bp:name","Na +"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29879"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29882"],["bp:stoichiometricCoefficient","4.0"]]],["bp:cellularLocation",[["bp:physicalEntity",[["bp:displayName","Na+"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26708",[["bp:standardName","sodium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26708"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","Na"],["bp:displayName","sodium atom"],["bp:name","natrium"],["bp:name","[Na]"],["bp:name","Natrium"],["bp:name","11Na"],["bp:name","sodio"],["bp:name","Na"],["bp:molecularWeight","22.99"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d012964"],["bp:comment","has_role CHEBI:75772"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29781"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_12975"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/Na"]]]]],["bp:name","Na +"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29879"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29882"],["bp:stoichiometricCoefficient","4.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","Na+"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26708",[["bp:standardName","sodium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26708"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","Na"],["bp:displayName","sodium atom"],["bp:name","natrium"],["bp:name","[Na]"],["bp:name","Natrium"],["bp:name","11Na"],["bp:name","sodio"],["bp:name","Na"],["bp:molecularWeight","22.99"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d012964"],["bp:comment","has_role CHEBI:75772"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29781"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_12975"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/Na"]]]]],["bp:name","Na +"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29879"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29882"],["bp:stoichiometricCoefficient","4.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29881"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29881"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29884"],["bp:stoichiometricCoefficient","1.0"]]],["bp:xref",[["bp:physicalEntity",[["bp:displayName","Na + (4 Units)"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","Na+"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26708",[["bp:standardName","sodium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26708"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","Na"],["bp:displayName","sodium atom"],["bp:name","natrium"],["bp:name","[Na]"],["bp:name","Natrium"],["bp:name","11Na"],["bp:name","sodio"],["bp:name","Na"],["bp:molecularWeight","22.99"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d012964"],["bp:comment","has_role CHEBI:75772"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29781"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_12975"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/Na"]]]]],["bp:name","Na +"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29879"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29882"],["bp:stoichiometricCoefficient","4.0"]]],["bp:cellularLocation",[["bp:physicalEntity",[["bp:displayName","Na+"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26708",[["bp:standardName","sodium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26708"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","Na"],["bp:displayName","sodium atom"],["bp:name","natrium"],["bp:name","[Na]"],["bp:name","Natrium"],["bp:name","11Na"],["bp:name","sodio"],["bp:name","Na"],["bp:molecularWeight","22.99"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d012964"],["bp:comment","has_role CHEBI:75772"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29781"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_12975"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/Na"]]]]],["bp:name","Na +"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29879"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29882"],["bp:stoichiometricCoefficient","4.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","Na+"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26708",[["bp:standardName","sodium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26708"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","Na"],["bp:displayName","sodium atom"],["bp:name","natrium"],["bp:name","[Na]"],["bp:name","Natrium"],["bp:name","11Na"],["bp:name","sodio"],["bp:name","Na"],["bp:molecularWeight","22.99"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d012964"],["bp:comment","has_role CHEBI:75772"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29781"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_12975"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/Na"]]]]],["bp:name","Na +"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29879"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29882"],["bp:stoichiometricCoefficient","4.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29881"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29881"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29884"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","Na + (4 Units)"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","Na+"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26708",[["bp:standardName","sodium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26708"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","Na"],["bp:displayName","sodium atom"],["bp:name","natrium"],["bp:name","[Na]"],["bp:name","Natrium"],["bp:name","11Na"],["bp:name","sodio"],["bp:name","Na"],["bp:molecularWeight","22.99"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d012964"],["bp:comment","has_role CHEBI:75772"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29781"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_12975"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/Na"]]]]],["bp:name","Na +"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29879"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29882"],["bp:stoichiometricCoefficient","4.0"]]],["bp:cellularLocation",[["bp:physicalEntity",[["bp:displayName","Na+"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26708",[["bp:standardName","sodium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26708"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","Na"],["bp:displayName","sodium atom"],["bp:name","natrium"],["bp:name","[Na]"],["bp:name","Natrium"],["bp:name","11Na"],["bp:name","sodio"],["bp:name","Na"],["bp:molecularWeight","22.99"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d012964"],["bp:comment","has_role CHEBI:75772"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29781"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_12975"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/Na"]]]]],["bp:name","Na +"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29879"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29882"],["bp:stoichiometricCoefficient","4.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","Na+"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26708",[["bp:standardName","sodium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26708"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","Na"],["bp:displayName","sodium atom"],["bp:name","natrium"],["bp:name","[Na]"],["bp:name","Natrium"],["bp:name","11Na"],["bp:name","sodio"],["bp:name","Na"],["bp:molecularWeight","22.99"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d012964"],["bp:comment","has_role CHEBI:75772"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29781"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_12975"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/Na"]]]]],["bp:name","Na +"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29879"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29882"],["bp:stoichiometricCoefficient","4.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29881"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29881"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29884"],["bp:stoichiometricCoefficient","1.0"]]],["bp:right",[["bp:physicalEntity",[["bp:displayName","Na + (4 Units)"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","Na+"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26708",[["bp:standardName","sodium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26708"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","Na"],["bp:displayName","sodium atom"],["bp:name","natrium"],["bp:name","[Na]"],["bp:name","Natrium"],["bp:name","11Na"],["bp:name","sodio"],["bp:name","Na"],["bp:molecularWeight","22.99"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d012964"],["bp:comment","has_role CHEBI:75772"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29781"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_12975"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/Na"]]]]],["bp:name","Na +"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29879"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29882"],["bp:stoichiometricCoefficient","4.0"]]],["bp:cellularLocation",[["bp:physicalEntity",[["bp:displayName","Na+"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26708",[["bp:standardName","sodium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26708"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","Na"],["bp:displayName","sodium atom"],["bp:name","natrium"],["bp:name","[Na]"],["bp:name","Natrium"],["bp:name","11Na"],["bp:name","sodio"],["bp:name","Na"],["bp:molecularWeight","22.99"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d012964"],["bp:comment","has_role CHEBI:75772"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29781"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_12975"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/Na"]]]]],["bp:name","Na +"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29879"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29882"],["bp:stoichiometricCoefficient","4.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","Na+"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26708",[["bp:standardName","sodium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26708"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","Na"],["bp:displayName","sodium atom"],["bp:name","natrium"],["bp:name","[Na]"],["bp:name","Natrium"],["bp:name","11Na"],["bp:name","sodio"],["bp:name","Na"],["bp:molecularWeight","22.99"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d012964"],["bp:comment","has_role CHEBI:75772"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29781"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_12975"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/Na"]]]]],["bp:name","Na +"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29879"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29882"],["bp:stoichiometricCoefficient","4.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29881"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29881"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29884"],["bp:stoichiometricCoefficient","1.0"]]],["bp:left",[["bp:physicalEntity",[["bp:displayName","Na + (4 Units)"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","Na+"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26708",[["bp:standardName","sodium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26708"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","Na"],["bp:displayName","sodium atom"],["bp:name","natrium"],["bp:name","[Na]"],["bp:name","Natrium"],["bp:name","11Na"],["bp:name","sodio"],["bp:name","Na"],["bp:molecularWeight","22.99"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d012964"],["bp:comment","has_role CHEBI:75772"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29781"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_12975"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/Na"]]]]],["bp:name","Na +"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29879"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29882"],["bp:stoichiometricCoefficient","4.0"]]],["bp:cellularLocation",[["bp:physicalEntity",[["bp:displayName","Na+"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26708",[["bp:standardName","sodium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26708"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","Na"],["bp:displayName","sodium atom"],["bp:name","natrium"],["bp:name","[Na]"],["bp:name","Natrium"],["bp:name","11Na"],["bp:name","sodio"],["bp:name","Na"],["bp:molecularWeight","22.99"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d012964"],["bp:comment","has_role CHEBI:75772"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29781"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_12975"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/Na"]]]]],["bp:name","Na +"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29879"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29882"],["bp:stoichiometricCoefficient","4.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","Na+"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26708",[["bp:standardName","sodium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26708"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","Na"],["bp:displayName","sodium atom"],["bp:name","natrium"],["bp:name","[Na]"],["bp:name","Natrium"],["bp:name","11Na"],["bp:name","sodio"],["bp:name","Na"],["bp:molecularWeight","22.99"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d012964"],["bp:comment","has_role CHEBI:75772"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29781"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_12975"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/Na"]]]]],["bp:name","Na +"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29879"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29882"],["bp:stoichiometricCoefficient","4.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29881"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29881"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29884"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29877"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29877"]]}},{"data":{"id":"Transport_7492807daea2b2ce89e699ac17445326_LEFT_TO_RIGHT","class":"process","label":"","parent":"cytoplasm","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":980.6846,"y":898.711,"w":15,"h":15},"metadata":[["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","Na +"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005737"],["bp:db","gene ontology"]]],["bp:term","cytoplasm"],["bp:term","Cytoplasm"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26708",[["bp:standardName","sodium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26708"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","Na"],["bp:displayName","sodium atom"],["bp:name","natrium"],["bp:name","[Na]"],["bp:name","Natrium"],["bp:name","11Na"],["bp:name","sodio"],["bp:name","Na"],["bp:molecularWeight","22.99"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d012964"],["bp:comment","has_role CHEBI:75772"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29781"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_12975"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/Na"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29782"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29784"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","Na +"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005737"],["bp:db","gene ontology"]]],["bp:term","cytoplasm"],["bp:term","Cytoplasm"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26708",[["bp:standardName","sodium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26708"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","Na"],["bp:displayName","sodium atom"],["bp:name","natrium"],["bp:name","[Na]"],["bp:name","Natrium"],["bp:name","11Na"],["bp:name","sodio"],["bp:name","Na"],["bp:molecularWeight","22.99"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d012964"],["bp:comment","has_role CHEBI:75772"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29781"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_12975"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/Na"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29782"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29784"],["bp:stoichiometricCoefficient","1.0"]]],["bp:xref",[["bp:physicalEntity",[["bp:displayName","Na +"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005737"],["bp:db","gene ontology"]]],["bp:term","cytoplasm"],["bp:term","Cytoplasm"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26708",[["bp:standardName","sodium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26708"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","Na"],["bp:displayName","sodium atom"],["bp:name","natrium"],["bp:name","[Na]"],["bp:name","Natrium"],["bp:name","11Na"],["bp:name","sodio"],["bp:name","Na"],["bp:molecularWeight","22.99"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d012964"],["bp:comment","has_role CHEBI:75772"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29781"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_12975"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/Na"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29782"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29784"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","Na +"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005737"],["bp:db","gene ontology"]]],["bp:term","cytoplasm"],["bp:term","Cytoplasm"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26708",[["bp:standardName","sodium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26708"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","Na"],["bp:displayName","sodium atom"],["bp:name","natrium"],["bp:name","[Na]"],["bp:name","Natrium"],["bp:name","11Na"],["bp:name","sodio"],["bp:name","Na"],["bp:molecularWeight","22.99"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d012964"],["bp:comment","has_role CHEBI:75772"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29781"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_12975"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/Na"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29782"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29784"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","Na +"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005737"],["bp:db","gene ontology"]]],["bp:term","cytoplasm"],["bp:term","Cytoplasm"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26708",[["bp:standardName","sodium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26708"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","Na"],["bp:displayName","sodium atom"],["bp:name","natrium"],["bp:name","[Na]"],["bp:name","Natrium"],["bp:name","11Na"],["bp:name","sodio"],["bp:name","Na"],["bp:molecularWeight","22.99"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d012964"],["bp:comment","has_role CHEBI:75772"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29781"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_12975"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/Na"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29782"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29784"],["bp:stoichiometricCoefficient","1.0"]]],["bp:right",[["bp:physicalEntity",[["bp:displayName","Na +"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005737"],["bp:db","gene ontology"]]],["bp:term","cytoplasm"],["bp:term","Cytoplasm"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26708",[["bp:standardName","sodium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26708"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","Na"],["bp:displayName","sodium atom"],["bp:name","natrium"],["bp:name","[Na]"],["bp:name","Natrium"],["bp:name","11Na"],["bp:name","sodio"],["bp:name","Na"],["bp:molecularWeight","22.99"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d012964"],["bp:comment","has_role CHEBI:75772"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29781"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_12975"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/Na"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29782"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29784"],["bp:stoichiometricCoefficient","1.0"]]],["bp:left",[["bp:physicalEntity",[["bp:displayName","Na +"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005737"],["bp:db","gene ontology"]]],["bp:term","cytoplasm"],["bp:term","Cytoplasm"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26708",[["bp:standardName","sodium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26708"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","Na"],["bp:displayName","sodium atom"],["bp:name","natrium"],["bp:name","[Na]"],["bp:name","Natrium"],["bp:name","11Na"],["bp:name","sodio"],["bp:name","Na"],["bp:molecularWeight","22.99"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d012964"],["bp:comment","has_role CHEBI:75772"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29781"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_12975"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/Na"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29782"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29784"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29779"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29779"]]}},{"data":{"id":"Transport_607b1da044a923e5881717ffa2bf5e3f_LEFT_TO_RIGHT","class":"process","label":"","parent":"cytoplasm","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":1058.7002,"y":964.34375,"w":15,"h":15},"metadata":[["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","K +"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005737"],["bp:db","gene ontology"]]],["bp:term","cytoplasm"],["bp:term","Cytoplasm"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26216",[["bp:standardName","potassium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26216"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:33937"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","K"],["bp:displayName","potassium atom"],["bp:name","19K"],["bp:name","kalium"],["bp:name","[K]"],["bp:name","K"],["bp:name","Kalium"],["bp:name","potasio"],["bp:molecularWeight","39.0983"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29788"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB01345"],["bp:comment","has_role CHEBI:75772"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d011188"],["bp:comment","has_role CHEBI:33937"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/K"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29792"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","K +"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005737"],["bp:db","gene ontology"]]],["bp:term","cytoplasm"],["bp:term","Cytoplasm"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26216",[["bp:standardName","potassium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26216"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:33937"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","K"],["bp:displayName","potassium atom"],["bp:name","19K"],["bp:name","kalium"],["bp:name","[K]"],["bp:name","K"],["bp:name","Kalium"],["bp:name","potasio"],["bp:molecularWeight","39.0983"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29788"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB01345"],["bp:comment","has_role CHEBI:75772"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d011188"],["bp:comment","has_role CHEBI:33937"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/K"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29792"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","K +"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005737"],["bp:db","gene ontology"]]],["bp:term","cytoplasm"],["bp:term","Cytoplasm"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26216",[["bp:standardName","potassium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26216"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:33937"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","K"],["bp:displayName","potassium atom"],["bp:name","19K"],["bp:name","kalium"],["bp:name","[K]"],["bp:name","K"],["bp:name","Kalium"],["bp:name","potasio"],["bp:molecularWeight","39.0983"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29788"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB01345"],["bp:comment","has_role CHEBI:75772"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d011188"],["bp:comment","has_role CHEBI:33937"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/K"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29792"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","K +"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005737"],["bp:db","gene ontology"]]],["bp:term","cytoplasm"],["bp:term","Cytoplasm"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26216",[["bp:standardName","potassium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26216"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:33937"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","K"],["bp:displayName","potassium atom"],["bp:name","19K"],["bp:name","kalium"],["bp:name","[K]"],["bp:name","K"],["bp:name","Kalium"],["bp:name","potasio"],["bp:molecularWeight","39.0983"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29788"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB01345"],["bp:comment","has_role CHEBI:75772"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d011188"],["bp:comment","has_role CHEBI:33937"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/K"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29792"],["bp:stoichiometricCoefficient","1.0"]]],["bp:xref",[["bp:physicalEntity",[["bp:displayName","K +"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005737"],["bp:db","gene ontology"]]],["bp:term","cytoplasm"],["bp:term","Cytoplasm"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26216",[["bp:standardName","potassium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26216"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:33937"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","K"],["bp:displayName","potassium atom"],["bp:name","19K"],["bp:name","kalium"],["bp:name","[K]"],["bp:name","K"],["bp:name","Kalium"],["bp:name","potasio"],["bp:molecularWeight","39.0983"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29788"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB01345"],["bp:comment","has_role CHEBI:75772"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d011188"],["bp:comment","has_role CHEBI:33937"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/K"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29792"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","K +"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005737"],["bp:db","gene ontology"]]],["bp:term","cytoplasm"],["bp:term","Cytoplasm"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26216",[["bp:standardName","potassium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26216"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:33937"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","K"],["bp:displayName","potassium atom"],["bp:name","19K"],["bp:name","kalium"],["bp:name","[K]"],["bp:name","K"],["bp:name","Kalium"],["bp:name","potasio"],["bp:molecularWeight","39.0983"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29788"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB01345"],["bp:comment","has_role CHEBI:75772"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d011188"],["bp:comment","has_role CHEBI:33937"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/K"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29792"],["bp:stoichiometricCoefficient","1.0"]]],["bp:right",[["bp:physicalEntity",[["bp:displayName","K +"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005737"],["bp:db","gene ontology"]]],["bp:term","cytoplasm"],["bp:term","Cytoplasm"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26216",[["bp:standardName","potassium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26216"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:33937"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","K"],["bp:displayName","potassium atom"],["bp:name","19K"],["bp:name","kalium"],["bp:name","[K]"],["bp:name","K"],["bp:name","Kalium"],["bp:name","potasio"],["bp:molecularWeight","39.0983"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29788"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB01345"],["bp:comment","has_role CHEBI:75772"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d011188"],["bp:comment","has_role CHEBI:33937"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/K"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29792"],["bp:stoichiometricCoefficient","1.0"]]],["bp:right",[["bp:physicalEntity",[["bp:displayName","K +"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005737"],["bp:db","gene ontology"]]],["bp:term","cytoplasm"],["bp:term","Cytoplasm"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26216",[["bp:standardName","potassium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26216"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:33937"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","K"],["bp:displayName","potassium atom"],["bp:name","19K"],["bp:name","kalium"],["bp:name","[K]"],["bp:name","K"],["bp:name","Kalium"],["bp:name","potasio"],["bp:molecularWeight","39.0983"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29788"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB01345"],["bp:comment","has_role CHEBI:75772"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d011188"],["bp:comment","has_role CHEBI:33937"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/K"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29792"],["bp:stoichiometricCoefficient","1.0"]]],["bp:left",[["bp:physicalEntity",[["bp:displayName","K +"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005737"],["bp:db","gene ontology"]]],["bp:term","cytoplasm"],["bp:term","Cytoplasm"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26216",[["bp:standardName","potassium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26216"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:33937"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","K"],["bp:displayName","potassium atom"],["bp:name","19K"],["bp:name","kalium"],["bp:name","[K]"],["bp:name","K"],["bp:name","Kalium"],["bp:name","potasio"],["bp:molecularWeight","39.0983"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29788"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB01345"],["bp:comment","has_role CHEBI:75772"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d011188"],["bp:comment","has_role CHEBI:33937"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/K"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29792"],["bp:stoichiometricCoefficient","1.0"]]],["bp:left",[["bp:physicalEntity",[["bp:displayName","K +"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005737"],["bp:db","gene ontology"]]],["bp:term","cytoplasm"],["bp:term","Cytoplasm"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26216",[["bp:standardName","potassium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26216"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:33937"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","K"],["bp:displayName","potassium atom"],["bp:name","19K"],["bp:name","kalium"],["bp:name","[K]"],["bp:name","K"],["bp:name","Kalium"],["bp:name","potasio"],["bp:molecularWeight","39.0983"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29788"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB01345"],["bp:comment","has_role CHEBI:75772"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d011188"],["bp:comment","has_role CHEBI:33937"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/K"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29787"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29787"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29792"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29786"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29786"]]}},{"data":{"id":"SmallMolecule_e630bbcee8096e9e453f64506e7b8b7f","class":"simple chemical","label":"Ca2+","parent":"cytoplasm","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":1079.8544,"y":819.2419,"w":48,"h":20},"metadata":[["bp:displayName","Ca2+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005737"],["bp:db","gene ontology"]]],["bp:term","cytoplasm"],["bp:term","Cytoplasm"]]],["bp:entityReference_#SmallMoleculeReference_872fa74c97864800541ad5fffd0ef1b0",[]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_8257"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]}},{"data":{"id":"Complex_2ce3afb19b8a69249e0ba29acea9e2bf","class":"complex","label":"GCAP Family/Ca ++","parent":"cytoplasm","clonemarker":false,"stateVariables":[{"id":"Complex_2ce3afb19b8a69249e0ba29acea9e2bf.info.1","class":"state variable","state":{"variable":"","value":"Ina"}}],"unitsOfInformation":[],"bbox":{"x":1210.7646,"y":710.23193,"w":52,"h":54},"metadata":[["bp:displayName","GCAP Family/Ca ++"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","Ca ++"],["bp:entityReference_#SmallMoleculeReference_c4f3ee343101b0db00f486ae19e8400f",[]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_75516"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29608"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29607"],["bp:stoichiometricCoefficient","1.0"]]],["bp:cellularLocation",[["bp:physicalEntity",[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29607"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29607"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29607"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29607"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29594"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29594"]]}},{"data":{"id":"Protein_d95c616d16b1d43598d8ef7c56c2075d_Complex_2ce3afb19b8a69249e0ba29acea9e2bf","class":"macromolecule","label":"GCAP Family","parent":"Complex_2ce3afb19b8a69249e0ba29acea9e2bf","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":1210.7646,"y":697.73193,"w":48,"h":25},"metadata":[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation",[["bp:sequencePosition","3"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation",[["bp:sequencePosition","3"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation",[["bp:sequencePosition","3"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"]]}},{"data":{"id":"SmallMolecule_0a1ba894c897d743382452da7ae9292e_Complex_2ce3afb19b8a69249e0ba29acea9e2bf","class":"simple chemical","label":"Ca ++","parent":"Complex_2ce3afb19b8a69249e0ba29acea9e2bf","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":1210.7646,"y":725.23193,"w":48,"h":20},"metadata":[["bp:displayName","Ca ++"],["bp:entityReference_#SmallMoleculeReference_c4f3ee343101b0db00f486ae19e8400f",[]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_75516"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]}},{"data":{"id":"SmallMolecule_0c81f39e6cd6aea223184468ac17f368","class":"simple chemical","label":"K +","parent":"cytoplasm","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":1114.7014,"y":866.18823,"w":48,"h":20},"metadata":[["bp:displayName","K +"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005737"],["bp:db","gene ontology"]]],["bp:term","cytoplasm"],["bp:term","Cytoplasm"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26216",[["bp:standardName","potassium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26216"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:33937"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","K"],["bp:displayName","potassium atom"],["bp:name","19K"],["bp:name","kalium"],["bp:name","[K]"],["bp:name","K"],["bp:name","Kalium"],["bp:name","potasio"],["bp:molecularWeight","39.0983"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29788"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB01345"],["bp:comment","has_role CHEBI:75772"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d011188"],["bp:comment","has_role CHEBI:33937"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/K"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29787"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]}},{"data":{"id":"SmallMolecule_6c83cd8ccb4d9cb825f76253908306fa","class":"simple chemical","label":"Na +","parent":"cytoplasm","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":1071.5465,"y":895.3144,"w":48,"h":20},"metadata":[["bp:displayName","Na +"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005737"],["bp:db","gene ontology"]]],["bp:term","cytoplasm"],["bp:term","Cytoplasm"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26708",[["bp:standardName","sodium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26708"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","Na"],["bp:displayName","sodium atom"],["bp:name","natrium"],["bp:name","[Na]"],["bp:name","Natrium"],["bp:name","11Na"],["bp:name","sodio"],["bp:name","Na"],["bp:molecularWeight","22.99"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d012964"],["bp:comment","has_role CHEBI:75772"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29781"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_12975"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/Na"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29782"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]}},{"data":{"id":"Complex_e3341bc18ae87f348a3784bb57f7d7ec","class":"complex","label":"Na + (4 Units)","parent":"cytoplasm","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":1233.9471,"y":866.821,"w":52,"h":24},"metadata":[["bp:displayName","Na + (4 Units)"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","Na+"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26708",[["bp:standardName","sodium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26708"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","Na"],["bp:displayName","sodium atom"],["bp:name","natrium"],["bp:name","[Na]"],["bp:name","Natrium"],["bp:name","11Na"],["bp:name","sodio"],["bp:name","Na"],["bp:molecularWeight","22.99"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d012964"],["bp:comment","has_role CHEBI:75772"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29781"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_12975"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/Na"]]]]],["bp:name","Na +"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29879"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29882"],["bp:stoichiometricCoefficient","4.0"]]],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005737"],["bp:db","gene ontology"]]],["bp:term","cytoplasm"],["bp:term","Cytoplasm"]]],["bp:component",[["bp:xref",[["bp:id","GO:0005737"],["bp:db","gene ontology"]]],["bp:term","cytoplasm"],["bp:term","Cytoplasm"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29881"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29881"]]}},{"data":{"id":"SmallMolecule_fd7520e2f13316ef6b449851a6ea06dd_Complex_e3341bc18ae87f348a3784bb57f7d7ec","class":"simple chemical","label":"Na+","parent":"Complex_e3341bc18ae87f348a3784bb57f7d7ec","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":1233.9471,"y":866.821,"w":48,"h":20},"metadata":[["bp:displayName","Na+"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:26708",[["bp:standardName","sodium"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22314"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:26708"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","Na"],["bp:displayName","sodium atom"],["bp:name","natrium"],["bp:name","[Na]"],["bp:name","Natrium"],["bp:name","11Na"],["bp:name","sodio"],["bp:name","Na"],["bp:molecularWeight","22.99"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d012964"],["bp:comment","has_role CHEBI:75772"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29781"],["bp:comment","is_a CHEBI:22314"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_12975"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/Na"]]]]],["bp:name","Na +"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29879"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]}},{"data":{"id":"extracellular_region","class":"compartment","label":"extracellular region","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":866.781565,"y":1133.519825,"w":246.75873,"h":129.43445},"metadata":null}},{"data":{"id":"plasma_membrane","class":"compartment","label":"plasma membrane","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":904.0032349999999,"y":452.83444499999996,"w":198.34875,"h":65.09125},"metadata":null}},{"data":{"id":"cytoplasm","class":"compartment","label":"cytoplasm","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":1116.565885,"y":827.5378400000001,"w":290.76257,"h":292.61182},"metadata":null}},{"data":{"id":"SmallMolecule_56e3033dde8d0eb1e072e60c6df6c966_ComplexAssembly_e25341187875d5db0c67decbbd98c874_LEFT_TO_RIGHT","class":"simple chemical","label":"phosphate","parent":"","clonemarker":true,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":365.93903,"y":470.5984,"w":45,"h":15},"metadata":[["bp:displayName","phosphate"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:18367",[["bp:standardName","tetraoxidophosphate(3-)"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:45024"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:43474"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:79387"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:7793"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:18367"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:14791"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:35780"],["bp:db","chebi"]]],["bp:chemicalFormula","O4P"],["bp:displayName","phosphate(3-)"],["bp:name","PHOSPHATE ION"],["bp:name","[PO4](3-)"],["bp:name","tetraoxophosphate(V)"],["bp:name","phosphate"],["bp:name","Orthophosphate"],["bp:name","tetraoxophosphate(3-)"],["bp:name","[O-]P([O-])([O-])=O"],["bp:name","Phosphate"],["bp:name","PO4(3-)"],["bp:name","O4P"],["bp:molecularWeight","94.97136"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_9042"],["bp:comment","is_a CHEBI:35780"],["bp:comment","A phosphate ion that is the conjugate base of hydrogenphosphate."],["bp:comment","is_a CHEBI:79387"],["bp:comment","is_conjugate_base_of CHEBI:43474"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/H3O4P/c1-5(2,3)4/h(H3,1,2,3,4)/p-3"]]]]],["bp:name","Phosphate"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_9041"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]}},{"data":{"id":"SmallMolecule_bccee74407d2f7a76e0e86b318622e2b_BiochemicalReaction_51f2b95182998dbe0cbfc10905f3feca_LEFT_TO_RIGHT","class":"simple chemical","label":"ATP","parent":"","clonemarker":true,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":341.6237,"y":205.63008,"w":45,"h":15},"metadata":[["bp:displayName","ATP"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:15422",[["bp:standardName","adenosine 5'-(tetrahydrogen triphosphate)"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22249"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:78675"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:10789"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:40938"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:27027"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37096"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13236"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37045"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37045"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37045"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37045"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37045"],["bp:db","chebi"]]],["bp:chemicalFormula","C10H16N5O13P3"],["bp:displayName","ATP"],["bp:name","H4atp"],["bp:name","Nc1ncnc2n(cnc12)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O"],["bp:name","C10H16N5O13P3"],["bp:name","Adenosine triphosphate"],["bp:name","Adenosine 5'-triphosphate"],["bp:name","ADENOSINE-5'-TRIPHOSPHATE"],["bp:name","CHEBI:15422"],["bp:molecularWeight","507.181"],["bp:comment","is_conjugate_acid_of CHEBI:57299"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB00538"],["bp:comment","REPLACED http://www.inoh.org/biopax/IMR_0001351_ATP"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/SmallMoleculeReference_bind_13_identity"],["bp:comment","REPLACED http://identifiers.org/kegg.compound/C00002"],["bp:comment","has_role CHEBI:27027"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00002.eref"],["bp:comment","has_role CHEBI:50733"],["bp:comment","is_a CHEBI:37096"],["bp:comment","has_role CHEBI:78675"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_2127"],["bp:comment","An adenosine 5'-phosphate in which the 5'-phosphate is a triphosphate group. It is involved in the transportation of chemical energy during metabolic pathways."],["bp:comment","is_a CHEBI:37045"],["bp:structure","is_a CHEBI:37045"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_2126"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_2126"]]}},{"data":{"id":"SmallMolecule_ad47b0bd5d53b98f714d186fd4ade87a_BiochemicalReaction_51f2b95182998dbe0cbfc10905f3feca_LEFT_TO_RIGHT","class":"simple chemical","label":"ADP","parent":"","clonemarker":true,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":383.62967,"y":47.92384,"w":45,"h":15},"metadata":[["bp:displayName","ADP"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16761",[["bp:standardName","adenosine 5'-(trihydrogen diphosphate)"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:87518"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22244"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37038"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:40553"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13222"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16761"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:456216"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:2342"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:2342"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:2342"],["bp:db","chebi"]]],["bp:chemicalFormula","C10H15N5O10P2"],["bp:displayName","ADP"],["bp:name","ADENOSINE-5'-DIPHOSPHATE"],["bp:name","Nc1ncnc2n(cnc12)[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O"],["bp:name","5'-adenylphosphoric acid"],["bp:name","Adenosine 5'-diphosphate"],["bp:name","H3adp"],["bp:name","C10H15N5O10P2"],["bp:molecularWeight","427.029"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_2133"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00008.eref"],["bp:comment","A purine ribonucleoside 5'-diphosphate having adenine as the nucleobase."],["bp:comment","REPLACED http://www.inoh.org/biopax/IMR_0001360_ADP"],["bp:comment","is_conjugate_acid_of CHEBI:456216"],["bp:comment","REPLACED http://identifiers.org/cas/58-64-0"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/SmallMoleculeReference_bind_14_identity"],["bp:comment","is_a CHEBI:37038"],["bp:comment","is_a CHEBI:37096"],["bp:comment","has_role CHEBI:78675"],["bp:comment","is_conjugate_acid_of CHEBI:87518"],["bp:comment","has_role CHEBI:77746"],["bp:structure","has_role CHEBI:77746"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_2132"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_2132"]]}},{"data":{"id":"SmallMolecule_4f4ea8c9f46fdd97ff867fe7c8860bda_BiochemicalReaction_ebe2587eee20076625365bcbf196a091_LEFT_TO_RIGHT","class":"simple chemical","label":"GTP","parent":"","clonemarker":true,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":712.26385,"y":1009.5502,"w":45,"h":15},"metadata":[["bp:displayName","GTP"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:15996",[["bp:standardName","guanosine 5'-(tetrahydrogen triphosphate)"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37121"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:5234"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13342"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37045"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:24451"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:15996"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:42934"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:76971"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57600"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57600"],["bp:db","chebi"]]],["bp:chemicalFormula","C10H16N5O14P3"],["bp:displayName","GTP"],["bp:name","Guanosine 5'-triphosphate"],["bp:name","guanosine triphosphate"],["bp:name","H4gtp"],["bp:name","Nc1nc2n(cnc2c(=O)[nH]1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O"],["bp:name","guanosine 5'-triphosphoric acid"],["bp:name","GUANOSINE-5'-TRIPHOSPHATE"],["bp:name","C10H16N5O14P3"],["bp:name","5'-GTP"],["bp:molecularWeight","523.1806"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/SmallMoleculeReference_bind_212_identity"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB04137"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_310"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://www.inoh.org/biopax/IMR_0001354_GTP"],["bp:comment","has_role CHEBI:76971"],["bp:comment","is_a CHEBI:37045"],["bp:comment","is_a CHEBI:37121"],["bp:comment","is_conjugate_acid_of CHEBI:57600"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00044.eref"],["bp:structure","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00044.eref"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_309"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_309"]]}},{"data":{"id":"BiochemicalReaction_39a2cf1134121f166f1af8fc476d59b6_LEFT_TO_RIGHT","class":"process","label":"","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":710.2361,"y":338.14725,"w":15,"h":15},"metadata":[["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:17898"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:17898"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29618"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:17898"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:17898"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29618"],["bp:stoichiometricCoefficient","1.0"]]],["bp:right",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:17898"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:17898"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29618"],["bp:stoichiometricCoefficient","1.0"]]],["bp:left",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:17898"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:17898"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29618"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29615"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29615"]]}},{"data":{"id":"Protein_0014fe7e9fa90edadb4857f80a0eb091","class":"macromolecule","label":"phospho-opsin phosphatase","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":692.7004,"y":234.28911,"w":48,"h":25},"metadata":[["bp:displayName","phospho-opsin phosphatase"],["bp:entityReference_#ProteinReference_bc39cfa3b60f4a86e02497455fb92cf7",[]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29892"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]}},{"data":{"id":"SmallMolecule_cf976f077ef4202f9148a7f67399a6c9","class":"simple chemical","label":"all-trans-retinol","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":664.2775,"y":403.86795,"w":48,"h":20},"metadata":[["bp:displayName","all-trans-retinol"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17336",[["bp:standardName","all-trans-retinol"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12783"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8816"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22349"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:17336"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H30O"],["bp:displayName","all-trans-retinol"],["bp:name","Alphalin"],["bp:name","all-trans-vitamin A alcohol"],["bp:name","Vitamin A1"],["bp:name","C20H30O"],["bp:name","Chocola A"],["bp:name","Vitamin A"],["bp:name","all-trans-Retinol"],["bp:name","CC(\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C/CO"],["bp:name","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol"],["bp:name","Retinol"],["bp:name","all-trans-retinyl alcohol"],["bp:name","CHEBI:17336"],["bp:molecularWeight","286.23"],["bp:comment","A retinol in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29617"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB00162"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00473.eref"],["bp:comment","is_a CHEBI:50211"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/C20H30O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,21H,7,10,14-15H2,1-5H3/b9-6+,12-11+,16-8+,17-13+"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29616"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]}},{"data":{"id":"Protein_2357f4b5860837413497201285410149","class":"macromolecule","label":"SAG","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":615.29767,"y":100.423996,"w":48,"h":25},"metadata":[["bp:displayName","Arrestin"],["bp:entityReference_http://identifiers.org/uniprot/P10523",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 234 234 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","234"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","S-arrestin"],["bp:xref",[["bp:id","P10523"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","SAG"],["bp:db","hgnc symbol"]]],["bp:organism",[["bp:relationshipType",null],["bp:id","SAG"],["bp:db","hgnc symbol"]]],["bp:displayName","ARRS_HUMAN"],["bp:name","48 kDa protein"],["bp:name","SAG"],["bp:name","S-AG"],["bp:name","Rod photoreceptor arrestin"],["bp:name","Retinal S-antigen"],["bp:comment","FUNCTION: Arrestin is one of the major proteins of the ros(retinal rod outer segments); it binds to photoactivated-phosphorylated rhodopsin, thereby apparently preventing thetransducin-mediated activation of phosphodiesterase.SUBUNIT: Monomer. Homodimer. Homotetramer.{ECO:0000269|PubMed:21288033}.TISSUE SPECIFICITY: Retina and pineal gland.DISEASE: Night blindness, congenital stationary, Oguchi type 1(CSNBO1) [MIM:258100]: A non-progressive retinal disordercharacterized by impaired night vision, often associated withnystagmus and myopia. Congenital stationary night blindness Oguchitype is an autosomal recessive form associated with fundusdiscoloration and abnormally slow dark adaptation.{ECO:0000269|PubMed:7670478}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Retinitis pigmentosa 47 (RP47) [MIM:613758]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:9565049}. Note=The disease iscaused by mutations affecting the gene represented in this entry.MISCELLANEOUS: Arrestin binds calcium.SIMILARITY: Belongs to the arrestin family. {ECO:0000305}.WEB RESOURCE: Name=Mutations of the SAG gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/sagmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01625_identity"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000532"],["bp:comment","ARRS_HUMAN Reviewed; 405 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6295"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29800"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]}},{"data":{"id":"Complex_7fba29591c0d3e0267091aedc2769edc","class":"complex","label":"GNB1/GNGT1","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":281.8985,"y":485.9452,"w":52,"h":59},"metadata":[["bp:displayName","GNB1/GNGT1"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNB1"],["bp:entityReference_http://identifiers.org/uniprot/P62873",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylserine"],["bp:term","N-acetylserine"]]],["bp:comment","MOD_RES 2 2 N-acetylserine."],["bp:featureLocation",[["bp:sequencePosition","2"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphohistidine"],["bp:term","MOD_RES Phosphohistidine"]]],["bp:comment","MOD_RES 266 266 Phosphohistidine."],["bp:featureLocation",[["bp:sequencePosition","266"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 2 2 Phosphoserine."],["bp:featureLocation","MOD_RES 2 2 Phosphoserine."]]],["bp:standardName","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:organism","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:displayName","GBB1_HUMAN"],["bp:name","GNB1"],["bp:name","Transducin beta chain 1"],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as a modulator or transducer in various transmembranesignaling systems. The beta and gamma chains are required for theGTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction.SUBUNIT: G proteins are composed of 3 units, alpha, beta andgamma. Interacts with ARHGEF18 and RASD2 (PubMed:14512443,PubMed:19255495). The heterodimer formed by GNB1 and GNG2interacts with ARHGEF5 (PubMed:19713215).{ECO:0000269|PubMed:14512443, ECO:0000269|PubMed:19255495,ECO:0000269|PubMed:19713215}.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=2;Name=1;IsoId=P62873-1; Sequence=Displayed;Name=2;IsoId=P62873-2; Sequence=VSP_055232;Note=No experimental confirmation available.;PTM: Phosphorylation at His-266 by NDKB contributes to G proteinactivation by increasing the high energetic phosphate transferonto GDP. {ECO:0000250}.DISEASE: Mental retardation, autosomal dominant 42 (MRD42)[MIM:616973]: A form of mental retardation, a disordercharacterized by significantly below average general intellectualfunctioning associated with impairments in adaptive behavior andmanifested during the developmental period. MRD42 patientsmanifest global developmental delay commonly accompanied byhypotonia, seizures of various types, ophthalmologicalmanifestations, and poor growth. {ECO:0000269|PubMed:25485910,ECO:0000269|PubMed:27108799, ECO:0000269|PubMed:27668284,ECO:0000269|PubMed:28087732}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the WD repeat G protein beta family.{ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2782"],["bp:comment","REPLACED http://identifiers.org/uniprot/B1AKQ8"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_786971"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_002065"],["bp:comment","GBB1_HUMAN Reviewed; 340 AA."],["bp:comment","REPLACED http://identifiers.org/refseq/XP_017175466"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_00766_identity"],["bp:comment","REPLACED http://identifiers.org/uniprot/P01946"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2782"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_dip_DIP-599N_identity"],["bp:comment","REPLACED http://identifiers.org/refseq/XP_016856548"],["bp:comment","REPLACED http://identifiers.org/uniprot/P04901"],["bp:comment","REPLACED http://identifiers.org/uniprot/P62874"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29537"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNB1"],["bp:entityReference_http://identifiers.org/uniprot/P62873",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylserine"],["bp:term","N-acetylserine"]]],["bp:comment","MOD_RES 2 2 N-acetylserine."],["bp:featureLocation",[["bp:sequencePosition","2"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphohistidine"],["bp:term","MOD_RES Phosphohistidine"]]],["bp:comment","MOD_RES 266 266 Phosphohistidine."],["bp:featureLocation",[["bp:sequencePosition","266"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 2 2 Phosphoserine."],["bp:featureLocation","MOD_RES 2 2 Phosphoserine."]]],["bp:standardName","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:organism","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:displayName","GBB1_HUMAN"],["bp:name","GNB1"],["bp:name","Transducin beta chain 1"],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as a modulator or transducer in various transmembranesignaling systems. The beta and gamma chains are required for theGTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction.SUBUNIT: G proteins are composed of 3 units, alpha, beta andgamma. Interacts with ARHGEF18 and RASD2 (PubMed:14512443,PubMed:19255495). The heterodimer formed by GNB1 and GNG2interacts with ARHGEF5 (PubMed:19713215).{ECO:0000269|PubMed:14512443, ECO:0000269|PubMed:19255495,ECO:0000269|PubMed:19713215}.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=2;Name=1;IsoId=P62873-1; Sequence=Displayed;Name=2;IsoId=P62873-2; Sequence=VSP_055232;Note=No experimental confirmation available.;PTM: Phosphorylation at His-266 by NDKB contributes to G proteinactivation by increasing the high energetic phosphate transferonto GDP. {ECO:0000250}.DISEASE: Mental retardation, autosomal dominant 42 (MRD42)[MIM:616973]: A form of mental retardation, a disordercharacterized by significantly below average general intellectualfunctioning associated with impairments in adaptive behavior andmanifested during the developmental period. MRD42 patientsmanifest global developmental delay commonly accompanied byhypotonia, seizures of various types, ophthalmologicalmanifestations, and poor growth. {ECO:0000269|PubMed:25485910,ECO:0000269|PubMed:27108799, ECO:0000269|PubMed:27668284,ECO:0000269|PubMed:28087732}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the WD repeat G protein beta family.{ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2782"],["bp:comment","REPLACED http://identifiers.org/uniprot/B1AKQ8"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_786971"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_002065"],["bp:comment","GBB1_HUMAN Reviewed; 340 AA."],["bp:comment","REPLACED http://identifiers.org/refseq/XP_017175466"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_00766_identity"],["bp:comment","REPLACED http://identifiers.org/uniprot/P01946"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2782"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_dip_DIP-599N_identity"],["bp:comment","REPLACED http://identifiers.org/refseq/XP_016856548"],["bp:comment","REPLACED http://identifiers.org/uniprot/P04901"],["bp:comment","REPLACED http://identifiers.org/uniprot/P62874"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29537"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNB1"],["bp:entityReference_http://identifiers.org/uniprot/P62873",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylserine"],["bp:term","N-acetylserine"]]],["bp:comment","MOD_RES 2 2 N-acetylserine."],["bp:featureLocation",[["bp:sequencePosition","2"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphohistidine"],["bp:term","MOD_RES Phosphohistidine"]]],["bp:comment","MOD_RES 266 266 Phosphohistidine."],["bp:featureLocation",[["bp:sequencePosition","266"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 2 2 Phosphoserine."],["bp:featureLocation","MOD_RES 2 2 Phosphoserine."]]],["bp:standardName","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:organism","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:displayName","GBB1_HUMAN"],["bp:name","GNB1"],["bp:name","Transducin beta chain 1"],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as a modulator or transducer in various transmembranesignaling systems. The beta and gamma chains are required for theGTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction.SUBUNIT: G proteins are composed of 3 units, alpha, beta andgamma. Interacts with ARHGEF18 and RASD2 (PubMed:14512443,PubMed:19255495). The heterodimer formed by GNB1 and GNG2interacts with ARHGEF5 (PubMed:19713215).{ECO:0000269|PubMed:14512443, ECO:0000269|PubMed:19255495,ECO:0000269|PubMed:19713215}.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=2;Name=1;IsoId=P62873-1; Sequence=Displayed;Name=2;IsoId=P62873-2; Sequence=VSP_055232;Note=No experimental confirmation available.;PTM: Phosphorylation at His-266 by NDKB contributes to G proteinactivation by increasing the high energetic phosphate transferonto GDP. {ECO:0000250}.DISEASE: Mental retardation, autosomal dominant 42 (MRD42)[MIM:616973]: A form of mental retardation, a disordercharacterized by significantly below average general intellectualfunctioning associated with impairments in adaptive behavior andmanifested during the developmental period. MRD42 patientsmanifest global developmental delay commonly accompanied byhypotonia, seizures of various types, ophthalmologicalmanifestations, and poor growth. {ECO:0000269|PubMed:25485910,ECO:0000269|PubMed:27108799, ECO:0000269|PubMed:27668284,ECO:0000269|PubMed:28087732}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the WD repeat G protein beta family.{ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2782"],["bp:comment","REPLACED http://identifiers.org/uniprot/B1AKQ8"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_786971"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_002065"],["bp:comment","GBB1_HUMAN Reviewed; 340 AA."],["bp:comment","REPLACED http://identifiers.org/refseq/XP_017175466"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_00766_identity"],["bp:comment","REPLACED http://identifiers.org/uniprot/P01946"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2782"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_dip_DIP-599N_identity"],["bp:comment","REPLACED http://identifiers.org/refseq/XP_016856548"],["bp:comment","REPLACED http://identifiers.org/uniprot/P04901"],["bp:comment","REPLACED http://identifiers.org/uniprot/P62874"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29537"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNB1"],["bp:entityReference_http://identifiers.org/uniprot/P62873",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylserine"],["bp:term","N-acetylserine"]]],["bp:comment","MOD_RES 2 2 N-acetylserine."],["bp:featureLocation",[["bp:sequencePosition","2"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphohistidine"],["bp:term","MOD_RES Phosphohistidine"]]],["bp:comment","MOD_RES 266 266 Phosphohistidine."],["bp:featureLocation",[["bp:sequencePosition","266"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 2 2 Phosphoserine."],["bp:featureLocation","MOD_RES 2 2 Phosphoserine."]]],["bp:standardName","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:organism","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:displayName","GBB1_HUMAN"],["bp:name","GNB1"],["bp:name","Transducin beta chain 1"],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as a modulator or transducer in various transmembranesignaling systems. The beta and gamma chains are required for theGTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction.SUBUNIT: G proteins are composed of 3 units, alpha, beta andgamma. Interacts with ARHGEF18 and RASD2 (PubMed:14512443,PubMed:19255495). The heterodimer formed by GNB1 and GNG2interacts with ARHGEF5 (PubMed:19713215).{ECO:0000269|PubMed:14512443, ECO:0000269|PubMed:19255495,ECO:0000269|PubMed:19713215}.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=2;Name=1;IsoId=P62873-1; Sequence=Displayed;Name=2;IsoId=P62873-2; Sequence=VSP_055232;Note=No experimental confirmation available.;PTM: Phosphorylation at His-266 by NDKB contributes to G proteinactivation by increasing the high energetic phosphate transferonto GDP. {ECO:0000250}.DISEASE: Mental retardation, autosomal dominant 42 (MRD42)[MIM:616973]: A form of mental retardation, a disordercharacterized by significantly below average general intellectualfunctioning associated with impairments in adaptive behavior andmanifested during the developmental period. MRD42 patientsmanifest global developmental delay commonly accompanied byhypotonia, seizures of various types, ophthalmologicalmanifestations, and poor growth. {ECO:0000269|PubMed:25485910,ECO:0000269|PubMed:27108799, ECO:0000269|PubMed:27668284,ECO:0000269|PubMed:28087732}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the WD repeat G protein beta family.{ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2782"],["bp:comment","REPLACED http://identifiers.org/uniprot/B1AKQ8"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_786971"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_002065"],["bp:comment","GBB1_HUMAN Reviewed; 340 AA."],["bp:comment","REPLACED http://identifiers.org/refseq/XP_017175466"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_00766_identity"],["bp:comment","REPLACED http://identifiers.org/uniprot/P01946"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2782"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_dip_DIP-599N_identity"],["bp:comment","REPLACED http://identifiers.org/refseq/XP_016856548"],["bp:comment","REPLACED http://identifiers.org/uniprot/P04901"],["bp:comment","REPLACED http://identifiers.org/uniprot/P62874"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29537"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29532"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29532"]]}},{"data":{"id":"Protein_fc6578580632db5c34bab285a2cac2d3_Complex_7fba29591c0d3e0267091aedc2769edc","class":"macromolecule","label":"GNB1","parent":"Complex_7fba29591c0d3e0267091aedc2769edc","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":281.8985,"y":500.9452,"w":48,"h":25},"metadata":[["bp:displayName","GNB1"],["bp:entityReference_http://identifiers.org/uniprot/P62873",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylserine"],["bp:term","N-acetylserine"]]],["bp:comment","MOD_RES 2 2 N-acetylserine."],["bp:featureLocation",[["bp:sequencePosition","2"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphohistidine"],["bp:term","MOD_RES Phosphohistidine"]]],["bp:comment","MOD_RES 266 266 Phosphohistidine."],["bp:featureLocation",[["bp:sequencePosition","266"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 2 2 Phosphoserine."],["bp:featureLocation","MOD_RES 2 2 Phosphoserine."]]],["bp:standardName","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref",[["bp:id","P62873"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:id","P62873"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","P62873"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","GBB1_HUMAN"],["bp:name","GNB1"],["bp:name","Transducin beta chain 1"],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as a modulator or transducer in various transmembranesignaling systems. The beta and gamma chains are required for theGTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction.SUBUNIT: G proteins are composed of 3 units, alpha, beta andgamma. Interacts with ARHGEF18 and RASD2 (PubMed:14512443,PubMed:19255495). The heterodimer formed by GNB1 and GNG2interacts with ARHGEF5 (PubMed:19713215).{ECO:0000269|PubMed:14512443, ECO:0000269|PubMed:19255495,ECO:0000269|PubMed:19713215}.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=2;Name=1;IsoId=P62873-1; Sequence=Displayed;Name=2;IsoId=P62873-2; Sequence=VSP_055232;Note=No experimental confirmation available.;PTM: Phosphorylation at His-266 by NDKB contributes to G proteinactivation by increasing the high energetic phosphate transferonto GDP. {ECO:0000250}.DISEASE: Mental retardation, autosomal dominant 42 (MRD42)[MIM:616973]: A form of mental retardation, a disordercharacterized by significantly below average general intellectualfunctioning associated with impairments in adaptive behavior andmanifested during the developmental period. MRD42 patientsmanifest global developmental delay commonly accompanied byhypotonia, seizures of various types, ophthalmologicalmanifestations, and poor growth. {ECO:0000269|PubMed:25485910,ECO:0000269|PubMed:27108799, ECO:0000269|PubMed:27668284,ECO:0000269|PubMed:28087732}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the WD repeat G protein beta family.{ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2782"],["bp:comment","REPLACED http://identifiers.org/uniprot/B1AKQ8"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_786971"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_002065"],["bp:comment","GBB1_HUMAN Reviewed; 340 AA."],["bp:comment","REPLACED http://identifiers.org/refseq/XP_017175466"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_00766_identity"],["bp:comment","REPLACED http://identifiers.org/uniprot/P01946"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2782"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_dip_DIP-599N_identity"],["bp:comment","REPLACED http://identifiers.org/refseq/XP_016856548"],["bp:comment","REPLACED http://identifiers.org/uniprot/P04901"],["bp:comment","REPLACED http://identifiers.org/uniprot/P62874"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"]]}},{"data":{"id":"Protein_456904e61c81af9fe82f6fc56ddd2183_Complex_7fba29591c0d3e0267091aedc2769edc","class":"macromolecule","label":"GNGT1","parent":"Complex_7fba29591c0d3e0267091aedc2769edc","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":281.8985,"y":470.9452,"w":48,"h":25},"metadata":[["bp:displayName","GNGT1"],["bp:entityReference_http://identifiers.org/uniprot/P63211",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Cysteine methyl ester"],["bp:term","MOD_RES Cysteine methyl ester"]]],["bp:comment","MOD_RES 71 71 Cysteine methyl ester."],["bp:featureLocation",[["bp:sequencePosition","71"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(T) subunit gamma-T1"],["bp:xref",[["bp:relationshipType",null],["bp:id","GNGT1"],["bp:db","hgnc symbol"]]],["bp:xref",[["bp:id","P63211"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","P63211"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","GBG1_HUMAN"],["bp:name","Transducin gamma chain"],["bp:name","GNGT1"],["bp:comment","GBG1_HUMAN Reviewed; 74 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2792"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_dip_DIP-471N_identity"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_068774"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2792"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01805_identity"],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as a modulator or transducer in various transmembranesignaling systems. The beta and gamma chains are required for theGTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction.SUBUNIT: G proteins are composed of 3 units, alpha, beta andgamma.SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Lipid-anchor{ECO:0000305}; Cytoplasmic side {ECO:0000305}.TISSUE SPECIFICITY: Retinal rod outer segment.SIMILARITY: Belongs to the G protein gamma family. {ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_intact_EBI-5774280_identity"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29533"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]}},{"data":{"id":"SmallMolecule_3be66134bf02bbe333791a9380f11481","class":"simple chemical","label":"all-trans-retinal","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":614.7971,"y":245.2599,"w":48,"h":20},"metadata":[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:17898"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:67195"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13+"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]}},{"data":{"id":"SmallMolecule_5edfcfcaa4b53c1c3e305c425b8b94ca","class":"simple chemical","label":"GMP (4 units)","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":403.31384,"y":927.0214,"w":48,"h":20},"metadata":[["bp:displayName","GMP (4 units)"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:132932",[["bp:standardName","disodium 5'-O-phosphonatoguanosine"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:35617"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:132932"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:38700"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:58115"],["bp:db","chebi"]]],["bp:chemicalFormula","C10H12N5Na2O8P"],["bp:displayName","disodium 5'-guanylate"],["bp:name","CHEBI:132932"],["bp:name","disodium 5'-GMP"],["bp:name","disodium GMP"],["bp:name","guanosine 5'-phosphate disodium salt"],["bp:name","C1(=O)NC(=NC2=C1N=CN2[C@@H]3O[C@H](COP(=O)([O-])[O-])[C@@H](O)[C@H]3O)N.[Na+].[Na+]"],["bp:name","disodium guanosine 5'-monophosphate"],["bp:name","E627"],["bp:name","disodium guanosine-5'-monophosphate"],["bp:name","sodium guanylate"],["bp:name","GMP disodium salt"],["bp:name","guanosine 5'-monophosphate disodium salt"],["bp:name","5'-gmp disodium salt"],["bp:name","C10H12N5Na2O8P"],["bp:name","5-guanylic acid disodium salt"],["bp:name","disodium guanylate"],["bp:molecularWeight","407.185"],["bp:comment","has_role CHEBI:35617"],["bp:comment","has_part CHEBI:58115"],["bp:comment","is_a CHEBI:38700"],["bp:comment","An organic sodium salt that is the disodium salt of GMP."],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29704"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/C10H14N5O8P.2Na/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(23-9)1-22-24(19,20)21;;/h2-3,5-6,9,16-17H,1H2,(H2,19,20,21)(H3,11,13,14,18);;/q;2*+1/p-2/t3-,5-,6-,9-;;/m1../s1"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29703"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]}},{"data":{"id":"BiochemicalReaction_3122526332e38d855b69ebef2bc40068_LEFT_TO_RIGHT","class":"process","label":"","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":951.0448,"y":361.5263,"w":15,"h":15},"metadata":[["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinylester"],["bp:entityReference_#SmallMoleculeReference_ee9b3742a16b293296c9be0e66638385",[]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29625"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29629"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","11-cis-retinol"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16302",[["bp:standardName","11-cis-retinol"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11310"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H30O"],["bp:displayName","11-cis-retinol"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\CO"],["bp:name","11-cis-Retinol"],["bp:name","C20H30O"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol"],["bp:molecularWeight","286.23"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00899.eref"],["bp:comment","has_role CHEBI:75771"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMoleculeReference75454"],["bp:comment","is_a CHEBI:50211"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29628"],["bp:structure","REPLACED http://pid.nci.nih.gov/biopax#pid_29628"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29627"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29627"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29630"],["bp:stoichiometricCoefficient","1.0"]]],["bp:xref",[["bp:physicalEntity",[["bp:displayName","11-cis-retinol"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16302",[["bp:standardName","11-cis-retinol"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11310"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H30O"],["bp:displayName","11-cis-retinol"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\CO"],["bp:name","11-cis-Retinol"],["bp:name","C20H30O"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol"],["bp:molecularWeight","286.23"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00899.eref"],["bp:comment","has_role CHEBI:75771"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMoleculeReference75454"],["bp:comment","is_a CHEBI:50211"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29628"],["bp:structure","REPLACED http://pid.nci.nih.gov/biopax#pid_29628"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29627"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29627"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29630"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","11-cis-retinol"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16302",[["bp:standardName","11-cis-retinol"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11310"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H30O"],["bp:displayName","11-cis-retinol"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\CO"],["bp:name","11-cis-Retinol"],["bp:name","C20H30O"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol"],["bp:molecularWeight","286.23"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00899.eref"],["bp:comment","has_role CHEBI:75771"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMoleculeReference75454"],["bp:comment","is_a CHEBI:50211"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29628"],["bp:structure","REPLACED http://pid.nci.nih.gov/biopax#pid_29628"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29627"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29627"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29630"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","11-cis-retinol"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16302",[["bp:standardName","11-cis-retinol"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11310"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H30O"],["bp:displayName","11-cis-retinol"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\CO"],["bp:name","11-cis-Retinol"],["bp:name","C20H30O"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol"],["bp:molecularWeight","286.23"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00899.eref"],["bp:comment","has_role CHEBI:75771"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMoleculeReference75454"],["bp:comment","is_a CHEBI:50211"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29628"],["bp:structure","REPLACED http://pid.nci.nih.gov/biopax#pid_29628"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29627"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29627"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29630"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","11-cis-retinol"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16302",[["bp:standardName","11-cis-retinol"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11310"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H30O"],["bp:displayName","11-cis-retinol"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\CO"],["bp:name","11-cis-Retinol"],["bp:name","C20H30O"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol"],["bp:molecularWeight","286.23"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00899.eref"],["bp:comment","has_role CHEBI:75771"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMoleculeReference75454"],["bp:comment","is_a CHEBI:50211"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29628"],["bp:structure","REPLACED http://pid.nci.nih.gov/biopax#pid_29628"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29627"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29627"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29630"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","11-cis-retinol"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16302",[["bp:standardName","11-cis-retinol"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11310"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H30O"],["bp:displayName","11-cis-retinol"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\CO"],["bp:name","11-cis-Retinol"],["bp:name","C20H30O"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol"],["bp:molecularWeight","286.23"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00899.eref"],["bp:comment","has_role CHEBI:75771"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMoleculeReference75454"],["bp:comment","is_a CHEBI:50211"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29628"],["bp:structure","REPLACED http://pid.nci.nih.gov/biopax#pid_29628"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29627"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29627"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29630"],["bp:stoichiometricCoefficient","1.0"]]],["bp:right",[["bp:physicalEntity",[["bp:displayName","11-cis-retinol"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16302",[["bp:standardName","11-cis-retinol"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11310"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H30O"],["bp:displayName","11-cis-retinol"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\CO"],["bp:name","11-cis-Retinol"],["bp:name","C20H30O"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol"],["bp:molecularWeight","286.23"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00899.eref"],["bp:comment","has_role CHEBI:75771"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMoleculeReference75454"],["bp:comment","is_a CHEBI:50211"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29628"],["bp:structure","REPLACED http://pid.nci.nih.gov/biopax#pid_29628"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29627"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29627"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29630"],["bp:stoichiometricCoefficient","1.0"]]],["bp:left",[["bp:physicalEntity",[["bp:displayName","11-cis-retinol"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16302",[["bp:standardName","11-cis-retinol"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11310"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H30O"],["bp:displayName","11-cis-retinol"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\CO"],["bp:name","11-cis-Retinol"],["bp:name","C20H30O"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol"],["bp:molecularWeight","286.23"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00899.eref"],["bp:comment","has_role CHEBI:75771"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMoleculeReference75454"],["bp:comment","is_a CHEBI:50211"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29628"],["bp:structure","REPLACED http://pid.nci.nih.gov/biopax#pid_29628"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29627"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29627"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29630"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29624"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29624"]]}},{"data":{"id":"Complex_1edcbd716fcdb6653d759a6e49903878","class":"complex","label":"Metarhodopsin II/Arrestin","parent":"","clonemarker":false,"stateVariables":[{"id":"Complex_1edcbd716fcdb6653d759a6e49903878.info.1","class":"state variable","state":{"variable":"","value":"Ina"}}],"unitsOfInformation":[],"bbox":{"x":763.8904,"y":73.15791300000001,"w":89,"h":89},"metadata":[["bp:displayName","Metarhodopsin II/Arrestin"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:17898"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:17898"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:17898"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:17898"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:17898"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:17898"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:17898"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:17898"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:17898"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:17898"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:17898"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:17898"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:17898"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:17898"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29803"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29803"]]}},{"data":{"id":"Protein_3b1cb2a9dcdba096167eef98413b5f4b_Complex_1edcbd716fcdb6653d759a6e49903878","class":"macromolecule","label":"RHO","parent":"Complex_1edcbd716fcdb6653d759a6e49903878","clonemarker":false,"stateVariables":[{"id":"Protein_3b1cb2a9dcdba096167eef98413b5f4b_Complex_1edcbd716fcdb6653d759a6e49903878.info.1","class":"state variable","state":{"variable":"343","value":"opser"}},{"id":"Protein_3b1cb2a9dcdba096167eef98413b5f4b_Complex_1edcbd716fcdb6653d759a6e49903878.state.2","class":"state variable","state":{"variable":"342","value":"opthr"}},{"id":"Protein_3b1cb2a9dcdba096167eef98413b5f4b_Complex_1edcbd716fcdb6653d759a6e49903878.info.3","class":"state variable","state":{"variable":"336","value":"O-palmitoyl-L-threonine"}},{"id":"Protein_3b1cb2a9dcdba096167eef98413b5f4b_Complex_1edcbd716fcdb6653d759a6e49903878.state.4","class":"state variable","state":{"variable":"340","value":"opthr"}},{"id":"Protein_3b1cb2a9dcdba096167eef98413b5f4b_Complex_1edcbd716fcdb6653d759a6e49903878.info.5","class":"state variable","state":{"variable":"338","value":"opthr"}},{"id":"Protein_3b1cb2a9dcdba096167eef98413b5f4b_Complex_1edcbd716fcdb6653d759a6e49903878.state.6","class":"state variable","state":{"variable":"334","value":"opser"}}],"unitsOfInformation":[],"bbox":{"x":763.8904,"y":43.157913,"w":85,"h":25},"metadata":[["bp:displayName","RHO"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00046"],["bp:db","protein modification ontology"]]],["bp:term","opser"],["bp:term","O-phospho-L-serine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29573"],["bp:featureLocation",[["bp:sequencePosition","343"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29574"]]]]],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00047"],["bp:db","protein modification ontology"]]],["bp:term","opthr"],["bp:term","O-phospho-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29571"],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29572"]]]]],["bp:feature",[["bp:modificationType",[["bp:xref",null],["bp:term","O-palmitoyl-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29567"],["bp:featureLocation","REPLACED http://pid.nci.nih.gov/biopax#pid_29567"]]],["bp:feature",[["bp:modificationType",[["bp:xref",null],["bp:term","O-palmitoyl-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29567"],["bp:featureLocation","REPLACED http://pid.nci.nih.gov/biopax#pid_29567"]]],["bp:feature",[["bp:modificationType",[["bp:xref",null],["bp:term","O-palmitoyl-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29567"],["bp:featureLocation","REPLACED http://pid.nci.nih.gov/biopax#pid_29567"]]],["bp:feature",[["bp:modificationType",[["bp:xref",null],["bp:term","O-palmitoyl-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29567"],["bp:featureLocation","REPLACED http://pid.nci.nih.gov/biopax#pid_29567"]]],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:modificationType",[["bp:xref",null],["bp:term","O-palmitoyl-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29567"],["bp:featureLocation","REPLACED http://pid.nci.nih.gov/biopax#pid_29567"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29563"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29563"]]}},{"data":{"id":"Protein_2357f4b5860837413497201285410149_Complex_1edcbd716fcdb6653d759a6e49903878","class":"macromolecule","label":"SAG","parent":"Complex_1edcbd716fcdb6653d759a6e49903878","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":745.3904,"y":78.15791,"w":48,"h":25},"metadata":[["bp:displayName","Arrestin"],["bp:entityReference_http://identifiers.org/uniprot/P10523",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 234 234 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","234"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","S-arrestin"],["bp:xref",[["bp:id","P10523"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","SAG"],["bp:db","hgnc symbol"]]],["bp:organism",[["bp:relationshipType",null],["bp:id","SAG"],["bp:db","hgnc symbol"]]],["bp:displayName","ARRS_HUMAN"],["bp:name","48 kDa protein"],["bp:name","SAG"],["bp:name","S-AG"],["bp:name","Rod photoreceptor arrestin"],["bp:name","Retinal S-antigen"],["bp:comment","FUNCTION: Arrestin is one of the major proteins of the ros(retinal rod outer segments); it binds to photoactivated-phosphorylated rhodopsin, thereby apparently preventing thetransducin-mediated activation of phosphodiesterase.SUBUNIT: Monomer. Homodimer. Homotetramer.{ECO:0000269|PubMed:21288033}.TISSUE SPECIFICITY: Retina and pineal gland.DISEASE: Night blindness, congenital stationary, Oguchi type 1(CSNBO1) [MIM:258100]: A non-progressive retinal disordercharacterized by impaired night vision, often associated withnystagmus and myopia. Congenital stationary night blindness Oguchitype is an autosomal recessive form associated with fundusdiscoloration and abnormally slow dark adaptation.{ECO:0000269|PubMed:7670478}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Retinitis pigmentosa 47 (RP47) [MIM:613758]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:9565049}. Note=The disease iscaused by mutations affecting the gene represented in this entry.MISCELLANEOUS: Arrestin binds calcium.SIMILARITY: Belongs to the arrestin family. {ECO:0000305}.WEB RESOURCE: Name=Mutations of the SAG gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/sagmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01625_identity"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000532"],["bp:comment","ARRS_HUMAN Reviewed; 405 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6295"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29800"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]}},{"data":{"id":"SmallMolecule_3be66134bf02bbe333791a9380f11481_Complex_1edcbd716fcdb6653d759a6e49903878","class":"simple chemical","label":"all-trans-retinal","parent":"Complex_1edcbd716fcdb6653d759a6e49903878","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":745.3904,"y":105.65791,"w":48,"h":20},"metadata":[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:17898"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:67195"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13+"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]}},{"data":{"id":"Protein_42540b2c5224aad9e9d215624eb93672","class":"macromolecule","label":"LRAT","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":722.0019,"y":539.7674,"w":48,"h":25},"metadata":[["bp:displayName","Lecithin Retinol Acyl Transferase"],["bp:entityReference_http://identifiers.org/uniprot/O95237",[["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_O95237"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_O95237"]]],["bp:standardName","Lecithin retinol acyltransferase"],["bp:xref",[["bp:id","O95237"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","LRAT"],["bp:db","hgnc symbol"]]],["bp:organism",[["bp:relationshipType",null],["bp:id","LRAT"],["bp:db","hgnc symbol"]]],["bp:displayName","LRAT_HUMAN"],["bp:name","2.3.1.135"],["bp:name","Phosphatidylcholine--retinol O-acyltransferase"],["bp:name","LRAT"],["bp:comment","LRAT_HUMAN Reviewed; 230 AA."],["bp:comment","REPLACED http://identifiers.org/refseq/XP_006714475"],["bp:comment","FUNCTION: Transfers the acyl group from the sn-1 position ofphosphatidylcholine to all-trans retinol, producing all-transretinyl esters. Retinyl esters are storage forms of vitamin A.LRAT plays a critical role in vision. It provides the all-transretinyl ester substrates for the isomerohydrolase which processesthe esters into 11-cis-retinol in the retinal pigment epithelium;due to a membrane-associated alcohol dehydrogenase, 11 cis-retinolis oxidized and converted into 11-cis-retinaldehyde which is thechromophore for rhodopsin and the cone photopigments.{ECO:0000269|PubMed:9920938}.CATALYTIC ACTIVITY: Phosphatidylcholine + retinol--[cellular-retinol-binding-protein] = 2-acylglycerophosphocholine + retinyl-ester--[cellular-retinol-binding-protein].ENZYME REGULATION: Inhibited by all-trans-retinyl alpha-bromoacetate and N-boc-L-biocytinyl-11-aminoundecane chloro-methylketone (BACMK). {ECO:0000269|PubMed:9920938}.PATHWAY: Cofactor metabolism; retinol metabolism.SUBCELLULAR LOCATION: Endoplasmic reticulum membrane{ECO:0000250}; Single-pass membrane protein {ECO:0000250}. Roughendoplasmic reticulum {ECO:0000250}. Endosome, multivesicular body{ECO:0000250}. Cytoplasm, perinuclear region {ECO:0000250}.Note=Present in the rough endoplasmic reticulum and multivesicularbody in hepatic stellate cells. Present in the rough endoplasmicreticulum and perinuclear region in endothelial cells (Bysimilarity). {ECO:0000250}.TISSUE SPECIFICITY: Hepatic stellate cells and endothelial cells(at protein level). Found at high levels in testis and liver,followed by retinal pigment epithelium, small intestine, prostate,pancreas and colon. Low expression observed in brain. In fetaltissues, expressed in retinal pigment epithelium and liver, andbarely in the brain. {ECO:0000269|PubMed:18544127,ECO:0000269|PubMed:9920938}.INDUCTION: LRAT activity is up-regulated by dietary vitamin A.Under conditions of vitamin A depletion, LRAT expression in theliver is induced by retinoic acid (By similarity). {ECO:0000250}.DISEASE: Leber congenital amaurosis 14 (LCA14) [MIM:613341]: Asevere dystrophy of the retina, typically becoming evident in thefirst years of life. Visual function is usually poor and oftenaccompanied by nystagmus, sluggish or near-absent pupillaryresponses, photophobia, high hyperopia and keratoconus.{ECO:0000269|PubMed:11381255, ECO:0000269|PubMed:17011878,ECO:0000269|PubMed:18055821}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the H-rev107 family. {ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_9227"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_9227"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_05332_identity"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29776"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]}},{"data":{"id":"BiochemicalReaction_51f2b95182998dbe0cbfc10905f3feca_LEFT_TO_RIGHT","class":"process","label":"","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":368.19226,"y":135.87495,"w":15,"h":15},"metadata":[["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","ATP"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:15422",[["bp:standardName","adenosine 5'-(tetrahydrogen triphosphate)"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22249"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:78675"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:10789"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:40938"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:27027"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37096"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:chemicalFormula","C10H16N5O13P3"],["bp:displayName","ATP"],["bp:name","H4atp"],["bp:name","Nc1ncnc2n(cnc12)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O"],["bp:name","C10H16N5O13P3"],["bp:name","Adenosine triphosphate"],["bp:name","Adenosine 5'-triphosphate"],["bp:name","ADENOSINE-5'-TRIPHOSPHATE"],["bp:name","CHEBI:15422"],["bp:molecularWeight","507.181"],["bp:comment","is_conjugate_acid_of CHEBI:57299"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB00538"],["bp:comment","REPLACED http://www.inoh.org/biopax/IMR_0001351_ATP"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/SmallMoleculeReference_bind_13_identity"],["bp:comment","REPLACED http://identifiers.org/kegg.compound/C00002"],["bp:comment","has_role CHEBI:27027"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00002.eref"],["bp:comment","has_role CHEBI:50733"],["bp:comment","is_a CHEBI:37096"],["bp:comment","has_role CHEBI:78675"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_2127"],["bp:comment","An adenosine 5'-phosphate in which the 5'-phosphate is a triphosphate group. It is involved in the transportation of chemical energy during metabolic pathways."],["bp:comment","is_a CHEBI:37045"],["bp:structure","is_a CHEBI:37045"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_2126"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_2126"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29578"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","ATP"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:15422",[["bp:standardName","adenosine 5'-(tetrahydrogen triphosphate)"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22249"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:78675"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:10789"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:40938"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:27027"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37096"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:chemicalFormula","C10H16N5O13P3"],["bp:displayName","ATP"],["bp:name","H4atp"],["bp:name","Nc1ncnc2n(cnc12)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O"],["bp:name","C10H16N5O13P3"],["bp:name","Adenosine triphosphate"],["bp:name","Adenosine 5'-triphosphate"],["bp:name","ADENOSINE-5'-TRIPHOSPHATE"],["bp:name","CHEBI:15422"],["bp:molecularWeight","507.181"],["bp:comment","is_conjugate_acid_of CHEBI:57299"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB00538"],["bp:comment","REPLACED http://www.inoh.org/biopax/IMR_0001351_ATP"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/SmallMoleculeReference_bind_13_identity"],["bp:comment","REPLACED http://identifiers.org/kegg.compound/C00002"],["bp:comment","has_role CHEBI:27027"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00002.eref"],["bp:comment","has_role CHEBI:50733"],["bp:comment","is_a CHEBI:37096"],["bp:comment","has_role CHEBI:78675"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_2127"],["bp:comment","An adenosine 5'-phosphate in which the 5'-phosphate is a triphosphate group. It is involved in the transportation of chemical energy during metabolic pathways."],["bp:comment","is_a CHEBI:37045"],["bp:structure","is_a CHEBI:37045"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_2126"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_2126"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29578"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","ATP"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:15422",[["bp:standardName","adenosine 5'-(tetrahydrogen triphosphate)"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22249"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:78675"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:10789"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:40938"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:27027"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37096"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:chemicalFormula","C10H16N5O13P3"],["bp:displayName","ATP"],["bp:name","H4atp"],["bp:name","Nc1ncnc2n(cnc12)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O"],["bp:name","C10H16N5O13P3"],["bp:name","Adenosine triphosphate"],["bp:name","Adenosine 5'-triphosphate"],["bp:name","ADENOSINE-5'-TRIPHOSPHATE"],["bp:name","CHEBI:15422"],["bp:molecularWeight","507.181"],["bp:comment","is_conjugate_acid_of CHEBI:57299"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB00538"],["bp:comment","REPLACED http://www.inoh.org/biopax/IMR_0001351_ATP"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/SmallMoleculeReference_bind_13_identity"],["bp:comment","REPLACED http://identifiers.org/kegg.compound/C00002"],["bp:comment","has_role CHEBI:27027"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00002.eref"],["bp:comment","has_role CHEBI:50733"],["bp:comment","is_a CHEBI:37096"],["bp:comment","has_role CHEBI:78675"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_2127"],["bp:comment","An adenosine 5'-phosphate in which the 5'-phosphate is a triphosphate group. It is involved in the transportation of chemical energy during metabolic pathways."],["bp:comment","is_a CHEBI:37045"],["bp:structure","is_a CHEBI:37045"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_2126"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_2126"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29578"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","ATP"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:15422",[["bp:standardName","adenosine 5'-(tetrahydrogen triphosphate)"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22249"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:78675"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:10789"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:40938"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:27027"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37096"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:chemicalFormula","C10H16N5O13P3"],["bp:displayName","ATP"],["bp:name","H4atp"],["bp:name","Nc1ncnc2n(cnc12)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O"],["bp:name","C10H16N5O13P3"],["bp:name","Adenosine triphosphate"],["bp:name","Adenosine 5'-triphosphate"],["bp:name","ADENOSINE-5'-TRIPHOSPHATE"],["bp:name","CHEBI:15422"],["bp:molecularWeight","507.181"],["bp:comment","is_conjugate_acid_of CHEBI:57299"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB00538"],["bp:comment","REPLACED http://www.inoh.org/biopax/IMR_0001351_ATP"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/SmallMoleculeReference_bind_13_identity"],["bp:comment","REPLACED http://identifiers.org/kegg.compound/C00002"],["bp:comment","has_role CHEBI:27027"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00002.eref"],["bp:comment","has_role CHEBI:50733"],["bp:comment","is_a CHEBI:37096"],["bp:comment","has_role CHEBI:78675"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_2127"],["bp:comment","An adenosine 5'-phosphate in which the 5'-phosphate is a triphosphate group. It is involved in the transportation of chemical energy during metabolic pathways."],["bp:comment","is_a CHEBI:37045"],["bp:structure","is_a CHEBI:37045"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_2126"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_2126"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29578"],["bp:stoichiometricCoefficient","1.0"]]],["bp:xref",[["bp:physicalEntity",[["bp:displayName","ATP"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:15422",[["bp:standardName","adenosine 5'-(tetrahydrogen triphosphate)"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22249"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:78675"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:10789"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:40938"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:27027"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37096"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:chemicalFormula","C10H16N5O13P3"],["bp:displayName","ATP"],["bp:name","H4atp"],["bp:name","Nc1ncnc2n(cnc12)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O"],["bp:name","C10H16N5O13P3"],["bp:name","Adenosine triphosphate"],["bp:name","Adenosine 5'-triphosphate"],["bp:name","ADENOSINE-5'-TRIPHOSPHATE"],["bp:name","CHEBI:15422"],["bp:molecularWeight","507.181"],["bp:comment","is_conjugate_acid_of CHEBI:57299"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB00538"],["bp:comment","REPLACED http://www.inoh.org/biopax/IMR_0001351_ATP"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/SmallMoleculeReference_bind_13_identity"],["bp:comment","REPLACED http://identifiers.org/kegg.compound/C00002"],["bp:comment","has_role CHEBI:27027"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00002.eref"],["bp:comment","has_role CHEBI:50733"],["bp:comment","is_a CHEBI:37096"],["bp:comment","has_role CHEBI:78675"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_2127"],["bp:comment","An adenosine 5'-phosphate in which the 5'-phosphate is a triphosphate group. It is involved in the transportation of chemical energy during metabolic pathways."],["bp:comment","is_a CHEBI:37045"],["bp:structure","is_a CHEBI:37045"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_2126"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_2126"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29578"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","ATP"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:15422",[["bp:standardName","adenosine 5'-(tetrahydrogen triphosphate)"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22249"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:78675"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:10789"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:40938"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:27027"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37096"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:chemicalFormula","C10H16N5O13P3"],["bp:displayName","ATP"],["bp:name","H4atp"],["bp:name","Nc1ncnc2n(cnc12)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O"],["bp:name","C10H16N5O13P3"],["bp:name","Adenosine triphosphate"],["bp:name","Adenosine 5'-triphosphate"],["bp:name","ADENOSINE-5'-TRIPHOSPHATE"],["bp:name","CHEBI:15422"],["bp:molecularWeight","507.181"],["bp:comment","is_conjugate_acid_of CHEBI:57299"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB00538"],["bp:comment","REPLACED http://www.inoh.org/biopax/IMR_0001351_ATP"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/SmallMoleculeReference_bind_13_identity"],["bp:comment","REPLACED http://identifiers.org/kegg.compound/C00002"],["bp:comment","has_role CHEBI:27027"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00002.eref"],["bp:comment","has_role CHEBI:50733"],["bp:comment","is_a CHEBI:37096"],["bp:comment","has_role CHEBI:78675"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_2127"],["bp:comment","An adenosine 5'-phosphate in which the 5'-phosphate is a triphosphate group. It is involved in the transportation of chemical energy during metabolic pathways."],["bp:comment","is_a CHEBI:37045"],["bp:structure","is_a CHEBI:37045"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_2126"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_2126"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29578"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","ATP"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:15422",[["bp:standardName","adenosine 5'-(tetrahydrogen triphosphate)"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22249"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:78675"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:10789"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:40938"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:27027"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37096"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:chemicalFormula","C10H16N5O13P3"],["bp:displayName","ATP"],["bp:name","H4atp"],["bp:name","Nc1ncnc2n(cnc12)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O"],["bp:name","C10H16N5O13P3"],["bp:name","Adenosine triphosphate"],["bp:name","Adenosine 5'-triphosphate"],["bp:name","ADENOSINE-5'-TRIPHOSPHATE"],["bp:name","CHEBI:15422"],["bp:molecularWeight","507.181"],["bp:comment","is_conjugate_acid_of CHEBI:57299"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB00538"],["bp:comment","REPLACED http://www.inoh.org/biopax/IMR_0001351_ATP"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/SmallMoleculeReference_bind_13_identity"],["bp:comment","REPLACED http://identifiers.org/kegg.compound/C00002"],["bp:comment","has_role CHEBI:27027"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00002.eref"],["bp:comment","has_role CHEBI:50733"],["bp:comment","is_a CHEBI:37096"],["bp:comment","has_role CHEBI:78675"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_2127"],["bp:comment","An adenosine 5'-phosphate in which the 5'-phosphate is a triphosphate group. It is involved in the transportation of chemical energy during metabolic pathways."],["bp:comment","is_a CHEBI:37045"],["bp:structure","is_a CHEBI:37045"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_2126"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_2126"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29578"],["bp:stoichiometricCoefficient","1.0"]]],["bp:right",[["bp:physicalEntity",[["bp:displayName","ATP"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:15422",[["bp:standardName","adenosine 5'-(tetrahydrogen triphosphate)"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22249"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:78675"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:10789"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:40938"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:27027"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37096"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:chemicalFormula","C10H16N5O13P3"],["bp:displayName","ATP"],["bp:name","H4atp"],["bp:name","Nc1ncnc2n(cnc12)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O"],["bp:name","C10H16N5O13P3"],["bp:name","Adenosine triphosphate"],["bp:name","Adenosine 5'-triphosphate"],["bp:name","ADENOSINE-5'-TRIPHOSPHATE"],["bp:name","CHEBI:15422"],["bp:molecularWeight","507.181"],["bp:comment","is_conjugate_acid_of CHEBI:57299"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB00538"],["bp:comment","REPLACED http://www.inoh.org/biopax/IMR_0001351_ATP"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/SmallMoleculeReference_bind_13_identity"],["bp:comment","REPLACED http://identifiers.org/kegg.compound/C00002"],["bp:comment","has_role CHEBI:27027"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00002.eref"],["bp:comment","has_role CHEBI:50733"],["bp:comment","is_a CHEBI:37096"],["bp:comment","has_role CHEBI:78675"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_2127"],["bp:comment","An adenosine 5'-phosphate in which the 5'-phosphate is a triphosphate group. It is involved in the transportation of chemical energy during metabolic pathways."],["bp:comment","is_a CHEBI:37045"],["bp:structure","is_a CHEBI:37045"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_2126"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_2126"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29578"],["bp:stoichiometricCoefficient","1.0"]]],["bp:right",[["bp:physicalEntity",[["bp:displayName","ATP"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:15422",[["bp:standardName","adenosine 5'-(tetrahydrogen triphosphate)"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22249"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:78675"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:10789"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:40938"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:27027"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37096"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:chemicalFormula","C10H16N5O13P3"],["bp:displayName","ATP"],["bp:name","H4atp"],["bp:name","Nc1ncnc2n(cnc12)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O"],["bp:name","C10H16N5O13P3"],["bp:name","Adenosine triphosphate"],["bp:name","Adenosine 5'-triphosphate"],["bp:name","ADENOSINE-5'-TRIPHOSPHATE"],["bp:name","CHEBI:15422"],["bp:molecularWeight","507.181"],["bp:comment","is_conjugate_acid_of CHEBI:57299"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB00538"],["bp:comment","REPLACED http://www.inoh.org/biopax/IMR_0001351_ATP"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/SmallMoleculeReference_bind_13_identity"],["bp:comment","REPLACED http://identifiers.org/kegg.compound/C00002"],["bp:comment","has_role CHEBI:27027"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00002.eref"],["bp:comment","has_role CHEBI:50733"],["bp:comment","is_a CHEBI:37096"],["bp:comment","has_role CHEBI:78675"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_2127"],["bp:comment","An adenosine 5'-phosphate in which the 5'-phosphate is a triphosphate group. It is involved in the transportation of chemical energy during metabolic pathways."],["bp:comment","is_a CHEBI:37045"],["bp:structure","is_a CHEBI:37045"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_2126"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_2126"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29578"],["bp:stoichiometricCoefficient","1.0"]]],["bp:left",[["bp:physicalEntity",[["bp:displayName","ATP"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:15422",[["bp:standardName","adenosine 5'-(tetrahydrogen triphosphate)"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22249"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:78675"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:10789"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:40938"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:27027"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37096"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:chemicalFormula","C10H16N5O13P3"],["bp:displayName","ATP"],["bp:name","H4atp"],["bp:name","Nc1ncnc2n(cnc12)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O"],["bp:name","C10H16N5O13P3"],["bp:name","Adenosine triphosphate"],["bp:name","Adenosine 5'-triphosphate"],["bp:name","ADENOSINE-5'-TRIPHOSPHATE"],["bp:name","CHEBI:15422"],["bp:molecularWeight","507.181"],["bp:comment","is_conjugate_acid_of CHEBI:57299"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB00538"],["bp:comment","REPLACED http://www.inoh.org/biopax/IMR_0001351_ATP"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/SmallMoleculeReference_bind_13_identity"],["bp:comment","REPLACED http://identifiers.org/kegg.compound/C00002"],["bp:comment","has_role CHEBI:27027"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00002.eref"],["bp:comment","has_role CHEBI:50733"],["bp:comment","is_a CHEBI:37096"],["bp:comment","has_role CHEBI:78675"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_2127"],["bp:comment","An adenosine 5'-phosphate in which the 5'-phosphate is a triphosphate group. It is involved in the transportation of chemical energy during metabolic pathways."],["bp:comment","is_a CHEBI:37045"],["bp:structure","is_a CHEBI:37045"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_2126"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_2126"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29578"],["bp:stoichiometricCoefficient","1.0"]]],["bp:left",[["bp:physicalEntity",[["bp:displayName","ATP"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:15422",[["bp:standardName","adenosine 5'-(tetrahydrogen triphosphate)"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22249"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:78675"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:10789"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:40938"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:27027"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37096"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57299"],["bp:db","chebi"]]],["bp:chemicalFormula","C10H16N5O13P3"],["bp:displayName","ATP"],["bp:name","H4atp"],["bp:name","Nc1ncnc2n(cnc12)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O"],["bp:name","C10H16N5O13P3"],["bp:name","Adenosine triphosphate"],["bp:name","Adenosine 5'-triphosphate"],["bp:name","ADENOSINE-5'-TRIPHOSPHATE"],["bp:name","CHEBI:15422"],["bp:molecularWeight","507.181"],["bp:comment","is_conjugate_acid_of CHEBI:57299"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB00538"],["bp:comment","REPLACED http://www.inoh.org/biopax/IMR_0001351_ATP"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/SmallMoleculeReference_bind_13_identity"],["bp:comment","REPLACED http://identifiers.org/kegg.compound/C00002"],["bp:comment","has_role CHEBI:27027"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00002.eref"],["bp:comment","has_role CHEBI:50733"],["bp:comment","is_a CHEBI:37096"],["bp:comment","has_role CHEBI:78675"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_2127"],["bp:comment","An adenosine 5'-phosphate in which the 5'-phosphate is a triphosphate group. It is involved in the transportation of chemical energy during metabolic pathways."],["bp:comment","is_a CHEBI:37045"],["bp:structure","is_a CHEBI:37045"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_2126"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_2126"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29578"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29551"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29551"]]}},{"data":{"id":"Protein_f67dbfea94353a8979ca197d59be5795","class":"macromolecule","label":"GCAP Family","parent":"","clonemarker":false,"stateVariables":[{"id":"Protein_f67dbfea94353a8979ca197d59be5795.info.1","class":"state variable","state":{"variable":"","value":"Act"}}],"unitsOfInformation":[],"bbox":{"x":873.1311,"y":696.04675,"w":48,"h":25},"metadata":[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation",[["bp:sequencePosition","3"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation",[["bp:sequencePosition","3"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation",[["bp:sequencePosition","3"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:feature","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"]]}},{"data":{"id":"ComplexAssembly_8cdd666c217309a6e1c376231760e8ed_LEFT_TO_RIGHT","class":"process","label":"","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":781.527,"y":268.16833,"w":15,"h":15},"metadata":[["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","Rhodopsin"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","11-cis-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16066",[["bp:standardName","11-cis-retinal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11311"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:23240"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:727"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16066"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","11-cis-retinal"],["bp:name","11-cis-retinene"],["bp:name","11-cis-vitamin A aldehyde"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:name","11-cis-Retinal"],["bp:name","11-cis-Vitamin A aldehyde"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\C=O"],["bp:name","C20H28O"],["bp:name","11-cis-Retinene"],["bp:molecularWeight","284.214"],["bp:comment","A retinal having 2E,4Z,6E,8E-double bond geometry."],["bp:comment","has_role CHEBI:23240"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB02152"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29746"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"],["bp:structure","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29749"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","11-cis-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16066",[["bp:standardName","11-cis-retinal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11311"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:23240"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:727"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16066"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","11-cis-retinal"],["bp:name","11-cis-retinene"],["bp:name","11-cis-vitamin A aldehyde"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:name","11-cis-Retinal"],["bp:name","11-cis-Vitamin A aldehyde"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\C=O"],["bp:name","C20H28O"],["bp:name","11-cis-Retinene"],["bp:molecularWeight","284.214"],["bp:comment","A retinal having 2E,4Z,6E,8E-double bond geometry."],["bp:comment","has_role CHEBI:23240"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB02152"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29746"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"],["bp:structure","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29749"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","11-cis-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16066",[["bp:standardName","11-cis-retinal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11311"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:23240"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:727"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16066"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","11-cis-retinal"],["bp:name","11-cis-retinene"],["bp:name","11-cis-vitamin A aldehyde"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:name","11-cis-Retinal"],["bp:name","11-cis-Vitamin A aldehyde"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\C=O"],["bp:name","C20H28O"],["bp:name","11-cis-Retinene"],["bp:molecularWeight","284.214"],["bp:comment","A retinal having 2E,4Z,6E,8E-double bond geometry."],["bp:comment","has_role CHEBI:23240"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB02152"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29746"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"],["bp:structure","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29749"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","11-cis-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16066",[["bp:standardName","11-cis-retinal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11311"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:23240"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:727"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16066"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","11-cis-retinal"],["bp:name","11-cis-retinene"],["bp:name","11-cis-vitamin A aldehyde"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:name","11-cis-Retinal"],["bp:name","11-cis-Vitamin A aldehyde"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\C=O"],["bp:name","C20H28O"],["bp:name","11-cis-Retinene"],["bp:molecularWeight","284.214"],["bp:comment","A retinal having 2E,4Z,6E,8E-double bond geometry."],["bp:comment","has_role CHEBI:23240"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB02152"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29746"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"],["bp:structure","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29749"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","11-cis-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16066",[["bp:standardName","11-cis-retinal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11311"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:23240"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:727"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16066"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","11-cis-retinal"],["bp:name","11-cis-retinene"],["bp:name","11-cis-vitamin A aldehyde"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:name","11-cis-Retinal"],["bp:name","11-cis-Vitamin A aldehyde"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\C=O"],["bp:name","C20H28O"],["bp:name","11-cis-Retinene"],["bp:molecularWeight","284.214"],["bp:comment","A retinal having 2E,4Z,6E,8E-double bond geometry."],["bp:comment","has_role CHEBI:23240"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB02152"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29746"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"],["bp:structure","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29749"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29747"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29747"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29753"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","Rhodopsin"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","11-cis-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16066",[["bp:standardName","11-cis-retinal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11311"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:23240"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:727"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16066"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","11-cis-retinal"],["bp:name","11-cis-retinene"],["bp:name","11-cis-vitamin A aldehyde"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:name","11-cis-Retinal"],["bp:name","11-cis-Vitamin A aldehyde"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\C=O"],["bp:name","C20H28O"],["bp:name","11-cis-Retinene"],["bp:molecularWeight","284.214"],["bp:comment","A retinal having 2E,4Z,6E,8E-double bond geometry."],["bp:comment","has_role CHEBI:23240"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB02152"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29746"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"],["bp:structure","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29749"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","11-cis-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16066",[["bp:standardName","11-cis-retinal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11311"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:23240"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:727"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16066"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","11-cis-retinal"],["bp:name","11-cis-retinene"],["bp:name","11-cis-vitamin A aldehyde"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:name","11-cis-Retinal"],["bp:name","11-cis-Vitamin A aldehyde"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\C=O"],["bp:name","C20H28O"],["bp:name","11-cis-Retinene"],["bp:molecularWeight","284.214"],["bp:comment","A retinal having 2E,4Z,6E,8E-double bond geometry."],["bp:comment","has_role CHEBI:23240"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB02152"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29746"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"],["bp:structure","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29749"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","11-cis-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16066",[["bp:standardName","11-cis-retinal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11311"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:23240"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:727"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16066"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","11-cis-retinal"],["bp:name","11-cis-retinene"],["bp:name","11-cis-vitamin A aldehyde"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:name","11-cis-Retinal"],["bp:name","11-cis-Vitamin A aldehyde"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\C=O"],["bp:name","C20H28O"],["bp:name","11-cis-Retinene"],["bp:molecularWeight","284.214"],["bp:comment","A retinal having 2E,4Z,6E,8E-double bond geometry."],["bp:comment","has_role CHEBI:23240"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB02152"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29746"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"],["bp:structure","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29749"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","11-cis-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16066",[["bp:standardName","11-cis-retinal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11311"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:23240"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:727"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16066"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","11-cis-retinal"],["bp:name","11-cis-retinene"],["bp:name","11-cis-vitamin A aldehyde"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:name","11-cis-Retinal"],["bp:name","11-cis-Vitamin A aldehyde"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\C=O"],["bp:name","C20H28O"],["bp:name","11-cis-Retinene"],["bp:molecularWeight","284.214"],["bp:comment","A retinal having 2E,4Z,6E,8E-double bond geometry."],["bp:comment","has_role CHEBI:23240"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB02152"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29746"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"],["bp:structure","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29749"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","11-cis-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16066",[["bp:standardName","11-cis-retinal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11311"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:23240"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:727"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16066"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","11-cis-retinal"],["bp:name","11-cis-retinene"],["bp:name","11-cis-vitamin A aldehyde"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:name","11-cis-Retinal"],["bp:name","11-cis-Vitamin A aldehyde"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\C=O"],["bp:name","C20H28O"],["bp:name","11-cis-Retinene"],["bp:molecularWeight","284.214"],["bp:comment","A retinal having 2E,4Z,6E,8E-double bond geometry."],["bp:comment","has_role CHEBI:23240"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB02152"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29746"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"],["bp:structure","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29749"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29747"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29747"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29753"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","Rhodopsin"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","11-cis-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16066",[["bp:standardName","11-cis-retinal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11311"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:23240"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:727"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16066"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","11-cis-retinal"],["bp:name","11-cis-retinene"],["bp:name","11-cis-vitamin A aldehyde"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:name","11-cis-Retinal"],["bp:name","11-cis-Vitamin A aldehyde"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\C=O"],["bp:name","C20H28O"],["bp:name","11-cis-Retinene"],["bp:molecularWeight","284.214"],["bp:comment","A retinal having 2E,4Z,6E,8E-double bond geometry."],["bp:comment","has_role CHEBI:23240"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB02152"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29746"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"],["bp:structure","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29749"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","11-cis-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16066",[["bp:standardName","11-cis-retinal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11311"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:23240"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:727"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16066"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","11-cis-retinal"],["bp:name","11-cis-retinene"],["bp:name","11-cis-vitamin A aldehyde"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:name","11-cis-Retinal"],["bp:name","11-cis-Vitamin A aldehyde"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\C=O"],["bp:name","C20H28O"],["bp:name","11-cis-Retinene"],["bp:molecularWeight","284.214"],["bp:comment","A retinal having 2E,4Z,6E,8E-double bond geometry."],["bp:comment","has_role CHEBI:23240"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB02152"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29746"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"],["bp:structure","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29749"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","11-cis-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16066",[["bp:standardName","11-cis-retinal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11311"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:23240"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:727"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16066"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","11-cis-retinal"],["bp:name","11-cis-retinene"],["bp:name","11-cis-vitamin A aldehyde"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:name","11-cis-Retinal"],["bp:name","11-cis-Vitamin A aldehyde"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\C=O"],["bp:name","C20H28O"],["bp:name","11-cis-Retinene"],["bp:molecularWeight","284.214"],["bp:comment","A retinal having 2E,4Z,6E,8E-double bond geometry."],["bp:comment","has_role CHEBI:23240"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB02152"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29746"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"],["bp:structure","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29749"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","11-cis-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16066",[["bp:standardName","11-cis-retinal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11311"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:23240"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:727"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16066"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","11-cis-retinal"],["bp:name","11-cis-retinene"],["bp:name","11-cis-vitamin A aldehyde"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:name","11-cis-Retinal"],["bp:name","11-cis-Vitamin A aldehyde"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\C=O"],["bp:name","C20H28O"],["bp:name","11-cis-Retinene"],["bp:molecularWeight","284.214"],["bp:comment","A retinal having 2E,4Z,6E,8E-double bond geometry."],["bp:comment","has_role CHEBI:23240"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB02152"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29746"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"],["bp:structure","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29749"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","11-cis-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16066",[["bp:standardName","11-cis-retinal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11311"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:23240"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:727"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16066"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","11-cis-retinal"],["bp:name","11-cis-retinene"],["bp:name","11-cis-vitamin A aldehyde"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:name","11-cis-Retinal"],["bp:name","11-cis-Vitamin A aldehyde"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\C=O"],["bp:name","C20H28O"],["bp:name","11-cis-Retinene"],["bp:molecularWeight","284.214"],["bp:comment","A retinal having 2E,4Z,6E,8E-double bond geometry."],["bp:comment","has_role CHEBI:23240"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB02152"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29746"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"],["bp:structure","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29749"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29747"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29747"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29753"],["bp:stoichiometricCoefficient","1.0"]]],["bp:right",[["bp:physicalEntity",[["bp:displayName","Rhodopsin"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","11-cis-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16066",[["bp:standardName","11-cis-retinal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11311"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:23240"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:727"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16066"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","11-cis-retinal"],["bp:name","11-cis-retinene"],["bp:name","11-cis-vitamin A aldehyde"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:name","11-cis-Retinal"],["bp:name","11-cis-Vitamin A aldehyde"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\C=O"],["bp:name","C20H28O"],["bp:name","11-cis-Retinene"],["bp:molecularWeight","284.214"],["bp:comment","A retinal having 2E,4Z,6E,8E-double bond geometry."],["bp:comment","has_role CHEBI:23240"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB02152"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29746"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"],["bp:structure","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29749"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","11-cis-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16066",[["bp:standardName","11-cis-retinal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11311"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:23240"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:727"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16066"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","11-cis-retinal"],["bp:name","11-cis-retinene"],["bp:name","11-cis-vitamin A aldehyde"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:name","11-cis-Retinal"],["bp:name","11-cis-Vitamin A aldehyde"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\C=O"],["bp:name","C20H28O"],["bp:name","11-cis-Retinene"],["bp:molecularWeight","284.214"],["bp:comment","A retinal having 2E,4Z,6E,8E-double bond geometry."],["bp:comment","has_role CHEBI:23240"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB02152"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29746"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"],["bp:structure","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29749"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","11-cis-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16066",[["bp:standardName","11-cis-retinal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11311"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:23240"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:727"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16066"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","11-cis-retinal"],["bp:name","11-cis-retinene"],["bp:name","11-cis-vitamin A aldehyde"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:name","11-cis-Retinal"],["bp:name","11-cis-Vitamin A aldehyde"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\C=O"],["bp:name","C20H28O"],["bp:name","11-cis-Retinene"],["bp:molecularWeight","284.214"],["bp:comment","A retinal having 2E,4Z,6E,8E-double bond geometry."],["bp:comment","has_role CHEBI:23240"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB02152"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29746"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"],["bp:structure","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29749"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","11-cis-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16066",[["bp:standardName","11-cis-retinal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11311"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:23240"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:727"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16066"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","11-cis-retinal"],["bp:name","11-cis-retinene"],["bp:name","11-cis-vitamin A aldehyde"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:name","11-cis-Retinal"],["bp:name","11-cis-Vitamin A aldehyde"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\C=O"],["bp:name","C20H28O"],["bp:name","11-cis-Retinene"],["bp:molecularWeight","284.214"],["bp:comment","A retinal having 2E,4Z,6E,8E-double bond geometry."],["bp:comment","has_role CHEBI:23240"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB02152"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29746"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"],["bp:structure","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29749"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","11-cis-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16066",[["bp:standardName","11-cis-retinal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11311"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:23240"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:727"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16066"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","11-cis-retinal"],["bp:name","11-cis-retinene"],["bp:name","11-cis-vitamin A aldehyde"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:name","11-cis-Retinal"],["bp:name","11-cis-Vitamin A aldehyde"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\C=O"],["bp:name","C20H28O"],["bp:name","11-cis-Retinene"],["bp:molecularWeight","284.214"],["bp:comment","A retinal having 2E,4Z,6E,8E-double bond geometry."],["bp:comment","has_role CHEBI:23240"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB02152"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29746"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"],["bp:structure","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29749"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29747"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29747"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29753"],["bp:stoichiometricCoefficient","1.0"]]],["bp:spontaneous","true"],["bp:left","true"],["bp:left","true"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29737"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29737"]]}},{"data":{"id":"Protein_4ff4878e3bfef76a8eb2e70eb877ae31","class":"macromolecule","label":"GRK1","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":456.0502,"y":157.52603,"w":48,"h":25},"metadata":[["bp:displayName","GRK1"],["bp:entityReference_http://identifiers.org/uniprot/Q15835",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 21 21 Phosphoserine; by PKA and autocatalysis."],["bp:featureLocation",[["bp:sequencePosition","21"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 492 492 Phosphothreonine; by autocatalysis."],["bp:featureLocation",[["bp:sequencePosition","492"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Cysteine methyl ester"],["bp:term","MOD_RES Cysteine methyl ester"]]],["bp:comment","MOD_RES 560 560 Cysteine methyl ester."],["bp:featureLocation",[["bp:sequencePosition","560"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Cysteine methyl ester"],["bp:term","MOD_RES Cysteine methyl ester"]]],["bp:comment","MOD_RES 560 560 Cysteine methyl ester."],["bp:featureLocation",[["bp:sequencePosition","560"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Cysteine methyl ester"],["bp:term","MOD_RES Cysteine methyl ester"]]],["bp:comment","MOD_RES 560 560 Cysteine methyl ester."],["bp:featureLocation",[["bp:sequencePosition","560"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Cysteine methyl ester"],["bp:term","MOD_RES Cysteine methyl ester"]]],["bp:comment","MOD_RES 560 560 Cysteine methyl ester."],["bp:featureLocation",[["bp:sequencePosition","560"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin kinase"],["bp:xref","Rhodopsin kinase"],["bp:xref","Rhodopsin kinase"],["bp:organism","Rhodopsin kinase"],["bp:displayName","RK_HUMAN"],["bp:name","GRK1"],["bp:name","RK"],["bp:name","RHOK"],["bp:name","G protein-coupled receptor kinase 1"],["bp:name","2.7.11.14"],["bp:comment","FUNCTION: Retina-specific kinase involved in the signal turnoffvia phosphorylation of rhodopsin (RHO), the G protein- coupledreceptor that initiates the phototransduction cascade. This rapiddesensitization is essential for scotopic vision and permits rapidadaptation to changes in illumination.{ECO:0000269|PubMed:15946941}.CATALYTIC ACTIVITY: ATP + [rhodopsin] = ADP + [rhodopsin]phosphate. {ECO:0000269|PubMed:15946941}.ENZYME REGULATION: Inhibited by phosphorylation of Ser-21.{ECO:0000269|PubMed:15946941}.BIOPHYSICOCHEMICAL PROPERTIES:Kinetic parameters:KM=3.5 uM for rhodopsin {ECO:0000269|PubMed:15946941};KM=10.6 uM for ATP {ECO:0000269|PubMed:15946941};Vmax=1132 nmol/min/mg enzyme {ECO:0000269|PubMed:15946941};SUBUNIT: Interacts (when prenylated) with PDE6D; this promotesrelease from membranes. {ECO:0000250|UniProtKB:P28327}.SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:P28327};Lipid-anchor {ECO:0000250|UniProtKB:P28327}.TISSUE SPECIFICITY: Retinal-specific. Expressed in rods and conescells. {ECO:0000269|PubMed:11717351}.PTM: Autophosphorylated, Ser-21 is a minor site ofautophosphorylation compared to Ser-491 and Thr-492 (Bysimilarity). Phosphorylation at Ser-21 is regulated by light andactivated by cAMP. {ECO:0000250, ECO:0000269|PubMed:15946941}.PTM: Farnesylation is required for full activity.{ECO:0000250|UniProtKB:P28327}.DISEASE: Night blindness, congenital stationary, Oguchi type 2(CSNBO2) [MIM:613411]: A non-progressive retinal disordercharacterized by impaired night vision, often associated withnystagmus and myopia. Congenital stationary night blindness Oguchitype is associated with fundus discoloration and abnormally slowdark adaptation. {ECO:0000269|PubMed:17070587,ECO:0000269|PubMed:9020843}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thrprotein kinase family. GPRK subfamily. {ECO:0000305}.WEB RESOURCE: Name=Mutations of the RHOK gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rkmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","RK_HUMAN Reviewed; 563 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6011"],["bp:comment","REPLACED http://www.phosphosite.org/phosphosite.owl#po_753"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_002920"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01585_identity"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29583"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29583"]]}},{"data":{"id":"Complex_839bbfb17f833b9521c6a6ea96aa610a","class":"complex","label":"Rhodopsin","parent":"","clonemarker":false,"stateVariables":[{"id":"Complex_839bbfb17f833b9521c6a6ea96aa610a.info.1","class":"state variable","state":{"variable":"","value":"Ina"}}],"unitsOfInformation":[],"bbox":{"x":605.6831,"y":318.2402,"w":89,"h":59},"metadata":[["bp:displayName","Rhodopsin"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","11-cis-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16066",[["bp:standardName","11-cis-retinal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11311"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:23240"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:727"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16066"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","11-cis-retinal"],["bp:name","11-cis-retinene"],["bp:name","11-cis-vitamin A aldehyde"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:name","11-cis-Retinal"],["bp:name","11-cis-Vitamin A aldehyde"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\C=O"],["bp:name","C20H28O"],["bp:name","11-cis-Retinene"],["bp:molecularWeight","284.214"],["bp:comment","A retinal having 2E,4Z,6E,8E-double bond geometry."],["bp:comment","has_role CHEBI:23240"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB02152"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29746"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"],["bp:structure","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29749"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","11-cis-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16066",[["bp:standardName","11-cis-retinal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11311"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:23240"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:727"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16066"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","11-cis-retinal"],["bp:name","11-cis-retinene"],["bp:name","11-cis-vitamin A aldehyde"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:name","11-cis-Retinal"],["bp:name","11-cis-Vitamin A aldehyde"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\C=O"],["bp:name","C20H28O"],["bp:name","11-cis-Retinene"],["bp:molecularWeight","284.214"],["bp:comment","A retinal having 2E,4Z,6E,8E-double bond geometry."],["bp:comment","has_role CHEBI:23240"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB02152"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29746"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"],["bp:structure","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29749"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","11-cis-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16066",[["bp:standardName","11-cis-retinal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11311"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:23240"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:727"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16066"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","11-cis-retinal"],["bp:name","11-cis-retinene"],["bp:name","11-cis-vitamin A aldehyde"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:name","11-cis-Retinal"],["bp:name","11-cis-Vitamin A aldehyde"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\C=O"],["bp:name","C20H28O"],["bp:name","11-cis-Retinene"],["bp:molecularWeight","284.214"],["bp:comment","A retinal having 2E,4Z,6E,8E-double bond geometry."],["bp:comment","has_role CHEBI:23240"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB02152"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29746"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"],["bp:structure","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29749"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","11-cis-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16066",[["bp:standardName","11-cis-retinal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11311"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:23240"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:727"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16066"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","11-cis-retinal"],["bp:name","11-cis-retinene"],["bp:name","11-cis-vitamin A aldehyde"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:name","11-cis-Retinal"],["bp:name","11-cis-Vitamin A aldehyde"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\C=O"],["bp:name","C20H28O"],["bp:name","11-cis-Retinene"],["bp:molecularWeight","284.214"],["bp:comment","A retinal having 2E,4Z,6E,8E-double bond geometry."],["bp:comment","has_role CHEBI:23240"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB02152"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29746"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"],["bp:structure","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29749"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","11-cis-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16066",[["bp:standardName","11-cis-retinal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11311"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:23240"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:727"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16066"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","11-cis-retinal"],["bp:name","11-cis-retinene"],["bp:name","11-cis-vitamin A aldehyde"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:name","11-cis-Retinal"],["bp:name","11-cis-Vitamin A aldehyde"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\C=O"],["bp:name","C20H28O"],["bp:name","11-cis-Retinene"],["bp:molecularWeight","284.214"],["bp:comment","A retinal having 2E,4Z,6E,8E-double bond geometry."],["bp:comment","has_role CHEBI:23240"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB02152"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29746"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"],["bp:structure","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29749"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29747"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29747"]]}},{"data":{"id":"Protein_3e7d00184038f5fbc042e46fe22f53ec_Complex_839bbfb17f833b9521c6a6ea96aa610a","class":"macromolecule","label":"RHO","parent":"Complex_839bbfb17f833b9521c6a6ea96aa610a","clonemarker":false,"stateVariables":[{"id":"Protein_3e7d00184038f5fbc042e46fe22f53ec_Complex_839bbfb17f833b9521c6a6ea96aa610a.info.1","class":"state variable","state":{"variable":"C322","value":"Pal"}},{"id":"Protein_3e7d00184038f5fbc042e46fe22f53ec_Complex_839bbfb17f833b9521c6a6ea96aa610a.state.2","class":"state variable","state":{"variable":"1","value":"N-acetyl-L-methionine"}},{"id":"Protein_3e7d00184038f5fbc042e46fe22f53ec_Complex_839bbfb17f833b9521c6a6ea96aa610a.info.3","class":"state variable","state":{"variable":"15","value":"n4glycoasn"}},{"id":"Protein_3e7d00184038f5fbc042e46fe22f53ec_Complex_839bbfb17f833b9521c6a6ea96aa610a.state.4","class":"state variable","state":{"variable":"2","value":"n4glycoasn"}},{"id":"Protein_3e7d00184038f5fbc042e46fe22f53ec_Complex_839bbfb17f833b9521c6a6ea96aa610a.info.5","class":"state variable","state":{"variable":"C323","value":"Pal"}}],"unitsOfInformation":[],"bbox":{"x":605.6831,"y":303.2402,"w":85,"h":25},"metadata":[["bp:displayName","RHO"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00115"],["bp:db","protein modification ontology"]]],["bp:term","S-palmitoyl-L-cysteine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29742"],["bp:featureLocation",[["bp:sequencePosition","322"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29743"]]]]],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29739"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:feature",[["bp:modificationType",[["bp:xref",null],["bp:term","n4glycoasn"],["bp:term","N4-glycosyl-L-asparagine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29741"],["bp:featureLocation","REPLACED http://pid.nci.nih.gov/biopax#pid_29741"]]],["bp:feature",[["bp:modificationType",[["bp:xref",null],["bp:term","n4glycoasn"],["bp:term","N4-glycosyl-L-asparagine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29741"],["bp:featureLocation","REPLACED http://pid.nci.nih.gov/biopax#pid_29741"]]],["bp:feature",[["bp:modificationType",[["bp:xref",null],["bp:term","n4glycoasn"],["bp:term","N4-glycosyl-L-asparagine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29741"],["bp:featureLocation","REPLACED http://pid.nci.nih.gov/biopax#pid_29741"]]],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:modificationType",[["bp:xref",null],["bp:term","n4glycoasn"],["bp:term","N4-glycosyl-L-asparagine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29741"],["bp:featureLocation","REPLACED http://pid.nci.nih.gov/biopax#pid_29741"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29738"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29738"]]}},{"data":{"id":"SmallMolecule_7414b0b55879a305bd7ba983351edd98_Complex_839bbfb17f833b9521c6a6ea96aa610a","class":"simple chemical","label":"11-cis-retinal","parent":"Complex_839bbfb17f833b9521c6a6ea96aa610a","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":587.1831,"y":335.7402,"w":48,"h":20},"metadata":[["bp:displayName","11-cis-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16066",[["bp:standardName","11-cis-retinal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11311"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:23240"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:727"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16066"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:19119"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","11-cis-retinal"],["bp:name","11-cis-retinene"],["bp:name","11-cis-vitamin A aldehyde"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:name","11-cis-Retinal"],["bp:name","11-cis-Vitamin A aldehyde"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\C=O"],["bp:name","C20H28O"],["bp:name","11-cis-Retinene"],["bp:molecularWeight","284.214"],["bp:comment","A retinal having 2E,4Z,6E,8E-double bond geometry."],["bp:comment","has_role CHEBI:23240"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB02152"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29746"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6-,12-11+,16-8+,17-13+"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"]]}},{"data":{"id":"BiochemicalReaction_3c445c3f24014e21fe546aa259e68e5c_LEFT_TO_RIGHT","class":"process","label":"","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":734.5668,"y":448.63327,"w":15,"h":15},"metadata":[["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","2-acylglycerophosphocholine"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:11502",[["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:60479"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:11502"],["bp:db","chebi"]]],["bp:chemicalFormula","C9H20NO7PR"],["bp:displayName","2-acylglycerophosphocholine"],["bp:name","C9H20NO7PR"],["bp:name","2-acylglycerophosphocholines"],["bp:name","LPC"],["bp:name","C[N+](C)(C)CCOP(O)(=O)OCC(CO)OC([*])=O"],["bp:molecularWeight","285.2314"],["bp:comment","A glycerophosphocholine having an unspecified acyl group attached at the 2-position."],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29770"],["bp:comment","is_a CHEBI:60479"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29769"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29774"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinol"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17336",[["bp:standardName","all-trans-retinol"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H30O"],["bp:displayName","all-trans-retinol"],["bp:name","Alphalin"],["bp:name","all-trans-vitamin A alcohol"],["bp:name","Vitamin A1"],["bp:name","C20H30O"],["bp:name","Chocola A"],["bp:name","Vitamin A"],["bp:name","all-trans-Retinol"],["bp:name","CC(\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C/CO"],["bp:name","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol"],["bp:name","Retinol"],["bp:name","all-trans-retinyl alcohol"],["bp:name","CHEBI:17336"],["bp:molecularWeight","286.23"],["bp:comment","A retinol in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29617"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB00162"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00473.eref"],["bp:comment","is_a CHEBI:50211"],["bp:structure","is_a CHEBI:50211"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29616"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29616"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29771"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinol"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17336",[["bp:standardName","all-trans-retinol"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H30O"],["bp:displayName","all-trans-retinol"],["bp:name","Alphalin"],["bp:name","all-trans-vitamin A alcohol"],["bp:name","Vitamin A1"],["bp:name","C20H30O"],["bp:name","Chocola A"],["bp:name","Vitamin A"],["bp:name","all-trans-Retinol"],["bp:name","CC(\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C/CO"],["bp:name","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol"],["bp:name","Retinol"],["bp:name","all-trans-retinyl alcohol"],["bp:name","CHEBI:17336"],["bp:molecularWeight","286.23"],["bp:comment","A retinol in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29617"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB00162"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00473.eref"],["bp:comment","is_a CHEBI:50211"],["bp:structure","is_a CHEBI:50211"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29616"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29616"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29771"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinol"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17336",[["bp:standardName","all-trans-retinol"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H30O"],["bp:displayName","all-trans-retinol"],["bp:name","Alphalin"],["bp:name","all-trans-vitamin A alcohol"],["bp:name","Vitamin A1"],["bp:name","C20H30O"],["bp:name","Chocola A"],["bp:name","Vitamin A"],["bp:name","all-trans-Retinol"],["bp:name","CC(\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C/CO"],["bp:name","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol"],["bp:name","Retinol"],["bp:name","all-trans-retinyl alcohol"],["bp:name","CHEBI:17336"],["bp:molecularWeight","286.23"],["bp:comment","A retinol in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29617"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB00162"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00473.eref"],["bp:comment","is_a CHEBI:50211"],["bp:structure","is_a CHEBI:50211"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29616"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29616"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29771"],["bp:stoichiometricCoefficient","1.0"]]],["bp:right",[["bp:physicalEntity",[["bp:displayName","all-trans-retinol"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17336",[["bp:standardName","all-trans-retinol"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H30O"],["bp:displayName","all-trans-retinol"],["bp:name","Alphalin"],["bp:name","all-trans-vitamin A alcohol"],["bp:name","Vitamin A1"],["bp:name","C20H30O"],["bp:name","Chocola A"],["bp:name","Vitamin A"],["bp:name","all-trans-Retinol"],["bp:name","CC(\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C/CO"],["bp:name","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol"],["bp:name","Retinol"],["bp:name","all-trans-retinyl alcohol"],["bp:name","CHEBI:17336"],["bp:molecularWeight","286.23"],["bp:comment","A retinol in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29617"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB00162"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00473.eref"],["bp:comment","is_a CHEBI:50211"],["bp:structure","is_a CHEBI:50211"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29616"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29616"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29771"],["bp:stoichiometricCoefficient","1.0"]]],["bp:right",[["bp:physicalEntity",[["bp:displayName","all-trans-retinol"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17336",[["bp:standardName","all-trans-retinol"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H30O"],["bp:displayName","all-trans-retinol"],["bp:name","Alphalin"],["bp:name","all-trans-vitamin A alcohol"],["bp:name","Vitamin A1"],["bp:name","C20H30O"],["bp:name","Chocola A"],["bp:name","Vitamin A"],["bp:name","all-trans-Retinol"],["bp:name","CC(\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C/CO"],["bp:name","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol"],["bp:name","Retinol"],["bp:name","all-trans-retinyl alcohol"],["bp:name","CHEBI:17336"],["bp:molecularWeight","286.23"],["bp:comment","A retinol in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29617"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB00162"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00473.eref"],["bp:comment","is_a CHEBI:50211"],["bp:structure","is_a CHEBI:50211"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29616"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29616"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29771"],["bp:stoichiometricCoefficient","1.0"]]],["bp:left",[["bp:physicalEntity",[["bp:displayName","all-trans-retinol"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17336",[["bp:standardName","all-trans-retinol"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H30O"],["bp:displayName","all-trans-retinol"],["bp:name","Alphalin"],["bp:name","all-trans-vitamin A alcohol"],["bp:name","Vitamin A1"],["bp:name","C20H30O"],["bp:name","Chocola A"],["bp:name","Vitamin A"],["bp:name","all-trans-Retinol"],["bp:name","CC(\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C/CO"],["bp:name","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol"],["bp:name","Retinol"],["bp:name","all-trans-retinyl alcohol"],["bp:name","CHEBI:17336"],["bp:molecularWeight","286.23"],["bp:comment","A retinol in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29617"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB00162"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00473.eref"],["bp:comment","is_a CHEBI:50211"],["bp:structure","is_a CHEBI:50211"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29616"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29616"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29771"],["bp:stoichiometricCoefficient","1.0"]]],["bp:left",[["bp:physicalEntity",[["bp:displayName","all-trans-retinol"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17336",[["bp:standardName","all-trans-retinol"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H30O"],["bp:displayName","all-trans-retinol"],["bp:name","Alphalin"],["bp:name","all-trans-vitamin A alcohol"],["bp:name","Vitamin A1"],["bp:name","C20H30O"],["bp:name","Chocola A"],["bp:name","Vitamin A"],["bp:name","all-trans-Retinol"],["bp:name","CC(\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C/CO"],["bp:name","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol"],["bp:name","Retinol"],["bp:name","all-trans-retinyl alcohol"],["bp:name","CHEBI:17336"],["bp:molecularWeight","286.23"],["bp:comment","A retinol in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29617"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB00162"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00473.eref"],["bp:comment","is_a CHEBI:50211"],["bp:structure","is_a CHEBI:50211"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29616"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29616"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29771"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29766"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29766"]]}},{"data":{"id":"Protein_5e6544b9ca2610522930422e887fd7f1","class":"macromolecule","label":"RHO","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":547.3694,"y":177.11162,"w":48,"h":25},"metadata":[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation",[["bp:sequencePosition","338"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 343 343 Phosphoserine."],["bp:featureLocation","MOD_RES 343 343 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 343 343 Phosphoserine."],["bp:featureLocation","MOD_RES 343 343 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 343 343 Phosphoserine."],["bp:featureLocation","MOD_RES 343 343 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 343 343 Phosphoserine."],["bp:featureLocation","MOD_RES 343 343 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 343 343 Phosphoserine."],["bp:featureLocation","MOD_RES 343 343 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 343 343 Phosphoserine."],["bp:featureLocation","MOD_RES 343 343 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 343 343 Phosphoserine."],["bp:featureLocation","MOD_RES 343 343 Phosphoserine."]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]}},{"data":{"id":"Complex_0474d84a6ffcbc5067d637d13cb69efa","class":"complex","label":"PDE6A/B","parent":"","clonemarker":false,"stateVariables":[{"id":"Complex_0474d84a6ffcbc5067d637d13cb69efa.info.1","class":"state variable","state":{"variable":"","value":"Act"}}],"unitsOfInformation":[],"bbox":{"x":345.36047,"y":749.6182,"w":52,"h":59},"metadata":[["bp:displayName","PDE6A/B"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","PDE6B"],["bp:entityReference_http://identifiers.org/uniprot/P35913",[["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P35913"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P35913"]]],["bp:standardName","Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta"],["bp:xref",[["bp:id","P35913"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","PDE6B"],["bp:db","hgnc symbol"]]],["bp:organism",[["bp:relationshipType",null],["bp:id","PDE6B"],["bp:db","hgnc symbol"]]],["bp:displayName","PDE6B_HUMAN"],["bp:name","PDEB"],["bp:name","3.1.4.35"],["bp:name","PDE6B"],["bp:name","GMP-PDE beta"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_5158"],["bp:comment","PDE6B_HUMAN Reviewed; 854 AA."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01571_identity"],["bp:comment","REPLACED http://www.humanmetabolism.org/#ref_http://www.humanmetabolism.org/#protein_PDE6B"],["bp:comment","FUNCTION: This protein participates in processes of transmissionand amplification of the visual signal. Necessary for theformation of a functional phosphodiesterase holoenzyme.CATALYTIC ACTIVITY: Guanosine 3',5'-cyclic phosphate + H(2)O =guanosine 5'-phosphate.COFACTOR:Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240;Evidence={ECO:0000250};Note=Binds 2 divalent metal cations per subunit. Site 1 maypreferentially bind zinc ions, while site 2 has a preference formagnesium and/or manganese ions. {ECO:0000250};SUBUNIT: Oligomer composed of two catalytic chains (alpha andbeta), an inhibitory chain (gamma) and the delta chain.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=3;Name=1;IsoId=P35913-1; Sequence=Displayed;Name=2;IsoId=P35913-2; Sequence=VSP_036884;Name=3;IsoId=P35913-3; Sequence=VSP_044919;Note=No experimental confirmation available.;DISEASE: Retinitis pigmentosa 40 (RP40) [MIM:613801]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:22334370,ECO:0000269|PubMed:8394174, ECO:0000269|PubMed:8557257,ECO:0000269|PubMed:8595886, ECO:0000269|PubMed:8698075,ECO:0000269|PubMed:8956055, ECO:0000269|PubMed:9543643}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 2 (CSNBAD2) [MIM:163500]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:8075643}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the cyclic nucleotide phosphodiesterasefamily. {ECO:0000305}.WEB RESOURCE: Name=Mutations of the PDE6A/B/G genes; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/pdemut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29727"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29731"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","PDE6B"],["bp:entityReference_http://identifiers.org/uniprot/P35913",[["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P35913"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P35913"]]],["bp:standardName","Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta"],["bp:xref",[["bp:id","P35913"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","PDE6B"],["bp:db","hgnc symbol"]]],["bp:organism",[["bp:relationshipType",null],["bp:id","PDE6B"],["bp:db","hgnc symbol"]]],["bp:displayName","PDE6B_HUMAN"],["bp:name","PDEB"],["bp:name","3.1.4.35"],["bp:name","PDE6B"],["bp:name","GMP-PDE beta"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_5158"],["bp:comment","PDE6B_HUMAN Reviewed; 854 AA."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01571_identity"],["bp:comment","REPLACED http://www.humanmetabolism.org/#ref_http://www.humanmetabolism.org/#protein_PDE6B"],["bp:comment","FUNCTION: This protein participates in processes of transmissionand amplification of the visual signal. Necessary for theformation of a functional phosphodiesterase holoenzyme.CATALYTIC ACTIVITY: Guanosine 3',5'-cyclic phosphate + H(2)O =guanosine 5'-phosphate.COFACTOR:Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240;Evidence={ECO:0000250};Note=Binds 2 divalent metal cations per subunit. Site 1 maypreferentially bind zinc ions, while site 2 has a preference formagnesium and/or manganese ions. {ECO:0000250};SUBUNIT: Oligomer composed of two catalytic chains (alpha andbeta), an inhibitory chain (gamma) and the delta chain.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=3;Name=1;IsoId=P35913-1; Sequence=Displayed;Name=2;IsoId=P35913-2; Sequence=VSP_036884;Name=3;IsoId=P35913-3; Sequence=VSP_044919;Note=No experimental confirmation available.;DISEASE: Retinitis pigmentosa 40 (RP40) [MIM:613801]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:22334370,ECO:0000269|PubMed:8394174, ECO:0000269|PubMed:8557257,ECO:0000269|PubMed:8595886, ECO:0000269|PubMed:8698075,ECO:0000269|PubMed:8956055, ECO:0000269|PubMed:9543643}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 2 (CSNBAD2) [MIM:163500]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:8075643}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the cyclic nucleotide phosphodiesterasefamily. {ECO:0000305}.WEB RESOURCE: Name=Mutations of the PDE6A/B/G genes; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/pdemut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29727"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29731"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","PDE6B"],["bp:entityReference_http://identifiers.org/uniprot/P35913",[["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P35913"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P35913"]]],["bp:standardName","Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta"],["bp:xref",[["bp:id","P35913"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","PDE6B"],["bp:db","hgnc symbol"]]],["bp:organism",[["bp:relationshipType",null],["bp:id","PDE6B"],["bp:db","hgnc symbol"]]],["bp:displayName","PDE6B_HUMAN"],["bp:name","PDEB"],["bp:name","3.1.4.35"],["bp:name","PDE6B"],["bp:name","GMP-PDE beta"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_5158"],["bp:comment","PDE6B_HUMAN Reviewed; 854 AA."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01571_identity"],["bp:comment","REPLACED http://www.humanmetabolism.org/#ref_http://www.humanmetabolism.org/#protein_PDE6B"],["bp:comment","FUNCTION: This protein participates in processes of transmissionand amplification of the visual signal. Necessary for theformation of a functional phosphodiesterase holoenzyme.CATALYTIC ACTIVITY: Guanosine 3',5'-cyclic phosphate + H(2)O =guanosine 5'-phosphate.COFACTOR:Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240;Evidence={ECO:0000250};Note=Binds 2 divalent metal cations per subunit. Site 1 maypreferentially bind zinc ions, while site 2 has a preference formagnesium and/or manganese ions. {ECO:0000250};SUBUNIT: Oligomer composed of two catalytic chains (alpha andbeta), an inhibitory chain (gamma) and the delta chain.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=3;Name=1;IsoId=P35913-1; Sequence=Displayed;Name=2;IsoId=P35913-2; Sequence=VSP_036884;Name=3;IsoId=P35913-3; Sequence=VSP_044919;Note=No experimental confirmation available.;DISEASE: Retinitis pigmentosa 40 (RP40) [MIM:613801]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:22334370,ECO:0000269|PubMed:8394174, ECO:0000269|PubMed:8557257,ECO:0000269|PubMed:8595886, ECO:0000269|PubMed:8698075,ECO:0000269|PubMed:8956055, ECO:0000269|PubMed:9543643}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 2 (CSNBAD2) [MIM:163500]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:8075643}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the cyclic nucleotide phosphodiesterasefamily. {ECO:0000305}.WEB RESOURCE: Name=Mutations of the PDE6A/B/G genes; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/pdemut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29727"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29731"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","PDE6B"],["bp:entityReference_http://identifiers.org/uniprot/P35913",[["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P35913"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P35913"]]],["bp:standardName","Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta"],["bp:xref",[["bp:id","P35913"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","PDE6B"],["bp:db","hgnc symbol"]]],["bp:organism",[["bp:relationshipType",null],["bp:id","PDE6B"],["bp:db","hgnc symbol"]]],["bp:displayName","PDE6B_HUMAN"],["bp:name","PDEB"],["bp:name","3.1.4.35"],["bp:name","PDE6B"],["bp:name","GMP-PDE beta"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_5158"],["bp:comment","PDE6B_HUMAN Reviewed; 854 AA."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01571_identity"],["bp:comment","REPLACED http://www.humanmetabolism.org/#ref_http://www.humanmetabolism.org/#protein_PDE6B"],["bp:comment","FUNCTION: This protein participates in processes of transmissionand amplification of the visual signal. Necessary for theformation of a functional phosphodiesterase holoenzyme.CATALYTIC ACTIVITY: Guanosine 3',5'-cyclic phosphate + H(2)O =guanosine 5'-phosphate.COFACTOR:Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240;Evidence={ECO:0000250};Note=Binds 2 divalent metal cations per subunit. Site 1 maypreferentially bind zinc ions, while site 2 has a preference formagnesium and/or manganese ions. {ECO:0000250};SUBUNIT: Oligomer composed of two catalytic chains (alpha andbeta), an inhibitory chain (gamma) and the delta chain.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=3;Name=1;IsoId=P35913-1; Sequence=Displayed;Name=2;IsoId=P35913-2; Sequence=VSP_036884;Name=3;IsoId=P35913-3; Sequence=VSP_044919;Note=No experimental confirmation available.;DISEASE: Retinitis pigmentosa 40 (RP40) [MIM:613801]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:22334370,ECO:0000269|PubMed:8394174, ECO:0000269|PubMed:8557257,ECO:0000269|PubMed:8595886, ECO:0000269|PubMed:8698075,ECO:0000269|PubMed:8956055, ECO:0000269|PubMed:9543643}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 2 (CSNBAD2) [MIM:163500]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:8075643}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the cyclic nucleotide phosphodiesterasefamily. {ECO:0000305}.WEB RESOURCE: Name=Mutations of the PDE6A/B/G genes; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/pdemut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29727"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29731"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","PDE6B"],["bp:entityReference_http://identifiers.org/uniprot/P35913",[["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P35913"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P35913"]]],["bp:standardName","Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta"],["bp:xref",[["bp:id","P35913"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","PDE6B"],["bp:db","hgnc symbol"]]],["bp:organism",[["bp:relationshipType",null],["bp:id","PDE6B"],["bp:db","hgnc symbol"]]],["bp:displayName","PDE6B_HUMAN"],["bp:name","PDEB"],["bp:name","3.1.4.35"],["bp:name","PDE6B"],["bp:name","GMP-PDE beta"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_5158"],["bp:comment","PDE6B_HUMAN Reviewed; 854 AA."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01571_identity"],["bp:comment","REPLACED http://www.humanmetabolism.org/#ref_http://www.humanmetabolism.org/#protein_PDE6B"],["bp:comment","FUNCTION: This protein participates in processes of transmissionand amplification of the visual signal. Necessary for theformation of a functional phosphodiesterase holoenzyme.CATALYTIC ACTIVITY: Guanosine 3',5'-cyclic phosphate + H(2)O =guanosine 5'-phosphate.COFACTOR:Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240;Evidence={ECO:0000250};Note=Binds 2 divalent metal cations per subunit. Site 1 maypreferentially bind zinc ions, while site 2 has a preference formagnesium and/or manganese ions. {ECO:0000250};SUBUNIT: Oligomer composed of two catalytic chains (alpha andbeta), an inhibitory chain (gamma) and the delta chain.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=3;Name=1;IsoId=P35913-1; Sequence=Displayed;Name=2;IsoId=P35913-2; Sequence=VSP_036884;Name=3;IsoId=P35913-3; Sequence=VSP_044919;Note=No experimental confirmation available.;DISEASE: Retinitis pigmentosa 40 (RP40) [MIM:613801]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:22334370,ECO:0000269|PubMed:8394174, ECO:0000269|PubMed:8557257,ECO:0000269|PubMed:8595886, ECO:0000269|PubMed:8698075,ECO:0000269|PubMed:8956055, ECO:0000269|PubMed:9543643}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 2 (CSNBAD2) [MIM:163500]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:8075643}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the cyclic nucleotide phosphodiesterasefamily. {ECO:0000305}.WEB RESOURCE: Name=Mutations of the PDE6A/B/G genes; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/pdemut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29727"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29731"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29723"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29723"]]}},{"data":{"id":"Protein_6ce3b51fadf91900491c3fffa3efa81f_Complex_0474d84a6ffcbc5067d637d13cb69efa","class":"macromolecule","label":"PDE6B","parent":"Complex_0474d84a6ffcbc5067d637d13cb69efa","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":345.36047,"y":764.6182,"w":48,"h":25},"metadata":[["bp:displayName","PDE6B"],["bp:entityReference_http://identifiers.org/uniprot/P35913",[["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P35913"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P35913"]]],["bp:standardName","Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta"],["bp:xref",[["bp:id","P35913"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","PDE6B"],["bp:db","hgnc symbol"]]],["bp:organism",[["bp:relationshipType",null],["bp:id","PDE6B"],["bp:db","hgnc symbol"]]],["bp:displayName","PDE6B_HUMAN"],["bp:name","PDEB"],["bp:name","3.1.4.35"],["bp:name","PDE6B"],["bp:name","GMP-PDE beta"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_5158"],["bp:comment","PDE6B_HUMAN Reviewed; 854 AA."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01571_identity"],["bp:comment","REPLACED http://www.humanmetabolism.org/#ref_http://www.humanmetabolism.org/#protein_PDE6B"],["bp:comment","FUNCTION: This protein participates in processes of transmissionand amplification of the visual signal. Necessary for theformation of a functional phosphodiesterase holoenzyme.CATALYTIC ACTIVITY: Guanosine 3',5'-cyclic phosphate + H(2)O =guanosine 5'-phosphate.COFACTOR:Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240;Evidence={ECO:0000250};Note=Binds 2 divalent metal cations per subunit. Site 1 maypreferentially bind zinc ions, while site 2 has a preference formagnesium and/or manganese ions. {ECO:0000250};SUBUNIT: Oligomer composed of two catalytic chains (alpha andbeta), an inhibitory chain (gamma) and the delta chain.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=3;Name=1;IsoId=P35913-1; Sequence=Displayed;Name=2;IsoId=P35913-2; Sequence=VSP_036884;Name=3;IsoId=P35913-3; Sequence=VSP_044919;Note=No experimental confirmation available.;DISEASE: Retinitis pigmentosa 40 (RP40) [MIM:613801]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:22334370,ECO:0000269|PubMed:8394174, ECO:0000269|PubMed:8557257,ECO:0000269|PubMed:8595886, ECO:0000269|PubMed:8698075,ECO:0000269|PubMed:8956055, ECO:0000269|PubMed:9543643}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 2 (CSNBAD2) [MIM:163500]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:8075643}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the cyclic nucleotide phosphodiesterasefamily. {ECO:0000305}.WEB RESOURCE: Name=Mutations of the PDE6A/B/G genes; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/pdemut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29727"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]}},{"data":{"id":"Protein_d8f4da528c4f69813bc1c0472e4c4f6a_Complex_0474d84a6ffcbc5067d637d13cb69efa","class":"macromolecule","label":"PDE6A","parent":"Complex_0474d84a6ffcbc5067d637d13cb69efa","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":345.36047,"y":734.6182,"w":48,"h":25},"metadata":[["bp:displayName","PDE6A"],["bp:entityReference_http://identifiers.org/uniprot/P16499",[["bp:entityFeature",[["bp:modificationType",[["bp:term","N-acetylglycine"],["bp:term","MOD_RES N-acetylglycine"]]],["bp:comment","MOD_RES 2 2 N-acetylglycine."],["bp:featureLocation",[["bp:sequencePosition","2"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Cysteine methyl ester"],["bp:term","MOD_RES Cysteine methyl ester"]]],["bp:comment","MOD_RES 857 857 Cysteine methyl ester."],["bp:featureLocation",[["bp:sequencePosition","857"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P16499"]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P16499"]]],["bp:standardName","Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha"],["bp:xref","Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha"],["bp:xref","Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha"],["bp:organism","Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha"],["bp:displayName","PDE6A_HUMAN"],["bp:name","PDEA"],["bp:name","3.1.4.35"],["bp:name","PDE6A"],["bp:name","PDE V-B1"],["bp:name","GMP-PDE alpha"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01570_identity"],["bp:comment","FUNCTION: This protein participates in processes of transmissionand amplification of the visual signal.CATALYTIC ACTIVITY: Guanosine 3',5'-cyclic phosphate + H(2)O =guanosine 5'-phosphate.COFACTOR:Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240;Evidence={ECO:0000250};Note=Binds 2 divalent metal cations per subunit. Site 1 maypreferentially bind zinc ions, while site 2 has a preference formagnesium and/or manganese ions. {ECO:0000250};SUBUNIT: Oligomer composed of two catalytic chains (alpha andbeta), an inhibitory chain (gamma) and the delta chain.SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Lipid-anchor{ECO:0000305}; Cytoplasmic side {ECO:0000305}.DISEASE: Retinitis pigmentosa 43 (RP43) [MIM:613810]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:10393062,ECO:0000269|PubMed:7493036}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the cyclic nucleotide phosphodiesterasefamily. {ECO:0000305}.WEB RESOURCE: Name=Mutations of the PDE6A/B/G genes; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/pdemut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","PDE6A_HUMAN Reviewed; 860 AA."],["bp:comment","REPLACED http://www.humanmetabolism.org/#ref_http://www.humanmetabolism.org/#protein_PDE6A"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_5145"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000431"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29724"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29724"]]}},{"data":{"id":"Complex_681c549d7df39ee36faec933344df711","class":"complex","label":"GNAT1/GDP","parent":"","clonemarker":false,"stateVariables":[{"id":"Complex_681c549d7df39ee36faec933344df711.info.1","class":"state variable","state":{"variable":"","value":"Ina"}}],"unitsOfInformation":[],"bbox":{"x":425.9336,"y":514.39618,"w":52,"h":54},"metadata":[["bp:displayName","GNAT1/GDP"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29522"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29522"]]}},{"data":{"id":"SmallMolecule_2544e7a4b5003313120ca13ed284937d_Complex_681c549d7df39ee36faec933344df711","class":"simple chemical","label":"GDP","parent":"Complex_681c549d7df39ee36faec933344df711","clonemarker":true,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":424.4336,"y":531.8962,"w":45,"h":15},"metadata":[["bp:displayName","GDP"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17552",[["bp:standardName","guanosine 5'-(trihydrogen diphosphate)"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37121"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:65180"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:5212"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37038"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:24448"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:14379"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:42738"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:76971"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:76971"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:76971"],["bp:db","chebi"]]],["bp:chemicalFormula","C10H15N5O11P2"],["bp:displayName","GDP"],["bp:name","C10H15N5O11P2"],["bp:name","Guanosine diphosphate"],["bp:name","Nc1nc2n(cnc2c(=O)[nH]1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O"],["bp:name","Guanosine 5'-diphosphate"],["bp:molecularWeight","443.2007"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00035.eref"],["bp:comment","has_role CHEBI:76971"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/SmallMoleculeReference_bind_1035_identity"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB04315"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_302"],["bp:comment","REPLACED http://identifiers.org/cas/146-91-8"],["bp:comment","is_a CHEBI:37038"],["bp:comment","is_conjugate_acid_of CHEBI:65180"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/glG10620.eref"],["bp:comment","REPLACED http://www.inoh.org/biopax/IMR_0001357_GDP"],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:37121"],["bp:structure","is_a CHEBI:37121"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_301"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_301"]]}},{"data":{"id":"Protein_e4ab0eff9265bbdc4140f63f513badef_Complex_681c549d7df39ee36faec933344df711","class":"macromolecule","label":"GNAT1","parent":"Complex_681c549d7df39ee36faec933344df711","clonemarker":false,"stateVariables":[{"id":"Protein_e4ab0eff9265bbdc4140f63f513badef_Complex_681c549d7df39ee36faec933344df711.info.1","class":"state variable","state":{"variable":"1","value":"N-acetyl-L-methionine"}}],"unitsOfInformation":[],"bbox":{"x":425.9336,"y":501.89618,"w":48,"h":25},"metadata":[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]}},{"data":{"id":"SmallMolecule_591e0b6209251306d628e16e6156d216","class":"simple chemical","label":"11-cis-retinol","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":1055.0442,"y":308.04166,"w":48,"h":20},"metadata":[["bp:displayName","11-cis-retinol"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16302",[["bp:standardName","11-cis-retinol"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11310"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:19120"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:728"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11312"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H30O"],["bp:displayName","11-cis-retinol"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\CO"],["bp:name","11-cis-Retinol"],["bp:name","C20H30O"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol"],["bp:molecularWeight","286.23"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00899.eref"],["bp:comment","has_role CHEBI:75771"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMoleculeReference75454"],["bp:comment","is_a CHEBI:50211"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29628"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/C20H30O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,21H,7,10,14-15H2,1-5H3/b9-6-,12-11+,16-8+,17-13+"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29627"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29627"]]}},{"data":{"id":"Complex_0bb5c23dbe663791dc41f100b9a03e6d","class":"complex","label":"CNG Channel","parent":"","clonemarker":false,"stateVariables":[{"id":"Complex_0bb5c23dbe663791dc41f100b9a03e6d.info.1","class":"state variable","state":{"variable":"","value":"Ina"}}],"unitsOfInformation":[],"bbox":{"x":429.866,"y":856.3789,"w":52,"h":59},"metadata":[["bp:displayName","CNG Channel"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","CNGA1"],["bp:entityReference_http://identifiers.org/uniprot/P29973",[["bp:standardName","cGMP-gated cation channel alpha-1"],["bp:xref",[["bp:relationshipType",null],["bp:id","CNGA1"],["bp:db","hgnc symbol"]]],["bp:xref",[["bp:id","P29973"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","P29973"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","CNGA1_HUMAN"],["bp:name","Cyclic nucleotide-gated channel alpha-1"],["bp:name","CNCG1"],["bp:name","Cyclic nucleotide-gated channel, photoreceptor"],["bp:name","CNG1"],["bp:name","CNGA1"],["bp:name","CNG channel alpha-1"],["bp:name","CNCG"],["bp:name","Rod photoreceptor cGMP-gated channel subunit alpha"],["bp:name","CNG-1"],["bp:name","Cyclic nucleotide-gated cation channel 1"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_00445_identity"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_1259"],["bp:comment","FUNCTION: Visual signal transduction is mediated by a G-proteincoupled cascade using cGMP as second messenger. This protein canbe activated by cyclic GMP which leads to an opening of the cationchannel and thereby causing a depolarization of rodphotoreceptors.SUBUNIT: Tetramer formed of three CNGA1 and one CNGB1 modulatorysubunits. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=2;Name=1;IsoId=P29973-1; Sequence=Displayed;Name=2;IsoId=P29973-2; Sequence=VSP_047170;Note=No experimental confirmation available.;TISSUE SPECIFICITY: Rod cells in the retina.DOMAIN: The C-terminal coiled-coil domain mediateshomotrimerization of CNGA subunits. {ECO:0000250}.DISEASE: Retinitis pigmentosa 49 (RP49) [MIM:613756]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:15570217,ECO:0000269|PubMed:7479749}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel(TC 1.A.1.5) family. CNGA1 subfamily. {ECO:0000305}.CAUTION: It is uncertain whether Met-1 or Met-5 is the initiator.{ECO:0000305}.SEQUENCE CAUTION:Sequence=AAB22778.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the CNGA1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/cnga1mut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/XP_005248106"],["bp:comment","CNGA1_HUMAN Reviewed; 690 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29693"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29707"],["bp:stoichiometricCoefficient","3.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","CNGB1"],["bp:entityReference_http://identifiers.org/uniprot/Q14028",[["bp:standardName","Cyclic nucleotide-gated cation channel beta-1"],["bp:xref",[["bp:id","Q14028"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:id","Q14028"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","Q14028"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","CNGB1_HUMAN"],["bp:name","CNCG4"],["bp:name","CNCG2"],["bp:name","CNG4"],["bp:name","CNG channel 4"],["bp:name","CNGB1"],["bp:name","CNG-4"],["bp:name","RCNC2"],["bp:name","Glutamic acid-rich protein"],["bp:name","Cyclic nucleotide-gated cation channel 4"],["bp:name","CNCG3L"],["bp:name","GARP"],["bp:name","Cyclic nucleotide-gated cation channel modulatory subunit"],["bp:name","Cyclic nucleotide-gated channel beta-1"],["bp:name","Cyclic nucleotide-gated cation channel gamma"],["bp:name","CNG channel beta-1"],["bp:comment","FUNCTION: Subunit of cyclic nucleotide-gated (CNG) channels,nonselective cation channels, which play important roles in bothvisual and olfactory signal transduction. When associated withCNGA1, it is involved in the regulation of ion flow into the rodphotoreceptor outer segment (ROS), in response to light-inducedalteration of the levels of intracellular cGMP.FUNCTION: Isoform GARP2 is a high affinity rod photoreceptorphosphodiesterase (PDE6)-binding protein that modulates itscatalytic properties: it is a regulator of spontaneous activationof rod PDE6, thereby serving to lower rod photoreceptor 'darknoise' and allowing these sensory cells to operate at the singlephoton detection limit.SUBUNIT: Tetramer formed of three CNGA1 and one CNGB1 modulatorysubunits. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=4;Comment=There is no evidence for an ortholog to bovine GARP1 inthe human genome.;Name=RCNC2B;IsoId=Q14028-1; Sequence=Displayed;Name=RCNC2A;IsoId=Q14028-2; Sequence=VSP_001110;Name=GARP2; Synonyms=GARP;IsoId=Q14028-3; Sequence=VSP_037921, VSP_037922;Note=In the rod cells, the CNGB1 locus encodes the cyclicnucleotide-gated cation channel beta-1 subunit and severalglutamic-acid-rich proteins (GARPs).;Name=4;IsoId=Q14028-4; Sequence=VSP_053421;DISEASE: Retinitis pigmentosa 45 (RP45) [MIM:613767]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:11379879}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel(TC 1.A.1.5) family. CNGB1 subfamily. {ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","CNGB1_HUMAN Reviewed; 1251 AA."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_07204_identity"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_1258"],["bp:comment","REPLACED http://identifiers.org/uniprot/Q9UMG2"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_1258"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29708"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","CNGB1"],["bp:entityReference_http://identifiers.org/uniprot/Q14028",[["bp:standardName","Cyclic nucleotide-gated cation channel beta-1"],["bp:xref",[["bp:id","Q14028"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:id","Q14028"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","Q14028"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","CNGB1_HUMAN"],["bp:name","CNCG4"],["bp:name","CNCG2"],["bp:name","CNG4"],["bp:name","CNG channel 4"],["bp:name","CNGB1"],["bp:name","CNG-4"],["bp:name","RCNC2"],["bp:name","Glutamic acid-rich protein"],["bp:name","Cyclic nucleotide-gated cation channel 4"],["bp:name","CNCG3L"],["bp:name","GARP"],["bp:name","Cyclic nucleotide-gated cation channel modulatory subunit"],["bp:name","Cyclic nucleotide-gated channel beta-1"],["bp:name","Cyclic nucleotide-gated cation channel gamma"],["bp:name","CNG channel beta-1"],["bp:comment","FUNCTION: Subunit of cyclic nucleotide-gated (CNG) channels,nonselective cation channels, which play important roles in bothvisual and olfactory signal transduction. When associated withCNGA1, it is involved in the regulation of ion flow into the rodphotoreceptor outer segment (ROS), in response to light-inducedalteration of the levels of intracellular cGMP.FUNCTION: Isoform GARP2 is a high affinity rod photoreceptorphosphodiesterase (PDE6)-binding protein that modulates itscatalytic properties: it is a regulator of spontaneous activationof rod PDE6, thereby serving to lower rod photoreceptor 'darknoise' and allowing these sensory cells to operate at the singlephoton detection limit.SUBUNIT: Tetramer formed of three CNGA1 and one CNGB1 modulatorysubunits. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=4;Comment=There is no evidence for an ortholog to bovine GARP1 inthe human genome.;Name=RCNC2B;IsoId=Q14028-1; Sequence=Displayed;Name=RCNC2A;IsoId=Q14028-2; Sequence=VSP_001110;Name=GARP2; Synonyms=GARP;IsoId=Q14028-3; Sequence=VSP_037921, VSP_037922;Note=In the rod cells, the CNGB1 locus encodes the cyclicnucleotide-gated cation channel beta-1 subunit and severalglutamic-acid-rich proteins (GARPs).;Name=4;IsoId=Q14028-4; Sequence=VSP_053421;DISEASE: Retinitis pigmentosa 45 (RP45) [MIM:613767]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:11379879}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel(TC 1.A.1.5) family. CNGB1 subfamily. {ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","CNGB1_HUMAN Reviewed; 1251 AA."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_07204_identity"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_1258"],["bp:comment","REPLACED http://identifiers.org/uniprot/Q9UMG2"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_1258"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29708"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","CNGB1"],["bp:entityReference_http://identifiers.org/uniprot/Q14028",[["bp:standardName","Cyclic nucleotide-gated cation channel beta-1"],["bp:xref",[["bp:id","Q14028"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:id","Q14028"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","Q14028"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","CNGB1_HUMAN"],["bp:name","CNCG4"],["bp:name","CNCG2"],["bp:name","CNG4"],["bp:name","CNG channel 4"],["bp:name","CNGB1"],["bp:name","CNG-4"],["bp:name","RCNC2"],["bp:name","Glutamic acid-rich protein"],["bp:name","Cyclic nucleotide-gated cation channel 4"],["bp:name","CNCG3L"],["bp:name","GARP"],["bp:name","Cyclic nucleotide-gated cation channel modulatory subunit"],["bp:name","Cyclic nucleotide-gated channel beta-1"],["bp:name","Cyclic nucleotide-gated cation channel gamma"],["bp:name","CNG channel beta-1"],["bp:comment","FUNCTION: Subunit of cyclic nucleotide-gated (CNG) channels,nonselective cation channels, which play important roles in bothvisual and olfactory signal transduction. When associated withCNGA1, it is involved in the regulation of ion flow into the rodphotoreceptor outer segment (ROS), in response to light-inducedalteration of the levels of intracellular cGMP.FUNCTION: Isoform GARP2 is a high affinity rod photoreceptorphosphodiesterase (PDE6)-binding protein that modulates itscatalytic properties: it is a regulator of spontaneous activationof rod PDE6, thereby serving to lower rod photoreceptor 'darknoise' and allowing these sensory cells to operate at the singlephoton detection limit.SUBUNIT: Tetramer formed of three CNGA1 and one CNGB1 modulatorysubunits. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=4;Comment=There is no evidence for an ortholog to bovine GARP1 inthe human genome.;Name=RCNC2B;IsoId=Q14028-1; Sequence=Displayed;Name=RCNC2A;IsoId=Q14028-2; Sequence=VSP_001110;Name=GARP2; Synonyms=GARP;IsoId=Q14028-3; Sequence=VSP_037921, VSP_037922;Note=In the rod cells, the CNGB1 locus encodes the cyclicnucleotide-gated cation channel beta-1 subunit and severalglutamic-acid-rich proteins (GARPs).;Name=4;IsoId=Q14028-4; Sequence=VSP_053421;DISEASE: Retinitis pigmentosa 45 (RP45) [MIM:613767]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:11379879}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel(TC 1.A.1.5) family. CNGB1 subfamily. {ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","CNGB1_HUMAN Reviewed; 1251 AA."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_07204_identity"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_1258"],["bp:comment","REPLACED http://identifiers.org/uniprot/Q9UMG2"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_1258"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29708"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","CNGB1"],["bp:entityReference_http://identifiers.org/uniprot/Q14028",[["bp:standardName","Cyclic nucleotide-gated cation channel beta-1"],["bp:xref",[["bp:id","Q14028"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:id","Q14028"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","Q14028"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","CNGB1_HUMAN"],["bp:name","CNCG4"],["bp:name","CNCG2"],["bp:name","CNG4"],["bp:name","CNG channel 4"],["bp:name","CNGB1"],["bp:name","CNG-4"],["bp:name","RCNC2"],["bp:name","Glutamic acid-rich protein"],["bp:name","Cyclic nucleotide-gated cation channel 4"],["bp:name","CNCG3L"],["bp:name","GARP"],["bp:name","Cyclic nucleotide-gated cation channel modulatory subunit"],["bp:name","Cyclic nucleotide-gated channel beta-1"],["bp:name","Cyclic nucleotide-gated cation channel gamma"],["bp:name","CNG channel beta-1"],["bp:comment","FUNCTION: Subunit of cyclic nucleotide-gated (CNG) channels,nonselective cation channels, which play important roles in bothvisual and olfactory signal transduction. When associated withCNGA1, it is involved in the regulation of ion flow into the rodphotoreceptor outer segment (ROS), in response to light-inducedalteration of the levels of intracellular cGMP.FUNCTION: Isoform GARP2 is a high affinity rod photoreceptorphosphodiesterase (PDE6)-binding protein that modulates itscatalytic properties: it is a regulator of spontaneous activationof rod PDE6, thereby serving to lower rod photoreceptor 'darknoise' and allowing these sensory cells to operate at the singlephoton detection limit.SUBUNIT: Tetramer formed of three CNGA1 and one CNGB1 modulatorysubunits. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=4;Comment=There is no evidence for an ortholog to bovine GARP1 inthe human genome.;Name=RCNC2B;IsoId=Q14028-1; Sequence=Displayed;Name=RCNC2A;IsoId=Q14028-2; Sequence=VSP_001110;Name=GARP2; Synonyms=GARP;IsoId=Q14028-3; Sequence=VSP_037921, VSP_037922;Note=In the rod cells, the CNGB1 locus encodes the cyclicnucleotide-gated cation channel beta-1 subunit and severalglutamic-acid-rich proteins (GARPs).;Name=4;IsoId=Q14028-4; Sequence=VSP_053421;DISEASE: Retinitis pigmentosa 45 (RP45) [MIM:613767]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:11379879}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel(TC 1.A.1.5) family. CNGB1 subfamily. {ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","CNGB1_HUMAN Reviewed; 1251 AA."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_07204_identity"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_1258"],["bp:comment","REPLACED http://identifiers.org/uniprot/Q9UMG2"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_1258"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29708"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29706"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29706"]]}},{"data":{"id":"Protein_fb83bda4c371013f9121bce5c93f7e36_Complex_0bb5c23dbe663791dc41f100b9a03e6d","class":"macromolecule","label":"CNGA1","parent":"Complex_0bb5c23dbe663791dc41f100b9a03e6d","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":429.866,"y":871.3789,"w":48,"h":25},"metadata":[["bp:displayName","CNGA1"],["bp:entityReference_http://identifiers.org/uniprot/P29973",[["bp:standardName","cGMP-gated cation channel alpha-1"],["bp:xref",[["bp:relationshipType",null],["bp:id","CNGA1"],["bp:db","hgnc symbol"]]],["bp:xref",[["bp:id","P29973"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","P29973"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","CNGA1_HUMAN"],["bp:name","Cyclic nucleotide-gated channel alpha-1"],["bp:name","CNCG1"],["bp:name","Cyclic nucleotide-gated channel, photoreceptor"],["bp:name","CNG1"],["bp:name","CNGA1"],["bp:name","CNG channel alpha-1"],["bp:name","CNCG"],["bp:name","Rod photoreceptor cGMP-gated channel subunit alpha"],["bp:name","CNG-1"],["bp:name","Cyclic nucleotide-gated cation channel 1"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_00445_identity"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_1259"],["bp:comment","FUNCTION: Visual signal transduction is mediated by a G-proteincoupled cascade using cGMP as second messenger. This protein canbe activated by cyclic GMP which leads to an opening of the cationchannel and thereby causing a depolarization of rodphotoreceptors.SUBUNIT: Tetramer formed of three CNGA1 and one CNGB1 modulatorysubunits. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=2;Name=1;IsoId=P29973-1; Sequence=Displayed;Name=2;IsoId=P29973-2; Sequence=VSP_047170;Note=No experimental confirmation available.;TISSUE SPECIFICITY: Rod cells in the retina.DOMAIN: The C-terminal coiled-coil domain mediateshomotrimerization of CNGA subunits. {ECO:0000250}.DISEASE: Retinitis pigmentosa 49 (RP49) [MIM:613756]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:15570217,ECO:0000269|PubMed:7479749}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel(TC 1.A.1.5) family. CNGA1 subfamily. {ECO:0000305}.CAUTION: It is uncertain whether Met-1 or Met-5 is the initiator.{ECO:0000305}.SEQUENCE CAUTION:Sequence=AAB22778.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the CNGA1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/cnga1mut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/XP_005248106"],["bp:comment","CNGA1_HUMAN Reviewed; 690 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29693"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]}},{"data":{"id":"Protein_5ba98a5f4e066cfe9d858ffbda349c69_Complex_0bb5c23dbe663791dc41f100b9a03e6d","class":"macromolecule","label":"CNGB1","parent":"Complex_0bb5c23dbe663791dc41f100b9a03e6d","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":429.866,"y":841.3789,"w":48,"h":25},"metadata":[["bp:displayName","CNGB1"],["bp:entityReference_http://identifiers.org/uniprot/Q14028",[["bp:standardName","Cyclic nucleotide-gated cation channel beta-1"],["bp:xref",[["bp:id","Q14028"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CNGB1"],["bp:db","hgnc symbol"]]],["bp:organism",[["bp:relationshipType",null],["bp:id","CNGB1"],["bp:db","hgnc symbol"]]],["bp:displayName","CNGB1_HUMAN"],["bp:name","CNCG4"],["bp:name","CNCG2"],["bp:name","CNG4"],["bp:name","CNG channel 4"],["bp:name","CNGB1"],["bp:name","CNG-4"],["bp:name","RCNC2"],["bp:name","Glutamic acid-rich protein"],["bp:name","Cyclic nucleotide-gated cation channel 4"],["bp:name","CNCG3L"],["bp:name","GARP"],["bp:name","Cyclic nucleotide-gated cation channel modulatory subunit"],["bp:name","Cyclic nucleotide-gated channel beta-1"],["bp:name","Cyclic nucleotide-gated cation channel gamma"],["bp:name","CNG channel beta-1"],["bp:comment","FUNCTION: Subunit of cyclic nucleotide-gated (CNG) channels,nonselective cation channels, which play important roles in bothvisual and olfactory signal transduction. When associated withCNGA1, it is involved in the regulation of ion flow into the rodphotoreceptor outer segment (ROS), in response to light-inducedalteration of the levels of intracellular cGMP.FUNCTION: Isoform GARP2 is a high affinity rod photoreceptorphosphodiesterase (PDE6)-binding protein that modulates itscatalytic properties: it is a regulator of spontaneous activationof rod PDE6, thereby serving to lower rod photoreceptor 'darknoise' and allowing these sensory cells to operate at the singlephoton detection limit.SUBUNIT: Tetramer formed of three CNGA1 and one CNGB1 modulatorysubunits. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=4;Comment=There is no evidence for an ortholog to bovine GARP1 inthe human genome.;Name=RCNC2B;IsoId=Q14028-1; Sequence=Displayed;Name=RCNC2A;IsoId=Q14028-2; Sequence=VSP_001110;Name=GARP2; Synonyms=GARP;IsoId=Q14028-3; Sequence=VSP_037921, VSP_037922;Note=In the rod cells, the CNGB1 locus encodes the cyclicnucleotide-gated cation channel beta-1 subunit and severalglutamic-acid-rich proteins (GARPs).;Name=4;IsoId=Q14028-4; Sequence=VSP_053421;DISEASE: Retinitis pigmentosa 45 (RP45) [MIM:613767]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:11379879}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel(TC 1.A.1.5) family. CNGB1 subfamily. {ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","CNGB1_HUMAN Reviewed; 1251 AA."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_07204_identity"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_1258"],["bp:comment","REPLACED http://identifiers.org/uniprot/Q9UMG2"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_1258"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]}},{"data":{"id":"ComplexAssembly_d15ded55f902648b3b2f9ad1aebe99d7_LEFT_TO_RIGHT","class":"process","label":"","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":289.0595,"y":650.6293,"w":15,"h":15},"metadata":[["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1/GTP"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29653"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29653"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29865"],["bp:stoichiometricCoefficient","2.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1/GTP"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29653"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29653"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29865"],["bp:stoichiometricCoefficient","2.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1/GTP"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29653"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29653"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29865"],["bp:stoichiometricCoefficient","2.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1/GTP"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29653"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29653"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29865"],["bp:stoichiometricCoefficient","2.0"]]],["bp:xref",[["bp:physicalEntity",[["bp:displayName","GNAT1/GTP"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29653"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29653"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29865"],["bp:stoichiometricCoefficient","2.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","GNAT1/GTP"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29653"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29653"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29865"],["bp:stoichiometricCoefficient","2.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","GNAT1/GTP"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29653"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29653"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29865"],["bp:stoichiometricCoefficient","2.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","GNAT1/GTP"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29653"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29653"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29865"],["bp:stoichiometricCoefficient","2.0"]]],["bp:right",[["bp:physicalEntity",[["bp:displayName","GNAT1/GTP"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29653"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29653"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29865"],["bp:stoichiometricCoefficient","2.0"]]],["bp:right",[["bp:physicalEntity",[["bp:displayName","GNAT1/GTP"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29653"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29653"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29865"],["bp:stoichiometricCoefficient","2.0"]]],["bp:spontaneous","true"],["bp:left","true"],["bp:left","true"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29853"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29853"]]}},{"data":{"id":"Complex_7ffe09f1835e4d2f8483e067d5f712ff","class":"complex","label":"PDE6","parent":"","clonemarker":false,"stateVariables":[{"id":"Complex_7ffe09f1835e4d2f8483e067d5f712ff.info.1","class":"state variable","state":{"variable":"","value":"Act"}}],"unitsOfInformation":[],"bbox":{"x":519.6338949999999,"y":439.72067,"w":52.00003,"h":89},"metadata":[["bp:displayName","PDE6"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","PDE6B"],["bp:entityReference_http://identifiers.org/uniprot/P35913",[["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P35913"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P35913"]]],["bp:standardName","Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta"],["bp:xref",[["bp:id","P35913"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","PDE6B"],["bp:db","hgnc symbol"]]],["bp:organism",[["bp:relationshipType",null],["bp:id","PDE6B"],["bp:db","hgnc symbol"]]],["bp:displayName","PDE6B_HUMAN"],["bp:name","PDEB"],["bp:name","3.1.4.35"],["bp:name","PDE6B"],["bp:name","GMP-PDE beta"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_5158"],["bp:comment","PDE6B_HUMAN Reviewed; 854 AA."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01571_identity"],["bp:comment","REPLACED http://www.humanmetabolism.org/#ref_http://www.humanmetabolism.org/#protein_PDE6B"],["bp:comment","FUNCTION: This protein participates in processes of transmissionand amplification of the visual signal. Necessary for theformation of a functional phosphodiesterase holoenzyme.CATALYTIC ACTIVITY: Guanosine 3',5'-cyclic phosphate + H(2)O =guanosine 5'-phosphate.COFACTOR:Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240;Evidence={ECO:0000250};Note=Binds 2 divalent metal cations per subunit. Site 1 maypreferentially bind zinc ions, while site 2 has a preference formagnesium and/or manganese ions. {ECO:0000250};SUBUNIT: Oligomer composed of two catalytic chains (alpha andbeta), an inhibitory chain (gamma) and the delta chain.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=3;Name=1;IsoId=P35913-1; Sequence=Displayed;Name=2;IsoId=P35913-2; Sequence=VSP_036884;Name=3;IsoId=P35913-3; Sequence=VSP_044919;Note=No experimental confirmation available.;DISEASE: Retinitis pigmentosa 40 (RP40) [MIM:613801]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:22334370,ECO:0000269|PubMed:8394174, ECO:0000269|PubMed:8557257,ECO:0000269|PubMed:8595886, ECO:0000269|PubMed:8698075,ECO:0000269|PubMed:8956055, ECO:0000269|PubMed:9543643}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 2 (CSNBAD2) [MIM:163500]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:8075643}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the cyclic nucleotide phosphodiesterasefamily. {ECO:0000305}.WEB RESOURCE: Name=Mutations of the PDE6A/B/G genes; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/pdemut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29727"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29825"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","PDE6B"],["bp:entityReference_http://identifiers.org/uniprot/P35913",[["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P35913"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P35913"]]],["bp:standardName","Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta"],["bp:xref",[["bp:id","P35913"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","PDE6B"],["bp:db","hgnc symbol"]]],["bp:organism",[["bp:relationshipType",null],["bp:id","PDE6B"],["bp:db","hgnc symbol"]]],["bp:displayName","PDE6B_HUMAN"],["bp:name","PDEB"],["bp:name","3.1.4.35"],["bp:name","PDE6B"],["bp:name","GMP-PDE beta"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_5158"],["bp:comment","PDE6B_HUMAN Reviewed; 854 AA."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01571_identity"],["bp:comment","REPLACED http://www.humanmetabolism.org/#ref_http://www.humanmetabolism.org/#protein_PDE6B"],["bp:comment","FUNCTION: This protein participates in processes of transmissionand amplification of the visual signal. Necessary for theformation of a functional phosphodiesterase holoenzyme.CATALYTIC ACTIVITY: Guanosine 3',5'-cyclic phosphate + H(2)O =guanosine 5'-phosphate.COFACTOR:Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240;Evidence={ECO:0000250};Note=Binds 2 divalent metal cations per subunit. Site 1 maypreferentially bind zinc ions, while site 2 has a preference formagnesium and/or manganese ions. {ECO:0000250};SUBUNIT: Oligomer composed of two catalytic chains (alpha andbeta), an inhibitory chain (gamma) and the delta chain.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=3;Name=1;IsoId=P35913-1; Sequence=Displayed;Name=2;IsoId=P35913-2; Sequence=VSP_036884;Name=3;IsoId=P35913-3; Sequence=VSP_044919;Note=No experimental confirmation available.;DISEASE: Retinitis pigmentosa 40 (RP40) [MIM:613801]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:22334370,ECO:0000269|PubMed:8394174, ECO:0000269|PubMed:8557257,ECO:0000269|PubMed:8595886, ECO:0000269|PubMed:8698075,ECO:0000269|PubMed:8956055, ECO:0000269|PubMed:9543643}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 2 (CSNBAD2) [MIM:163500]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:8075643}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the cyclic nucleotide phosphodiesterasefamily. {ECO:0000305}.WEB RESOURCE: Name=Mutations of the PDE6A/B/G genes; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/pdemut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29727"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29825"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","PDE6B"],["bp:entityReference_http://identifiers.org/uniprot/P35913",[["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P35913"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P35913"]]],["bp:standardName","Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta"],["bp:xref",[["bp:id","P35913"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","PDE6B"],["bp:db","hgnc symbol"]]],["bp:organism",[["bp:relationshipType",null],["bp:id","PDE6B"],["bp:db","hgnc symbol"]]],["bp:displayName","PDE6B_HUMAN"],["bp:name","PDEB"],["bp:name","3.1.4.35"],["bp:name","PDE6B"],["bp:name","GMP-PDE beta"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_5158"],["bp:comment","PDE6B_HUMAN Reviewed; 854 AA."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01571_identity"],["bp:comment","REPLACED http://www.humanmetabolism.org/#ref_http://www.humanmetabolism.org/#protein_PDE6B"],["bp:comment","FUNCTION: This protein participates in processes of transmissionand amplification of the visual signal. Necessary for theformation of a functional phosphodiesterase holoenzyme.CATALYTIC ACTIVITY: Guanosine 3',5'-cyclic phosphate + H(2)O =guanosine 5'-phosphate.COFACTOR:Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240;Evidence={ECO:0000250};Note=Binds 2 divalent metal cations per subunit. Site 1 maypreferentially bind zinc ions, while site 2 has a preference formagnesium and/or manganese ions. {ECO:0000250};SUBUNIT: Oligomer composed of two catalytic chains (alpha andbeta), an inhibitory chain (gamma) and the delta chain.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=3;Name=1;IsoId=P35913-1; Sequence=Displayed;Name=2;IsoId=P35913-2; Sequence=VSP_036884;Name=3;IsoId=P35913-3; Sequence=VSP_044919;Note=No experimental confirmation available.;DISEASE: Retinitis pigmentosa 40 (RP40) [MIM:613801]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:22334370,ECO:0000269|PubMed:8394174, ECO:0000269|PubMed:8557257,ECO:0000269|PubMed:8595886, ECO:0000269|PubMed:8698075,ECO:0000269|PubMed:8956055, ECO:0000269|PubMed:9543643}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 2 (CSNBAD2) [MIM:163500]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:8075643}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the cyclic nucleotide phosphodiesterasefamily. {ECO:0000305}.WEB RESOURCE: Name=Mutations of the PDE6A/B/G genes; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/pdemut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29727"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29825"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","PDE6B"],["bp:entityReference_http://identifiers.org/uniprot/P35913",[["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P35913"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P35913"]]],["bp:standardName","Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta"],["bp:xref",[["bp:id","P35913"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","PDE6B"],["bp:db","hgnc symbol"]]],["bp:organism",[["bp:relationshipType",null],["bp:id","PDE6B"],["bp:db","hgnc symbol"]]],["bp:displayName","PDE6B_HUMAN"],["bp:name","PDEB"],["bp:name","3.1.4.35"],["bp:name","PDE6B"],["bp:name","GMP-PDE beta"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_5158"],["bp:comment","PDE6B_HUMAN Reviewed; 854 AA."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01571_identity"],["bp:comment","REPLACED http://www.humanmetabolism.org/#ref_http://www.humanmetabolism.org/#protein_PDE6B"],["bp:comment","FUNCTION: This protein participates in processes of transmissionand amplification of the visual signal. Necessary for theformation of a functional phosphodiesterase holoenzyme.CATALYTIC ACTIVITY: Guanosine 3',5'-cyclic phosphate + H(2)O =guanosine 5'-phosphate.COFACTOR:Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240;Evidence={ECO:0000250};Note=Binds 2 divalent metal cations per subunit. Site 1 maypreferentially bind zinc ions, while site 2 has a preference formagnesium and/or manganese ions. {ECO:0000250};SUBUNIT: Oligomer composed of two catalytic chains (alpha andbeta), an inhibitory chain (gamma) and the delta chain.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=3;Name=1;IsoId=P35913-1; Sequence=Displayed;Name=2;IsoId=P35913-2; Sequence=VSP_036884;Name=3;IsoId=P35913-3; Sequence=VSP_044919;Note=No experimental confirmation available.;DISEASE: Retinitis pigmentosa 40 (RP40) [MIM:613801]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:22334370,ECO:0000269|PubMed:8394174, ECO:0000269|PubMed:8557257,ECO:0000269|PubMed:8595886, ECO:0000269|PubMed:8698075,ECO:0000269|PubMed:8956055, ECO:0000269|PubMed:9543643}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 2 (CSNBAD2) [MIM:163500]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:8075643}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the cyclic nucleotide phosphodiesterasefamily. {ECO:0000305}.WEB RESOURCE: Name=Mutations of the PDE6A/B/G genes; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/pdemut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29727"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29825"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","PDE6B"],["bp:entityReference_http://identifiers.org/uniprot/P35913",[["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P35913"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P35913"]]],["bp:standardName","Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta"],["bp:xref",[["bp:id","P35913"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","PDE6B"],["bp:db","hgnc symbol"]]],["bp:organism",[["bp:relationshipType",null],["bp:id","PDE6B"],["bp:db","hgnc symbol"]]],["bp:displayName","PDE6B_HUMAN"],["bp:name","PDEB"],["bp:name","3.1.4.35"],["bp:name","PDE6B"],["bp:name","GMP-PDE beta"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_5158"],["bp:comment","PDE6B_HUMAN Reviewed; 854 AA."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01571_identity"],["bp:comment","REPLACED http://www.humanmetabolism.org/#ref_http://www.humanmetabolism.org/#protein_PDE6B"],["bp:comment","FUNCTION: This protein participates in processes of transmissionand amplification of the visual signal. Necessary for theformation of a functional phosphodiesterase holoenzyme.CATALYTIC ACTIVITY: Guanosine 3',5'-cyclic phosphate + H(2)O =guanosine 5'-phosphate.COFACTOR:Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240;Evidence={ECO:0000250};Note=Binds 2 divalent metal cations per subunit. Site 1 maypreferentially bind zinc ions, while site 2 has a preference formagnesium and/or manganese ions. {ECO:0000250};SUBUNIT: Oligomer composed of two catalytic chains (alpha andbeta), an inhibitory chain (gamma) and the delta chain.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=3;Name=1;IsoId=P35913-1; Sequence=Displayed;Name=2;IsoId=P35913-2; Sequence=VSP_036884;Name=3;IsoId=P35913-3; Sequence=VSP_044919;Note=No experimental confirmation available.;DISEASE: Retinitis pigmentosa 40 (RP40) [MIM:613801]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:22334370,ECO:0000269|PubMed:8394174, ECO:0000269|PubMed:8557257,ECO:0000269|PubMed:8595886, ECO:0000269|PubMed:8698075,ECO:0000269|PubMed:8956055, ECO:0000269|PubMed:9543643}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 2 (CSNBAD2) [MIM:163500]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:8075643}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the cyclic nucleotide phosphodiesterasefamily. {ECO:0000305}.WEB RESOURCE: Name=Mutations of the PDE6A/B/G genes; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/pdemut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29727"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29825"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","PDE6B"],["bp:entityReference_http://identifiers.org/uniprot/P35913",[["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P35913"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P35913"]]],["bp:standardName","Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta"],["bp:xref",[["bp:id","P35913"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","PDE6B"],["bp:db","hgnc symbol"]]],["bp:organism",[["bp:relationshipType",null],["bp:id","PDE6B"],["bp:db","hgnc symbol"]]],["bp:displayName","PDE6B_HUMAN"],["bp:name","PDEB"],["bp:name","3.1.4.35"],["bp:name","PDE6B"],["bp:name","GMP-PDE beta"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_5158"],["bp:comment","PDE6B_HUMAN Reviewed; 854 AA."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01571_identity"],["bp:comment","REPLACED http://www.humanmetabolism.org/#ref_http://www.humanmetabolism.org/#protein_PDE6B"],["bp:comment","FUNCTION: This protein participates in processes of transmissionand amplification of the visual signal. Necessary for theformation of a functional phosphodiesterase holoenzyme.CATALYTIC ACTIVITY: Guanosine 3',5'-cyclic phosphate + H(2)O =guanosine 5'-phosphate.COFACTOR:Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240;Evidence={ECO:0000250};Note=Binds 2 divalent metal cations per subunit. Site 1 maypreferentially bind zinc ions, while site 2 has a preference formagnesium and/or manganese ions. {ECO:0000250};SUBUNIT: Oligomer composed of two catalytic chains (alpha andbeta), an inhibitory chain (gamma) and the delta chain.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=3;Name=1;IsoId=P35913-1; Sequence=Displayed;Name=2;IsoId=P35913-2; Sequence=VSP_036884;Name=3;IsoId=P35913-3; Sequence=VSP_044919;Note=No experimental confirmation available.;DISEASE: Retinitis pigmentosa 40 (RP40) [MIM:613801]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:22334370,ECO:0000269|PubMed:8394174, ECO:0000269|PubMed:8557257,ECO:0000269|PubMed:8595886, ECO:0000269|PubMed:8698075,ECO:0000269|PubMed:8956055, ECO:0000269|PubMed:9543643}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 2 (CSNBAD2) [MIM:163500]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:8075643}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the cyclic nucleotide phosphodiesterasefamily. {ECO:0000305}.WEB RESOURCE: Name=Mutations of the PDE6A/B/G genes; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/pdemut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29727"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29825"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","PDE6B"],["bp:entityReference_http://identifiers.org/uniprot/P35913",[["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P35913"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P35913"]]],["bp:standardName","Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta"],["bp:xref",[["bp:id","P35913"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","PDE6B"],["bp:db","hgnc symbol"]]],["bp:organism",[["bp:relationshipType",null],["bp:id","PDE6B"],["bp:db","hgnc symbol"]]],["bp:displayName","PDE6B_HUMAN"],["bp:name","PDEB"],["bp:name","3.1.4.35"],["bp:name","PDE6B"],["bp:name","GMP-PDE beta"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_5158"],["bp:comment","PDE6B_HUMAN Reviewed; 854 AA."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01571_identity"],["bp:comment","REPLACED http://www.humanmetabolism.org/#ref_http://www.humanmetabolism.org/#protein_PDE6B"],["bp:comment","FUNCTION: This protein participates in processes of transmissionand amplification of the visual signal. Necessary for theformation of a functional phosphodiesterase holoenzyme.CATALYTIC ACTIVITY: Guanosine 3',5'-cyclic phosphate + H(2)O =guanosine 5'-phosphate.COFACTOR:Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240;Evidence={ECO:0000250};Note=Binds 2 divalent metal cations per subunit. Site 1 maypreferentially bind zinc ions, while site 2 has a preference formagnesium and/or manganese ions. {ECO:0000250};SUBUNIT: Oligomer composed of two catalytic chains (alpha andbeta), an inhibitory chain (gamma) and the delta chain.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=3;Name=1;IsoId=P35913-1; Sequence=Displayed;Name=2;IsoId=P35913-2; Sequence=VSP_036884;Name=3;IsoId=P35913-3; Sequence=VSP_044919;Note=No experimental confirmation available.;DISEASE: Retinitis pigmentosa 40 (RP40) [MIM:613801]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:22334370,ECO:0000269|PubMed:8394174, ECO:0000269|PubMed:8557257,ECO:0000269|PubMed:8595886, ECO:0000269|PubMed:8698075,ECO:0000269|PubMed:8956055, ECO:0000269|PubMed:9543643}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 2 (CSNBAD2) [MIM:163500]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:8075643}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the cyclic nucleotide phosphodiesterasefamily. {ECO:0000305}.WEB RESOURCE: Name=Mutations of the PDE6A/B/G genes; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/pdemut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29727"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29825"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29822"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29822"]]}},{"data":{"id":"Protein_6ce3b51fadf91900491c3fffa3efa81f_Complex_7ffe09f1835e4d2f8483e067d5f712ff","class":"macromolecule","label":"PDE6B","parent":"Complex_7ffe09f1835e4d2f8483e067d5f712ff","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":519.63388,"y":469.72067,"w":48,"h":25},"metadata":[["bp:displayName","PDE6B"],["bp:entityReference_http://identifiers.org/uniprot/P35913",[["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P35913"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P35913"]]],["bp:standardName","Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta"],["bp:xref",[["bp:id","P35913"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","PDE6B"],["bp:db","hgnc symbol"]]],["bp:organism",[["bp:relationshipType",null],["bp:id","PDE6B"],["bp:db","hgnc symbol"]]],["bp:displayName","PDE6B_HUMAN"],["bp:name","PDEB"],["bp:name","3.1.4.35"],["bp:name","PDE6B"],["bp:name","GMP-PDE beta"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_5158"],["bp:comment","PDE6B_HUMAN Reviewed; 854 AA."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01571_identity"],["bp:comment","REPLACED http://www.humanmetabolism.org/#ref_http://www.humanmetabolism.org/#protein_PDE6B"],["bp:comment","FUNCTION: This protein participates in processes of transmissionand amplification of the visual signal. Necessary for theformation of a functional phosphodiesterase holoenzyme.CATALYTIC ACTIVITY: Guanosine 3',5'-cyclic phosphate + H(2)O =guanosine 5'-phosphate.COFACTOR:Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240;Evidence={ECO:0000250};Note=Binds 2 divalent metal cations per subunit. Site 1 maypreferentially bind zinc ions, while site 2 has a preference formagnesium and/or manganese ions. {ECO:0000250};SUBUNIT: Oligomer composed of two catalytic chains (alpha andbeta), an inhibitory chain (gamma) and the delta chain.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=3;Name=1;IsoId=P35913-1; Sequence=Displayed;Name=2;IsoId=P35913-2; Sequence=VSP_036884;Name=3;IsoId=P35913-3; Sequence=VSP_044919;Note=No experimental confirmation available.;DISEASE: Retinitis pigmentosa 40 (RP40) [MIM:613801]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:22334370,ECO:0000269|PubMed:8394174, ECO:0000269|PubMed:8557257,ECO:0000269|PubMed:8595886, ECO:0000269|PubMed:8698075,ECO:0000269|PubMed:8956055, ECO:0000269|PubMed:9543643}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 2 (CSNBAD2) [MIM:163500]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:8075643}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the cyclic nucleotide phosphodiesterasefamily. {ECO:0000305}.WEB RESOURCE: Name=Mutations of the PDE6A/B/G genes; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/pdemut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29727"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]}},{"data":{"id":"Protein_83df3ed854aac8299449f5b80091d2b8_Complex_7ffe09f1835e4d2f8483e067d5f712ff","class":"macromolecule","label":"PDE6G","parent":"Complex_7ffe09f1835e4d2f8483e067d5f712ff","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":519.63388,"y":439.72067,"w":48,"h":25},"metadata":[["bp:displayName","PDE6G"],["bp:entityReference_http://identifiers.org/uniprot/P18545",[["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P18545"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylmethionine"],["bp:term","N-acetylmethionine"]]],["bp:comment","MOD_RES 1 1 N-acetylmethionine."],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P18545"]]],["bp:standardName","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma"],["bp:xref",[["bp:id","P18545"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","PDE6G"],["bp:db","hgnc symbol"]]],["bp:organism",[["bp:relationshipType",null],["bp:id","PDE6G"],["bp:db","hgnc symbol"]]],["bp:displayName","CNRG_HUMAN"],["bp:name","3.1.4.35"],["bp:name","PDE6G"],["bp:name","PDEG"],["bp:name","GMP-PDE gamma"],["bp:comment","FUNCTION: Participates in processes of transmission andamplification of the visual signal. cGMP-PDEs are the effectormolecules in G-protein-mediated phototransduction in vertebraterods and cones.CATALYTIC ACTIVITY: Guanosine 3',5'-cyclic phosphate + H(2)O =guanosine 5'-phosphate.SUBUNIT: Oligomer composed of two catalytic chains (alpha andbeta), an inhibitory chain (gamma) and the delta chain.DISEASE: Retinitis pigmentosa 57 (RP57) [MIM:613582]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:20655036}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the rod/cone cGMP-PDE gamma subunit family.{ECO:0000305}.SEQUENCE CAUTION:Sequence=CAD97656.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};Sequence=EAW89666.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the PDE6A/B/G genes; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/pdemut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_002593"],["bp:comment","REPLACED http://www.humanmetabolism.org/#ref_http://www.humanmetabolism.org/#protein_PDE6G"],["bp:comment","CNRG_HUMAN Reviewed; 87 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_5148"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29715"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29715"]]}},{"data":{"id":"Protein_d8f4da528c4f69813bc1c0472e4c4f6a_Complex_7ffe09f1835e4d2f8483e067d5f712ff","class":"macromolecule","label":"PDE6A","parent":"Complex_7ffe09f1835e4d2f8483e067d5f712ff","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":519.63388,"y":409.72067,"w":48,"h":25},"metadata":[["bp:displayName","PDE6A"],["bp:entityReference_http://identifiers.org/uniprot/P16499",[["bp:entityFeature",[["bp:modificationType",[["bp:term","N-acetylglycine"],["bp:term","MOD_RES N-acetylglycine"]]],["bp:comment","MOD_RES 2 2 N-acetylglycine."],["bp:featureLocation",[["bp:sequencePosition","2"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Cysteine methyl ester"],["bp:term","MOD_RES Cysteine methyl ester"]]],["bp:comment","MOD_RES 857 857 Cysteine methyl ester."],["bp:featureLocation",[["bp:sequencePosition","857"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P16499"]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P16499"]]],["bp:standardName","Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha"],["bp:xref","Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha"],["bp:xref","Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha"],["bp:organism","Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha"],["bp:displayName","PDE6A_HUMAN"],["bp:name","PDEA"],["bp:name","3.1.4.35"],["bp:name","PDE6A"],["bp:name","PDE V-B1"],["bp:name","GMP-PDE alpha"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01570_identity"],["bp:comment","FUNCTION: This protein participates in processes of transmissionand amplification of the visual signal.CATALYTIC ACTIVITY: Guanosine 3',5'-cyclic phosphate + H(2)O =guanosine 5'-phosphate.COFACTOR:Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240;Evidence={ECO:0000250};Note=Binds 2 divalent metal cations per subunit. Site 1 maypreferentially bind zinc ions, while site 2 has a preference formagnesium and/or manganese ions. {ECO:0000250};SUBUNIT: Oligomer composed of two catalytic chains (alpha andbeta), an inhibitory chain (gamma) and the delta chain.SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Lipid-anchor{ECO:0000305}; Cytoplasmic side {ECO:0000305}.DISEASE: Retinitis pigmentosa 43 (RP43) [MIM:613810]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:10393062,ECO:0000269|PubMed:7493036}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the cyclic nucleotide phosphodiesterasefamily. {ECO:0000305}.WEB RESOURCE: Name=Mutations of the PDE6A/B/G genes; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/pdemut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","PDE6A_HUMAN Reviewed; 860 AA."],["bp:comment","REPLACED http://www.humanmetabolism.org/#ref_http://www.humanmetabolism.org/#protein_PDE6A"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_5145"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000431"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29724"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29724"]]}},{"data":{"id":"Complex_bfe4c390a209f35f4c9f85fc26a08004","class":"complex","label":"Metarhodopsin II","parent":"","clonemarker":false,"stateVariables":[{"id":"Complex_bfe4c390a209f35f4c9f85fc26a08004.info.1","class":"state variable","state":{"variable":"","value":"Act"}}],"unitsOfInformation":[],"bbox":{"x":351.3534,"y":281.40063,"w":52,"h":54},"metadata":[["bp:displayName","Metarhodopsin II"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:17898"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:17898"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:17898"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:17898"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:17898"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:17898"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:17898"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:17898"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:17898"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:17898"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29552"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29552"]]}},{"data":{"id":"Protein_5e6544b9ca2610522930422e887fd7f1_Complex_bfe4c390a209f35f4c9f85fc26a08004","class":"macromolecule","label":"RHO","parent":"Complex_bfe4c390a209f35f4c9f85fc26a08004","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":351.3534,"y":268.90063,"w":48,"h":25},"metadata":[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation",[["bp:sequencePosition","338"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 343 343 Phosphoserine."],["bp:featureLocation","MOD_RES 343 343 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 343 343 Phosphoserine."],["bp:featureLocation","MOD_RES 343 343 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 343 343 Phosphoserine."],["bp:featureLocation","MOD_RES 343 343 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 343 343 Phosphoserine."],["bp:featureLocation","MOD_RES 343 343 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 343 343 Phosphoserine."],["bp:featureLocation","MOD_RES 343 343 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 343 343 Phosphoserine."],["bp:featureLocation","MOD_RES 343 343 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 343 343 Phosphoserine."],["bp:featureLocation","MOD_RES 343 343 Phosphoserine."]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]}},{"data":{"id":"SmallMolecule_3be66134bf02bbe333791a9380f11481_Complex_bfe4c390a209f35f4c9f85fc26a08004","class":"simple chemical","label":"all-trans-retinal","parent":"Complex_bfe4c390a209f35f4c9f85fc26a08004","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":351.3534,"y":296.40063,"w":48,"h":20},"metadata":[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:17898"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:67195"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13+"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]}},{"data":{"id":"ComplexAssembly_6593325a4d9e7048801c4f61cb410015_LEFT_TO_RIGHT","class":"process","label":"","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":225.54774,"y":301.5124,"w":15,"h":15},"metadata":[["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","Metarhodopsin II/Transducin"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29645"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29645"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29906"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","Metarhodopsin II/Transducin"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29645"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29645"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29906"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","Metarhodopsin II/Transducin"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29645"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29645"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29906"],["bp:stoichiometricCoefficient","1.0"]]],["bp:right",[["bp:physicalEntity",[["bp:displayName","Metarhodopsin II/Transducin"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29645"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29645"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29906"],["bp:stoichiometricCoefficient","1.0"]]],["bp:spontaneous","true"],["bp:left","true"],["bp:left","true"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29903"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29903"]]}},{"data":{"id":"Protein_85331f89b392effc75c17fa2a1817c39","class":"macromolecule","label":"GUCY2D","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":813.3907,"y":734.15594,"w":48,"h":25},"metadata":[["bp:displayName","GC1"],["bp:entityReference_http://identifiers.org/uniprot/Q02846",[["bp:standardName","Retinal guanylyl cyclase 1"],["bp:xref",[["bp:id","Q02846"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","GUCY2D"],["bp:db","hgnc symbol"]]],["bp:organism",[["bp:relationshipType",null],["bp:id","GUCY2D"],["bp:db","hgnc symbol"]]],["bp:displayName","GUC2D_HUMAN"],["bp:name","RETGC1"],["bp:name","Guanylate cyclase 2D, retinal"],["bp:name","GUC2D"],["bp:name","RETGC-1"],["bp:name","GUCY2D"],["bp:name","Rod outer segment membrane guanylate cyclase"],["bp:name","4.6.1.2"],["bp:name","RETGC"],["bp:name","CORD6"],["bp:name","GUC1A4"],["bp:name","ROS-GC"],["bp:comment","GUC2D_HUMAN Reviewed; 1103 AA."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000171"],["bp:comment","FUNCTION: Probably plays a specific functional role in the rodsand/or cones of photoreceptors. It may be the enzyme involved inthe resynthesis of cGMP required for recovery of the dark stateafter phototransduction.CATALYTIC ACTIVITY: GTP = 3',5'-cyclic GMP + diphosphate.ENZYME REGULATION: Activated by GCAP-1; inhibited by calcium.SUBCELLULAR LOCATION: Membrane; Single-pass type I membraneprotein.TISSUE SPECIFICITY: Retina. Localized exclusively in the nucleiand inner segments of the rod and cone photoreceptor cells.DISEASE: Leber congenital amaurosis 1 (LCA1) [MIM:204000]: Asevere dystrophy of the retina, typically becoming evident in thefirst years of life. Visual function is usually poor and oftenaccompanied by nystagmus, sluggish or near-absent pupillaryresponses, photophobia, high hyperopia and keratoconus.{ECO:0000269|PubMed:11035546, ECO:0000269|PubMed:12365911,ECO:0000269|PubMed:15123990, ECO:0000269|PubMed:17724218,ECO:0000269|PubMed:21602930, ECO:0000269|PubMed:8944027,ECO:0000269|PubMed:9888789}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Cone-rod dystrophy 6 (CORD6) [MIM:601777]: An inheritedretinal dystrophy characterized by retinal pigment depositsvisible on fundus examination, predominantly in the macularregion, and initial loss of cone photoreceptors followed by roddegeneration. This leads to decreased visual acuity andsensitivity in the central visual field, followed by loss ofperipheral vision. Severe loss of vision occurs earlier than inretinitis pigmentosa, due to cone photoreceptors degenerating at ahigher rate than rod photoreceptors. {ECO:0000269|PubMed:12552567,ECO:0000269|PubMed:15111605, ECO:0000269|PubMed:18332321,ECO:0000269|PubMed:18487367, ECO:0000269|PubMed:20517349,ECO:0000269|PubMed:21552474, ECO:0000269|PubMed:22194653,ECO:0000269|PubMed:23734073, ECO:0000269|PubMed:24480840,ECO:0000269|PubMed:9618177, ECO:0000269|PubMed:9683616}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the adenylyl cyclase class-4/guanylylcyclase family. {ECO:0000255|PROSITE-ProRule:PRU00099}.WEB RESOURCE: Name=Mutations of the GUCY2D gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02550_identity"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29684"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]}},{"data":{"id":"BiochemicalReaction_ebe2587eee20076625365bcbf196a091_LEFT_TO_RIGHT","class":"process","label":"","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":643.96985,"y":967.49164,"w":15,"h":15},"metadata":[["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","cGMP"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16356",[["bp:standardName","guanosine 3',5'-(hydrogen phosphate)"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11675"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:61295"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:76971"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:1327"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:chemicalFormula","C10H12N5O7P"],["bp:displayName","3',5'-cyclic GMP"],["bp:name","Cyclic GMP"],["bp:name","C10H12N5O7P"],["bp:name","cGMP"],["bp:name","3',5'-Cyclic GMP"],["bp:name","Guanosine 3',5'-cyclic phosphate"],["bp:name","Guanosine cyclic monophosphate"],["bp:name","Guanosine 3',5'-cyclic monophosphate"],["bp:name","Nc1nc2n(cnc2c(=O)[nH]1)[C@@H]1O[C@@H]2COP(O)(=O)O[C@H]2[C@H]1O"],["bp:molecularWeight","345.20554"],["bp:comment","has_role CHEBI:76971"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/SmallMoleculeReference_1ad519ed0c8517fe4c5844c6e94414bc"],["bp:comment","REPLACED http://www.inoh.org/biopax/IMR_0100025_cGMP"],["bp:comment","is_a CHEBI:19834"],["bp:comment","is_conjugate_acid_of CHEBI:57746"],["bp:comment","has_role CHEBI:76924"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29665"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60184"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d006152"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00942.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01314"],["bp:comment","A 3',5'-cyclic purine nucleotide that is 3',5'-cyclic GMP."],["bp:comment","is_a CHEBI:61295"],["bp:comment","has_role CHEBI:75772"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB02315"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://identifiers.org/pubchem.compound/24316"],["bp:structure","REPLACED http://identifiers.org/pubchem.compound/24316"]]],["bp:name","cGMP (4 units)"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60183"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_60183"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60197"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","cGMP"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16356",[["bp:standardName","guanosine 3',5'-(hydrogen phosphate)"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11675"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:61295"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:76971"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:1327"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:chemicalFormula","C10H12N5O7P"],["bp:displayName","3',5'-cyclic GMP"],["bp:name","Cyclic GMP"],["bp:name","C10H12N5O7P"],["bp:name","cGMP"],["bp:name","3',5'-Cyclic GMP"],["bp:name","Guanosine 3',5'-cyclic phosphate"],["bp:name","Guanosine cyclic monophosphate"],["bp:name","Guanosine 3',5'-cyclic monophosphate"],["bp:name","Nc1nc2n(cnc2c(=O)[nH]1)[C@@H]1O[C@@H]2COP(O)(=O)O[C@H]2[C@H]1O"],["bp:molecularWeight","345.20554"],["bp:comment","has_role CHEBI:76971"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/SmallMoleculeReference_1ad519ed0c8517fe4c5844c6e94414bc"],["bp:comment","REPLACED http://www.inoh.org/biopax/IMR_0100025_cGMP"],["bp:comment","is_a CHEBI:19834"],["bp:comment","is_conjugate_acid_of CHEBI:57746"],["bp:comment","has_role CHEBI:76924"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29665"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60184"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d006152"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00942.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01314"],["bp:comment","A 3',5'-cyclic purine nucleotide that is 3',5'-cyclic GMP."],["bp:comment","is_a CHEBI:61295"],["bp:comment","has_role CHEBI:75772"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB02315"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://identifiers.org/pubchem.compound/24316"],["bp:structure","REPLACED http://identifiers.org/pubchem.compound/24316"]]],["bp:name","cGMP (4 units)"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60183"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_60183"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60197"],["bp:stoichiometricCoefficient","1.0"]]],["bp:xref",[["bp:physicalEntity",[["bp:displayName","cGMP"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16356",[["bp:standardName","guanosine 3',5'-(hydrogen phosphate)"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11675"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:61295"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:76971"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:1327"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:chemicalFormula","C10H12N5O7P"],["bp:displayName","3',5'-cyclic GMP"],["bp:name","Cyclic GMP"],["bp:name","C10H12N5O7P"],["bp:name","cGMP"],["bp:name","3',5'-Cyclic GMP"],["bp:name","Guanosine 3',5'-cyclic phosphate"],["bp:name","Guanosine cyclic monophosphate"],["bp:name","Guanosine 3',5'-cyclic monophosphate"],["bp:name","Nc1nc2n(cnc2c(=O)[nH]1)[C@@H]1O[C@@H]2COP(O)(=O)O[C@H]2[C@H]1O"],["bp:molecularWeight","345.20554"],["bp:comment","has_role CHEBI:76971"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/SmallMoleculeReference_1ad519ed0c8517fe4c5844c6e94414bc"],["bp:comment","REPLACED http://www.inoh.org/biopax/IMR_0100025_cGMP"],["bp:comment","is_a CHEBI:19834"],["bp:comment","is_conjugate_acid_of CHEBI:57746"],["bp:comment","has_role CHEBI:76924"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29665"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60184"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d006152"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00942.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01314"],["bp:comment","A 3',5'-cyclic purine nucleotide that is 3',5'-cyclic GMP."],["bp:comment","is_a CHEBI:61295"],["bp:comment","has_role CHEBI:75772"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB02315"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://identifiers.org/pubchem.compound/24316"],["bp:structure","REPLACED http://identifiers.org/pubchem.compound/24316"]]],["bp:name","cGMP (4 units)"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60183"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_60183"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60197"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","cGMP"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16356",[["bp:standardName","guanosine 3',5'-(hydrogen phosphate)"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11675"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:61295"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:76971"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:1327"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:chemicalFormula","C10H12N5O7P"],["bp:displayName","3',5'-cyclic GMP"],["bp:name","Cyclic GMP"],["bp:name","C10H12N5O7P"],["bp:name","cGMP"],["bp:name","3',5'-Cyclic GMP"],["bp:name","Guanosine 3',5'-cyclic phosphate"],["bp:name","Guanosine cyclic monophosphate"],["bp:name","Guanosine 3',5'-cyclic monophosphate"],["bp:name","Nc1nc2n(cnc2c(=O)[nH]1)[C@@H]1O[C@@H]2COP(O)(=O)O[C@H]2[C@H]1O"],["bp:molecularWeight","345.20554"],["bp:comment","has_role CHEBI:76971"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/SmallMoleculeReference_1ad519ed0c8517fe4c5844c6e94414bc"],["bp:comment","REPLACED http://www.inoh.org/biopax/IMR_0100025_cGMP"],["bp:comment","is_a CHEBI:19834"],["bp:comment","is_conjugate_acid_of CHEBI:57746"],["bp:comment","has_role CHEBI:76924"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29665"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60184"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d006152"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00942.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01314"],["bp:comment","A 3',5'-cyclic purine nucleotide that is 3',5'-cyclic GMP."],["bp:comment","is_a CHEBI:61295"],["bp:comment","has_role CHEBI:75772"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB02315"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://identifiers.org/pubchem.compound/24316"],["bp:structure","REPLACED http://identifiers.org/pubchem.compound/24316"]]],["bp:name","cGMP (4 units)"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60183"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_60183"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60197"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","cGMP"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16356",[["bp:standardName","guanosine 3',5'-(hydrogen phosphate)"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11675"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:61295"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:76971"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:1327"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:chemicalFormula","C10H12N5O7P"],["bp:displayName","3',5'-cyclic GMP"],["bp:name","Cyclic GMP"],["bp:name","C10H12N5O7P"],["bp:name","cGMP"],["bp:name","3',5'-Cyclic GMP"],["bp:name","Guanosine 3',5'-cyclic phosphate"],["bp:name","Guanosine cyclic monophosphate"],["bp:name","Guanosine 3',5'-cyclic monophosphate"],["bp:name","Nc1nc2n(cnc2c(=O)[nH]1)[C@@H]1O[C@@H]2COP(O)(=O)O[C@H]2[C@H]1O"],["bp:molecularWeight","345.20554"],["bp:comment","has_role CHEBI:76971"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/SmallMoleculeReference_1ad519ed0c8517fe4c5844c6e94414bc"],["bp:comment","REPLACED http://www.inoh.org/biopax/IMR_0100025_cGMP"],["bp:comment","is_a CHEBI:19834"],["bp:comment","is_conjugate_acid_of CHEBI:57746"],["bp:comment","has_role CHEBI:76924"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29665"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60184"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d006152"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00942.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01314"],["bp:comment","A 3',5'-cyclic purine nucleotide that is 3',5'-cyclic GMP."],["bp:comment","is_a CHEBI:61295"],["bp:comment","has_role CHEBI:75772"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB02315"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://identifiers.org/pubchem.compound/24316"],["bp:structure","REPLACED http://identifiers.org/pubchem.compound/24316"]]],["bp:name","cGMP (4 units)"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60183"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_60183"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60197"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","cGMP"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16356",[["bp:standardName","guanosine 3',5'-(hydrogen phosphate)"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11675"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:61295"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:76971"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:1327"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:chemicalFormula","C10H12N5O7P"],["bp:displayName","3',5'-cyclic GMP"],["bp:name","Cyclic GMP"],["bp:name","C10H12N5O7P"],["bp:name","cGMP"],["bp:name","3',5'-Cyclic GMP"],["bp:name","Guanosine 3',5'-cyclic phosphate"],["bp:name","Guanosine cyclic monophosphate"],["bp:name","Guanosine 3',5'-cyclic monophosphate"],["bp:name","Nc1nc2n(cnc2c(=O)[nH]1)[C@@H]1O[C@@H]2COP(O)(=O)O[C@H]2[C@H]1O"],["bp:molecularWeight","345.20554"],["bp:comment","has_role CHEBI:76971"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/SmallMoleculeReference_1ad519ed0c8517fe4c5844c6e94414bc"],["bp:comment","REPLACED http://www.inoh.org/biopax/IMR_0100025_cGMP"],["bp:comment","is_a CHEBI:19834"],["bp:comment","is_conjugate_acid_of CHEBI:57746"],["bp:comment","has_role CHEBI:76924"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29665"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60184"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d006152"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00942.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01314"],["bp:comment","A 3',5'-cyclic purine nucleotide that is 3',5'-cyclic GMP."],["bp:comment","is_a CHEBI:61295"],["bp:comment","has_role CHEBI:75772"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB02315"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://identifiers.org/pubchem.compound/24316"],["bp:structure","REPLACED http://identifiers.org/pubchem.compound/24316"]]],["bp:name","cGMP (4 units)"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60183"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_60183"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60197"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","cGMP"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16356",[["bp:standardName","guanosine 3',5'-(hydrogen phosphate)"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11675"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:61295"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:76971"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:1327"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:chemicalFormula","C10H12N5O7P"],["bp:displayName","3',5'-cyclic GMP"],["bp:name","Cyclic GMP"],["bp:name","C10H12N5O7P"],["bp:name","cGMP"],["bp:name","3',5'-Cyclic GMP"],["bp:name","Guanosine 3',5'-cyclic phosphate"],["bp:name","Guanosine cyclic monophosphate"],["bp:name","Guanosine 3',5'-cyclic monophosphate"],["bp:name","Nc1nc2n(cnc2c(=O)[nH]1)[C@@H]1O[C@@H]2COP(O)(=O)O[C@H]2[C@H]1O"],["bp:molecularWeight","345.20554"],["bp:comment","has_role CHEBI:76971"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/SmallMoleculeReference_1ad519ed0c8517fe4c5844c6e94414bc"],["bp:comment","REPLACED http://www.inoh.org/biopax/IMR_0100025_cGMP"],["bp:comment","is_a CHEBI:19834"],["bp:comment","is_conjugate_acid_of CHEBI:57746"],["bp:comment","has_role CHEBI:76924"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29665"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60184"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d006152"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00942.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01314"],["bp:comment","A 3',5'-cyclic purine nucleotide that is 3',5'-cyclic GMP."],["bp:comment","is_a CHEBI:61295"],["bp:comment","has_role CHEBI:75772"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB02315"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://identifiers.org/pubchem.compound/24316"],["bp:structure","REPLACED http://identifiers.org/pubchem.compound/24316"]]],["bp:name","cGMP (4 units)"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60183"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_60183"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60197"],["bp:stoichiometricCoefficient","1.0"]]],["bp:right",[["bp:physicalEntity",[["bp:displayName","cGMP"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16356",[["bp:standardName","guanosine 3',5'-(hydrogen phosphate)"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11675"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:61295"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:76971"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:1327"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:chemicalFormula","C10H12N5O7P"],["bp:displayName","3',5'-cyclic GMP"],["bp:name","Cyclic GMP"],["bp:name","C10H12N5O7P"],["bp:name","cGMP"],["bp:name","3',5'-Cyclic GMP"],["bp:name","Guanosine 3',5'-cyclic phosphate"],["bp:name","Guanosine cyclic monophosphate"],["bp:name","Guanosine 3',5'-cyclic monophosphate"],["bp:name","Nc1nc2n(cnc2c(=O)[nH]1)[C@@H]1O[C@@H]2COP(O)(=O)O[C@H]2[C@H]1O"],["bp:molecularWeight","345.20554"],["bp:comment","has_role CHEBI:76971"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/SmallMoleculeReference_1ad519ed0c8517fe4c5844c6e94414bc"],["bp:comment","REPLACED http://www.inoh.org/biopax/IMR_0100025_cGMP"],["bp:comment","is_a CHEBI:19834"],["bp:comment","is_conjugate_acid_of CHEBI:57746"],["bp:comment","has_role CHEBI:76924"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29665"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60184"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d006152"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00942.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01314"],["bp:comment","A 3',5'-cyclic purine nucleotide that is 3',5'-cyclic GMP."],["bp:comment","is_a CHEBI:61295"],["bp:comment","has_role CHEBI:75772"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB02315"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://identifiers.org/pubchem.compound/24316"],["bp:structure","REPLACED http://identifiers.org/pubchem.compound/24316"]]],["bp:name","cGMP (4 units)"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60183"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_60183"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60197"],["bp:stoichiometricCoefficient","1.0"]]],["bp:left",[["bp:physicalEntity",[["bp:displayName","cGMP"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16356",[["bp:standardName","guanosine 3',5'-(hydrogen phosphate)"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11675"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:61295"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:76971"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:1327"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:chemicalFormula","C10H12N5O7P"],["bp:displayName","3',5'-cyclic GMP"],["bp:name","Cyclic GMP"],["bp:name","C10H12N5O7P"],["bp:name","cGMP"],["bp:name","3',5'-Cyclic GMP"],["bp:name","Guanosine 3',5'-cyclic phosphate"],["bp:name","Guanosine cyclic monophosphate"],["bp:name","Guanosine 3',5'-cyclic monophosphate"],["bp:name","Nc1nc2n(cnc2c(=O)[nH]1)[C@@H]1O[C@@H]2COP(O)(=O)O[C@H]2[C@H]1O"],["bp:molecularWeight","345.20554"],["bp:comment","has_role CHEBI:76971"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/SmallMoleculeReference_1ad519ed0c8517fe4c5844c6e94414bc"],["bp:comment","REPLACED http://www.inoh.org/biopax/IMR_0100025_cGMP"],["bp:comment","is_a CHEBI:19834"],["bp:comment","is_conjugate_acid_of CHEBI:57746"],["bp:comment","has_role CHEBI:76924"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29665"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60184"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d006152"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00942.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01314"],["bp:comment","A 3',5'-cyclic purine nucleotide that is 3',5'-cyclic GMP."],["bp:comment","is_a CHEBI:61295"],["bp:comment","has_role CHEBI:75772"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB02315"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://identifiers.org/pubchem.compound/24316"],["bp:structure","REPLACED http://identifiers.org/pubchem.compound/24316"]]],["bp:name","cGMP (4 units)"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60183"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_60183"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60197"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60195"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_60195"]]}},{"data":{"id":"ComplexAssembly_2a75f0ef389321d172c1969c8bfe7d63_LEFT_TO_RIGHT","class":"process","label":"","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":632.46277,"y":29.232624,"w":15,"h":15},"metadata":[["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","Metarhodopsin II/Arrestin"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29803"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29803"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29810"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","Metarhodopsin II/Arrestin"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29803"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29803"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29810"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","Metarhodopsin II/Arrestin"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29803"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29803"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29810"],["bp:stoichiometricCoefficient","1.0"]]],["bp:xref",[["bp:physicalEntity",[["bp:displayName","Metarhodopsin II/Arrestin"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29803"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29803"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29810"],["bp:stoichiometricCoefficient","1.0"]]],["bp:xref",[["bp:physicalEntity",[["bp:displayName","Metarhodopsin II/Arrestin"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29803"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29803"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29810"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","Metarhodopsin II/Arrestin"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29803"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29803"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29810"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","Metarhodopsin II/Arrestin"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29803"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29803"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29810"],["bp:stoichiometricCoefficient","1.0"]]],["bp:right",[["bp:physicalEntity",[["bp:displayName","Metarhodopsin II/Arrestin"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29806"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29803"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29803"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29810"],["bp:stoichiometricCoefficient","1.0"]]],["bp:spontaneous","true"],["bp:left","true"],["bp:left","true"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29799"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29799"]]}},{"data":{"id":"SmallMolecule_a33aac33a3d8a89ead56da53b388c23c","class":"simple chemical","label":"2-acylglycerophosphocholine","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":816.7604,"y":358.24576,"w":48,"h":20},"metadata":[["bp:displayName","2-acylglycerophosphocholine"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:11502",[["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:60479"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:11502"],["bp:db","chebi"]]],["bp:chemicalFormula","C9H20NO7PR"],["bp:displayName","2-acylglycerophosphocholine"],["bp:name","C9H20NO7PR"],["bp:name","2-acylglycerophosphocholines"],["bp:name","LPC"],["bp:name","C[N+](C)(C)CCOP(O)(=O)OCC(CO)OC([*])=O"],["bp:molecularWeight","285.2314"],["bp:comment","A glycerophosphocholine having an unspecified acyl group attached at the 2-position."],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29770"],["bp:comment","is_a CHEBI:60479"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29769"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]}},{"data":{"id":"SmallMolecule_0410492d790c65d4bd97585d42aabbd5","class":"simple chemical","label":"cGMP","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":546.08966,"y":973.08514,"w":48,"h":20},"metadata":[["bp:displayName","cGMP"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16356",[["bp:standardName","guanosine 3',5'-(hydrogen phosphate)"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11675"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:61295"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:76971"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:1327"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:44957"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:19834"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:19834"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:19834"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:19834"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:19834"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:19834"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:19834"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:19834"],["bp:db","chebi"]]],["bp:chemicalFormula","C10H12N5O7P"],["bp:displayName","3',5'-cyclic GMP"],["bp:name","Cyclic GMP"],["bp:name","C10H12N5O7P"],["bp:name","cGMP"],["bp:name","3',5'-Cyclic GMP"],["bp:name","Guanosine 3',5'-cyclic phosphate"],["bp:name","Guanosine cyclic monophosphate"],["bp:name","Guanosine 3',5'-cyclic monophosphate"],["bp:name","Nc1nc2n(cnc2c(=O)[nH]1)[C@@H]1O[C@@H]2COP(O)(=O)O[C@H]2[C@H]1O"],["bp:molecularWeight","345.20554"],["bp:comment","has_role CHEBI:76971"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/SmallMoleculeReference_1ad519ed0c8517fe4c5844c6e94414bc"],["bp:comment","REPLACED http://www.inoh.org/biopax/IMR_0100025_cGMP"],["bp:comment","is_a CHEBI:19834"],["bp:comment","is_conjugate_acid_of CHEBI:57746"],["bp:comment","has_role CHEBI:76924"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29665"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60184"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d006152"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00942.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01314"],["bp:comment","A 3',5'-cyclic purine nucleotide that is 3',5'-cyclic GMP."],["bp:comment","is_a CHEBI:61295"],["bp:comment","has_role CHEBI:75772"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB02315"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://identifiers.org/pubchem.compound/24316"],["bp:structure","REPLACED http://identifiers.org/pubchem.compound/24316"]]],["bp:name","cGMP (4 units)"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60183"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_60183"]]}},{"data":{"id":"Complex_06656978d62db153fd8034cbecaae575","class":"complex","label":"Metarhodopsin II","parent":"","clonemarker":false,"stateVariables":[{"id":"Complex_06656978d62db153fd8034cbecaae575.info.1","class":"state variable","state":{"variable":"","value":"Ina"}}],"unitsOfInformation":[],"bbox":{"x":496.563215,"y":65.24290500000001,"w":89.00003,"h":59},"metadata":[["bp:displayName","Metarhodopsin II"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00046"],["bp:db","protein modification ontology"]]],["bp:term","opser"],["bp:term","O-phospho-L-serine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29573"],["bp:featureLocation",[["bp:sequencePosition","343"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29574"]]]]],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00047"],["bp:db","protein modification ontology"]]],["bp:term","opthr"],["bp:term","O-phospho-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29571"],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29572"]]]]],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00047"],["bp:db","protein modification ontology"]]],["bp:term","opthr"],["bp:term","O-phospho-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29571"],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29572"]]]]],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00047"],["bp:db","protein modification ontology"]]],["bp:term","opthr"],["bp:term","O-phospho-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29571"],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29572"]]]]],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00047"],["bp:db","protein modification ontology"]]],["bp:term","opthr"],["bp:term","O-phospho-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29571"],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29572"]]]]],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00047"],["bp:db","protein modification ontology"]]],["bp:term","opthr"],["bp:term","O-phospho-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29571"],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29572"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00047"],["bp:db","protein modification ontology"]]],["bp:term","opthr"],["bp:term","O-phospho-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29571"],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29572"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29563"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29563"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29575"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00046"],["bp:db","protein modification ontology"]]],["bp:term","opser"],["bp:term","O-phospho-L-serine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29573"],["bp:featureLocation",[["bp:sequencePosition","343"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29574"]]]]],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00047"],["bp:db","protein modification ontology"]]],["bp:term","opthr"],["bp:term","O-phospho-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29571"],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29572"]]]]],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00047"],["bp:db","protein modification ontology"]]],["bp:term","opthr"],["bp:term","O-phospho-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29571"],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29572"]]]]],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00047"],["bp:db","protein modification ontology"]]],["bp:term","opthr"],["bp:term","O-phospho-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29571"],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29572"]]]]],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00047"],["bp:db","protein modification ontology"]]],["bp:term","opthr"],["bp:term","O-phospho-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29571"],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29572"]]]]],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00047"],["bp:db","protein modification ontology"]]],["bp:term","opthr"],["bp:term","O-phospho-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29571"],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29572"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00047"],["bp:db","protein modification ontology"]]],["bp:term","opthr"],["bp:term","O-phospho-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29571"],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29572"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29563"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29563"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29575"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00046"],["bp:db","protein modification ontology"]]],["bp:term","opser"],["bp:term","O-phospho-L-serine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29573"],["bp:featureLocation",[["bp:sequencePosition","343"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29574"]]]]],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00047"],["bp:db","protein modification ontology"]]],["bp:term","opthr"],["bp:term","O-phospho-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29571"],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29572"]]]]],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00047"],["bp:db","protein modification ontology"]]],["bp:term","opthr"],["bp:term","O-phospho-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29571"],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29572"]]]]],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00047"],["bp:db","protein modification ontology"]]],["bp:term","opthr"],["bp:term","O-phospho-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29571"],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29572"]]]]],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00047"],["bp:db","protein modification ontology"]]],["bp:term","opthr"],["bp:term","O-phospho-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29571"],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29572"]]]]],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00047"],["bp:db","protein modification ontology"]]],["bp:term","opthr"],["bp:term","O-phospho-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29571"],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29572"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00047"],["bp:db","protein modification ontology"]]],["bp:term","opthr"],["bp:term","O-phospho-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29571"],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29572"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29563"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29563"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29575"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00046"],["bp:db","protein modification ontology"]]],["bp:term","opser"],["bp:term","O-phospho-L-serine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29573"],["bp:featureLocation",[["bp:sequencePosition","343"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29574"]]]]],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00047"],["bp:db","protein modification ontology"]]],["bp:term","opthr"],["bp:term","O-phospho-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29571"],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29572"]]]]],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00047"],["bp:db","protein modification ontology"]]],["bp:term","opthr"],["bp:term","O-phospho-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29571"],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29572"]]]]],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00047"],["bp:db","protein modification ontology"]]],["bp:term","opthr"],["bp:term","O-phospho-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29571"],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29572"]]]]],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00047"],["bp:db","protein modification ontology"]]],["bp:term","opthr"],["bp:term","O-phospho-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29571"],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29572"]]]]],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00047"],["bp:db","protein modification ontology"]]],["bp:term","opthr"],["bp:term","O-phospho-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29571"],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29572"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00047"],["bp:db","protein modification ontology"]]],["bp:term","opthr"],["bp:term","O-phospho-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29571"],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29572"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29563"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29563"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29575"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00046"],["bp:db","protein modification ontology"]]],["bp:term","opser"],["bp:term","O-phospho-L-serine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29573"],["bp:featureLocation",[["bp:sequencePosition","343"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29574"]]]]],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00047"],["bp:db","protein modification ontology"]]],["bp:term","opthr"],["bp:term","O-phospho-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29571"],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29572"]]]]],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00047"],["bp:db","protein modification ontology"]]],["bp:term","opthr"],["bp:term","O-phospho-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29571"],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29572"]]]]],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00047"],["bp:db","protein modification ontology"]]],["bp:term","opthr"],["bp:term","O-phospho-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29571"],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29572"]]]]],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00047"],["bp:db","protein modification ontology"]]],["bp:term","opthr"],["bp:term","O-phospho-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29571"],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29572"]]]]],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00047"],["bp:db","protein modification ontology"]]],["bp:term","opthr"],["bp:term","O-phospho-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29571"],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29572"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00047"],["bp:db","protein modification ontology"]]],["bp:term","opthr"],["bp:term","O-phospho-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29571"],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29572"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29563"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29563"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29575"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29562"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29562"]]}},{"data":{"id":"Protein_3b1cb2a9dcdba096167eef98413b5f4b_Complex_06656978d62db153fd8034cbecaae575","class":"macromolecule","label":"RHO","parent":"Complex_06656978d62db153fd8034cbecaae575","clonemarker":false,"stateVariables":[{"id":"Protein_3b1cb2a9dcdba096167eef98413b5f4b_Complex_06656978d62db153fd8034cbecaae575.info.1","class":"state variable","state":{"variable":"343","value":"opser"}},{"id":"Protein_3b1cb2a9dcdba096167eef98413b5f4b_Complex_06656978d62db153fd8034cbecaae575.state.2","class":"state variable","state":{"variable":"342","value":"opthr"}},{"id":"Protein_3b1cb2a9dcdba096167eef98413b5f4b_Complex_06656978d62db153fd8034cbecaae575.info.3","class":"state variable","state":{"variable":"336","value":"O-palmitoyl-L-threonine"}},{"id":"Protein_3b1cb2a9dcdba096167eef98413b5f4b_Complex_06656978d62db153fd8034cbecaae575.state.4","class":"state variable","state":{"variable":"340","value":"opthr"}},{"id":"Protein_3b1cb2a9dcdba096167eef98413b5f4b_Complex_06656978d62db153fd8034cbecaae575.info.5","class":"state variable","state":{"variable":"338","value":"opthr"}},{"id":"Protein_3b1cb2a9dcdba096167eef98413b5f4b_Complex_06656978d62db153fd8034cbecaae575.state.6","class":"state variable","state":{"variable":"334","value":"opser"}}],"unitsOfInformation":[],"bbox":{"x":496.5632,"y":50.242905,"w":85,"h":25},"metadata":[["bp:displayName","RHO"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00046"],["bp:db","protein modification ontology"]]],["bp:term","opser"],["bp:term","O-phospho-L-serine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29573"],["bp:featureLocation",[["bp:sequencePosition","343"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29574"]]]]],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00047"],["bp:db","protein modification ontology"]]],["bp:term","opthr"],["bp:term","O-phospho-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29571"],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29572"]]]]],["bp:feature",[["bp:modificationType",[["bp:xref",null],["bp:term","O-palmitoyl-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29567"],["bp:featureLocation","REPLACED http://pid.nci.nih.gov/biopax#pid_29567"]]],["bp:feature",[["bp:modificationType",[["bp:xref",null],["bp:term","O-palmitoyl-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29567"],["bp:featureLocation","REPLACED http://pid.nci.nih.gov/biopax#pid_29567"]]],["bp:feature",[["bp:modificationType",[["bp:xref",null],["bp:term","O-palmitoyl-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29567"],["bp:featureLocation","REPLACED http://pid.nci.nih.gov/biopax#pid_29567"]]],["bp:feature",[["bp:modificationType",[["bp:xref",null],["bp:term","O-palmitoyl-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29567"],["bp:featureLocation","REPLACED http://pid.nci.nih.gov/biopax#pid_29567"]]],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:modificationType",[["bp:xref",null],["bp:term","O-palmitoyl-L-threonine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29567"],["bp:featureLocation","REPLACED http://pid.nci.nih.gov/biopax#pid_29567"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29563"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29563"]]}},{"data":{"id":"SmallMolecule_3be66134bf02bbe333791a9380f11481_Complex_06656978d62db153fd8034cbecaae575","class":"simple chemical","label":"all-trans-retinal","parent":"Complex_06656978d62db153fd8034cbecaae575","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":478.0632,"y":82.742905,"w":48,"h":20},"metadata":[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:17898"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:67195"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13+"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]}},{"data":{"id":"Complex_8427e7fa54571a2521093660159fa15a","class":"complex","label":"RGS9-1/Gbeta5/R9AP","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":543.761,"y":584.6307,"w":52,"h":94},"metadata":[["bp:displayName","RGS9-1/Gbeta5/R9AP"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","RGS9-1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00046"],["bp:db","protein modification ontology"]]],["bp:term","opser"],["bp:term","O-phospho-L-serine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29838"],["bp:featureLocation",[["bp:sequencePosition","428"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29839"]]]]],["bp:feature",[["bp:modificationType",null],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29837"],["bp:featureLocation",[["bp:sequencePosition","427"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_7533"]]]]],["bp:entityReference_http://identifiers.org/uniprot/O75916",[["bp:standardName","Regulator of G-protein signaling 9"],["bp:xref",[["bp:id","O75916"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:id","O75916"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","O75916"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","RGS9_HUMAN"],["bp:name","RGS9"],["bp:comment","REPLACED http://www.inoh.org/biopax/memberPR_UniProt_O75916"],["bp:comment","REPLACED http://identifiers.org/uniprot.isoform/O75916-3"],["bp:comment","RGS9_HUMAN Reviewed; 674 AA."],["bp:comment","FUNCTION: Inhibits signal transduction by increasing the GTPaseactivity of G protein alpha subunits thereby driving them intotheir inactive GDP-bound form. Binds to G(t)-alpha. Involved inphototransduction; key element in the recovery phase of visualtransduction (By similarity). {ECO:0000250}.SUBUNIT: Heterodimer with Gbeta5. Interacts with RGS7BP, leadingto regulate the subcellular location of the heterodimer formedwith Gbeta5. Component of the RGS9-1-Gbeta5 complex composed ofisoform 3 of RGS9 (RGS9-1), Gbeta5 (GNB5) and RGS9BP (Probable).{ECO:0000305}.SUBCELLULAR LOCATION: Isoform 3: Membrane; Peripheral membraneprotein. Note=Isoform 3 is targeted to the membrane via itsinteraction with RGS9BP. {ECO:0000250}.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=5;Name=1; Synonyms=RGS9L;IsoId=O75916-1; Sequence=Displayed;Name=2; Synonyms=RGS9S;IsoId=O75916-2; Sequence=VSP_005675;Name=3; Synonyms=RGS9-1;IsoId=O75916-3; Sequence=VSP_038381, VSP_038382, VSP_038383;Name=4;IsoId=O75916-4; Sequence=VSP_005674;Name=5;IsoId=O75916-5; Sequence=VSP_038381;TISSUE SPECIFICITY: Highly expressed in the caudate and putamen,lower levels found in the hypothalamus and nucleus accumbens andvery low levels in cerebellum. Not expressed in globus pallidus orcingulate cortex. Isoform 2 is expressed predominantly in pinealgland and retina. Isoform 3 is expressed in retina (abundant inphotoreceptors).DOMAIN: In photoreceptor cells the DEP domain is essential fortargeting RGS9 to the outer rod segments.PTM: Retinal isoform 3 is light-dependent phosphorylated at 'Ser-478'. Phosphorylation is decreased by light exposition (Bysimilarity). {ECO:0000250}.DISEASE: Prolonged electroretinal response suppression (PERRS)[MIM:608415]: Characterized by difficulty adjusting to suddenchanges in luminance levels mediated by cones.{ECO:0000269|PubMed:14702087}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=AAC25430.1; Type=Erroneous initiation; Evidence={ECO:0000305}; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_04962_identity"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29834"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29834"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29846"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","RGS9-1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00046"],["bp:db","protein modification ontology"]]],["bp:term","opser"],["bp:term","O-phospho-L-serine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29838"],["bp:featureLocation",[["bp:sequencePosition","428"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29839"]]]]],["bp:feature",[["bp:modificationType",null],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29837"],["bp:featureLocation",[["bp:sequencePosition","427"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_7533"]]]]],["bp:entityReference_http://identifiers.org/uniprot/O75916",[["bp:standardName","Regulator of G-protein signaling 9"],["bp:xref",[["bp:id","O75916"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:id","O75916"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","O75916"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","RGS9_HUMAN"],["bp:name","RGS9"],["bp:comment","REPLACED http://www.inoh.org/biopax/memberPR_UniProt_O75916"],["bp:comment","REPLACED http://identifiers.org/uniprot.isoform/O75916-3"],["bp:comment","RGS9_HUMAN Reviewed; 674 AA."],["bp:comment","FUNCTION: Inhibits signal transduction by increasing the GTPaseactivity of G protein alpha subunits thereby driving them intotheir inactive GDP-bound form. Binds to G(t)-alpha. Involved inphototransduction; key element in the recovery phase of visualtransduction (By similarity). {ECO:0000250}.SUBUNIT: Heterodimer with Gbeta5. Interacts with RGS7BP, leadingto regulate the subcellular location of the heterodimer formedwith Gbeta5. Component of the RGS9-1-Gbeta5 complex composed ofisoform 3 of RGS9 (RGS9-1), Gbeta5 (GNB5) and RGS9BP (Probable).{ECO:0000305}.SUBCELLULAR LOCATION: Isoform 3: Membrane; Peripheral membraneprotein. Note=Isoform 3 is targeted to the membrane via itsinteraction with RGS9BP. {ECO:0000250}.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=5;Name=1; Synonyms=RGS9L;IsoId=O75916-1; Sequence=Displayed;Name=2; Synonyms=RGS9S;IsoId=O75916-2; Sequence=VSP_005675;Name=3; Synonyms=RGS9-1;IsoId=O75916-3; Sequence=VSP_038381, VSP_038382, VSP_038383;Name=4;IsoId=O75916-4; Sequence=VSP_005674;Name=5;IsoId=O75916-5; Sequence=VSP_038381;TISSUE SPECIFICITY: Highly expressed in the caudate and putamen,lower levels found in the hypothalamus and nucleus accumbens andvery low levels in cerebellum. Not expressed in globus pallidus orcingulate cortex. Isoform 2 is expressed predominantly in pinealgland and retina. Isoform 3 is expressed in retina (abundant inphotoreceptors).DOMAIN: In photoreceptor cells the DEP domain is essential fortargeting RGS9 to the outer rod segments.PTM: Retinal isoform 3 is light-dependent phosphorylated at 'Ser-478'. Phosphorylation is decreased by light exposition (Bysimilarity). {ECO:0000250}.DISEASE: Prolonged electroretinal response suppression (PERRS)[MIM:608415]: Characterized by difficulty adjusting to suddenchanges in luminance levels mediated by cones.{ECO:0000269|PubMed:14702087}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=AAC25430.1; Type=Erroneous initiation; Evidence={ECO:0000305}; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_04962_identity"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29834"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29834"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29846"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","RGS9-1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00046"],["bp:db","protein modification ontology"]]],["bp:term","opser"],["bp:term","O-phospho-L-serine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29838"],["bp:featureLocation",[["bp:sequencePosition","428"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29839"]]]]],["bp:feature",[["bp:modificationType",null],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29837"],["bp:featureLocation",[["bp:sequencePosition","427"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_7533"]]]]],["bp:entityReference_http://identifiers.org/uniprot/O75916",[["bp:standardName","Regulator of G-protein signaling 9"],["bp:xref",[["bp:id","O75916"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:id","O75916"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","O75916"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","RGS9_HUMAN"],["bp:name","RGS9"],["bp:comment","REPLACED http://www.inoh.org/biopax/memberPR_UniProt_O75916"],["bp:comment","REPLACED http://identifiers.org/uniprot.isoform/O75916-3"],["bp:comment","RGS9_HUMAN Reviewed; 674 AA."],["bp:comment","FUNCTION: Inhibits signal transduction by increasing the GTPaseactivity of G protein alpha subunits thereby driving them intotheir inactive GDP-bound form. Binds to G(t)-alpha. Involved inphototransduction; key element in the recovery phase of visualtransduction (By similarity). {ECO:0000250}.SUBUNIT: Heterodimer with Gbeta5. Interacts with RGS7BP, leadingto regulate the subcellular location of the heterodimer formedwith Gbeta5. Component of the RGS9-1-Gbeta5 complex composed ofisoform 3 of RGS9 (RGS9-1), Gbeta5 (GNB5) and RGS9BP (Probable).{ECO:0000305}.SUBCELLULAR LOCATION: Isoform 3: Membrane; Peripheral membraneprotein. Note=Isoform 3 is targeted to the membrane via itsinteraction with RGS9BP. {ECO:0000250}.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=5;Name=1; Synonyms=RGS9L;IsoId=O75916-1; Sequence=Displayed;Name=2; Synonyms=RGS9S;IsoId=O75916-2; Sequence=VSP_005675;Name=3; Synonyms=RGS9-1;IsoId=O75916-3; Sequence=VSP_038381, VSP_038382, VSP_038383;Name=4;IsoId=O75916-4; Sequence=VSP_005674;Name=5;IsoId=O75916-5; Sequence=VSP_038381;TISSUE SPECIFICITY: Highly expressed in the caudate and putamen,lower levels found in the hypothalamus and nucleus accumbens andvery low levels in cerebellum. Not expressed in globus pallidus orcingulate cortex. Isoform 2 is expressed predominantly in pinealgland and retina. Isoform 3 is expressed in retina (abundant inphotoreceptors).DOMAIN: In photoreceptor cells the DEP domain is essential fortargeting RGS9 to the outer rod segments.PTM: Retinal isoform 3 is light-dependent phosphorylated at 'Ser-478'. Phosphorylation is decreased by light exposition (Bysimilarity). {ECO:0000250}.DISEASE: Prolonged electroretinal response suppression (PERRS)[MIM:608415]: Characterized by difficulty adjusting to suddenchanges in luminance levels mediated by cones.{ECO:0000269|PubMed:14702087}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=AAC25430.1; Type=Erroneous initiation; Evidence={ECO:0000305}; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_04962_identity"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29834"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29834"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29846"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","RGS9-1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00046"],["bp:db","protein modification ontology"]]],["bp:term","opser"],["bp:term","O-phospho-L-serine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29838"],["bp:featureLocation",[["bp:sequencePosition","428"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29839"]]]]],["bp:feature",[["bp:modificationType",null],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29837"],["bp:featureLocation",[["bp:sequencePosition","427"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_7533"]]]]],["bp:entityReference_http://identifiers.org/uniprot/O75916",[["bp:standardName","Regulator of G-protein signaling 9"],["bp:xref",[["bp:id","O75916"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:id","O75916"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","O75916"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","RGS9_HUMAN"],["bp:name","RGS9"],["bp:comment","REPLACED http://www.inoh.org/biopax/memberPR_UniProt_O75916"],["bp:comment","REPLACED http://identifiers.org/uniprot.isoform/O75916-3"],["bp:comment","RGS9_HUMAN Reviewed; 674 AA."],["bp:comment","FUNCTION: Inhibits signal transduction by increasing the GTPaseactivity of G protein alpha subunits thereby driving them intotheir inactive GDP-bound form. Binds to G(t)-alpha. Involved inphototransduction; key element in the recovery phase of visualtransduction (By similarity). {ECO:0000250}.SUBUNIT: Heterodimer with Gbeta5. Interacts with RGS7BP, leadingto regulate the subcellular location of the heterodimer formedwith Gbeta5. Component of the RGS9-1-Gbeta5 complex composed ofisoform 3 of RGS9 (RGS9-1), Gbeta5 (GNB5) and RGS9BP (Probable).{ECO:0000305}.SUBCELLULAR LOCATION: Isoform 3: Membrane; Peripheral membraneprotein. Note=Isoform 3 is targeted to the membrane via itsinteraction with RGS9BP. {ECO:0000250}.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=5;Name=1; Synonyms=RGS9L;IsoId=O75916-1; Sequence=Displayed;Name=2; Synonyms=RGS9S;IsoId=O75916-2; Sequence=VSP_005675;Name=3; Synonyms=RGS9-1;IsoId=O75916-3; Sequence=VSP_038381, VSP_038382, VSP_038383;Name=4;IsoId=O75916-4; Sequence=VSP_005674;Name=5;IsoId=O75916-5; Sequence=VSP_038381;TISSUE SPECIFICITY: Highly expressed in the caudate and putamen,lower levels found in the hypothalamus and nucleus accumbens andvery low levels in cerebellum. Not expressed in globus pallidus orcingulate cortex. Isoform 2 is expressed predominantly in pinealgland and retina. Isoform 3 is expressed in retina (abundant inphotoreceptors).DOMAIN: In photoreceptor cells the DEP domain is essential fortargeting RGS9 to the outer rod segments.PTM: Retinal isoform 3 is light-dependent phosphorylated at 'Ser-478'. Phosphorylation is decreased by light exposition (Bysimilarity). {ECO:0000250}.DISEASE: Prolonged electroretinal response suppression (PERRS)[MIM:608415]: Characterized by difficulty adjusting to suddenchanges in luminance levels mediated by cones.{ECO:0000269|PubMed:14702087}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=AAC25430.1; Type=Erroneous initiation; Evidence={ECO:0000305}; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_04962_identity"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29834"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29834"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29846"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","RGS9-1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00046"],["bp:db","protein modification ontology"]]],["bp:term","opser"],["bp:term","O-phospho-L-serine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29838"],["bp:featureLocation",[["bp:sequencePosition","428"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29839"]]]]],["bp:feature",[["bp:modificationType",null],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29837"],["bp:featureLocation",[["bp:sequencePosition","427"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_7533"]]]]],["bp:entityReference_http://identifiers.org/uniprot/O75916",[["bp:standardName","Regulator of G-protein signaling 9"],["bp:xref",[["bp:id","O75916"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:id","O75916"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","O75916"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","RGS9_HUMAN"],["bp:name","RGS9"],["bp:comment","REPLACED http://www.inoh.org/biopax/memberPR_UniProt_O75916"],["bp:comment","REPLACED http://identifiers.org/uniprot.isoform/O75916-3"],["bp:comment","RGS9_HUMAN Reviewed; 674 AA."],["bp:comment","FUNCTION: Inhibits signal transduction by increasing the GTPaseactivity of G protein alpha subunits thereby driving them intotheir inactive GDP-bound form. Binds to G(t)-alpha. Involved inphototransduction; key element in the recovery phase of visualtransduction (By similarity). {ECO:0000250}.SUBUNIT: Heterodimer with Gbeta5. Interacts with RGS7BP, leadingto regulate the subcellular location of the heterodimer formedwith Gbeta5. Component of the RGS9-1-Gbeta5 complex composed ofisoform 3 of RGS9 (RGS9-1), Gbeta5 (GNB5) and RGS9BP (Probable).{ECO:0000305}.SUBCELLULAR LOCATION: Isoform 3: Membrane; Peripheral membraneprotein. Note=Isoform 3 is targeted to the membrane via itsinteraction with RGS9BP. {ECO:0000250}.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=5;Name=1; Synonyms=RGS9L;IsoId=O75916-1; Sequence=Displayed;Name=2; Synonyms=RGS9S;IsoId=O75916-2; Sequence=VSP_005675;Name=3; Synonyms=RGS9-1;IsoId=O75916-3; Sequence=VSP_038381, VSP_038382, VSP_038383;Name=4;IsoId=O75916-4; Sequence=VSP_005674;Name=5;IsoId=O75916-5; Sequence=VSP_038381;TISSUE SPECIFICITY: Highly expressed in the caudate and putamen,lower levels found in the hypothalamus and nucleus accumbens andvery low levels in cerebellum. Not expressed in globus pallidus orcingulate cortex. Isoform 2 is expressed predominantly in pinealgland and retina. Isoform 3 is expressed in retina (abundant inphotoreceptors).DOMAIN: In photoreceptor cells the DEP domain is essential fortargeting RGS9 to the outer rod segments.PTM: Retinal isoform 3 is light-dependent phosphorylated at 'Ser-478'. Phosphorylation is decreased by light exposition (Bysimilarity). {ECO:0000250}.DISEASE: Prolonged electroretinal response suppression (PERRS)[MIM:608415]: Characterized by difficulty adjusting to suddenchanges in luminance levels mediated by cones.{ECO:0000269|PubMed:14702087}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=AAC25430.1; Type=Erroneous initiation; Evidence={ECO:0000305}; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_04962_identity"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29834"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29834"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29846"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","RGS9-1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00046"],["bp:db","protein modification ontology"]]],["bp:term","opser"],["bp:term","O-phospho-L-serine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29838"],["bp:featureLocation",[["bp:sequencePosition","428"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29839"]]]]],["bp:feature",[["bp:modificationType",null],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29837"],["bp:featureLocation",[["bp:sequencePosition","427"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_7533"]]]]],["bp:entityReference_http://identifiers.org/uniprot/O75916",[["bp:standardName","Regulator of G-protein signaling 9"],["bp:xref",[["bp:id","O75916"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:id","O75916"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","O75916"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","RGS9_HUMAN"],["bp:name","RGS9"],["bp:comment","REPLACED http://www.inoh.org/biopax/memberPR_UniProt_O75916"],["bp:comment","REPLACED http://identifiers.org/uniprot.isoform/O75916-3"],["bp:comment","RGS9_HUMAN Reviewed; 674 AA."],["bp:comment","FUNCTION: Inhibits signal transduction by increasing the GTPaseactivity of G protein alpha subunits thereby driving them intotheir inactive GDP-bound form. Binds to G(t)-alpha. Involved inphototransduction; key element in the recovery phase of visualtransduction (By similarity). {ECO:0000250}.SUBUNIT: Heterodimer with Gbeta5. Interacts with RGS7BP, leadingto regulate the subcellular location of the heterodimer formedwith Gbeta5. Component of the RGS9-1-Gbeta5 complex composed ofisoform 3 of RGS9 (RGS9-1), Gbeta5 (GNB5) and RGS9BP (Probable).{ECO:0000305}.SUBCELLULAR LOCATION: Isoform 3: Membrane; Peripheral membraneprotein. Note=Isoform 3 is targeted to the membrane via itsinteraction with RGS9BP. {ECO:0000250}.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=5;Name=1; Synonyms=RGS9L;IsoId=O75916-1; Sequence=Displayed;Name=2; Synonyms=RGS9S;IsoId=O75916-2; Sequence=VSP_005675;Name=3; Synonyms=RGS9-1;IsoId=O75916-3; Sequence=VSP_038381, VSP_038382, VSP_038383;Name=4;IsoId=O75916-4; Sequence=VSP_005674;Name=5;IsoId=O75916-5; Sequence=VSP_038381;TISSUE SPECIFICITY: Highly expressed in the caudate and putamen,lower levels found in the hypothalamus and nucleus accumbens andvery low levels in cerebellum. Not expressed in globus pallidus orcingulate cortex. Isoform 2 is expressed predominantly in pinealgland and retina. Isoform 3 is expressed in retina (abundant inphotoreceptors).DOMAIN: In photoreceptor cells the DEP domain is essential fortargeting RGS9 to the outer rod segments.PTM: Retinal isoform 3 is light-dependent phosphorylated at 'Ser-478'. Phosphorylation is decreased by light exposition (Bysimilarity). {ECO:0000250}.DISEASE: Prolonged electroretinal response suppression (PERRS)[MIM:608415]: Characterized by difficulty adjusting to suddenchanges in luminance levels mediated by cones.{ECO:0000269|PubMed:14702087}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=AAC25430.1; Type=Erroneous initiation; Evidence={ECO:0000305}; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_04962_identity"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29834"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29834"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29846"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29833"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29833"]]}},{"data":{"id":"Protein_5476a456a7429c70c2272cf4a2938c58_Complex_8427e7fa54571a2521093660159fa15a","class":"macromolecule","label":"RGS9","parent":"Complex_8427e7fa54571a2521093660159fa15a","clonemarker":false,"stateVariables":[{"id":"Protein_5476a456a7429c70c2272cf4a2938c58_Complex_8427e7fa54571a2521093660159fa15a.info.1","class":"state variable","state":{"variable":"428","value":"opser"}},{"id":"Protein_5476a456a7429c70c2272cf4a2938c58_Complex_8427e7fa54571a2521093660159fa15a.state.2","class":"state variable","state":{"variable":"427","value":"opser"}}],"unitsOfInformation":[],"bbox":{"x":543.761,"y":552.1307,"w":48,"h":25},"metadata":[["bp:displayName","RGS9-1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00046"],["bp:db","protein modification ontology"]]],["bp:term","opser"],["bp:term","O-phospho-L-serine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29838"],["bp:featureLocation",[["bp:sequencePosition","428"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29839"]]]]],["bp:feature",[["bp:modificationType",null],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29837"],["bp:featureLocation",[["bp:sequencePosition","427"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_7533"]]]]],["bp:entityReference_http://identifiers.org/uniprot/O75916",[["bp:standardName","Regulator of G-protein signaling 9"],["bp:xref",[["bp:id","O75916"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","RGS9"],["bp:db","hgnc symbol"]]],["bp:organism",[["bp:relationshipType",null],["bp:id","RGS9"],["bp:db","hgnc symbol"]]],["bp:displayName","RGS9_HUMAN"],["bp:name","RGS9"],["bp:comment","REPLACED http://www.inoh.org/biopax/memberPR_UniProt_O75916"],["bp:comment","REPLACED http://identifiers.org/uniprot.isoform/O75916-3"],["bp:comment","RGS9_HUMAN Reviewed; 674 AA."],["bp:comment","FUNCTION: Inhibits signal transduction by increasing the GTPaseactivity of G protein alpha subunits thereby driving them intotheir inactive GDP-bound form. Binds to G(t)-alpha. Involved inphototransduction; key element in the recovery phase of visualtransduction (By similarity). {ECO:0000250}.SUBUNIT: Heterodimer with Gbeta5. Interacts with RGS7BP, leadingto regulate the subcellular location of the heterodimer formedwith Gbeta5. Component of the RGS9-1-Gbeta5 complex composed ofisoform 3 of RGS9 (RGS9-1), Gbeta5 (GNB5) and RGS9BP (Probable).{ECO:0000305}.SUBCELLULAR LOCATION: Isoform 3: Membrane; Peripheral membraneprotein. Note=Isoform 3 is targeted to the membrane via itsinteraction with RGS9BP. {ECO:0000250}.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=5;Name=1; Synonyms=RGS9L;IsoId=O75916-1; Sequence=Displayed;Name=2; Synonyms=RGS9S;IsoId=O75916-2; Sequence=VSP_005675;Name=3; Synonyms=RGS9-1;IsoId=O75916-3; Sequence=VSP_038381, VSP_038382, VSP_038383;Name=4;IsoId=O75916-4; Sequence=VSP_005674;Name=5;IsoId=O75916-5; Sequence=VSP_038381;TISSUE SPECIFICITY: Highly expressed in the caudate and putamen,lower levels found in the hypothalamus and nucleus accumbens andvery low levels in cerebellum. Not expressed in globus pallidus orcingulate cortex. Isoform 2 is expressed predominantly in pinealgland and retina. Isoform 3 is expressed in retina (abundant inphotoreceptors).DOMAIN: In photoreceptor cells the DEP domain is essential fortargeting RGS9 to the outer rod segments.PTM: Retinal isoform 3 is light-dependent phosphorylated at 'Ser-478'. Phosphorylation is decreased by light exposition (Bysimilarity). {ECO:0000250}.DISEASE: Prolonged electroretinal response suppression (PERRS)[MIM:608415]: Characterized by difficulty adjusting to suddenchanges in luminance levels mediated by cones.{ECO:0000269|PubMed:14702087}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=AAC25430.1; Type=Erroneous initiation; Evidence={ECO:0000305}; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_04962_identity"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29834"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]}},{"data":{"id":"Protein_e31dab51425b0b82fed334cffbed4ce8_Complex_8427e7fa54571a2521093660159fa15a","class":"macromolecule","label":"GNB5","parent":"Complex_8427e7fa54571a2521093660159fa15a","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":543.761,"y":617.1307,"w":48,"h":25},"metadata":[["bp:displayName","Gbeta5"],["bp:entityReference_http://identifiers.org/uniprot/O14775",[["bp:standardName","Guanine nucleotide-binding protein subunit beta-5"],["bp:xref",[["bp:relationshipType",null],["bp:id","GNB5"],["bp:db","hgnc symbol"]]],["bp:xref",[["bp:id","O14775"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","O14775"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","GNB5_HUMAN"],["bp:name","GNB5"],["bp:name","Transducin beta chain 5"],["bp:name","Gbeta5"],["bp:comment","REPLACED http://identifiers.org/uniprot.isoform/O14775-1"],["bp:comment","FUNCTION: Enhances GTPase-activating protein (GAP) activity ofregulator of G protein signaling (RGS) proteins, hence involved inthe termination of the signaling initiated by the G proteincoupled receptors (GPCRs) by accelerating the GTP hydrolysis onthe G-alpha subunits, thereby promoting their inactivation(Probable). Increases RGS9 GTPase-activating protein (GAP)activity, hence contributes to the deactivation of G proteinsignaling initiated by D(2) dopamine receptors (PubMed:27677260).May play an important role in neuronal signaling, including in theparasympathetic, but not sympathetic, control of heart rate (Bysimilarity). {ECO:0000250|UniProtKB:A1L271,ECO:0000269|PubMed:27677260, ECO:0000305}.SUBUNIT: Component of a complex composed of RGS9 (isoform RGS9-1),GNB5 and RGS9BP; within this complex, the presence of GNB5stabilizes both itself and RGS9 and increases RGS9 GTPase-activating protein (GAP) activity (By similarity)(PubMed:27677260). Interacts with RGS6 and RGS7 (PubMed:10339615,PubMed:10521509). {ECO:0000250|UniProtKB:P62881,ECO:0000269|PubMed:10339615, ECO:0000269|PubMed:10521509,ECO:0000269|PubMed:27677260}.SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:P62881}.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=3;Name=1; Synonyms=Long, Beta-5L;IsoId=O14775-1; Sequence=Displayed;Name=2;IsoId=O14775-2; Sequence=VSP_008765;Name=3;IsoId=O14775-3; Sequence=VSP_008765, VSP_039101;TISSUE SPECIFICITY: Widely expressed.{ECO:0000269|PubMed:9606987}.DISEASE: Intellectual developmental disorder with cardiacarrhythmia (IDDCA) [MIM:617173]: An autosomal recessivemultisystem disorder characterized by delayed psychomotordevelopment, severe intellectual disability with poor or absentspeech, and bradycardia and/or cardiac sinus arrhythmias.Additional features include visual abnormalities, seizures,hypotonia, and gastric reflux. {ECO:0000269|PubMed:27523599}.Note=The disease is caused by mutations affecting the generepresented in this entry.DISEASE: Language delay and attention deficit-hyperactivitydisorder/cognitive impairment with or without cardiac arrhythmia(LADCI) [MIM:617182]: An autosomal recessive neurodevelopmentaldisorder characterized by speech impairment and variableexpressivity of attention deficit hyperactivity disorder. Somepatients manifest developmental and motor delay, hypotonia, andsinus-node dysfunction. {ECO:0000269|PubMed:27523599,ECO:0000269|PubMed:27677260}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the WD repeat G protein beta family.{ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_10681"],["bp:comment","GNB5_HUMAN Reviewed; 395 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_10681"],["bp:comment","REPLACED http://www.inoh.org/biopax/memberPR_UniProt_O14775"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_09191_identity"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29843"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]}},{"data":{"id":"Protein_957045ea2cf8bdae962e6c46f354e107_Complex_8427e7fa54571a2521093660159fa15a","class":"macromolecule","label":"RGS9BP","parent":"Complex_8427e7fa54571a2521093660159fa15a","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":543.761,"y":587.1307,"w":48,"h":25},"metadata":[["bp:displayName","R9AP"],["bp:entityReference_http://identifiers.org/uniprot/Q6ZS82",[["bp:standardName","Regulator of G-protein signaling 9-binding protein"],["bp:xref",[["bp:relationshipType",null],["bp:id","RGS9BP"],["bp:db","hgnc symbol"]]],["bp:xref",[["bp:id","Q6ZS82"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","Q6ZS82"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","R9BP_HUMAN"],["bp:name","RGS9-anchoring protein"],["bp:name","R9AP"],["bp:name","RGS9BP"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_388531"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_16991_identity"],["bp:comment","R9BP_HUMAN Reviewed; 235 AA."],["bp:comment","FUNCTION: Regulator of G protein-coupled receptor (GPCR) signalingin phototransduction. Participates in the recovery phase of visualtransduction via its interaction with RGS9-1 isoform. Acts as amembrane-anchor that mediates the targeting of RGS9-1 to thephotoreceptor outer segment, where phototransduction takes place.Enhances the ability of RGS9-1 to stimulate G protein GTPaseactivity, allowing the visual signal to be terminated on thephysiologically time scale. It also controls the proteolyticstability of RGS9-1, probably by protecting it from degradation(By similarity). {ECO:0000250}.SUBUNIT: Specifically interacts with isoform RGS9-1 of RGS9.Component of the RGS9-1-Gbeta5 complex composed of RGS9-1, Gbeta5(GNB5) and RGS9BP (By similarity). {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Single-pass type IVmembrane protein {ECO:0000250}.DISEASE: Prolonged electroretinal response suppression (PERRS)[MIM:608415]: Characterized by difficulty adjusting to suddenchanges in luminance levels mediated by cones.{ECO:0000269|PubMed:14702087}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the RGS7BP/RGS9BP family. {ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_997274"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29840"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]}},{"data":{"id":"Complex_6f5987bf8a98e642454a66b4fc7108b4","class":"complex","label":"Metarhodopsin II/Transducin","parent":"","clonemarker":false,"stateVariables":[{"id":"Complex_6f5987bf8a98e642454a66b4fc7108b4.info.1","class":"state variable","state":{"variable":"","value":"Act"}}],"unitsOfInformation":[],"bbox":{"x":80.502017,"y":288.57376999999997,"w":104.99999,"h":128.99998},"metadata":[["bp:displayName","Metarhodopsin II/Transducin"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29647"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29645"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29645"]]}},{"data":{"id":"Protein_fc6578580632db5c34bab285a2cac2d3_Complex_6f5987bf8a98e642454a66b4fc7108b4","class":"macromolecule","label":"GNB1","parent":"Complex_6f5987bf8a98e642454a66b4fc7108b4","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":54.002022,"y":338.57376,"w":48,"h":25},"metadata":[["bp:displayName","GNB1"],["bp:entityReference_http://identifiers.org/uniprot/P62873",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylserine"],["bp:term","N-acetylserine"]]],["bp:comment","MOD_RES 2 2 N-acetylserine."],["bp:featureLocation",[["bp:sequencePosition","2"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphohistidine"],["bp:term","MOD_RES Phosphohistidine"]]],["bp:comment","MOD_RES 266 266 Phosphohistidine."],["bp:featureLocation",[["bp:sequencePosition","266"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 2 2 Phosphoserine."],["bp:featureLocation","MOD_RES 2 2 Phosphoserine."]]],["bp:standardName","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref",[["bp:id","P62873"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:id","P62873"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","P62873"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","GBB1_HUMAN"],["bp:name","GNB1"],["bp:name","Transducin beta chain 1"],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as a modulator or transducer in various transmembranesignaling systems. The beta and gamma chains are required for theGTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction.SUBUNIT: G proteins are composed of 3 units, alpha, beta andgamma. Interacts with ARHGEF18 and RASD2 (PubMed:14512443,PubMed:19255495). The heterodimer formed by GNB1 and GNG2interacts with ARHGEF5 (PubMed:19713215).{ECO:0000269|PubMed:14512443, ECO:0000269|PubMed:19255495,ECO:0000269|PubMed:19713215}.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=2;Name=1;IsoId=P62873-1; Sequence=Displayed;Name=2;IsoId=P62873-2; Sequence=VSP_055232;Note=No experimental confirmation available.;PTM: Phosphorylation at His-266 by NDKB contributes to G proteinactivation by increasing the high energetic phosphate transferonto GDP. {ECO:0000250}.DISEASE: Mental retardation, autosomal dominant 42 (MRD42)[MIM:616973]: A form of mental retardation, a disordercharacterized by significantly below average general intellectualfunctioning associated with impairments in adaptive behavior andmanifested during the developmental period. MRD42 patientsmanifest global developmental delay commonly accompanied byhypotonia, seizures of various types, ophthalmologicalmanifestations, and poor growth. {ECO:0000269|PubMed:25485910,ECO:0000269|PubMed:27108799, ECO:0000269|PubMed:27668284,ECO:0000269|PubMed:28087732}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the WD repeat G protein beta family.{ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2782"],["bp:comment","REPLACED http://identifiers.org/uniprot/B1AKQ8"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_786971"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_002065"],["bp:comment","GBB1_HUMAN Reviewed; 340 AA."],["bp:comment","REPLACED http://identifiers.org/refseq/XP_017175466"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_00766_identity"],["bp:comment","REPLACED http://identifiers.org/uniprot/P01946"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2782"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_dip_DIP-599N_identity"],["bp:comment","REPLACED http://identifiers.org/refseq/XP_016856548"],["bp:comment","REPLACED http://identifiers.org/uniprot/P04901"],["bp:comment","REPLACED http://identifiers.org/uniprot/P62874"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"]]}},{"data":{"id":"Protein_91825223fb5bfcba336efdffb9e9723c_Complex_6f5987bf8a98e642454a66b4fc7108b4","class":"macromolecule","label":"GNGT1","parent":"Complex_6f5987bf8a98e642454a66b4fc7108b4","clonemarker":false,"stateVariables":[{"id":"Protein_91825223fb5bfcba336efdffb9e9723c_Complex_6f5987bf8a98e642454a66b4fc7108b4.info.1","class":"state variable","state":{"variable":"","value":"S-farnesyl-L-cysteine"}}],"unitsOfInformation":[],"bbox":{"x":54.002022,"y":273.57376,"w":48,"h":25},"metadata":[["bp:displayName","GNGT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00111"],["bp:db","protein modification ontology"]]],["bp:term","S-farnesyl-L-cysteine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29542"]]],["bp:entityReference_http://identifiers.org/uniprot/P63211",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Cysteine methyl ester"],["bp:term","MOD_RES Cysteine methyl ester"]]],["bp:comment","MOD_RES 71 71 Cysteine methyl ester."],["bp:featureLocation",[["bp:sequencePosition","71"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(T) subunit gamma-T1"],["bp:xref",[["bp:relationshipType",null],["bp:id","GNGT1"],["bp:db","hgnc symbol"]]],["bp:xref",[["bp:id","P63211"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","P63211"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","GBG1_HUMAN"],["bp:name","Transducin gamma chain"],["bp:name","GNGT1"],["bp:comment","GBG1_HUMAN Reviewed; 74 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2792"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_dip_DIP-471N_identity"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_068774"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2792"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01805_identity"],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as a modulator or transducer in various transmembranesignaling systems. The beta and gamma chains are required for theGTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction.SUBUNIT: G proteins are composed of 3 units, alpha, beta andgamma.SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Lipid-anchor{ECO:0000305}; Cytoplasmic side {ECO:0000305}.TISSUE SPECIFICITY: Retinal rod outer segment.SIMILARITY: Belongs to the G protein gamma family. {ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_intact_EBI-5774280_identity"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29539"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]}},{"data":{"id":"Protein_5e6544b9ca2610522930422e887fd7f1_Complex_6f5987bf8a98e642454a66b4fc7108b4","class":"macromolecule","label":"RHO","parent":"Complex_6f5987bf8a98e642454a66b4fc7108b4","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":54.002022,"y":308.57376,"w":48,"h":25},"metadata":[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation",[["bp:sequencePosition","338"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 343 343 Phosphoserine."],["bp:featureLocation","MOD_RES 343 343 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 343 343 Phosphoserine."],["bp:featureLocation","MOD_RES 343 343 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 343 343 Phosphoserine."],["bp:featureLocation","MOD_RES 343 343 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 343 343 Phosphoserine."],["bp:featureLocation","MOD_RES 343 343 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 343 343 Phosphoserine."],["bp:featureLocation","MOD_RES 343 343 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 343 343 Phosphoserine."],["bp:featureLocation","MOD_RES 343 343 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 343 343 Phosphoserine."],["bp:featureLocation","MOD_RES 343 343 Phosphoserine."]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]}},{"data":{"id":"SmallMolecule_3be66134bf02bbe333791a9380f11481_Complex_6f5987bf8a98e642454a66b4fc7108b4","class":"simple chemical","label":"all-trans-retinal","parent":"Complex_6f5987bf8a98e642454a66b4fc7108b4","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":107.00202,"y":236.07378,"w":48,"h":20},"metadata":[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:17898"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:67195"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13+"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]}},{"data":{"id":"SmallMolecule_2544e7a4b5003313120ca13ed284937d_Complex_6f5987bf8a98e642454a66b4fc7108b4","class":"simple chemical","label":"GDP","parent":"Complex_6f5987bf8a98e642454a66b4fc7108b4","clonemarker":true,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":105.50202,"y":268.57376,"w":45,"h":15},"metadata":[["bp:displayName","GDP"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17552",[["bp:standardName","guanosine 5'-(trihydrogen diphosphate)"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37121"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:65180"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:5212"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37038"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:24448"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:14379"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:42738"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:76971"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:76971"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:76971"],["bp:db","chebi"]]],["bp:chemicalFormula","C10H15N5O11P2"],["bp:displayName","GDP"],["bp:name","C10H15N5O11P2"],["bp:name","Guanosine diphosphate"],["bp:name","Nc1nc2n(cnc2c(=O)[nH]1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O"],["bp:name","Guanosine 5'-diphosphate"],["bp:molecularWeight","443.2007"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00035.eref"],["bp:comment","has_role CHEBI:76971"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/SmallMoleculeReference_bind_1035_identity"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB04315"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_302"],["bp:comment","REPLACED http://identifiers.org/cas/146-91-8"],["bp:comment","is_a CHEBI:37038"],["bp:comment","is_conjugate_acid_of CHEBI:65180"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/glG10620.eref"],["bp:comment","REPLACED http://www.inoh.org/biopax/IMR_0001357_GDP"],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:37121"],["bp:structure","is_a CHEBI:37121"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_301"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_301"]]}},{"data":{"id":"Protein_e4ab0eff9265bbdc4140f63f513badef_Complex_6f5987bf8a98e642454a66b4fc7108b4","class":"macromolecule","label":"GNAT1","parent":"Complex_6f5987bf8a98e642454a66b4fc7108b4","clonemarker":false,"stateVariables":[{"id":"Protein_e4ab0eff9265bbdc4140f63f513badef_Complex_6f5987bf8a98e642454a66b4fc7108b4.info.1","class":"state variable","state":{"variable":"1","value":"N-acetyl-L-methionine"}}],"unitsOfInformation":[],"bbox":{"x":54.002022,"y":238.57378,"w":48,"h":25},"metadata":[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]}},{"data":{"id":"BiochemicalReaction_033023272a65b72d1b378b0e31385d69_LEFT_TO_RIGHT","class":"process","label":"","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":521.43854,"y":848.95624,"w":15,"h":15},"metadata":[["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","CNG Channel"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","CNGA1"],["bp:entityReference_http://identifiers.org/uniprot/P29973",[["bp:standardName","cGMP-gated cation channel alpha-1"],["bp:xref",[["bp:relationshipType",null],["bp:id","CNGA1"],["bp:db","hgnc symbol"]]],["bp:xref",[["bp:id","P29973"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","P29973"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","CNGA1_HUMAN"],["bp:name","Cyclic nucleotide-gated channel alpha-1"],["bp:name","CNCG1"],["bp:name","Cyclic nucleotide-gated channel, photoreceptor"],["bp:name","CNG1"],["bp:name","CNGA1"],["bp:name","CNG channel alpha-1"],["bp:name","CNCG"],["bp:name","Rod photoreceptor cGMP-gated channel subunit alpha"],["bp:name","CNG-1"],["bp:name","Cyclic nucleotide-gated cation channel 1"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_00445_identity"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_1259"],["bp:comment","FUNCTION: Visual signal transduction is mediated by a G-proteincoupled cascade using cGMP as second messenger. This protein canbe activated by cyclic GMP which leads to an opening of the cationchannel and thereby causing a depolarization of rodphotoreceptors.SUBUNIT: Tetramer formed of three CNGA1 and one CNGB1 modulatorysubunits. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=2;Name=1;IsoId=P29973-1; Sequence=Displayed;Name=2;IsoId=P29973-2; Sequence=VSP_047170;Note=No experimental confirmation available.;TISSUE SPECIFICITY: Rod cells in the retina.DOMAIN: The C-terminal coiled-coil domain mediateshomotrimerization of CNGA subunits. {ECO:0000250}.DISEASE: Retinitis pigmentosa 49 (RP49) [MIM:613756]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:15570217,ECO:0000269|PubMed:7479749}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel(TC 1.A.1.5) family. CNGA1 subfamily. {ECO:0000305}.CAUTION: It is uncertain whether Met-1 or Met-5 is the initiator.{ECO:0000305}.SEQUENCE CAUTION:Sequence=AAB22778.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the CNGA1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/cnga1mut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/XP_005248106"],["bp:comment","CNGA1_HUMAN Reviewed; 690 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29693"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29707"],["bp:stoichiometricCoefficient","3.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","CNGB1"],["bp:entityReference_http://identifiers.org/uniprot/Q14028","CNGB1"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29708"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","CNGB1"],["bp:entityReference_http://identifiers.org/uniprot/Q14028","CNGB1"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29708"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","CNGB1"],["bp:entityReference_http://identifiers.org/uniprot/Q14028","CNGB1"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29708"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","CNGB1"],["bp:entityReference_http://identifiers.org/uniprot/Q14028","CNGB1"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29708"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29706"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29706"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29711"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","CNG Channel"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","CNGA1"],["bp:entityReference_http://identifiers.org/uniprot/P29973",[["bp:standardName","cGMP-gated cation channel alpha-1"],["bp:xref",[["bp:relationshipType",null],["bp:id","CNGA1"],["bp:db","hgnc symbol"]]],["bp:xref",[["bp:id","P29973"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","P29973"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","CNGA1_HUMAN"],["bp:name","Cyclic nucleotide-gated channel alpha-1"],["bp:name","CNCG1"],["bp:name","Cyclic nucleotide-gated channel, photoreceptor"],["bp:name","CNG1"],["bp:name","CNGA1"],["bp:name","CNG channel alpha-1"],["bp:name","CNCG"],["bp:name","Rod photoreceptor cGMP-gated channel subunit alpha"],["bp:name","CNG-1"],["bp:name","Cyclic nucleotide-gated cation channel 1"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_00445_identity"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_1259"],["bp:comment","FUNCTION: Visual signal transduction is mediated by a G-proteincoupled cascade using cGMP as second messenger. This protein canbe activated by cyclic GMP which leads to an opening of the cationchannel and thereby causing a depolarization of rodphotoreceptors.SUBUNIT: Tetramer formed of three CNGA1 and one CNGB1 modulatorysubunits. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=2;Name=1;IsoId=P29973-1; Sequence=Displayed;Name=2;IsoId=P29973-2; Sequence=VSP_047170;Note=No experimental confirmation available.;TISSUE SPECIFICITY: Rod cells in the retina.DOMAIN: The C-terminal coiled-coil domain mediateshomotrimerization of CNGA subunits. {ECO:0000250}.DISEASE: Retinitis pigmentosa 49 (RP49) [MIM:613756]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:15570217,ECO:0000269|PubMed:7479749}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel(TC 1.A.1.5) family. CNGA1 subfamily. {ECO:0000305}.CAUTION: It is uncertain whether Met-1 or Met-5 is the initiator.{ECO:0000305}.SEQUENCE CAUTION:Sequence=AAB22778.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the CNGA1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/cnga1mut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/XP_005248106"],["bp:comment","CNGA1_HUMAN Reviewed; 690 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29693"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29707"],["bp:stoichiometricCoefficient","3.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","CNGB1"],["bp:entityReference_http://identifiers.org/uniprot/Q14028","CNGB1"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29708"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","CNGB1"],["bp:entityReference_http://identifiers.org/uniprot/Q14028","CNGB1"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29708"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","CNGB1"],["bp:entityReference_http://identifiers.org/uniprot/Q14028","CNGB1"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29708"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","CNGB1"],["bp:entityReference_http://identifiers.org/uniprot/Q14028","CNGB1"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29708"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29706"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29706"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29711"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","CNG Channel"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","CNGA1"],["bp:entityReference_http://identifiers.org/uniprot/P29973",[["bp:standardName","cGMP-gated cation channel alpha-1"],["bp:xref",[["bp:relationshipType",null],["bp:id","CNGA1"],["bp:db","hgnc symbol"]]],["bp:xref",[["bp:id","P29973"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","P29973"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","CNGA1_HUMAN"],["bp:name","Cyclic nucleotide-gated channel alpha-1"],["bp:name","CNCG1"],["bp:name","Cyclic nucleotide-gated channel, photoreceptor"],["bp:name","CNG1"],["bp:name","CNGA1"],["bp:name","CNG channel alpha-1"],["bp:name","CNCG"],["bp:name","Rod photoreceptor cGMP-gated channel subunit alpha"],["bp:name","CNG-1"],["bp:name","Cyclic nucleotide-gated cation channel 1"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_00445_identity"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_1259"],["bp:comment","FUNCTION: Visual signal transduction is mediated by a G-proteincoupled cascade using cGMP as second messenger. This protein canbe activated by cyclic GMP which leads to an opening of the cationchannel and thereby causing a depolarization of rodphotoreceptors.SUBUNIT: Tetramer formed of three CNGA1 and one CNGB1 modulatorysubunits. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=2;Name=1;IsoId=P29973-1; Sequence=Displayed;Name=2;IsoId=P29973-2; Sequence=VSP_047170;Note=No experimental confirmation available.;TISSUE SPECIFICITY: Rod cells in the retina.DOMAIN: The C-terminal coiled-coil domain mediateshomotrimerization of CNGA subunits. {ECO:0000250}.DISEASE: Retinitis pigmentosa 49 (RP49) [MIM:613756]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:15570217,ECO:0000269|PubMed:7479749}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel(TC 1.A.1.5) family. CNGA1 subfamily. {ECO:0000305}.CAUTION: It is uncertain whether Met-1 or Met-5 is the initiator.{ECO:0000305}.SEQUENCE CAUTION:Sequence=AAB22778.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the CNGA1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/cnga1mut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/XP_005248106"],["bp:comment","CNGA1_HUMAN Reviewed; 690 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29693"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29707"],["bp:stoichiometricCoefficient","3.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","CNGB1"],["bp:entityReference_http://identifiers.org/uniprot/Q14028","CNGB1"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29708"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","CNGB1"],["bp:entityReference_http://identifiers.org/uniprot/Q14028","CNGB1"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29708"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","CNGB1"],["bp:entityReference_http://identifiers.org/uniprot/Q14028","CNGB1"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29708"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","CNGB1"],["bp:entityReference_http://identifiers.org/uniprot/Q14028","CNGB1"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29708"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29706"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29706"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29711"],["bp:stoichiometricCoefficient","1.0"]]],["bp:right",[["bp:physicalEntity",[["bp:displayName","CNG Channel"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","CNGA1"],["bp:entityReference_http://identifiers.org/uniprot/P29973",[["bp:standardName","cGMP-gated cation channel alpha-1"],["bp:xref",[["bp:relationshipType",null],["bp:id","CNGA1"],["bp:db","hgnc symbol"]]],["bp:xref",[["bp:id","P29973"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","P29973"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","CNGA1_HUMAN"],["bp:name","Cyclic nucleotide-gated channel alpha-1"],["bp:name","CNCG1"],["bp:name","Cyclic nucleotide-gated channel, photoreceptor"],["bp:name","CNG1"],["bp:name","CNGA1"],["bp:name","CNG channel alpha-1"],["bp:name","CNCG"],["bp:name","Rod photoreceptor cGMP-gated channel subunit alpha"],["bp:name","CNG-1"],["bp:name","Cyclic nucleotide-gated cation channel 1"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_00445_identity"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_1259"],["bp:comment","FUNCTION: Visual signal transduction is mediated by a G-proteincoupled cascade using cGMP as second messenger. This protein canbe activated by cyclic GMP which leads to an opening of the cationchannel and thereby causing a depolarization of rodphotoreceptors.SUBUNIT: Tetramer formed of three CNGA1 and one CNGB1 modulatorysubunits. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=2;Name=1;IsoId=P29973-1; Sequence=Displayed;Name=2;IsoId=P29973-2; Sequence=VSP_047170;Note=No experimental confirmation available.;TISSUE SPECIFICITY: Rod cells in the retina.DOMAIN: The C-terminal coiled-coil domain mediateshomotrimerization of CNGA subunits. {ECO:0000250}.DISEASE: Retinitis pigmentosa 49 (RP49) [MIM:613756]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:15570217,ECO:0000269|PubMed:7479749}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel(TC 1.A.1.5) family. CNGA1 subfamily. {ECO:0000305}.CAUTION: It is uncertain whether Met-1 or Met-5 is the initiator.{ECO:0000305}.SEQUENCE CAUTION:Sequence=AAB22778.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the CNGA1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/cnga1mut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/XP_005248106"],["bp:comment","CNGA1_HUMAN Reviewed; 690 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29693"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29707"],["bp:stoichiometricCoefficient","3.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","CNGB1"],["bp:entityReference_http://identifiers.org/uniprot/Q14028","CNGB1"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29708"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","CNGB1"],["bp:entityReference_http://identifiers.org/uniprot/Q14028","CNGB1"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29708"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","CNGB1"],["bp:entityReference_http://identifiers.org/uniprot/Q14028","CNGB1"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29708"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","CNGB1"],["bp:entityReference_http://identifiers.org/uniprot/Q14028","CNGB1"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29708"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29706"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29706"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29711"],["bp:stoichiometricCoefficient","1.0"]]],["bp:right",[["bp:physicalEntity",[["bp:displayName","CNG Channel"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","CNGA1"],["bp:entityReference_http://identifiers.org/uniprot/P29973",[["bp:standardName","cGMP-gated cation channel alpha-1"],["bp:xref",[["bp:relationshipType",null],["bp:id","CNGA1"],["bp:db","hgnc symbol"]]],["bp:xref",[["bp:id","P29973"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","P29973"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","CNGA1_HUMAN"],["bp:name","Cyclic nucleotide-gated channel alpha-1"],["bp:name","CNCG1"],["bp:name","Cyclic nucleotide-gated channel, photoreceptor"],["bp:name","CNG1"],["bp:name","CNGA1"],["bp:name","CNG channel alpha-1"],["bp:name","CNCG"],["bp:name","Rod photoreceptor cGMP-gated channel subunit alpha"],["bp:name","CNG-1"],["bp:name","Cyclic nucleotide-gated cation channel 1"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_00445_identity"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_1259"],["bp:comment","FUNCTION: Visual signal transduction is mediated by a G-proteincoupled cascade using cGMP as second messenger. This protein canbe activated by cyclic GMP which leads to an opening of the cationchannel and thereby causing a depolarization of rodphotoreceptors.SUBUNIT: Tetramer formed of three CNGA1 and one CNGB1 modulatorysubunits. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=2;Name=1;IsoId=P29973-1; Sequence=Displayed;Name=2;IsoId=P29973-2; Sequence=VSP_047170;Note=No experimental confirmation available.;TISSUE SPECIFICITY: Rod cells in the retina.DOMAIN: The C-terminal coiled-coil domain mediateshomotrimerization of CNGA subunits. {ECO:0000250}.DISEASE: Retinitis pigmentosa 49 (RP49) [MIM:613756]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:15570217,ECO:0000269|PubMed:7479749}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel(TC 1.A.1.5) family. CNGA1 subfamily. {ECO:0000305}.CAUTION: It is uncertain whether Met-1 or Met-5 is the initiator.{ECO:0000305}.SEQUENCE CAUTION:Sequence=AAB22778.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the CNGA1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/cnga1mut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/XP_005248106"],["bp:comment","CNGA1_HUMAN Reviewed; 690 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29693"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29707"],["bp:stoichiometricCoefficient","3.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","CNGB1"],["bp:entityReference_http://identifiers.org/uniprot/Q14028","CNGB1"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29708"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","CNGB1"],["bp:entityReference_http://identifiers.org/uniprot/Q14028","CNGB1"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29708"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","CNGB1"],["bp:entityReference_http://identifiers.org/uniprot/Q14028","CNGB1"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29708"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","CNGB1"],["bp:entityReference_http://identifiers.org/uniprot/Q14028","CNGB1"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29708"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29706"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29706"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29711"],["bp:stoichiometricCoefficient","1.0"]]],["bp:left",[["bp:physicalEntity",[["bp:displayName","CNG Channel"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","CNGA1"],["bp:entityReference_http://identifiers.org/uniprot/P29973",[["bp:standardName","cGMP-gated cation channel alpha-1"],["bp:xref",[["bp:relationshipType",null],["bp:id","CNGA1"],["bp:db","hgnc symbol"]]],["bp:xref",[["bp:id","P29973"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","P29973"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","CNGA1_HUMAN"],["bp:name","Cyclic nucleotide-gated channel alpha-1"],["bp:name","CNCG1"],["bp:name","Cyclic nucleotide-gated channel, photoreceptor"],["bp:name","CNG1"],["bp:name","CNGA1"],["bp:name","CNG channel alpha-1"],["bp:name","CNCG"],["bp:name","Rod photoreceptor cGMP-gated channel subunit alpha"],["bp:name","CNG-1"],["bp:name","Cyclic nucleotide-gated cation channel 1"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_00445_identity"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_1259"],["bp:comment","FUNCTION: Visual signal transduction is mediated by a G-proteincoupled cascade using cGMP as second messenger. This protein canbe activated by cyclic GMP which leads to an opening of the cationchannel and thereby causing a depolarization of rodphotoreceptors.SUBUNIT: Tetramer formed of three CNGA1 and one CNGB1 modulatorysubunits. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=2;Name=1;IsoId=P29973-1; Sequence=Displayed;Name=2;IsoId=P29973-2; Sequence=VSP_047170;Note=No experimental confirmation available.;TISSUE SPECIFICITY: Rod cells in the retina.DOMAIN: The C-terminal coiled-coil domain mediateshomotrimerization of CNGA subunits. {ECO:0000250}.DISEASE: Retinitis pigmentosa 49 (RP49) [MIM:613756]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:15570217,ECO:0000269|PubMed:7479749}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel(TC 1.A.1.5) family. CNGA1 subfamily. {ECO:0000305}.CAUTION: It is uncertain whether Met-1 or Met-5 is the initiator.{ECO:0000305}.SEQUENCE CAUTION:Sequence=AAB22778.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the CNGA1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/cnga1mut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/XP_005248106"],["bp:comment","CNGA1_HUMAN Reviewed; 690 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29693"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29707"],["bp:stoichiometricCoefficient","3.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","CNGB1"],["bp:entityReference_http://identifiers.org/uniprot/Q14028","CNGB1"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29708"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","CNGB1"],["bp:entityReference_http://identifiers.org/uniprot/Q14028","CNGB1"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29708"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","CNGB1"],["bp:entityReference_http://identifiers.org/uniprot/Q14028","CNGB1"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29708"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","CNGB1"],["bp:entityReference_http://identifiers.org/uniprot/Q14028","CNGB1"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29708"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29706"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29706"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29711"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29691"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29691"]]}},{"data":{"id":"ComplexAssembly_3bc924c5cd39f7ee06d898b63d989d08_LEFT_TO_RIGHT","class":"process","label":"","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":639.9634,"y":168.64012,"w":15,"h":15},"metadata":[["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29889"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29889"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29889"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29889"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29889"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29889"],["bp:stoichiometricCoefficient","1.0"]]],["bp:right",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29889"],["bp:stoichiometricCoefficient","1.0"]]],["bp:right",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29889"],["bp:stoichiometricCoefficient","1.0"]]],["bp:right",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29889"],["bp:stoichiometricCoefficient","1.0"]]],["bp:left",[["bp:physicalEntity",[["bp:displayName","RHO"],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 342 342 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","342"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 340 340 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","340"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 338 338 Phosphoserine."],["bp:featureLocation","MOD_RES 338 338 Phosphoserine."]]],["bp:standardName","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:xref","Rhodopsin"],["bp:organism","Rhodopsin"],["bp:displayName","OPSD_HUMAN"],["bp:name","RHO"],["bp:name","OPN2"],["bp:name","Opsin-2"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000530"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01584_identity"],["bp:comment","OPSD_HUMAN Reviewed; 348 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6010"],["bp:comment","FUNCTION: Photoreceptor required for image-forming vision at lowlight intensity. Required for photoreceptor cell viability afterbirth. Light-induced isomerization of 11-cis to all-trans retinaltriggers a conformational change leading to G-protein activationand release of all-trans retinal.BIOPHYSICOCHEMICAL PROPERTIES:Absorption:Abs(max)=495 nm;SUBUNIT: Homodimer. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19934218};Multi-pass membrane protein {ECO:0000269|PubMed:19934218}.Note=Synthesized in the inner segment (IS) of rod photoreceptorcells before vectorial transport to the rod outer segment (OS)photosensory cilia.TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediatesvision in dim light.PTM: Phosphorylated on some or all of the serine and threonineresidues present in the C-terminal region.PTM: Contains one covalently linked retinal chromophore.{ECO:0000250}.DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:1302614,ECO:0000269|PubMed:1391967, ECO:0000269|PubMed:1833777,ECO:0000269|PubMed:1840561, ECO:0000269|PubMed:1862076,ECO:0000269|PubMed:1897520, ECO:0000269|PubMed:1985460,ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:19960070,ECO:0000269|PubMed:2137202, ECO:0000269|PubMed:2215617,ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:2239971,ECO:0000269|PubMed:7633434, ECO:0000269|PubMed:7981701,ECO:0000269|PubMed:7987326, ECO:0000269|PubMed:7987331,ECO:0000269|PubMed:8045708, ECO:0000269|PubMed:8076945,ECO:0000269|PubMed:8081400, ECO:0000269|PubMed:8088850,ECO:0000269|PubMed:8317502, ECO:0000269|PubMed:8353500,ECO:0000269|PubMed:8554077, ECO:0000269|PubMed:9452035}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:7846071,ECO:0000269|PubMed:8358437, ECO:0000269|PubMed:9888392}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the G-protein coupled receptor 1 family.Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.WEB RESOURCE: Name=Mutations of the RHO gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rhomut.htm\";WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;URL=\"https://en.wikipedia.org/wiki/Rhodopsin\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6010"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29553"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29889"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29886"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29886"]]}},{"data":{"id":"Complex_a8839e630eb701d733e0eb95a4de7522","class":"complex","label":"GC1/GCAP Family","parent":"","clonemarker":false,"stateVariables":[{"id":"Complex_a8839e630eb701d733e0eb95a4de7522.info.1","class":"state variable","state":{"variable":"","value":"Act"}}],"unitsOfInformation":[],"bbox":{"x":595.0226,"y":1089.4156,"w":52,"h":64},"metadata":[["bp:displayName","GC1/GCAP Family"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29675"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29675"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29675"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29675"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29675"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29670"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29670"]]}},{"data":{"id":"Protein_cd015613e74378c096239e4ae3222d58_Complex_a8839e630eb701d733e0eb95a4de7522","class":"macromolecule","label":"GUCY2D","parent":"Complex_a8839e630eb701d733e0eb95a4de7522","clonemarker":false,"stateVariables":[{"id":"Protein_cd015613e74378c096239e4ae3222d58_Complex_a8839e630eb701d733e0eb95a4de7522.info.1","class":"state variable","state":{"variable":"G2","value":"My"}}],"unitsOfInformation":[],"bbox":{"x":595.0226,"y":1071.9156,"w":48,"h":25},"metadata":[["bp:displayName","GC1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00068"],["bp:db","protein modification ontology"]]],["bp:term","N-myristoyl-glycine"],["bp:term","N-myristoylglycine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29674"],["bp:featureLocation",[["bp:sequencePosition","2"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_7264"]]]]],["bp:entityReference_http://identifiers.org/uniprot/Q02846",[["bp:standardName","Retinal guanylyl cyclase 1"],["bp:xref",[["bp:id","Q02846"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","GUCY2D"],["bp:db","hgnc symbol"]]],["bp:organism",[["bp:relationshipType",null],["bp:id","GUCY2D"],["bp:db","hgnc symbol"]]],["bp:displayName","GUC2D_HUMAN"],["bp:name","RETGC1"],["bp:name","Guanylate cyclase 2D, retinal"],["bp:name","GUC2D"],["bp:name","RETGC-1"],["bp:name","GUCY2D"],["bp:name","Rod outer segment membrane guanylate cyclase"],["bp:name","4.6.1.2"],["bp:name","RETGC"],["bp:name","CORD6"],["bp:name","GUC1A4"],["bp:name","ROS-GC"],["bp:comment","GUC2D_HUMAN Reviewed; 1103 AA."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000171"],["bp:comment","FUNCTION: Probably plays a specific functional role in the rodsand/or cones of photoreceptors. It may be the enzyme involved inthe resynthesis of cGMP required for recovery of the dark stateafter phototransduction.CATALYTIC ACTIVITY: GTP = 3',5'-cyclic GMP + diphosphate.ENZYME REGULATION: Activated by GCAP-1; inhibited by calcium.SUBCELLULAR LOCATION: Membrane; Single-pass type I membraneprotein.TISSUE SPECIFICITY: Retina. Localized exclusively in the nucleiand inner segments of the rod and cone photoreceptor cells.DISEASE: Leber congenital amaurosis 1 (LCA1) [MIM:204000]: Asevere dystrophy of the retina, typically becoming evident in thefirst years of life. Visual function is usually poor and oftenaccompanied by nystagmus, sluggish or near-absent pupillaryresponses, photophobia, high hyperopia and keratoconus.{ECO:0000269|PubMed:11035546, ECO:0000269|PubMed:12365911,ECO:0000269|PubMed:15123990, ECO:0000269|PubMed:17724218,ECO:0000269|PubMed:21602930, ECO:0000269|PubMed:8944027,ECO:0000269|PubMed:9888789}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Cone-rod dystrophy 6 (CORD6) [MIM:601777]: An inheritedretinal dystrophy characterized by retinal pigment depositsvisible on fundus examination, predominantly in the macularregion, and initial loss of cone photoreceptors followed by roddegeneration. This leads to decreased visual acuity andsensitivity in the central visual field, followed by loss ofperipheral vision. Severe loss of vision occurs earlier than inretinitis pigmentosa, due to cone photoreceptors degenerating at ahigher rate than rod photoreceptors. {ECO:0000269|PubMed:12552567,ECO:0000269|PubMed:15111605, ECO:0000269|PubMed:18332321,ECO:0000269|PubMed:18487367, ECO:0000269|PubMed:20517349,ECO:0000269|PubMed:21552474, ECO:0000269|PubMed:22194653,ECO:0000269|PubMed:23734073, ECO:0000269|PubMed:24480840,ECO:0000269|PubMed:9618177, ECO:0000269|PubMed:9683616}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the adenylyl cyclase class-4/guanylylcyclase family. {ECO:0000255|PROSITE-ProRule:PRU00099}.WEB RESOURCE: Name=Mutations of the GUCY2D gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02550_identity"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29671"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]}},{"data":{"id":"Protein_d95c616d16b1d43598d8ef7c56c2075d_Complex_a8839e630eb701d733e0eb95a4de7522","class":"macromolecule","label":"GCAP Family","parent":"Complex_a8839e630eb701d733e0eb95a4de7522","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":595.0226,"y":1106.9156,"w":48,"h":25},"metadata":[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation",[["bp:sequencePosition","3"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation",[["bp:sequencePosition","3"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation",[["bp:sequencePosition","3"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"]]}},{"data":{"id":"Complex_c11edd9737faa91eb365922aa30c5be4","class":"complex","label":"Transducin","parent":"","clonemarker":false,"stateVariables":[{"id":"Complex_c11edd9737faa91eb365922aa30c5be4.info.1","class":"state variable","state":{"variable":"","value":"Ina"}}],"unitsOfInformation":[],"bbox":{"x":250.99548,"y":177.854769,"w":52,"h":118.99999},"metadata":[["bp:displayName","Transducin"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GDP"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17552",[["bp:standardName","guanosine 5'-(trihydrogen diphosphate)"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37121"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:65180"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:5212"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37038"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:24448"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:14379"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:chemicalFormula","C10H15N5O11P2"],["bp:displayName","GDP"],["bp:name","C10H15N5O11P2"],["bp:name","Guanosine diphosphate"],["bp:name","Nc1nc2n(cnc2c(=O)[nH]1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O"],["bp:name","Guanosine 5'-diphosphate"],["bp:molecularWeight","443.2007"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00035.eref"],["bp:comment","has_role CHEBI:76971"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/SmallMoleculeReference_bind_1035_identity"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB04315"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_302"],["bp:comment","REPLACED http://identifiers.org/cas/146-91-8"],["bp:comment","is_a CHEBI:37038"],["bp:comment","is_conjugate_acid_of CHEBI:65180"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/glG10620.eref"],["bp:comment","REPLACED http://www.inoh.org/biopax/IMR_0001357_GDP"],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:37121"],["bp:structure","is_a CHEBI:37121"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_301"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_301"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29544"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GDP"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17552",[["bp:standardName","guanosine 5'-(trihydrogen diphosphate)"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37121"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:65180"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:5212"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37038"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:24448"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:14379"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:chemicalFormula","C10H15N5O11P2"],["bp:displayName","GDP"],["bp:name","C10H15N5O11P2"],["bp:name","Guanosine diphosphate"],["bp:name","Nc1nc2n(cnc2c(=O)[nH]1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O"],["bp:name","Guanosine 5'-diphosphate"],["bp:molecularWeight","443.2007"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00035.eref"],["bp:comment","has_role CHEBI:76971"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/SmallMoleculeReference_bind_1035_identity"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB04315"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_302"],["bp:comment","REPLACED http://identifiers.org/cas/146-91-8"],["bp:comment","is_a CHEBI:37038"],["bp:comment","is_conjugate_acid_of CHEBI:65180"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/glG10620.eref"],["bp:comment","REPLACED http://www.inoh.org/biopax/IMR_0001357_GDP"],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:37121"],["bp:structure","is_a CHEBI:37121"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_301"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_301"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29544"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GDP"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17552",[["bp:standardName","guanosine 5'-(trihydrogen diphosphate)"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37121"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:65180"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:5212"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37038"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:24448"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:14379"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:chemicalFormula","C10H15N5O11P2"],["bp:displayName","GDP"],["bp:name","C10H15N5O11P2"],["bp:name","Guanosine diphosphate"],["bp:name","Nc1nc2n(cnc2c(=O)[nH]1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O"],["bp:name","Guanosine 5'-diphosphate"],["bp:molecularWeight","443.2007"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00035.eref"],["bp:comment","has_role CHEBI:76971"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/SmallMoleculeReference_bind_1035_identity"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB04315"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_302"],["bp:comment","REPLACED http://identifiers.org/cas/146-91-8"],["bp:comment","is_a CHEBI:37038"],["bp:comment","is_conjugate_acid_of CHEBI:65180"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/glG10620.eref"],["bp:comment","REPLACED http://www.inoh.org/biopax/IMR_0001357_GDP"],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:37121"],["bp:structure","is_a CHEBI:37121"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_301"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_301"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29544"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GDP"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17552",[["bp:standardName","guanosine 5'-(trihydrogen diphosphate)"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37121"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:65180"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:5212"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37038"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:24448"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:14379"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:chemicalFormula","C10H15N5O11P2"],["bp:displayName","GDP"],["bp:name","C10H15N5O11P2"],["bp:name","Guanosine diphosphate"],["bp:name","Nc1nc2n(cnc2c(=O)[nH]1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O"],["bp:name","Guanosine 5'-diphosphate"],["bp:molecularWeight","443.2007"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00035.eref"],["bp:comment","has_role CHEBI:76971"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/SmallMoleculeReference_bind_1035_identity"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB04315"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_302"],["bp:comment","REPLACED http://identifiers.org/cas/146-91-8"],["bp:comment","is_a CHEBI:37038"],["bp:comment","is_conjugate_acid_of CHEBI:65180"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/glG10620.eref"],["bp:comment","REPLACED http://www.inoh.org/biopax/IMR_0001357_GDP"],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:37121"],["bp:structure","is_a CHEBI:37121"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_301"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_301"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29544"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GDP"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17552",[["bp:standardName","guanosine 5'-(trihydrogen diphosphate)"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37121"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:65180"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:5212"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37038"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:24448"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:14379"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:chemicalFormula","C10H15N5O11P2"],["bp:displayName","GDP"],["bp:name","C10H15N5O11P2"],["bp:name","Guanosine diphosphate"],["bp:name","Nc1nc2n(cnc2c(=O)[nH]1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O"],["bp:name","Guanosine 5'-diphosphate"],["bp:molecularWeight","443.2007"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00035.eref"],["bp:comment","has_role CHEBI:76971"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/SmallMoleculeReference_bind_1035_identity"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB04315"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_302"],["bp:comment","REPLACED http://identifiers.org/cas/146-91-8"],["bp:comment","is_a CHEBI:37038"],["bp:comment","is_conjugate_acid_of CHEBI:65180"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/glG10620.eref"],["bp:comment","REPLACED http://www.inoh.org/biopax/IMR_0001357_GDP"],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:37121"],["bp:structure","is_a CHEBI:37121"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_301"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_301"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29544"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GDP"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17552",[["bp:standardName","guanosine 5'-(trihydrogen diphosphate)"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37121"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:65180"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:5212"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37038"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:24448"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:14379"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:chemicalFormula","C10H15N5O11P2"],["bp:displayName","GDP"],["bp:name","C10H15N5O11P2"],["bp:name","Guanosine diphosphate"],["bp:name","Nc1nc2n(cnc2c(=O)[nH]1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O"],["bp:name","Guanosine 5'-diphosphate"],["bp:molecularWeight","443.2007"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00035.eref"],["bp:comment","has_role CHEBI:76971"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/SmallMoleculeReference_bind_1035_identity"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB04315"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_302"],["bp:comment","REPLACED http://identifiers.org/cas/146-91-8"],["bp:comment","is_a CHEBI:37038"],["bp:comment","is_conjugate_acid_of CHEBI:65180"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/glG10620.eref"],["bp:comment","REPLACED http://www.inoh.org/biopax/IMR_0001357_GDP"],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:37121"],["bp:structure","is_a CHEBI:37121"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_301"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_301"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29544"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GDP"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17552",[["bp:standardName","guanosine 5'-(trihydrogen diphosphate)"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37121"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:65180"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:5212"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37038"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:24448"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:14379"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:chemicalFormula","C10H15N5O11P2"],["bp:displayName","GDP"],["bp:name","C10H15N5O11P2"],["bp:name","Guanosine diphosphate"],["bp:name","Nc1nc2n(cnc2c(=O)[nH]1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O"],["bp:name","Guanosine 5'-diphosphate"],["bp:molecularWeight","443.2007"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00035.eref"],["bp:comment","has_role CHEBI:76971"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/SmallMoleculeReference_bind_1035_identity"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB04315"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_302"],["bp:comment","REPLACED http://identifiers.org/cas/146-91-8"],["bp:comment","is_a CHEBI:37038"],["bp:comment","is_conjugate_acid_of CHEBI:65180"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/glG10620.eref"],["bp:comment","REPLACED http://www.inoh.org/biopax/IMR_0001357_GDP"],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:37121"],["bp:structure","is_a CHEBI:37121"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_301"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_301"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29544"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GDP"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17552",[["bp:standardName","guanosine 5'-(trihydrogen diphosphate)"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37121"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:65180"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:5212"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37038"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:24448"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:14379"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:chemicalFormula","C10H15N5O11P2"],["bp:displayName","GDP"],["bp:name","C10H15N5O11P2"],["bp:name","Guanosine diphosphate"],["bp:name","Nc1nc2n(cnc2c(=O)[nH]1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O"],["bp:name","Guanosine 5'-diphosphate"],["bp:molecularWeight","443.2007"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00035.eref"],["bp:comment","has_role CHEBI:76971"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/SmallMoleculeReference_bind_1035_identity"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB04315"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_302"],["bp:comment","REPLACED http://identifiers.org/cas/146-91-8"],["bp:comment","is_a CHEBI:37038"],["bp:comment","is_conjugate_acid_of CHEBI:65180"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/glG10620.eref"],["bp:comment","REPLACED http://www.inoh.org/biopax/IMR_0001357_GDP"],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:37121"],["bp:structure","is_a CHEBI:37121"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_301"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_301"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29544"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","GDP"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17552",[["bp:standardName","guanosine 5'-(trihydrogen diphosphate)"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37121"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:65180"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:5212"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37038"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:24448"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:14379"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:chemicalFormula","C10H15N5O11P2"],["bp:displayName","GDP"],["bp:name","C10H15N5O11P2"],["bp:name","Guanosine diphosphate"],["bp:name","Nc1nc2n(cnc2c(=O)[nH]1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O"],["bp:name","Guanosine 5'-diphosphate"],["bp:molecularWeight","443.2007"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00035.eref"],["bp:comment","has_role CHEBI:76971"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/SmallMoleculeReference_bind_1035_identity"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB04315"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_302"],["bp:comment","REPLACED http://identifiers.org/cas/146-91-8"],["bp:comment","is_a CHEBI:37038"],["bp:comment","is_conjugate_acid_of CHEBI:65180"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/glG10620.eref"],["bp:comment","REPLACED http://www.inoh.org/biopax/IMR_0001357_GDP"],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:37121"],["bp:structure","is_a CHEBI:37121"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_301"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_301"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29544"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29538"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29538"]]}},{"data":{"id":"Protein_fc6578580632db5c34bab285a2cac2d3_Complex_c11edd9737faa91eb365922aa30c5be4","class":"macromolecule","label":"GNB1","parent":"Complex_c11edd9737faa91eb365922aa30c5be4","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":250.99548,"y":202.85477,"w":48,"h":25},"metadata":[["bp:displayName","GNB1"],["bp:entityReference_http://identifiers.org/uniprot/P62873",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylserine"],["bp:term","N-acetylserine"]]],["bp:comment","MOD_RES 2 2 N-acetylserine."],["bp:featureLocation",[["bp:sequencePosition","2"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphohistidine"],["bp:term","MOD_RES Phosphohistidine"]]],["bp:comment","MOD_RES 266 266 Phosphohistidine."],["bp:featureLocation",[["bp:sequencePosition","266"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 2 2 Phosphoserine."],["bp:featureLocation","MOD_RES 2 2 Phosphoserine."]]],["bp:standardName","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref",[["bp:id","P62873"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:id","P62873"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","P62873"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","GBB1_HUMAN"],["bp:name","GNB1"],["bp:name","Transducin beta chain 1"],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as a modulator or transducer in various transmembranesignaling systems. The beta and gamma chains are required for theGTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction.SUBUNIT: G proteins are composed of 3 units, alpha, beta andgamma. Interacts with ARHGEF18 and RASD2 (PubMed:14512443,PubMed:19255495). The heterodimer formed by GNB1 and GNG2interacts with ARHGEF5 (PubMed:19713215).{ECO:0000269|PubMed:14512443, ECO:0000269|PubMed:19255495,ECO:0000269|PubMed:19713215}.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=2;Name=1;IsoId=P62873-1; Sequence=Displayed;Name=2;IsoId=P62873-2; Sequence=VSP_055232;Note=No experimental confirmation available.;PTM: Phosphorylation at His-266 by NDKB contributes to G proteinactivation by increasing the high energetic phosphate transferonto GDP. {ECO:0000250}.DISEASE: Mental retardation, autosomal dominant 42 (MRD42)[MIM:616973]: A form of mental retardation, a disordercharacterized by significantly below average general intellectualfunctioning associated with impairments in adaptive behavior andmanifested during the developmental period. MRD42 patientsmanifest global developmental delay commonly accompanied byhypotonia, seizures of various types, ophthalmologicalmanifestations, and poor growth. {ECO:0000269|PubMed:25485910,ECO:0000269|PubMed:27108799, ECO:0000269|PubMed:27668284,ECO:0000269|PubMed:28087732}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the WD repeat G protein beta family.{ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2782"],["bp:comment","REPLACED http://identifiers.org/uniprot/B1AKQ8"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_786971"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_002065"],["bp:comment","GBB1_HUMAN Reviewed; 340 AA."],["bp:comment","REPLACED http://identifiers.org/refseq/XP_017175466"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_00766_identity"],["bp:comment","REPLACED http://identifiers.org/uniprot/P01946"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2782"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_dip_DIP-599N_identity"],["bp:comment","REPLACED http://identifiers.org/refseq/XP_016856548"],["bp:comment","REPLACED http://identifiers.org/uniprot/P04901"],["bp:comment","REPLACED http://identifiers.org/uniprot/P62874"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"]]}},{"data":{"id":"Protein_91825223fb5bfcba336efdffb9e9723c_Complex_c11edd9737faa91eb365922aa30c5be4","class":"macromolecule","label":"GNGT1","parent":"Complex_c11edd9737faa91eb365922aa30c5be4","clonemarker":false,"stateVariables":[{"id":"Protein_91825223fb5bfcba336efdffb9e9723c_Complex_c11edd9737faa91eb365922aa30c5be4.info.1","class":"state variable","state":{"variable":"","value":"S-farnesyl-L-cysteine"}}],"unitsOfInformation":[],"bbox":{"x":250.99548,"y":167.85477,"w":48,"h":25},"metadata":[["bp:displayName","GNGT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00111"],["bp:db","protein modification ontology"]]],["bp:term","S-farnesyl-L-cysteine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29542"]]],["bp:entityReference_http://identifiers.org/uniprot/P63211",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Cysteine methyl ester"],["bp:term","MOD_RES Cysteine methyl ester"]]],["bp:comment","MOD_RES 71 71 Cysteine methyl ester."],["bp:featureLocation",[["bp:sequencePosition","71"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(T) subunit gamma-T1"],["bp:xref",[["bp:relationshipType",null],["bp:id","GNGT1"],["bp:db","hgnc symbol"]]],["bp:xref",[["bp:id","P63211"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","P63211"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","GBG1_HUMAN"],["bp:name","Transducin gamma chain"],["bp:name","GNGT1"],["bp:comment","GBG1_HUMAN Reviewed; 74 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2792"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_dip_DIP-471N_identity"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_068774"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2792"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01805_identity"],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as a modulator or transducer in various transmembranesignaling systems. The beta and gamma chains are required for theGTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction.SUBUNIT: G proteins are composed of 3 units, alpha, beta andgamma.SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Lipid-anchor{ECO:0000305}; Cytoplasmic side {ECO:0000305}.TISSUE SPECIFICITY: Retinal rod outer segment.SIMILARITY: Belongs to the G protein gamma family. {ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_intact_EBI-5774280_identity"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29539"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]}},{"data":{"id":"SmallMolecule_2544e7a4b5003313120ca13ed284937d_Complex_c11edd9737faa91eb365922aa30c5be4","class":"simple chemical","label":"GDP","parent":"Complex_c11edd9737faa91eb365922aa30c5be4","clonemarker":true,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":249.49548,"y":227.85477,"w":45,"h":15},"metadata":[["bp:displayName","GDP"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17552",[["bp:standardName","guanosine 5'-(trihydrogen diphosphate)"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37121"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:65180"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:5212"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37038"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:24448"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:14379"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13327"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:42738"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:76971"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:76971"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:76971"],["bp:db","chebi"]]],["bp:chemicalFormula","C10H15N5O11P2"],["bp:displayName","GDP"],["bp:name","C10H15N5O11P2"],["bp:name","Guanosine diphosphate"],["bp:name","Nc1nc2n(cnc2c(=O)[nH]1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O"],["bp:name","Guanosine 5'-diphosphate"],["bp:molecularWeight","443.2007"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00035.eref"],["bp:comment","has_role CHEBI:76971"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/SmallMoleculeReference_bind_1035_identity"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB04315"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_302"],["bp:comment","REPLACED http://identifiers.org/cas/146-91-8"],["bp:comment","is_a CHEBI:37038"],["bp:comment","is_conjugate_acid_of CHEBI:65180"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/glG10620.eref"],["bp:comment","REPLACED http://www.inoh.org/biopax/IMR_0001357_GDP"],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:37121"],["bp:structure","is_a CHEBI:37121"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_301"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_301"]]}},{"data":{"id":"Protein_e4ab0eff9265bbdc4140f63f513badef_Complex_c11edd9737faa91eb365922aa30c5be4","class":"macromolecule","label":"GNAT1","parent":"Complex_c11edd9737faa91eb365922aa30c5be4","clonemarker":false,"stateVariables":[{"id":"Protein_e4ab0eff9265bbdc4140f63f513badef_Complex_c11edd9737faa91eb365922aa30c5be4.info.1","class":"state variable","state":{"variable":"1","value":"N-acetyl-L-methionine"}}],"unitsOfInformation":[],"bbox":{"x":250.99548,"y":132.85477400000002,"w":48,"h":25},"metadata":[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]}},{"data":{"id":"BiochemicalReaction_003a892501df9e94fa8f085fc17cdc2d_LEFT_TO_RIGHT","class":"process","label":"","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":465.58768,"y":333.4341,"w":15,"h":15},"metadata":[["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","Metarhodopsin II"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29552"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29552"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29817"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","Metarhodopsin II"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29552"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29552"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29817"],["bp:stoichiometricCoefficient","1.0"]]],["bp:right",[["bp:physicalEntity",[["bp:displayName","Metarhodopsin II"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29552"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29552"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29817"],["bp:stoichiometricCoefficient","1.0"]]],["bp:spontaneous","true"],["bp:left","true"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29815"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29815"]]}},{"data":{"id":"Complex_5884d043b0305ba6dc7cc2dda0e90bba","class":"complex","label":"GC1/GCAP Family","parent":"","clonemarker":false,"stateVariables":[{"id":"Complex_5884d043b0305ba6dc7cc2dda0e90bba.info.1","class":"state variable","state":{"variable":"","value":"Act"}}],"unitsOfInformation":[],"bbox":{"x":625.52167,"y":713.37396,"w":52,"h":59},"metadata":[["bp:displayName","GC1/GCAP Family"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29686"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29686"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29686"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29686"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29686"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29683"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29683"]]}},{"data":{"id":"Protein_85331f89b392effc75c17fa2a1817c39_Complex_5884d043b0305ba6dc7cc2dda0e90bba","class":"macromolecule","label":"GUCY2D","parent":"Complex_5884d043b0305ba6dc7cc2dda0e90bba","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":625.52167,"y":728.37396,"w":48,"h":25},"metadata":[["bp:displayName","GC1"],["bp:entityReference_http://identifiers.org/uniprot/Q02846",[["bp:standardName","Retinal guanylyl cyclase 1"],["bp:xref",[["bp:id","Q02846"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","GUCY2D"],["bp:db","hgnc symbol"]]],["bp:organism",[["bp:relationshipType",null],["bp:id","GUCY2D"],["bp:db","hgnc symbol"]]],["bp:displayName","GUC2D_HUMAN"],["bp:name","RETGC1"],["bp:name","Guanylate cyclase 2D, retinal"],["bp:name","GUC2D"],["bp:name","RETGC-1"],["bp:name","GUCY2D"],["bp:name","Rod outer segment membrane guanylate cyclase"],["bp:name","4.6.1.2"],["bp:name","RETGC"],["bp:name","CORD6"],["bp:name","GUC1A4"],["bp:name","ROS-GC"],["bp:comment","GUC2D_HUMAN Reviewed; 1103 AA."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000171"],["bp:comment","FUNCTION: Probably plays a specific functional role in the rodsand/or cones of photoreceptors. It may be the enzyme involved inthe resynthesis of cGMP required for recovery of the dark stateafter phototransduction.CATALYTIC ACTIVITY: GTP = 3',5'-cyclic GMP + diphosphate.ENZYME REGULATION: Activated by GCAP-1; inhibited by calcium.SUBCELLULAR LOCATION: Membrane; Single-pass type I membraneprotein.TISSUE SPECIFICITY: Retina. Localized exclusively in the nucleiand inner segments of the rod and cone photoreceptor cells.DISEASE: Leber congenital amaurosis 1 (LCA1) [MIM:204000]: Asevere dystrophy of the retina, typically becoming evident in thefirst years of life. Visual function is usually poor and oftenaccompanied by nystagmus, sluggish or near-absent pupillaryresponses, photophobia, high hyperopia and keratoconus.{ECO:0000269|PubMed:11035546, ECO:0000269|PubMed:12365911,ECO:0000269|PubMed:15123990, ECO:0000269|PubMed:17724218,ECO:0000269|PubMed:21602930, ECO:0000269|PubMed:8944027,ECO:0000269|PubMed:9888789}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Cone-rod dystrophy 6 (CORD6) [MIM:601777]: An inheritedretinal dystrophy characterized by retinal pigment depositsvisible on fundus examination, predominantly in the macularregion, and initial loss of cone photoreceptors followed by roddegeneration. This leads to decreased visual acuity andsensitivity in the central visual field, followed by loss ofperipheral vision. Severe loss of vision occurs earlier than inretinitis pigmentosa, due to cone photoreceptors degenerating at ahigher rate than rod photoreceptors. {ECO:0000269|PubMed:12552567,ECO:0000269|PubMed:15111605, ECO:0000269|PubMed:18332321,ECO:0000269|PubMed:18487367, ECO:0000269|PubMed:20517349,ECO:0000269|PubMed:21552474, ECO:0000269|PubMed:22194653,ECO:0000269|PubMed:23734073, ECO:0000269|PubMed:24480840,ECO:0000269|PubMed:9618177, ECO:0000269|PubMed:9683616}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the adenylyl cyclase class-4/guanylylcyclase family. {ECO:0000255|PROSITE-ProRule:PRU00099}.WEB RESOURCE: Name=Mutations of the GUCY2D gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02550_identity"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29684"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]}},{"data":{"id":"Protein_d95c616d16b1d43598d8ef7c56c2075d_Complex_5884d043b0305ba6dc7cc2dda0e90bba","class":"macromolecule","label":"GCAP Family","parent":"Complex_5884d043b0305ba6dc7cc2dda0e90bba","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":625.52167,"y":698.37396,"w":48,"h":25},"metadata":[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation",[["bp:sequencePosition","3"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation",[["bp:sequencePosition","3"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation",[["bp:sequencePosition","3"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"]]}},{"data":{"id":"Protein_58a1f719f8c2ed9b0882f7798a8df554","class":"macromolecule","label":"GUCY2F","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":807.2026,"y":681.5793,"w":48,"h":25},"metadata":[["bp:displayName","GC2"],["bp:entityReference_http://identifiers.org/uniprot/P51841",[["bp:standardName","Retinal guanylyl cyclase 2"],["bp:xref",[["bp:relationshipType",null],["bp:id","GUCY2F"],["bp:db","hgnc symbol"]]],["bp:xref",[["bp:id","P51841"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","P51841"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","GUC2F_HUMAN"],["bp:name","RETGC2"],["bp:name","GUC2F"],["bp:name","RETGC-2"],["bp:name","GUCY2F"],["bp:name","4.6.1.2"],["bp:name","Guanylate cyclase F"],["bp:name","GC-F"],["bp:name","Rod outer segment membrane guanylate cyclase 2"],["bp:name","ROS-GC2"],["bp:name","Guanylate cyclase 2F, retinal"],["bp:comment","GUC2F_HUMAN Reviewed; 1108 AA."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02078_identity"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_001513"],["bp:comment","FUNCTION: Probably plays a specific functional role in the rodsand/or cones of photoreceptors. It may be the enzyme involved inthe resynthesis of cGMP required for recovery of the dark stateafter phototransduction.CATALYTIC ACTIVITY: GTP = 3',5'-cyclic GMP + diphosphate.ENZYME REGULATION: Activated by GCAP-1; inhibited by calcium.SUBCELLULAR LOCATION: Membrane; Single-pass type I membraneprotein.TISSUE SPECIFICITY: Retina. Localized exclusively in the outernuclear layer and inner segments of the rod and cone photoreceptorcells.DOMAIN: The protein kinase domain is predicted to be catalyticallyinactive.PTM: There are 9 conserved cysteine residues in sensory guanylatecyclases, 6 in the extracellular domain, which may be involved inintra- or interchain disulfide bonds.SIMILARITY: Belongs to the adenylyl cyclase class-4/guanylylcyclase family. {ECO:0000255|PROSITE-ProRule:PRU00099}.WEB RESOURCE: Name=Mutations of the GUCY2F gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29759"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]}},{"data":{"id":"ComplexAssembly_a49775b5bf5a7b4bc9c3fee882a528e5_LEFT_TO_RIGHT","class":"process","label":"","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":813.3435,"y":797.4532,"w":15,"h":15},"metadata":[["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:feature","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60253"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:feature","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60253"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:feature","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60253"],["bp:stoichiometricCoefficient","1.0"]]],["bp:xref",[["bp:physicalEntity",[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:feature","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60253"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:feature","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60253"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:feature","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60253"],["bp:stoichiometricCoefficient","1.0"]]],["bp:right",[["bp:physicalEntity",[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation","MOD_RES 3 3 Deamidated asparagine."]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:feature","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60253"],["bp:stoichiometricCoefficient","1.0"]]],["bp:spontaneous","true"],["bp:left","true"],["bp:left","true"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60252"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_60252"]]}},{"data":{"id":"Complex_c4e02fccdf29968aa1e9e599de8ca892","class":"complex","label":"GNAT1/GTP","parent":"","clonemarker":false,"stateVariables":[{"id":"Complex_c4e02fccdf29968aa1e9e599de8ca892.info.1","class":"state variable","state":{"variable":"","value":"Act"}}],"unitsOfInformation":[],"bbox":{"x":172.20958,"y":506.0619,"w":52,"h":54},"metadata":[["bp:displayName","GNAT1/GTP"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29653"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29653"]]}},{"data":{"id":"SmallMolecule_4f4ea8c9f46fdd97ff867fe7c8860bda_Complex_c4e02fccdf29968aa1e9e599de8ca892","class":"simple chemical","label":"GTP","parent":"Complex_c4e02fccdf29968aa1e9e599de8ca892","clonemarker":true,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":170.70958,"y":523.5619,"w":45,"h":15},"metadata":[["bp:displayName","GTP"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:15996",[["bp:standardName","guanosine 5'-(tetrahydrogen triphosphate)"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37121"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:5234"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13342"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37045"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:24451"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:15996"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:42934"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:76971"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57600"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57600"],["bp:db","chebi"]]],["bp:chemicalFormula","C10H16N5O14P3"],["bp:displayName","GTP"],["bp:name","Guanosine 5'-triphosphate"],["bp:name","guanosine triphosphate"],["bp:name","H4gtp"],["bp:name","Nc1nc2n(cnc2c(=O)[nH]1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O"],["bp:name","guanosine 5'-triphosphoric acid"],["bp:name","GUANOSINE-5'-TRIPHOSPHATE"],["bp:name","C10H16N5O14P3"],["bp:name","5'-GTP"],["bp:molecularWeight","523.1806"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/SmallMoleculeReference_bind_212_identity"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB04137"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_310"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://www.inoh.org/biopax/IMR_0001354_GTP"],["bp:comment","has_role CHEBI:76971"],["bp:comment","is_a CHEBI:37045"],["bp:comment","is_a CHEBI:37121"],["bp:comment","is_conjugate_acid_of CHEBI:57600"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00044.eref"],["bp:structure","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00044.eref"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_309"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_309"]]}},{"data":{"id":"Protein_5d6c1415855226905a79c603d64a3009_Complex_c4e02fccdf29968aa1e9e599de8ca892","class":"macromolecule","label":"GNAT1","parent":"Complex_c4e02fccdf29968aa1e9e599de8ca892","clonemarker":false,"stateVariables":[{"id":"Protein_5d6c1415855226905a79c603d64a3009_Complex_c4e02fccdf29968aa1e9e599de8ca892.info.1","class":"state variable","state":{"variable":"","value":"Act"}}],"unitsOfInformation":[],"bbox":{"x":172.20958,"y":493.5619,"w":48,"h":25},"metadata":[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation",[["bp:sequencePosition","174"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P11488"]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P11488"]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P11488"]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]}},{"data":{"id":"Complex_273e090a34386a1ba38ce7060ea62c91","class":"complex","label":"cGMP/CNG Channel","parent":"","clonemarker":false,"stateVariables":[{"id":"Complex_273e090a34386a1ba38ce7060ea62c91.info.1","class":"state variable","state":{"variable":"","value":"Act"}}],"unitsOfInformation":[],"bbox":{"x":690.06165,"y":840.6521,"w":52,"h":84},"metadata":[["bp:displayName","cGMP/CNG Channel"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","CNGA1"],["bp:entityReference_http://identifiers.org/uniprot/P29973",[["bp:standardName","cGMP-gated cation channel alpha-1"],["bp:xref",[["bp:relationshipType",null],["bp:id","CNGA1"],["bp:db","hgnc symbol"]]],["bp:xref",[["bp:id","P29973"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","P29973"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","CNGA1_HUMAN"],["bp:name","Cyclic nucleotide-gated channel alpha-1"],["bp:name","CNCG1"],["bp:name","Cyclic nucleotide-gated channel, photoreceptor"],["bp:name","CNG1"],["bp:name","CNGA1"],["bp:name","CNG channel alpha-1"],["bp:name","CNCG"],["bp:name","Rod photoreceptor cGMP-gated channel subunit alpha"],["bp:name","CNG-1"],["bp:name","Cyclic nucleotide-gated cation channel 1"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_00445_identity"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_1259"],["bp:comment","FUNCTION: Visual signal transduction is mediated by a G-proteincoupled cascade using cGMP as second messenger. This protein canbe activated by cyclic GMP which leads to an opening of the cationchannel and thereby causing a depolarization of rodphotoreceptors.SUBUNIT: Tetramer formed of three CNGA1 and one CNGB1 modulatorysubunits. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=2;Name=1;IsoId=P29973-1; Sequence=Displayed;Name=2;IsoId=P29973-2; Sequence=VSP_047170;Note=No experimental confirmation available.;TISSUE SPECIFICITY: Rod cells in the retina.DOMAIN: The C-terminal coiled-coil domain mediateshomotrimerization of CNGA subunits. {ECO:0000250}.DISEASE: Retinitis pigmentosa 49 (RP49) [MIM:613756]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:15570217,ECO:0000269|PubMed:7479749}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel(TC 1.A.1.5) family. CNGA1 subfamily. {ECO:0000305}.CAUTION: It is uncertain whether Met-1 or Met-5 is the initiator.{ECO:0000305}.SEQUENCE CAUTION:Sequence=AAB22778.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the CNGA1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/cnga1mut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/XP_005248106"],["bp:comment","CNGA1_HUMAN Reviewed; 690 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29693"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29699"],["bp:stoichiometricCoefficient","3.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","CNGB1"],["bp:entityReference_http://identifiers.org/uniprot/Q14028",[["bp:standardName","Cyclic nucleotide-gated cation channel beta-1"],["bp:xref",[["bp:id","Q14028"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:id","Q14028"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","Q14028"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","CNGB1_HUMAN"],["bp:name","CNCG4"],["bp:name","CNCG2"],["bp:name","CNG4"],["bp:name","CNG channel 4"],["bp:name","CNGB1"],["bp:name","CNG-4"],["bp:name","RCNC2"],["bp:name","Glutamic acid-rich protein"],["bp:name","Cyclic nucleotide-gated cation channel 4"],["bp:name","CNCG3L"],["bp:name","GARP"],["bp:name","Cyclic nucleotide-gated cation channel modulatory subunit"],["bp:name","Cyclic nucleotide-gated channel beta-1"],["bp:name","Cyclic nucleotide-gated cation channel gamma"],["bp:name","CNG channel beta-1"],["bp:comment","FUNCTION: Subunit of cyclic nucleotide-gated (CNG) channels,nonselective cation channels, which play important roles in bothvisual and olfactory signal transduction. When associated withCNGA1, it is involved in the regulation of ion flow into the rodphotoreceptor outer segment (ROS), in response to light-inducedalteration of the levels of intracellular cGMP.FUNCTION: Isoform GARP2 is a high affinity rod photoreceptorphosphodiesterase (PDE6)-binding protein that modulates itscatalytic properties: it is a regulator of spontaneous activationof rod PDE6, thereby serving to lower rod photoreceptor 'darknoise' and allowing these sensory cells to operate at the singlephoton detection limit.SUBUNIT: Tetramer formed of three CNGA1 and one CNGB1 modulatorysubunits. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=4;Comment=There is no evidence for an ortholog to bovine GARP1 inthe human genome.;Name=RCNC2B;IsoId=Q14028-1; Sequence=Displayed;Name=RCNC2A;IsoId=Q14028-2; Sequence=VSP_001110;Name=GARP2; Synonyms=GARP;IsoId=Q14028-3; Sequence=VSP_037921, VSP_037922;Note=In the rod cells, the CNGB1 locus encodes the cyclicnucleotide-gated cation channel beta-1 subunit and severalglutamic-acid-rich proteins (GARPs).;Name=4;IsoId=Q14028-4; Sequence=VSP_053421;DISEASE: Retinitis pigmentosa 45 (RP45) [MIM:613767]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:11379879}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel(TC 1.A.1.5) family. CNGB1 subfamily. {ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","CNGB1_HUMAN Reviewed; 1251 AA."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_07204_identity"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_1258"],["bp:comment","REPLACED http://identifiers.org/uniprot/Q9UMG2"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_1258"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29701"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","CNGB1"],["bp:entityReference_http://identifiers.org/uniprot/Q14028",[["bp:standardName","Cyclic nucleotide-gated cation channel beta-1"],["bp:xref",[["bp:id","Q14028"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:id","Q14028"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","Q14028"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","CNGB1_HUMAN"],["bp:name","CNCG4"],["bp:name","CNCG2"],["bp:name","CNG4"],["bp:name","CNG channel 4"],["bp:name","CNGB1"],["bp:name","CNG-4"],["bp:name","RCNC2"],["bp:name","Glutamic acid-rich protein"],["bp:name","Cyclic nucleotide-gated cation channel 4"],["bp:name","CNCG3L"],["bp:name","GARP"],["bp:name","Cyclic nucleotide-gated cation channel modulatory subunit"],["bp:name","Cyclic nucleotide-gated channel beta-1"],["bp:name","Cyclic nucleotide-gated cation channel gamma"],["bp:name","CNG channel beta-1"],["bp:comment","FUNCTION: Subunit of cyclic nucleotide-gated (CNG) channels,nonselective cation channels, which play important roles in bothvisual and olfactory signal transduction. When associated withCNGA1, it is involved in the regulation of ion flow into the rodphotoreceptor outer segment (ROS), in response to light-inducedalteration of the levels of intracellular cGMP.FUNCTION: Isoform GARP2 is a high affinity rod photoreceptorphosphodiesterase (PDE6)-binding protein that modulates itscatalytic properties: it is a regulator of spontaneous activationof rod PDE6, thereby serving to lower rod photoreceptor 'darknoise' and allowing these sensory cells to operate at the singlephoton detection limit.SUBUNIT: Tetramer formed of three CNGA1 and one CNGB1 modulatorysubunits. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=4;Comment=There is no evidence for an ortholog to bovine GARP1 inthe human genome.;Name=RCNC2B;IsoId=Q14028-1; Sequence=Displayed;Name=RCNC2A;IsoId=Q14028-2; Sequence=VSP_001110;Name=GARP2; Synonyms=GARP;IsoId=Q14028-3; Sequence=VSP_037921, VSP_037922;Note=In the rod cells, the CNGB1 locus encodes the cyclicnucleotide-gated cation channel beta-1 subunit and severalglutamic-acid-rich proteins (GARPs).;Name=4;IsoId=Q14028-4; Sequence=VSP_053421;DISEASE: Retinitis pigmentosa 45 (RP45) [MIM:613767]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:11379879}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel(TC 1.A.1.5) family. CNGB1 subfamily. {ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","CNGB1_HUMAN Reviewed; 1251 AA."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_07204_identity"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_1258"],["bp:comment","REPLACED http://identifiers.org/uniprot/Q9UMG2"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_1258"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29701"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","CNGB1"],["bp:entityReference_http://identifiers.org/uniprot/Q14028",[["bp:standardName","Cyclic nucleotide-gated cation channel beta-1"],["bp:xref",[["bp:id","Q14028"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:id","Q14028"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","Q14028"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","CNGB1_HUMAN"],["bp:name","CNCG4"],["bp:name","CNCG2"],["bp:name","CNG4"],["bp:name","CNG channel 4"],["bp:name","CNGB1"],["bp:name","CNG-4"],["bp:name","RCNC2"],["bp:name","Glutamic acid-rich protein"],["bp:name","Cyclic nucleotide-gated cation channel 4"],["bp:name","CNCG3L"],["bp:name","GARP"],["bp:name","Cyclic nucleotide-gated cation channel modulatory subunit"],["bp:name","Cyclic nucleotide-gated channel beta-1"],["bp:name","Cyclic nucleotide-gated cation channel gamma"],["bp:name","CNG channel beta-1"],["bp:comment","FUNCTION: Subunit of cyclic nucleotide-gated (CNG) channels,nonselective cation channels, which play important roles in bothvisual and olfactory signal transduction. When associated withCNGA1, it is involved in the regulation of ion flow into the rodphotoreceptor outer segment (ROS), in response to light-inducedalteration of the levels of intracellular cGMP.FUNCTION: Isoform GARP2 is a high affinity rod photoreceptorphosphodiesterase (PDE6)-binding protein that modulates itscatalytic properties: it is a regulator of spontaneous activationof rod PDE6, thereby serving to lower rod photoreceptor 'darknoise' and allowing these sensory cells to operate at the singlephoton detection limit.SUBUNIT: Tetramer formed of three CNGA1 and one CNGB1 modulatorysubunits. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=4;Comment=There is no evidence for an ortholog to bovine GARP1 inthe human genome.;Name=RCNC2B;IsoId=Q14028-1; Sequence=Displayed;Name=RCNC2A;IsoId=Q14028-2; Sequence=VSP_001110;Name=GARP2; Synonyms=GARP;IsoId=Q14028-3; Sequence=VSP_037921, VSP_037922;Note=In the rod cells, the CNGB1 locus encodes the cyclicnucleotide-gated cation channel beta-1 subunit and severalglutamic-acid-rich proteins (GARPs).;Name=4;IsoId=Q14028-4; Sequence=VSP_053421;DISEASE: Retinitis pigmentosa 45 (RP45) [MIM:613767]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:11379879}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel(TC 1.A.1.5) family. CNGB1 subfamily. {ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","CNGB1_HUMAN Reviewed; 1251 AA."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_07204_identity"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_1258"],["bp:comment","REPLACED http://identifiers.org/uniprot/Q9UMG2"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_1258"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29701"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","CNGB1"],["bp:entityReference_http://identifiers.org/uniprot/Q14028",[["bp:standardName","Cyclic nucleotide-gated cation channel beta-1"],["bp:xref",[["bp:id","Q14028"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:id","Q14028"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","Q14028"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","CNGB1_HUMAN"],["bp:name","CNCG4"],["bp:name","CNCG2"],["bp:name","CNG4"],["bp:name","CNG channel 4"],["bp:name","CNGB1"],["bp:name","CNG-4"],["bp:name","RCNC2"],["bp:name","Glutamic acid-rich protein"],["bp:name","Cyclic nucleotide-gated cation channel 4"],["bp:name","CNCG3L"],["bp:name","GARP"],["bp:name","Cyclic nucleotide-gated cation channel modulatory subunit"],["bp:name","Cyclic nucleotide-gated channel beta-1"],["bp:name","Cyclic nucleotide-gated cation channel gamma"],["bp:name","CNG channel beta-1"],["bp:comment","FUNCTION: Subunit of cyclic nucleotide-gated (CNG) channels,nonselective cation channels, which play important roles in bothvisual and olfactory signal transduction. When associated withCNGA1, it is involved in the regulation of ion flow into the rodphotoreceptor outer segment (ROS), in response to light-inducedalteration of the levels of intracellular cGMP.FUNCTION: Isoform GARP2 is a high affinity rod photoreceptorphosphodiesterase (PDE6)-binding protein that modulates itscatalytic properties: it is a regulator of spontaneous activationof rod PDE6, thereby serving to lower rod photoreceptor 'darknoise' and allowing these sensory cells to operate at the singlephoton detection limit.SUBUNIT: Tetramer formed of three CNGA1 and one CNGB1 modulatorysubunits. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=4;Comment=There is no evidence for an ortholog to bovine GARP1 inthe human genome.;Name=RCNC2B;IsoId=Q14028-1; Sequence=Displayed;Name=RCNC2A;IsoId=Q14028-2; Sequence=VSP_001110;Name=GARP2; Synonyms=GARP;IsoId=Q14028-3; Sequence=VSP_037921, VSP_037922;Note=In the rod cells, the CNGB1 locus encodes the cyclicnucleotide-gated cation channel beta-1 subunit and severalglutamic-acid-rich proteins (GARPs).;Name=4;IsoId=Q14028-4; Sequence=VSP_053421;DISEASE: Retinitis pigmentosa 45 (RP45) [MIM:613767]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:11379879}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel(TC 1.A.1.5) family. CNGB1 subfamily. {ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","CNGB1_HUMAN Reviewed; 1251 AA."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_07204_identity"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_1258"],["bp:comment","REPLACED http://identifiers.org/uniprot/Q9UMG2"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_1258"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29701"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","CNGB1"],["bp:entityReference_http://identifiers.org/uniprot/Q14028",[["bp:standardName","Cyclic nucleotide-gated cation channel beta-1"],["bp:xref",[["bp:id","Q14028"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:id","Q14028"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","Q14028"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","CNGB1_HUMAN"],["bp:name","CNCG4"],["bp:name","CNCG2"],["bp:name","CNG4"],["bp:name","CNG channel 4"],["bp:name","CNGB1"],["bp:name","CNG-4"],["bp:name","RCNC2"],["bp:name","Glutamic acid-rich protein"],["bp:name","Cyclic nucleotide-gated cation channel 4"],["bp:name","CNCG3L"],["bp:name","GARP"],["bp:name","Cyclic nucleotide-gated cation channel modulatory subunit"],["bp:name","Cyclic nucleotide-gated channel beta-1"],["bp:name","Cyclic nucleotide-gated cation channel gamma"],["bp:name","CNG channel beta-1"],["bp:comment","FUNCTION: Subunit of cyclic nucleotide-gated (CNG) channels,nonselective cation channels, which play important roles in bothvisual and olfactory signal transduction. When associated withCNGA1, it is involved in the regulation of ion flow into the rodphotoreceptor outer segment (ROS), in response to light-inducedalteration of the levels of intracellular cGMP.FUNCTION: Isoform GARP2 is a high affinity rod photoreceptorphosphodiesterase (PDE6)-binding protein that modulates itscatalytic properties: it is a regulator of spontaneous activationof rod PDE6, thereby serving to lower rod photoreceptor 'darknoise' and allowing these sensory cells to operate at the singlephoton detection limit.SUBUNIT: Tetramer formed of three CNGA1 and one CNGB1 modulatorysubunits. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=4;Comment=There is no evidence for an ortholog to bovine GARP1 inthe human genome.;Name=RCNC2B;IsoId=Q14028-1; Sequence=Displayed;Name=RCNC2A;IsoId=Q14028-2; Sequence=VSP_001110;Name=GARP2; Synonyms=GARP;IsoId=Q14028-3; Sequence=VSP_037921, VSP_037922;Note=In the rod cells, the CNGB1 locus encodes the cyclicnucleotide-gated cation channel beta-1 subunit and severalglutamic-acid-rich proteins (GARPs).;Name=4;IsoId=Q14028-4; Sequence=VSP_053421;DISEASE: Retinitis pigmentosa 45 (RP45) [MIM:613767]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:11379879}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel(TC 1.A.1.5) family. CNGB1 subfamily. {ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","CNGB1_HUMAN Reviewed; 1251 AA."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_07204_identity"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_1258"],["bp:comment","REPLACED http://identifiers.org/uniprot/Q9UMG2"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_1258"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29701"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","CNGB1"],["bp:entityReference_http://identifiers.org/uniprot/Q14028",[["bp:standardName","Cyclic nucleotide-gated cation channel beta-1"],["bp:xref",[["bp:id","Q14028"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:id","Q14028"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","Q14028"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","CNGB1_HUMAN"],["bp:name","CNCG4"],["bp:name","CNCG2"],["bp:name","CNG4"],["bp:name","CNG channel 4"],["bp:name","CNGB1"],["bp:name","CNG-4"],["bp:name","RCNC2"],["bp:name","Glutamic acid-rich protein"],["bp:name","Cyclic nucleotide-gated cation channel 4"],["bp:name","CNCG3L"],["bp:name","GARP"],["bp:name","Cyclic nucleotide-gated cation channel modulatory subunit"],["bp:name","Cyclic nucleotide-gated channel beta-1"],["bp:name","Cyclic nucleotide-gated cation channel gamma"],["bp:name","CNG channel beta-1"],["bp:comment","FUNCTION: Subunit of cyclic nucleotide-gated (CNG) channels,nonselective cation channels, which play important roles in bothvisual and olfactory signal transduction. When associated withCNGA1, it is involved in the regulation of ion flow into the rodphotoreceptor outer segment (ROS), in response to light-inducedalteration of the levels of intracellular cGMP.FUNCTION: Isoform GARP2 is a high affinity rod photoreceptorphosphodiesterase (PDE6)-binding protein that modulates itscatalytic properties: it is a regulator of spontaneous activationof rod PDE6, thereby serving to lower rod photoreceptor 'darknoise' and allowing these sensory cells to operate at the singlephoton detection limit.SUBUNIT: Tetramer formed of three CNGA1 and one CNGB1 modulatorysubunits. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=4;Comment=There is no evidence for an ortholog to bovine GARP1 inthe human genome.;Name=RCNC2B;IsoId=Q14028-1; Sequence=Displayed;Name=RCNC2A;IsoId=Q14028-2; Sequence=VSP_001110;Name=GARP2; Synonyms=GARP;IsoId=Q14028-3; Sequence=VSP_037921, VSP_037922;Note=In the rod cells, the CNGB1 locus encodes the cyclicnucleotide-gated cation channel beta-1 subunit and severalglutamic-acid-rich proteins (GARPs).;Name=4;IsoId=Q14028-4; Sequence=VSP_053421;DISEASE: Retinitis pigmentosa 45 (RP45) [MIM:613767]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:11379879}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel(TC 1.A.1.5) family. CNGB1 subfamily. {ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","CNGB1_HUMAN Reviewed; 1251 AA."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_07204_identity"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_1258"],["bp:comment","REPLACED http://identifiers.org/uniprot/Q9UMG2"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_1258"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29701"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29692"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29692"]]}},{"data":{"id":"Protein_fb83bda4c371013f9121bce5c93f7e36_Complex_273e090a34386a1ba38ce7060ea62c91","class":"macromolecule","label":"CNGA1","parent":"Complex_273e090a34386a1ba38ce7060ea62c91","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":690.06165,"y":843.1521,"w":48,"h":25},"metadata":[["bp:displayName","CNGA1"],["bp:entityReference_http://identifiers.org/uniprot/P29973",[["bp:standardName","cGMP-gated cation channel alpha-1"],["bp:xref",[["bp:relationshipType",null],["bp:id","CNGA1"],["bp:db","hgnc symbol"]]],["bp:xref",[["bp:id","P29973"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","P29973"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","CNGA1_HUMAN"],["bp:name","Cyclic nucleotide-gated channel alpha-1"],["bp:name","CNCG1"],["bp:name","Cyclic nucleotide-gated channel, photoreceptor"],["bp:name","CNG1"],["bp:name","CNGA1"],["bp:name","CNG channel alpha-1"],["bp:name","CNCG"],["bp:name","Rod photoreceptor cGMP-gated channel subunit alpha"],["bp:name","CNG-1"],["bp:name","Cyclic nucleotide-gated cation channel 1"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_00445_identity"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_1259"],["bp:comment","FUNCTION: Visual signal transduction is mediated by a G-proteincoupled cascade using cGMP as second messenger. This protein canbe activated by cyclic GMP which leads to an opening of the cationchannel and thereby causing a depolarization of rodphotoreceptors.SUBUNIT: Tetramer formed of three CNGA1 and one CNGB1 modulatorysubunits. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=2;Name=1;IsoId=P29973-1; Sequence=Displayed;Name=2;IsoId=P29973-2; Sequence=VSP_047170;Note=No experimental confirmation available.;TISSUE SPECIFICITY: Rod cells in the retina.DOMAIN: The C-terminal coiled-coil domain mediateshomotrimerization of CNGA subunits. {ECO:0000250}.DISEASE: Retinitis pigmentosa 49 (RP49) [MIM:613756]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:15570217,ECO:0000269|PubMed:7479749}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel(TC 1.A.1.5) family. CNGA1 subfamily. {ECO:0000305}.CAUTION: It is uncertain whether Met-1 or Met-5 is the initiator.{ECO:0000305}.SEQUENCE CAUTION:Sequence=AAB22778.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the CNGA1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/cnga1mut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/XP_005248106"],["bp:comment","CNGA1_HUMAN Reviewed; 690 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29693"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]}},{"data":{"id":"Protein_5ba98a5f4e066cfe9d858ffbda349c69_Complex_273e090a34386a1ba38ce7060ea62c91","class":"macromolecule","label":"CNGB1","parent":"Complex_273e090a34386a1ba38ce7060ea62c91","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":690.06165,"y":813.1521,"w":48,"h":25},"metadata":[["bp:displayName","CNGB1"],["bp:entityReference_http://identifiers.org/uniprot/Q14028",[["bp:standardName","Cyclic nucleotide-gated cation channel beta-1"],["bp:xref",[["bp:id","Q14028"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CNGB1"],["bp:db","hgnc symbol"]]],["bp:organism",[["bp:relationshipType",null],["bp:id","CNGB1"],["bp:db","hgnc symbol"]]],["bp:displayName","CNGB1_HUMAN"],["bp:name","CNCG4"],["bp:name","CNCG2"],["bp:name","CNG4"],["bp:name","CNG channel 4"],["bp:name","CNGB1"],["bp:name","CNG-4"],["bp:name","RCNC2"],["bp:name","Glutamic acid-rich protein"],["bp:name","Cyclic nucleotide-gated cation channel 4"],["bp:name","CNCG3L"],["bp:name","GARP"],["bp:name","Cyclic nucleotide-gated cation channel modulatory subunit"],["bp:name","Cyclic nucleotide-gated channel beta-1"],["bp:name","Cyclic nucleotide-gated cation channel gamma"],["bp:name","CNG channel beta-1"],["bp:comment","FUNCTION: Subunit of cyclic nucleotide-gated (CNG) channels,nonselective cation channels, which play important roles in bothvisual and olfactory signal transduction. When associated withCNGA1, it is involved in the regulation of ion flow into the rodphotoreceptor outer segment (ROS), in response to light-inducedalteration of the levels of intracellular cGMP.FUNCTION: Isoform GARP2 is a high affinity rod photoreceptorphosphodiesterase (PDE6)-binding protein that modulates itscatalytic properties: it is a regulator of spontaneous activationof rod PDE6, thereby serving to lower rod photoreceptor 'darknoise' and allowing these sensory cells to operate at the singlephoton detection limit.SUBUNIT: Tetramer formed of three CNGA1 and one CNGB1 modulatorysubunits. {ECO:0000250}.SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=4;Comment=There is no evidence for an ortholog to bovine GARP1 inthe human genome.;Name=RCNC2B;IsoId=Q14028-1; Sequence=Displayed;Name=RCNC2A;IsoId=Q14028-2; Sequence=VSP_001110;Name=GARP2; Synonyms=GARP;IsoId=Q14028-3; Sequence=VSP_037921, VSP_037922;Note=In the rod cells, the CNGB1 locus encodes the cyclicnucleotide-gated cation channel beta-1 subunit and severalglutamic-acid-rich proteins (GARPs).;Name=4;IsoId=Q14028-4; Sequence=VSP_053421;DISEASE: Retinitis pigmentosa 45 (RP45) [MIM:613767]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:11379879}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel(TC 1.A.1.5) family. CNGB1 subfamily. {ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","CNGB1_HUMAN Reviewed; 1251 AA."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_07204_identity"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_1258"],["bp:comment","REPLACED http://identifiers.org/uniprot/Q9UMG2"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_1258"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29696"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]}},{"data":{"id":"SmallMolecule_0410492d790c65d4bd97585d42aabbd5_Complex_273e090a34386a1ba38ce7060ea62c91","class":"simple chemical","label":"cGMP","parent":"Complex_273e090a34386a1ba38ce7060ea62c91","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":690.06165,"y":870.6521,"w":48,"h":20},"metadata":[["bp:displayName","cGMP"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16356",[["bp:standardName","guanosine 3',5'-(hydrogen phosphate)"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11675"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:61295"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:76971"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:1327"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16356"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:44957"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:19834"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:19834"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:19834"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:19834"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:19834"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:19834"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:19834"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:19834"],["bp:db","chebi"]]],["bp:chemicalFormula","C10H12N5O7P"],["bp:displayName","3',5'-cyclic GMP"],["bp:name","Cyclic GMP"],["bp:name","C10H12N5O7P"],["bp:name","cGMP"],["bp:name","3',5'-Cyclic GMP"],["bp:name","Guanosine 3',5'-cyclic phosphate"],["bp:name","Guanosine cyclic monophosphate"],["bp:name","Guanosine 3',5'-cyclic monophosphate"],["bp:name","Nc1nc2n(cnc2c(=O)[nH]1)[C@@H]1O[C@@H]2COP(O)(=O)O[C@H]2[C@H]1O"],["bp:molecularWeight","345.20554"],["bp:comment","has_role CHEBI:76971"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/SmallMoleculeReference_1ad519ed0c8517fe4c5844c6e94414bc"],["bp:comment","REPLACED http://www.inoh.org/biopax/IMR_0100025_cGMP"],["bp:comment","is_a CHEBI:19834"],["bp:comment","is_conjugate_acid_of CHEBI:57746"],["bp:comment","has_role CHEBI:76924"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29665"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60184"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_chemical_mesh_d006152"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00942.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01314"],["bp:comment","A 3',5'-cyclic purine nucleotide that is 3',5'-cyclic GMP."],["bp:comment","is_a CHEBI:61295"],["bp:comment","has_role CHEBI:75772"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB02315"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://identifiers.org/pubchem.compound/24316"],["bp:structure","REPLACED http://identifiers.org/pubchem.compound/24316"]]],["bp:name","cGMP (4 units)"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60183"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_60183"]]}},{"data":{"id":"ComplexAssembly_ffc0fd905747da36e9042f7bced9650a_LEFT_TO_RIGHT","class":"process","label":"","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":488.72614,"y":237.82256,"w":15,"h":15},"metadata":[["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","Metarhodopsin II"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29552"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29552"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29590"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","Metarhodopsin II"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29552"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29552"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29590"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","Metarhodopsin II"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29552"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29552"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29590"],["bp:stoichiometricCoefficient","1.0"]]],["bp:right",[["bp:physicalEntity",[["bp:displayName","Metarhodopsin II"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29552"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29552"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29590"],["bp:stoichiometricCoefficient","1.0"]]],["bp:right",[["bp:physicalEntity",[["bp:displayName","Metarhodopsin II"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","all-trans-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17898",[["bp:standardName","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22348"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12776"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:8814"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","all-trans-retinal"],["bp:name","retinaldehyde"],["bp:name","Retinene"],["bp:name","all-trans-retinaldehyde"],["bp:name","CHEBI:17898"],["bp:name","C20H28O"],["bp:name","[H]C(=O)\\\\C=C(C)\\\\C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C"],["bp:name","all-trans-Vitamin A aldehyde"],["bp:name","all-trans-Retinal"],["bp:name","all-trans-Retinene"],["bp:name","Retinal"],["bp:name","Vitamin A aldehyde"],["bp:molecularWeight","284.43573"],["bp:comment","A retinal in which all four exocyclic double bonds have E- (trans-) geometry."],["bp:comment","has_role CHEBI:75771"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29557"],["bp:comment","has_role CHEBI:67195"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00376.eref"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB01358"],["bp:structure","REPLACED http://identifiers.org/hmdb/HMDB01358"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29556"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29560"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29552"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29552"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29590"],["bp:stoichiometricCoefficient","1.0"]]],["bp:spontaneous","true"],["bp:left","true"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29589"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29589"]]}},{"data":{"id":"ComplexAssembly_1a5f5156b2fa0b7d4490803d5803210d_LEFT_TO_RIGHT","class":"process","label":"","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":733.4726,"y":708.3002,"w":15,"h":15},"metadata":[["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","GC1"],["bp:entityReference_http://identifiers.org/uniprot/Q02846",[["bp:standardName","Retinal guanylyl cyclase 1"],["bp:xref",[["bp:id","Q02846"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","GUCY2D"],["bp:db","hgnc symbol"]]],["bp:organism",[["bp:relationshipType",null],["bp:id","GUCY2D"],["bp:db","hgnc symbol"]]],["bp:displayName","GUC2D_HUMAN"],["bp:name","RETGC1"],["bp:name","Guanylate cyclase 2D, retinal"],["bp:name","GUC2D"],["bp:name","RETGC-1"],["bp:name","GUCY2D"],["bp:name","Rod outer segment membrane guanylate cyclase"],["bp:name","4.6.1.2"],["bp:name","RETGC"],["bp:name","CORD6"],["bp:name","GUC1A4"],["bp:name","ROS-GC"],["bp:comment","GUC2D_HUMAN Reviewed; 1103 AA."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000171"],["bp:comment","FUNCTION: Probably plays a specific functional role in the rodsand/or cones of photoreceptors. It may be the enzyme involved inthe resynthesis of cGMP required for recovery of the dark stateafter phototransduction.CATALYTIC ACTIVITY: GTP = 3',5'-cyclic GMP + diphosphate.ENZYME REGULATION: Activated by GCAP-1; inhibited by calcium.SUBCELLULAR LOCATION: Membrane; Single-pass type I membraneprotein.TISSUE SPECIFICITY: Retina. Localized exclusively in the nucleiand inner segments of the rod and cone photoreceptor cells.DISEASE: Leber congenital amaurosis 1 (LCA1) [MIM:204000]: Asevere dystrophy of the retina, typically becoming evident in thefirst years of life. Visual function is usually poor and oftenaccompanied by nystagmus, sluggish or near-absent pupillaryresponses, photophobia, high hyperopia and keratoconus.{ECO:0000269|PubMed:11035546, ECO:0000269|PubMed:12365911,ECO:0000269|PubMed:15123990, ECO:0000269|PubMed:17724218,ECO:0000269|PubMed:21602930, ECO:0000269|PubMed:8944027,ECO:0000269|PubMed:9888789}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Cone-rod dystrophy 6 (CORD6) [MIM:601777]: An inheritedretinal dystrophy characterized by retinal pigment depositsvisible on fundus examination, predominantly in the macularregion, and initial loss of cone photoreceptors followed by roddegeneration. This leads to decreased visual acuity andsensitivity in the central visual field, followed by loss ofperipheral vision. Severe loss of vision occurs earlier than inretinitis pigmentosa, due to cone photoreceptors degenerating at ahigher rate than rod photoreceptors. {ECO:0000269|PubMed:12552567,ECO:0000269|PubMed:15111605, ECO:0000269|PubMed:18332321,ECO:0000269|PubMed:18487367, ECO:0000269|PubMed:20517349,ECO:0000269|PubMed:21552474, ECO:0000269|PubMed:22194653,ECO:0000269|PubMed:23734073, ECO:0000269|PubMed:24480840,ECO:0000269|PubMed:9618177, ECO:0000269|PubMed:9683616}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the adenylyl cyclase class-4/guanylylcyclase family. {ECO:0000255|PROSITE-ProRule:PRU00099}.WEB RESOURCE: Name=Mutations of the GUCY2D gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02550_identity"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29684"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60165"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:feature","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60164"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:feature","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60164"],["bp:stoichiometricCoefficient","1.0"]]],["bp:xref",[["bp:physicalEntity",[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:feature","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60164"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:feature","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60164"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:feature","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60164"],["bp:stoichiometricCoefficient","1.0"]]],["bp:right",[["bp:physicalEntity",[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:feature","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_60163"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60164"],["bp:stoichiometricCoefficient","1.0"]]],["bp:spontaneous","true"],["bp:left","true"],["bp:left","true"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_60162"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_60162"]]}},{"data":{"id":"Protein_8efc562e8cef905bbaae9997cd3d4eb4","class":"macromolecule","label":"RDH5","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":987.28564,"y":298.52527,"w":48,"h":25},"metadata":[["bp:displayName","RDH5"],["bp:entityReference_http://identifiers.org/uniprot/Q92781",[["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_Q92781"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_Q92781"]]],["bp:standardName","11-cis retinol dehydrogenase"],["bp:xref",[["bp:id","Q92781"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","RDH5"],["bp:db","hgnc symbol"]]],["bp:organism",[["bp:relationshipType",null],["bp:id","RDH5"],["bp:db","hgnc symbol"]]],["bp:displayName","RDH1_HUMAN"],["bp:name","RDH5"],["bp:name","11-cis RDH"],["bp:name","9-cis retinol dehydrogenase"],["bp:name","RDH1"],["bp:name","SDR9C5"],["bp:name","1.1.1.315"],["bp:name","Retinol dehydrogenase 5"],["bp:name","HSD17B9"],["bp:name","9cRDH"],["bp:name","11-cis RoDH"],["bp:name","Short chain dehydrogenase/reductase family 9C member 5"],["bp:comment","FUNCTION: Stereospecific 11-cis retinol dehydrogenase, whichcatalyzes the final step in the biosynthesis of 11-cisretinaldehyde, the universal chromophore of visual pigments. Alsoable to oxidize 9-cis-retinol and 13-cis-retinol, but not all-trans-retinol. Active in the presence of NAD as cofactor but notin the presence of NADP. {ECO:0000269|PubMed:10588954,ECO:0000269|PubMed:9115228}.CATALYTIC ACTIVITY: 11-cis-retinol-[retinal-binding-protein] +NAD(+) = 11-cis-retinal-[retinol-binding-protein] + NADH.{ECO:0000269|PubMed:10588954, ECO:0000269|PubMed:9115228}.ENZYME REGULATION: Inhibited by 9-cis-, 13-cis- and all-trans-retinoic acids, with the most potent inhibitor being 13-cis-retinoic acid. Weakly inhibited by oleic acid.{ECO:0000269|PubMed:10588954}.BIOPHYSICOCHEMICAL PROPERTIES:pH dependence:Optimum pH is 7.5-8.0 for 9-cis retinol dehydrogenase activity.{ECO:0000269|PubMed:9115228};PATHWAY: Cofactor metabolism; retinol metabolism.{ECO:0000269|PubMed:9115228}.SUBUNIT: Homodimer. {ECO:0000269|PubMed:11675386}.SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:11675386};Peripheral membrane protein {ECO:0000269|PubMed:11675386}.Endoplasmic reticulum lumen {ECO:0000269|PubMed:11675386}.TISSUE SPECIFICITY: Abundant in the retinal pigment epithelium.Expressed at high levels in mammary tissue, kidney and testis, andat lower levels in liver, heart, adrenal gland, lung, pancreas andskeletal muscle. {ECO:0000269|PubMed:9115228}.DISEASE: Fundus albipunctatus (FALBI) [MIM:136880]: A form offleck retina disease characterized by discrete uniform white dotsover the entire fundus with greatest density in the mid-peripheryand no macular involvement. Night blindness occurs. Inheritancecan be autosomal dominant or autosomal recessive.{ECO:0000269|PubMed:10369264, ECO:0000269|PubMed:10617778,ECO:0000269|PubMed:11053295, ECO:0000269|PubMed:11053296,ECO:0000269|PubMed:11078852, ECO:0000269|PubMed:11470705,ECO:0000269|PubMed:11675386, ECO:0000269|PubMed:12788147,ECO:0000269|PubMed:12967826, ECO:0000269|PubMed:25820994}.Note=The disease is caused by mutations affecting the generepresented in this entry.SIMILARITY: Belongs to the short-chain dehydrogenases/reductases(SDR) family. {ECO:0000305}.WEB RESOURCE: Name=Mutations of the RDH5 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/rdh5mut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_03370_identity"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_5959"],["bp:comment","RDH1_HUMAN Reviewed; 318 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_5959"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29900"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]}},{"data":{"id":"Protein_db5d1a64ad1654f31ca849da8e9b326d","class":"macromolecule","label":"SLC24A1","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":1153.8763,"y":1117.6809,"w":48,"h":25},"metadata":[["bp:displayName","NCKX1"],["bp:entityReference_http://identifiers.org/uniprot/O60721",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 658 658 Phosphoserine."],["bp:featureLocation",[["bp:sequencePosition","658"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Phosphothreonine"],["bp:term","Phosphothreonine"]]],["bp:comment","MOD_RES 724 724 Phosphothreonine."],["bp:featureLocation",[["bp:sequencePosition","724"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Sodium/potassium/calcium exchanger 1"],["bp:xref",[["bp:relationshipType",null],["bp:id","SLC24A1"],["bp:db","hgnc symbol"]]],["bp:xref",[["bp:id","O60721"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","O60721"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","NCKX1_HUMAN"],["bp:name","SLC24A1"],["bp:name","NCKX1"],["bp:name","Na(+)/K(+)/Ca(2+)-exchange protein 1"],["bp:name","Retinal rod Na-Ca+K exchanger"],["bp:name","KIAA0702"],["bp:name","Solute carrier family 24 member 1"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_04685_identity"],["bp:comment","FUNCTION: Critical component of the visual transduction cascade,controlling the calcium concentration of outer segments duringlight and darkness. Light causes a rapid lowering of cytosolicfree calcium in the outer segment of both retinal rod and conephotoreceptors and the light-induced lowering of calcium is causedby extrusion via this protein which plays a key role in theprocess of light adaptation. Transports 1 Ca(2+) and 1 K(+) inexchange for 4 Na(+). {ECO:0000269|PubMed:10608890}.SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=3;Name=1;IsoId=O60721-1; Sequence=Displayed;Name=2;IsoId=O60721-2; Sequence=VSP_006160;Note=No experimental confirmation available.;Name=3;IsoId=O60721-3; Sequence=VSP_054491;Note=No experimental confirmation available.;TISSUE SPECIFICITY: Expressed in the retina, particularly in theinner segment, outer and inner nuclear layers, and ganglion celllayer. {ECO:0000269|PubMed:20850105}.PTM: The uncleaved signal sequence is required for efficientmembrane targeting and proper membrane integration.DISEASE: Night blindness, congenital stationary, 1D (CSNB1D)[MIM:613830]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision. CSNB1D is characterized by a Riggs typeof electroretinogram (proportionally reduced a- and b-waves).Patients have visual acuity within the normal range and nosymptoms of myopia and/or nystagmus.{ECO:0000269|PubMed:20850105}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the Ca(2+):cation antiporter (CaCA)(TC 2.A.19) family. SLC24A subfamily. {ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","NCKX1_HUMAN Reviewed; 1099 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29796"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]}},{"data":{"id":"Protein_3e7d00184038f5fbc042e46fe22f53ec","class":"macromolecule","label":"RHO","parent":"","clonemarker":false,"stateVariables":[{"id":"Protein_3e7d00184038f5fbc042e46fe22f53ec.info.1","class":"state variable","state":{"variable":"C322","value":"Pal"}},{"id":"Protein_3e7d00184038f5fbc042e46fe22f53ec.state.2","class":"state variable","state":{"variable":"1","value":"N-acetyl-L-methionine"}},{"id":"Protein_3e7d00184038f5fbc042e46fe22f53ec.info.3","class":"state variable","state":{"variable":"15","value":"n4glycoasn"}},{"id":"Protein_3e7d00184038f5fbc042e46fe22f53ec.state.4","class":"state variable","state":{"variable":"2","value":"n4glycoasn"}},{"id":"Protein_3e7d00184038f5fbc042e46fe22f53ec.info.5","class":"state variable","state":{"variable":"C323","value":"Pal"}}],"unitsOfInformation":[],"bbox":{"x":878.3119,"y":219.6388,"w":85,"h":25},"metadata":[["bp:displayName","RHO"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00115"],["bp:db","protein modification ontology"]]],["bp:term","S-palmitoyl-L-cysteine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29742"],["bp:featureLocation",[["bp:sequencePosition","322"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29743"]]]]],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29739"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:feature",[["bp:modificationType",[["bp:xref",null],["bp:term","n4glycoasn"],["bp:term","N4-glycosyl-L-asparagine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29741"],["bp:featureLocation","REPLACED http://pid.nci.nih.gov/biopax#pid_29741"]]],["bp:feature",[["bp:modificationType",[["bp:xref",null],["bp:term","n4glycoasn"],["bp:term","N4-glycosyl-L-asparagine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29741"],["bp:featureLocation","REPLACED http://pid.nci.nih.gov/biopax#pid_29741"]]],["bp:feature",[["bp:modificationType",[["bp:xref",null],["bp:term","n4glycoasn"],["bp:term","N4-glycosyl-L-asparagine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29741"],["bp:featureLocation","REPLACED http://pid.nci.nih.gov/biopax#pid_29741"]]],["bp:entityReference_http://identifiers.org/uniprot/P08100",[["bp:modificationType",[["bp:xref",null],["bp:term","n4glycoasn"],["bp:term","N4-glycosyl-L-asparagine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29741"],["bp:featureLocation","REPLACED http://pid.nci.nih.gov/biopax#pid_29741"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29738"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29738"]]}},{"data":{"id":"ComplexAssembly_e25341187875d5db0c67decbbd98c874_LEFT_TO_RIGHT","class":"process","label":"","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":409.3319,"y":599.6683,"w":15,"h":15},"metadata":[["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1/GDP"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29522"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29522"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29831"],["bp:stoichiometricCoefficient","2.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1/GDP"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29522"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29522"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29831"],["bp:stoichiometricCoefficient","2.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1/GDP"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29522"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29522"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29831"],["bp:stoichiometricCoefficient","2.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1/GDP"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29522"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29522"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29831"],["bp:stoichiometricCoefficient","2.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1/GDP"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29522"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29522"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29831"],["bp:stoichiometricCoefficient","2.0"]]],["bp:xref",[["bp:physicalEntity",[["bp:displayName","GNAT1/GDP"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29522"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29522"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29831"],["bp:stoichiometricCoefficient","2.0"]]],["bp:xref",[["bp:physicalEntity",[["bp:displayName","GNAT1/GDP"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29522"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29522"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29831"],["bp:stoichiometricCoefficient","2.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","GNAT1/GDP"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29522"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29522"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29831"],["bp:stoichiometricCoefficient","2.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","GNAT1/GDP"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29522"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29522"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29831"],["bp:stoichiometricCoefficient","2.0"]]],["bp:right",[["bp:physicalEntity",[["bp:displayName","GNAT1/GDP"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29522"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29522"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29831"],["bp:stoichiometricCoefficient","2.0"]]],["bp:right",[["bp:physicalEntity",[["bp:displayName","GNAT1/GDP"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29522"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29522"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29831"],["bp:stoichiometricCoefficient","2.0"]]],["bp:right",[["bp:physicalEntity",[["bp:displayName","GNAT1/GDP"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29522"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29522"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29831"],["bp:stoichiometricCoefficient","2.0"]]],["bp:left",[["bp:physicalEntity",[["bp:displayName","GNAT1/GDP"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29522"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29522"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29831"],["bp:stoichiometricCoefficient","2.0"]]],["bp:left",[["bp:physicalEntity",[["bp:displayName","GNAT1/GDP"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00058"],["bp:db","protein modification ontology"]]],["bp:term","N-acetyl-L-methionine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29528"],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_1091"]]]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation","MOD_RES 142 142 Phosphotyrosine; by SRC."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29523"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29530"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29522"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29522"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29831"],["bp:stoichiometricCoefficient","2.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29821"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29821"]]}},{"data":{"id":"ComplexAssembly_d58b2e2cc5a8a1777140105132b2a01e_LEFT_TO_RIGHT","class":"process","label":"","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":354.0848,"y":377.15973,"w":15,"h":15},"metadata":[["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNB1/GNGT1"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNB1"],["bp:entityReference_http://identifiers.org/uniprot/P62873",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylserine"],["bp:term","N-acetylserine"]]],["bp:comment","MOD_RES 2 2 N-acetylserine."],["bp:featureLocation",[["bp:sequencePosition","2"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphohistidine"],["bp:term","MOD_RES Phosphohistidine"]]],["bp:comment","MOD_RES 266 266 Phosphohistidine."],["bp:featureLocation","MOD_RES 266 266 Phosphohistidine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphohistidine"],["bp:term","MOD_RES Phosphohistidine"]]],["bp:comment","MOD_RES 266 266 Phosphohistidine."],["bp:featureLocation","MOD_RES 266 266 Phosphohistidine."]]],["bp:standardName","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:organism","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:displayName","GBB1_HUMAN"],["bp:name","GNB1"],["bp:name","Transducin beta chain 1"],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as a modulator or transducer in various transmembranesignaling systems. The beta and gamma chains are required for theGTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction.SUBUNIT: G proteins are composed of 3 units, alpha, beta andgamma. Interacts with ARHGEF18 and RASD2 (PubMed:14512443,PubMed:19255495). The heterodimer formed by GNB1 and GNG2interacts with ARHGEF5 (PubMed:19713215).{ECO:0000269|PubMed:14512443, ECO:0000269|PubMed:19255495,ECO:0000269|PubMed:19713215}.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=2;Name=1;IsoId=P62873-1; Sequence=Displayed;Name=2;IsoId=P62873-2; Sequence=VSP_055232;Note=No experimental confirmation available.;PTM: Phosphorylation at His-266 by NDKB contributes to G proteinactivation by increasing the high energetic phosphate transferonto GDP. {ECO:0000250}.DISEASE: Mental retardation, autosomal dominant 42 (MRD42)[MIM:616973]: A form of mental retardation, a disordercharacterized by significantly below average general intellectualfunctioning associated with impairments in adaptive behavior andmanifested during the developmental period. MRD42 patientsmanifest global developmental delay commonly accompanied byhypotonia, seizures of various types, ophthalmologicalmanifestations, and poor growth. {ECO:0000269|PubMed:25485910,ECO:0000269|PubMed:27108799, ECO:0000269|PubMed:27668284,ECO:0000269|PubMed:28087732}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the WD repeat G protein beta family.{ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2782"],["bp:comment","REPLACED http://identifiers.org/uniprot/B1AKQ8"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_786971"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_002065"],["bp:comment","GBB1_HUMAN Reviewed; 340 AA."],["bp:comment","REPLACED http://identifiers.org/refseq/XP_017175466"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_00766_identity"],["bp:comment","REPLACED http://identifiers.org/uniprot/P01946"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2782"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_dip_DIP-599N_identity"],["bp:comment","REPLACED http://identifiers.org/refseq/XP_016856548"],["bp:comment","REPLACED http://identifiers.org/uniprot/P04901"],["bp:comment","REPLACED http://identifiers.org/uniprot/P62874"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29537"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNB1"],["bp:entityReference_http://identifiers.org/uniprot/P62873",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylserine"],["bp:term","N-acetylserine"]]],["bp:comment","MOD_RES 2 2 N-acetylserine."],["bp:featureLocation",[["bp:sequencePosition","2"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphohistidine"],["bp:term","MOD_RES Phosphohistidine"]]],["bp:comment","MOD_RES 266 266 Phosphohistidine."],["bp:featureLocation","MOD_RES 266 266 Phosphohistidine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphohistidine"],["bp:term","MOD_RES Phosphohistidine"]]],["bp:comment","MOD_RES 266 266 Phosphohistidine."],["bp:featureLocation","MOD_RES 266 266 Phosphohistidine."]]],["bp:standardName","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:organism","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:displayName","GBB1_HUMAN"],["bp:name","GNB1"],["bp:name","Transducin beta chain 1"],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as a modulator or transducer in various transmembranesignaling systems. The beta and gamma chains are required for theGTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction.SUBUNIT: G proteins are composed of 3 units, alpha, beta andgamma. Interacts with ARHGEF18 and RASD2 (PubMed:14512443,PubMed:19255495). The heterodimer formed by GNB1 and GNG2interacts with ARHGEF5 (PubMed:19713215).{ECO:0000269|PubMed:14512443, ECO:0000269|PubMed:19255495,ECO:0000269|PubMed:19713215}.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=2;Name=1;IsoId=P62873-1; Sequence=Displayed;Name=2;IsoId=P62873-2; Sequence=VSP_055232;Note=No experimental confirmation available.;PTM: Phosphorylation at His-266 by NDKB contributes to G proteinactivation by increasing the high energetic phosphate transferonto GDP. {ECO:0000250}.DISEASE: Mental retardation, autosomal dominant 42 (MRD42)[MIM:616973]: A form of mental retardation, a disordercharacterized by significantly below average general intellectualfunctioning associated with impairments in adaptive behavior andmanifested during the developmental period. MRD42 patientsmanifest global developmental delay commonly accompanied byhypotonia, seizures of various types, ophthalmologicalmanifestations, and poor growth. {ECO:0000269|PubMed:25485910,ECO:0000269|PubMed:27108799, ECO:0000269|PubMed:27668284,ECO:0000269|PubMed:28087732}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the WD repeat G protein beta family.{ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2782"],["bp:comment","REPLACED http://identifiers.org/uniprot/B1AKQ8"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_786971"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_002065"],["bp:comment","GBB1_HUMAN Reviewed; 340 AA."],["bp:comment","REPLACED http://identifiers.org/refseq/XP_017175466"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_00766_identity"],["bp:comment","REPLACED http://identifiers.org/uniprot/P01946"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2782"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_dip_DIP-599N_identity"],["bp:comment","REPLACED http://identifiers.org/refseq/XP_016856548"],["bp:comment","REPLACED http://identifiers.org/uniprot/P04901"],["bp:comment","REPLACED http://identifiers.org/uniprot/P62874"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29537"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNB1"],["bp:entityReference_http://identifiers.org/uniprot/P62873",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylserine"],["bp:term","N-acetylserine"]]],["bp:comment","MOD_RES 2 2 N-acetylserine."],["bp:featureLocation",[["bp:sequencePosition","2"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphohistidine"],["bp:term","MOD_RES Phosphohistidine"]]],["bp:comment","MOD_RES 266 266 Phosphohistidine."],["bp:featureLocation","MOD_RES 266 266 Phosphohistidine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphohistidine"],["bp:term","MOD_RES Phosphohistidine"]]],["bp:comment","MOD_RES 266 266 Phosphohistidine."],["bp:featureLocation","MOD_RES 266 266 Phosphohistidine."]]],["bp:standardName","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:organism","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:displayName","GBB1_HUMAN"],["bp:name","GNB1"],["bp:name","Transducin beta chain 1"],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as a modulator or transducer in various transmembranesignaling systems. The beta and gamma chains are required for theGTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction.SUBUNIT: G proteins are composed of 3 units, alpha, beta andgamma. Interacts with ARHGEF18 and RASD2 (PubMed:14512443,PubMed:19255495). The heterodimer formed by GNB1 and GNG2interacts with ARHGEF5 (PubMed:19713215).{ECO:0000269|PubMed:14512443, ECO:0000269|PubMed:19255495,ECO:0000269|PubMed:19713215}.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=2;Name=1;IsoId=P62873-1; Sequence=Displayed;Name=2;IsoId=P62873-2; Sequence=VSP_055232;Note=No experimental confirmation available.;PTM: Phosphorylation at His-266 by NDKB contributes to G proteinactivation by increasing the high energetic phosphate transferonto GDP. {ECO:0000250}.DISEASE: Mental retardation, autosomal dominant 42 (MRD42)[MIM:616973]: A form of mental retardation, a disordercharacterized by significantly below average general intellectualfunctioning associated with impairments in adaptive behavior andmanifested during the developmental period. MRD42 patientsmanifest global developmental delay commonly accompanied byhypotonia, seizures of various types, ophthalmologicalmanifestations, and poor growth. {ECO:0000269|PubMed:25485910,ECO:0000269|PubMed:27108799, ECO:0000269|PubMed:27668284,ECO:0000269|PubMed:28087732}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the WD repeat G protein beta family.{ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2782"],["bp:comment","REPLACED http://identifiers.org/uniprot/B1AKQ8"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_786971"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_002065"],["bp:comment","GBB1_HUMAN Reviewed; 340 AA."],["bp:comment","REPLACED http://identifiers.org/refseq/XP_017175466"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_00766_identity"],["bp:comment","REPLACED http://identifiers.org/uniprot/P01946"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2782"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_dip_DIP-599N_identity"],["bp:comment","REPLACED http://identifiers.org/refseq/XP_016856548"],["bp:comment","REPLACED http://identifiers.org/uniprot/P04901"],["bp:comment","REPLACED http://identifiers.org/uniprot/P62874"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29537"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNB1"],["bp:entityReference_http://identifiers.org/uniprot/P62873",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylserine"],["bp:term","N-acetylserine"]]],["bp:comment","MOD_RES 2 2 N-acetylserine."],["bp:featureLocation",[["bp:sequencePosition","2"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphohistidine"],["bp:term","MOD_RES Phosphohistidine"]]],["bp:comment","MOD_RES 266 266 Phosphohistidine."],["bp:featureLocation","MOD_RES 266 266 Phosphohistidine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphohistidine"],["bp:term","MOD_RES Phosphohistidine"]]],["bp:comment","MOD_RES 266 266 Phosphohistidine."],["bp:featureLocation","MOD_RES 266 266 Phosphohistidine."]]],["bp:standardName","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:organism","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:displayName","GBB1_HUMAN"],["bp:name","GNB1"],["bp:name","Transducin beta chain 1"],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as a modulator or transducer in various transmembranesignaling systems. The beta and gamma chains are required for theGTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction.SUBUNIT: G proteins are composed of 3 units, alpha, beta andgamma. Interacts with ARHGEF18 and RASD2 (PubMed:14512443,PubMed:19255495). The heterodimer formed by GNB1 and GNG2interacts with ARHGEF5 (PubMed:19713215).{ECO:0000269|PubMed:14512443, ECO:0000269|PubMed:19255495,ECO:0000269|PubMed:19713215}.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=2;Name=1;IsoId=P62873-1; Sequence=Displayed;Name=2;IsoId=P62873-2; Sequence=VSP_055232;Note=No experimental confirmation available.;PTM: Phosphorylation at His-266 by NDKB contributes to G proteinactivation by increasing the high energetic phosphate transferonto GDP. {ECO:0000250}.DISEASE: Mental retardation, autosomal dominant 42 (MRD42)[MIM:616973]: A form of mental retardation, a disordercharacterized by significantly below average general intellectualfunctioning associated with impairments in adaptive behavior andmanifested during the developmental period. MRD42 patientsmanifest global developmental delay commonly accompanied byhypotonia, seizures of various types, ophthalmologicalmanifestations, and poor growth. {ECO:0000269|PubMed:25485910,ECO:0000269|PubMed:27108799, ECO:0000269|PubMed:27668284,ECO:0000269|PubMed:28087732}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the WD repeat G protein beta family.{ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2782"],["bp:comment","REPLACED http://identifiers.org/uniprot/B1AKQ8"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_786971"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_002065"],["bp:comment","GBB1_HUMAN Reviewed; 340 AA."],["bp:comment","REPLACED http://identifiers.org/refseq/XP_017175466"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_00766_identity"],["bp:comment","REPLACED http://identifiers.org/uniprot/P01946"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2782"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_dip_DIP-599N_identity"],["bp:comment","REPLACED http://identifiers.org/refseq/XP_016856548"],["bp:comment","REPLACED http://identifiers.org/uniprot/P04901"],["bp:comment","REPLACED http://identifiers.org/uniprot/P62874"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29537"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29532"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29532"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29548"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNB1/GNGT1"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNB1"],["bp:entityReference_http://identifiers.org/uniprot/P62873",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylserine"],["bp:term","N-acetylserine"]]],["bp:comment","MOD_RES 2 2 N-acetylserine."],["bp:featureLocation",[["bp:sequencePosition","2"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphohistidine"],["bp:term","MOD_RES Phosphohistidine"]]],["bp:comment","MOD_RES 266 266 Phosphohistidine."],["bp:featureLocation","MOD_RES 266 266 Phosphohistidine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphohistidine"],["bp:term","MOD_RES Phosphohistidine"]]],["bp:comment","MOD_RES 266 266 Phosphohistidine."],["bp:featureLocation","MOD_RES 266 266 Phosphohistidine."]]],["bp:standardName","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:organism","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:displayName","GBB1_HUMAN"],["bp:name","GNB1"],["bp:name","Transducin beta chain 1"],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as a modulator or transducer in various transmembranesignaling systems. The beta and gamma chains are required for theGTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction.SUBUNIT: G proteins are composed of 3 units, alpha, beta andgamma. Interacts with ARHGEF18 and RASD2 (PubMed:14512443,PubMed:19255495). The heterodimer formed by GNB1 and GNG2interacts with ARHGEF5 (PubMed:19713215).{ECO:0000269|PubMed:14512443, ECO:0000269|PubMed:19255495,ECO:0000269|PubMed:19713215}.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=2;Name=1;IsoId=P62873-1; Sequence=Displayed;Name=2;IsoId=P62873-2; Sequence=VSP_055232;Note=No experimental confirmation available.;PTM: Phosphorylation at His-266 by NDKB contributes to G proteinactivation by increasing the high energetic phosphate transferonto GDP. {ECO:0000250}.DISEASE: Mental retardation, autosomal dominant 42 (MRD42)[MIM:616973]: A form of mental retardation, a disordercharacterized by significantly below average general intellectualfunctioning associated with impairments in adaptive behavior andmanifested during the developmental period. MRD42 patientsmanifest global developmental delay commonly accompanied byhypotonia, seizures of various types, ophthalmologicalmanifestations, and poor growth. {ECO:0000269|PubMed:25485910,ECO:0000269|PubMed:27108799, ECO:0000269|PubMed:27668284,ECO:0000269|PubMed:28087732}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the WD repeat G protein beta family.{ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2782"],["bp:comment","REPLACED http://identifiers.org/uniprot/B1AKQ8"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_786971"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_002065"],["bp:comment","GBB1_HUMAN Reviewed; 340 AA."],["bp:comment","REPLACED http://identifiers.org/refseq/XP_017175466"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_00766_identity"],["bp:comment","REPLACED http://identifiers.org/uniprot/P01946"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2782"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_dip_DIP-599N_identity"],["bp:comment","REPLACED http://identifiers.org/refseq/XP_016856548"],["bp:comment","REPLACED http://identifiers.org/uniprot/P04901"],["bp:comment","REPLACED http://identifiers.org/uniprot/P62874"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29537"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNB1"],["bp:entityReference_http://identifiers.org/uniprot/P62873",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylserine"],["bp:term","N-acetylserine"]]],["bp:comment","MOD_RES 2 2 N-acetylserine."],["bp:featureLocation",[["bp:sequencePosition","2"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphohistidine"],["bp:term","MOD_RES Phosphohistidine"]]],["bp:comment","MOD_RES 266 266 Phosphohistidine."],["bp:featureLocation","MOD_RES 266 266 Phosphohistidine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphohistidine"],["bp:term","MOD_RES Phosphohistidine"]]],["bp:comment","MOD_RES 266 266 Phosphohistidine."],["bp:featureLocation","MOD_RES 266 266 Phosphohistidine."]]],["bp:standardName","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:organism","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:displayName","GBB1_HUMAN"],["bp:name","GNB1"],["bp:name","Transducin beta chain 1"],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as a modulator or transducer in various transmembranesignaling systems. The beta and gamma chains are required for theGTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction.SUBUNIT: G proteins are composed of 3 units, alpha, beta andgamma. Interacts with ARHGEF18 and RASD2 (PubMed:14512443,PubMed:19255495). The heterodimer formed by GNB1 and GNG2interacts with ARHGEF5 (PubMed:19713215).{ECO:0000269|PubMed:14512443, ECO:0000269|PubMed:19255495,ECO:0000269|PubMed:19713215}.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=2;Name=1;IsoId=P62873-1; Sequence=Displayed;Name=2;IsoId=P62873-2; Sequence=VSP_055232;Note=No experimental confirmation available.;PTM: Phosphorylation at His-266 by NDKB contributes to G proteinactivation by increasing the high energetic phosphate transferonto GDP. {ECO:0000250}.DISEASE: Mental retardation, autosomal dominant 42 (MRD42)[MIM:616973]: A form of mental retardation, a disordercharacterized by significantly below average general intellectualfunctioning associated with impairments in adaptive behavior andmanifested during the developmental period. MRD42 patientsmanifest global developmental delay commonly accompanied byhypotonia, seizures of various types, ophthalmologicalmanifestations, and poor growth. {ECO:0000269|PubMed:25485910,ECO:0000269|PubMed:27108799, ECO:0000269|PubMed:27668284,ECO:0000269|PubMed:28087732}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the WD repeat G protein beta family.{ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2782"],["bp:comment","REPLACED http://identifiers.org/uniprot/B1AKQ8"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_786971"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_002065"],["bp:comment","GBB1_HUMAN Reviewed; 340 AA."],["bp:comment","REPLACED http://identifiers.org/refseq/XP_017175466"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_00766_identity"],["bp:comment","REPLACED http://identifiers.org/uniprot/P01946"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2782"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_dip_DIP-599N_identity"],["bp:comment","REPLACED http://identifiers.org/refseq/XP_016856548"],["bp:comment","REPLACED http://identifiers.org/uniprot/P04901"],["bp:comment","REPLACED http://identifiers.org/uniprot/P62874"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29537"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNB1"],["bp:entityReference_http://identifiers.org/uniprot/P62873",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylserine"],["bp:term","N-acetylserine"]]],["bp:comment","MOD_RES 2 2 N-acetylserine."],["bp:featureLocation",[["bp:sequencePosition","2"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphohistidine"],["bp:term","MOD_RES Phosphohistidine"]]],["bp:comment","MOD_RES 266 266 Phosphohistidine."],["bp:featureLocation","MOD_RES 266 266 Phosphohistidine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphohistidine"],["bp:term","MOD_RES Phosphohistidine"]]],["bp:comment","MOD_RES 266 266 Phosphohistidine."],["bp:featureLocation","MOD_RES 266 266 Phosphohistidine."]]],["bp:standardName","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:organism","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:displayName","GBB1_HUMAN"],["bp:name","GNB1"],["bp:name","Transducin beta chain 1"],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as a modulator or transducer in various transmembranesignaling systems. The beta and gamma chains are required for theGTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction.SUBUNIT: G proteins are composed of 3 units, alpha, beta andgamma. Interacts with ARHGEF18 and RASD2 (PubMed:14512443,PubMed:19255495). The heterodimer formed by GNB1 and GNG2interacts with ARHGEF5 (PubMed:19713215).{ECO:0000269|PubMed:14512443, ECO:0000269|PubMed:19255495,ECO:0000269|PubMed:19713215}.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=2;Name=1;IsoId=P62873-1; Sequence=Displayed;Name=2;IsoId=P62873-2; Sequence=VSP_055232;Note=No experimental confirmation available.;PTM: Phosphorylation at His-266 by NDKB contributes to G proteinactivation by increasing the high energetic phosphate transferonto GDP. {ECO:0000250}.DISEASE: Mental retardation, autosomal dominant 42 (MRD42)[MIM:616973]: A form of mental retardation, a disordercharacterized by significantly below average general intellectualfunctioning associated with impairments in adaptive behavior andmanifested during the developmental period. MRD42 patientsmanifest global developmental delay commonly accompanied byhypotonia, seizures of various types, ophthalmologicalmanifestations, and poor growth. {ECO:0000269|PubMed:25485910,ECO:0000269|PubMed:27108799, ECO:0000269|PubMed:27668284,ECO:0000269|PubMed:28087732}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the WD repeat G protein beta family.{ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2782"],["bp:comment","REPLACED http://identifiers.org/uniprot/B1AKQ8"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_786971"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_002065"],["bp:comment","GBB1_HUMAN Reviewed; 340 AA."],["bp:comment","REPLACED http://identifiers.org/refseq/XP_017175466"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_00766_identity"],["bp:comment","REPLACED http://identifiers.org/uniprot/P01946"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2782"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_dip_DIP-599N_identity"],["bp:comment","REPLACED http://identifiers.org/refseq/XP_016856548"],["bp:comment","REPLACED http://identifiers.org/uniprot/P04901"],["bp:comment","REPLACED http://identifiers.org/uniprot/P62874"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29537"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNB1"],["bp:entityReference_http://identifiers.org/uniprot/P62873",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylserine"],["bp:term","N-acetylserine"]]],["bp:comment","MOD_RES 2 2 N-acetylserine."],["bp:featureLocation",[["bp:sequencePosition","2"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphohistidine"],["bp:term","MOD_RES Phosphohistidine"]]],["bp:comment","MOD_RES 266 266 Phosphohistidine."],["bp:featureLocation","MOD_RES 266 266 Phosphohistidine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphohistidine"],["bp:term","MOD_RES Phosphohistidine"]]],["bp:comment","MOD_RES 266 266 Phosphohistidine."],["bp:featureLocation","MOD_RES 266 266 Phosphohistidine."]]],["bp:standardName","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:organism","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:displayName","GBB1_HUMAN"],["bp:name","GNB1"],["bp:name","Transducin beta chain 1"],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as a modulator or transducer in various transmembranesignaling systems. The beta and gamma chains are required for theGTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction.SUBUNIT: G proteins are composed of 3 units, alpha, beta andgamma. Interacts with ARHGEF18 and RASD2 (PubMed:14512443,PubMed:19255495). The heterodimer formed by GNB1 and GNG2interacts with ARHGEF5 (PubMed:19713215).{ECO:0000269|PubMed:14512443, ECO:0000269|PubMed:19255495,ECO:0000269|PubMed:19713215}.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=2;Name=1;IsoId=P62873-1; Sequence=Displayed;Name=2;IsoId=P62873-2; Sequence=VSP_055232;Note=No experimental confirmation available.;PTM: Phosphorylation at His-266 by NDKB contributes to G proteinactivation by increasing the high energetic phosphate transferonto GDP. {ECO:0000250}.DISEASE: Mental retardation, autosomal dominant 42 (MRD42)[MIM:616973]: A form of mental retardation, a disordercharacterized by significantly below average general intellectualfunctioning associated with impairments in adaptive behavior andmanifested during the developmental period. MRD42 patientsmanifest global developmental delay commonly accompanied byhypotonia, seizures of various types, ophthalmologicalmanifestations, and poor growth. {ECO:0000269|PubMed:25485910,ECO:0000269|PubMed:27108799, ECO:0000269|PubMed:27668284,ECO:0000269|PubMed:28087732}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the WD repeat G protein beta family.{ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2782"],["bp:comment","REPLACED http://identifiers.org/uniprot/B1AKQ8"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_786971"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_002065"],["bp:comment","GBB1_HUMAN Reviewed; 340 AA."],["bp:comment","REPLACED http://identifiers.org/refseq/XP_017175466"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_00766_identity"],["bp:comment","REPLACED http://identifiers.org/uniprot/P01946"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2782"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_dip_DIP-599N_identity"],["bp:comment","REPLACED http://identifiers.org/refseq/XP_016856548"],["bp:comment","REPLACED http://identifiers.org/uniprot/P04901"],["bp:comment","REPLACED http://identifiers.org/uniprot/P62874"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29537"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29532"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29532"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29548"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNB1/GNGT1"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNB1"],["bp:entityReference_http://identifiers.org/uniprot/P62873",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylserine"],["bp:term","N-acetylserine"]]],["bp:comment","MOD_RES 2 2 N-acetylserine."],["bp:featureLocation",[["bp:sequencePosition","2"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphohistidine"],["bp:term","MOD_RES Phosphohistidine"]]],["bp:comment","MOD_RES 266 266 Phosphohistidine."],["bp:featureLocation","MOD_RES 266 266 Phosphohistidine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphohistidine"],["bp:term","MOD_RES Phosphohistidine"]]],["bp:comment","MOD_RES 266 266 Phosphohistidine."],["bp:featureLocation","MOD_RES 266 266 Phosphohistidine."]]],["bp:standardName","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:organism","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:displayName","GBB1_HUMAN"],["bp:name","GNB1"],["bp:name","Transducin beta chain 1"],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as a modulator or transducer in various transmembranesignaling systems. The beta and gamma chains are required for theGTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction.SUBUNIT: G proteins are composed of 3 units, alpha, beta andgamma. Interacts with ARHGEF18 and RASD2 (PubMed:14512443,PubMed:19255495). The heterodimer formed by GNB1 and GNG2interacts with ARHGEF5 (PubMed:19713215).{ECO:0000269|PubMed:14512443, ECO:0000269|PubMed:19255495,ECO:0000269|PubMed:19713215}.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=2;Name=1;IsoId=P62873-1; Sequence=Displayed;Name=2;IsoId=P62873-2; Sequence=VSP_055232;Note=No experimental confirmation available.;PTM: Phosphorylation at His-266 by NDKB contributes to G proteinactivation by increasing the high energetic phosphate transferonto GDP. {ECO:0000250}.DISEASE: Mental retardation, autosomal dominant 42 (MRD42)[MIM:616973]: A form of mental retardation, a disordercharacterized by significantly below average general intellectualfunctioning associated with impairments in adaptive behavior andmanifested during the developmental period. MRD42 patientsmanifest global developmental delay commonly accompanied byhypotonia, seizures of various types, ophthalmologicalmanifestations, and poor growth. {ECO:0000269|PubMed:25485910,ECO:0000269|PubMed:27108799, ECO:0000269|PubMed:27668284,ECO:0000269|PubMed:28087732}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the WD repeat G protein beta family.{ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2782"],["bp:comment","REPLACED http://identifiers.org/uniprot/B1AKQ8"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_786971"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_002065"],["bp:comment","GBB1_HUMAN Reviewed; 340 AA."],["bp:comment","REPLACED http://identifiers.org/refseq/XP_017175466"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_00766_identity"],["bp:comment","REPLACED http://identifiers.org/uniprot/P01946"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2782"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_dip_DIP-599N_identity"],["bp:comment","REPLACED http://identifiers.org/refseq/XP_016856548"],["bp:comment","REPLACED http://identifiers.org/uniprot/P04901"],["bp:comment","REPLACED http://identifiers.org/uniprot/P62874"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29537"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNB1"],["bp:entityReference_http://identifiers.org/uniprot/P62873",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylserine"],["bp:term","N-acetylserine"]]],["bp:comment","MOD_RES 2 2 N-acetylserine."],["bp:featureLocation",[["bp:sequencePosition","2"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphohistidine"],["bp:term","MOD_RES Phosphohistidine"]]],["bp:comment","MOD_RES 266 266 Phosphohistidine."],["bp:featureLocation","MOD_RES 266 266 Phosphohistidine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphohistidine"],["bp:term","MOD_RES Phosphohistidine"]]],["bp:comment","MOD_RES 266 266 Phosphohistidine."],["bp:featureLocation","MOD_RES 266 266 Phosphohistidine."]]],["bp:standardName","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:organism","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:displayName","GBB1_HUMAN"],["bp:name","GNB1"],["bp:name","Transducin beta chain 1"],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as a modulator or transducer in various transmembranesignaling systems. The beta and gamma chains are required for theGTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction.SUBUNIT: G proteins are composed of 3 units, alpha, beta andgamma. Interacts with ARHGEF18 and RASD2 (PubMed:14512443,PubMed:19255495). The heterodimer formed by GNB1 and GNG2interacts with ARHGEF5 (PubMed:19713215).{ECO:0000269|PubMed:14512443, ECO:0000269|PubMed:19255495,ECO:0000269|PubMed:19713215}.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=2;Name=1;IsoId=P62873-1; Sequence=Displayed;Name=2;IsoId=P62873-2; Sequence=VSP_055232;Note=No experimental confirmation available.;PTM: Phosphorylation at His-266 by NDKB contributes to G proteinactivation by increasing the high energetic phosphate transferonto GDP. {ECO:0000250}.DISEASE: Mental retardation, autosomal dominant 42 (MRD42)[MIM:616973]: A form of mental retardation, a disordercharacterized by significantly below average general intellectualfunctioning associated with impairments in adaptive behavior andmanifested during the developmental period. MRD42 patientsmanifest global developmental delay commonly accompanied byhypotonia, seizures of various types, ophthalmologicalmanifestations, and poor growth. {ECO:0000269|PubMed:25485910,ECO:0000269|PubMed:27108799, ECO:0000269|PubMed:27668284,ECO:0000269|PubMed:28087732}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the WD repeat G protein beta family.{ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2782"],["bp:comment","REPLACED http://identifiers.org/uniprot/B1AKQ8"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_786971"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_002065"],["bp:comment","GBB1_HUMAN Reviewed; 340 AA."],["bp:comment","REPLACED http://identifiers.org/refseq/XP_017175466"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_00766_identity"],["bp:comment","REPLACED http://identifiers.org/uniprot/P01946"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2782"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_dip_DIP-599N_identity"],["bp:comment","REPLACED http://identifiers.org/refseq/XP_016856548"],["bp:comment","REPLACED http://identifiers.org/uniprot/P04901"],["bp:comment","REPLACED http://identifiers.org/uniprot/P62874"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29537"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNB1"],["bp:entityReference_http://identifiers.org/uniprot/P62873",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylserine"],["bp:term","N-acetylserine"]]],["bp:comment","MOD_RES 2 2 N-acetylserine."],["bp:featureLocation",[["bp:sequencePosition","2"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphohistidine"],["bp:term","MOD_RES Phosphohistidine"]]],["bp:comment","MOD_RES 266 266 Phosphohistidine."],["bp:featureLocation","MOD_RES 266 266 Phosphohistidine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphohistidine"],["bp:term","MOD_RES Phosphohistidine"]]],["bp:comment","MOD_RES 266 266 Phosphohistidine."],["bp:featureLocation","MOD_RES 266 266 Phosphohistidine."]]],["bp:standardName","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:organism","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:displayName","GBB1_HUMAN"],["bp:name","GNB1"],["bp:name","Transducin beta chain 1"],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as a modulator or transducer in various transmembranesignaling systems. The beta and gamma chains are required for theGTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction.SUBUNIT: G proteins are composed of 3 units, alpha, beta andgamma. Interacts with ARHGEF18 and RASD2 (PubMed:14512443,PubMed:19255495). The heterodimer formed by GNB1 and GNG2interacts with ARHGEF5 (PubMed:19713215).{ECO:0000269|PubMed:14512443, ECO:0000269|PubMed:19255495,ECO:0000269|PubMed:19713215}.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=2;Name=1;IsoId=P62873-1; Sequence=Displayed;Name=2;IsoId=P62873-2; Sequence=VSP_055232;Note=No experimental confirmation available.;PTM: Phosphorylation at His-266 by NDKB contributes to G proteinactivation by increasing the high energetic phosphate transferonto GDP. {ECO:0000250}.DISEASE: Mental retardation, autosomal dominant 42 (MRD42)[MIM:616973]: A form of mental retardation, a disordercharacterized by significantly below average general intellectualfunctioning associated with impairments in adaptive behavior andmanifested during the developmental period. MRD42 patientsmanifest global developmental delay commonly accompanied byhypotonia, seizures of various types, ophthalmologicalmanifestations, and poor growth. {ECO:0000269|PubMed:25485910,ECO:0000269|PubMed:27108799, ECO:0000269|PubMed:27668284,ECO:0000269|PubMed:28087732}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the WD repeat G protein beta family.{ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2782"],["bp:comment","REPLACED http://identifiers.org/uniprot/B1AKQ8"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_786971"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_002065"],["bp:comment","GBB1_HUMAN Reviewed; 340 AA."],["bp:comment","REPLACED http://identifiers.org/refseq/XP_017175466"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_00766_identity"],["bp:comment","REPLACED http://identifiers.org/uniprot/P01946"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2782"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_dip_DIP-599N_identity"],["bp:comment","REPLACED http://identifiers.org/refseq/XP_016856548"],["bp:comment","REPLACED http://identifiers.org/uniprot/P04901"],["bp:comment","REPLACED http://identifiers.org/uniprot/P62874"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29537"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNB1"],["bp:entityReference_http://identifiers.org/uniprot/P62873",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylserine"],["bp:term","N-acetylserine"]]],["bp:comment","MOD_RES 2 2 N-acetylserine."],["bp:featureLocation",[["bp:sequencePosition","2"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphohistidine"],["bp:term","MOD_RES Phosphohistidine"]]],["bp:comment","MOD_RES 266 266 Phosphohistidine."],["bp:featureLocation","MOD_RES 266 266 Phosphohistidine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphohistidine"],["bp:term","MOD_RES Phosphohistidine"]]],["bp:comment","MOD_RES 266 266 Phosphohistidine."],["bp:featureLocation","MOD_RES 266 266 Phosphohistidine."]]],["bp:standardName","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:organism","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:displayName","GBB1_HUMAN"],["bp:name","GNB1"],["bp:name","Transducin beta chain 1"],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as a modulator or transducer in various transmembranesignaling systems. The beta and gamma chains are required for theGTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction.SUBUNIT: G proteins are composed of 3 units, alpha, beta andgamma. Interacts with ARHGEF18 and RASD2 (PubMed:14512443,PubMed:19255495). The heterodimer formed by GNB1 and GNG2interacts with ARHGEF5 (PubMed:19713215).{ECO:0000269|PubMed:14512443, ECO:0000269|PubMed:19255495,ECO:0000269|PubMed:19713215}.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=2;Name=1;IsoId=P62873-1; Sequence=Displayed;Name=2;IsoId=P62873-2; Sequence=VSP_055232;Note=No experimental confirmation available.;PTM: Phosphorylation at His-266 by NDKB contributes to G proteinactivation by increasing the high energetic phosphate transferonto GDP. {ECO:0000250}.DISEASE: Mental retardation, autosomal dominant 42 (MRD42)[MIM:616973]: A form of mental retardation, a disordercharacterized by significantly below average general intellectualfunctioning associated with impairments in adaptive behavior andmanifested during the developmental period. MRD42 patientsmanifest global developmental delay commonly accompanied byhypotonia, seizures of various types, ophthalmologicalmanifestations, and poor growth. {ECO:0000269|PubMed:25485910,ECO:0000269|PubMed:27108799, ECO:0000269|PubMed:27668284,ECO:0000269|PubMed:28087732}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the WD repeat G protein beta family.{ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2782"],["bp:comment","REPLACED http://identifiers.org/uniprot/B1AKQ8"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_786971"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_002065"],["bp:comment","GBB1_HUMAN Reviewed; 340 AA."],["bp:comment","REPLACED http://identifiers.org/refseq/XP_017175466"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_00766_identity"],["bp:comment","REPLACED http://identifiers.org/uniprot/P01946"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2782"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_dip_DIP-599N_identity"],["bp:comment","REPLACED http://identifiers.org/refseq/XP_016856548"],["bp:comment","REPLACED http://identifiers.org/uniprot/P04901"],["bp:comment","REPLACED http://identifiers.org/uniprot/P62874"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29537"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29532"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29532"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29548"],["bp:stoichiometricCoefficient","1.0"]]],["bp:right",[["bp:physicalEntity",[["bp:displayName","GNB1/GNGT1"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNB1"],["bp:entityReference_http://identifiers.org/uniprot/P62873",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylserine"],["bp:term","N-acetylserine"]]],["bp:comment","MOD_RES 2 2 N-acetylserine."],["bp:featureLocation",[["bp:sequencePosition","2"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphohistidine"],["bp:term","MOD_RES Phosphohistidine"]]],["bp:comment","MOD_RES 266 266 Phosphohistidine."],["bp:featureLocation","MOD_RES 266 266 Phosphohistidine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphohistidine"],["bp:term","MOD_RES Phosphohistidine"]]],["bp:comment","MOD_RES 266 266 Phosphohistidine."],["bp:featureLocation","MOD_RES 266 266 Phosphohistidine."]]],["bp:standardName","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:organism","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:displayName","GBB1_HUMAN"],["bp:name","GNB1"],["bp:name","Transducin beta chain 1"],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as a modulator or transducer in various transmembranesignaling systems. The beta and gamma chains are required for theGTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction.SUBUNIT: G proteins are composed of 3 units, alpha, beta andgamma. Interacts with ARHGEF18 and RASD2 (PubMed:14512443,PubMed:19255495). The heterodimer formed by GNB1 and GNG2interacts with ARHGEF5 (PubMed:19713215).{ECO:0000269|PubMed:14512443, ECO:0000269|PubMed:19255495,ECO:0000269|PubMed:19713215}.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=2;Name=1;IsoId=P62873-1; Sequence=Displayed;Name=2;IsoId=P62873-2; Sequence=VSP_055232;Note=No experimental confirmation available.;PTM: Phosphorylation at His-266 by NDKB contributes to G proteinactivation by increasing the high energetic phosphate transferonto GDP. {ECO:0000250}.DISEASE: Mental retardation, autosomal dominant 42 (MRD42)[MIM:616973]: A form of mental retardation, a disordercharacterized by significantly below average general intellectualfunctioning associated with impairments in adaptive behavior andmanifested during the developmental period. MRD42 patientsmanifest global developmental delay commonly accompanied byhypotonia, seizures of various types, ophthalmologicalmanifestations, and poor growth. {ECO:0000269|PubMed:25485910,ECO:0000269|PubMed:27108799, ECO:0000269|PubMed:27668284,ECO:0000269|PubMed:28087732}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the WD repeat G protein beta family.{ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2782"],["bp:comment","REPLACED http://identifiers.org/uniprot/B1AKQ8"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_786971"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_002065"],["bp:comment","GBB1_HUMAN Reviewed; 340 AA."],["bp:comment","REPLACED http://identifiers.org/refseq/XP_017175466"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_00766_identity"],["bp:comment","REPLACED http://identifiers.org/uniprot/P01946"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2782"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_dip_DIP-599N_identity"],["bp:comment","REPLACED http://identifiers.org/refseq/XP_016856548"],["bp:comment","REPLACED http://identifiers.org/uniprot/P04901"],["bp:comment","REPLACED http://identifiers.org/uniprot/P62874"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29537"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNB1"],["bp:entityReference_http://identifiers.org/uniprot/P62873",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylserine"],["bp:term","N-acetylserine"]]],["bp:comment","MOD_RES 2 2 N-acetylserine."],["bp:featureLocation",[["bp:sequencePosition","2"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphohistidine"],["bp:term","MOD_RES Phosphohistidine"]]],["bp:comment","MOD_RES 266 266 Phosphohistidine."],["bp:featureLocation","MOD_RES 266 266 Phosphohistidine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphohistidine"],["bp:term","MOD_RES Phosphohistidine"]]],["bp:comment","MOD_RES 266 266 Phosphohistidine."],["bp:featureLocation","MOD_RES 266 266 Phosphohistidine."]]],["bp:standardName","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:organism","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:displayName","GBB1_HUMAN"],["bp:name","GNB1"],["bp:name","Transducin beta chain 1"],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as a modulator or transducer in various transmembranesignaling systems. The beta and gamma chains are required for theGTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction.SUBUNIT: G proteins are composed of 3 units, alpha, beta andgamma. Interacts with ARHGEF18 and RASD2 (PubMed:14512443,PubMed:19255495). The heterodimer formed by GNB1 and GNG2interacts with ARHGEF5 (PubMed:19713215).{ECO:0000269|PubMed:14512443, ECO:0000269|PubMed:19255495,ECO:0000269|PubMed:19713215}.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=2;Name=1;IsoId=P62873-1; Sequence=Displayed;Name=2;IsoId=P62873-2; Sequence=VSP_055232;Note=No experimental confirmation available.;PTM: Phosphorylation at His-266 by NDKB contributes to G proteinactivation by increasing the high energetic phosphate transferonto GDP. {ECO:0000250}.DISEASE: Mental retardation, autosomal dominant 42 (MRD42)[MIM:616973]: A form of mental retardation, a disordercharacterized by significantly below average general intellectualfunctioning associated with impairments in adaptive behavior andmanifested during the developmental period. MRD42 patientsmanifest global developmental delay commonly accompanied byhypotonia, seizures of various types, ophthalmologicalmanifestations, and poor growth. {ECO:0000269|PubMed:25485910,ECO:0000269|PubMed:27108799, ECO:0000269|PubMed:27668284,ECO:0000269|PubMed:28087732}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the WD repeat G protein beta family.{ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2782"],["bp:comment","REPLACED http://identifiers.org/uniprot/B1AKQ8"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_786971"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_002065"],["bp:comment","GBB1_HUMAN Reviewed; 340 AA."],["bp:comment","REPLACED http://identifiers.org/refseq/XP_017175466"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_00766_identity"],["bp:comment","REPLACED http://identifiers.org/uniprot/P01946"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2782"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_dip_DIP-599N_identity"],["bp:comment","REPLACED http://identifiers.org/refseq/XP_016856548"],["bp:comment","REPLACED http://identifiers.org/uniprot/P04901"],["bp:comment","REPLACED http://identifiers.org/uniprot/P62874"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29537"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNB1"],["bp:entityReference_http://identifiers.org/uniprot/P62873",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylserine"],["bp:term","N-acetylserine"]]],["bp:comment","MOD_RES 2 2 N-acetylserine."],["bp:featureLocation",[["bp:sequencePosition","2"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphohistidine"],["bp:term","MOD_RES Phosphohistidine"]]],["bp:comment","MOD_RES 266 266 Phosphohistidine."],["bp:featureLocation","MOD_RES 266 266 Phosphohistidine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphohistidine"],["bp:term","MOD_RES Phosphohistidine"]]],["bp:comment","MOD_RES 266 266 Phosphohistidine."],["bp:featureLocation","MOD_RES 266 266 Phosphohistidine."]]],["bp:standardName","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:organism","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:displayName","GBB1_HUMAN"],["bp:name","GNB1"],["bp:name","Transducin beta chain 1"],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as a modulator or transducer in various transmembranesignaling systems. The beta and gamma chains are required for theGTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction.SUBUNIT: G proteins are composed of 3 units, alpha, beta andgamma. Interacts with ARHGEF18 and RASD2 (PubMed:14512443,PubMed:19255495). The heterodimer formed by GNB1 and GNG2interacts with ARHGEF5 (PubMed:19713215).{ECO:0000269|PubMed:14512443, ECO:0000269|PubMed:19255495,ECO:0000269|PubMed:19713215}.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=2;Name=1;IsoId=P62873-1; Sequence=Displayed;Name=2;IsoId=P62873-2; Sequence=VSP_055232;Note=No experimental confirmation available.;PTM: Phosphorylation at His-266 by NDKB contributes to G proteinactivation by increasing the high energetic phosphate transferonto GDP. {ECO:0000250}.DISEASE: Mental retardation, autosomal dominant 42 (MRD42)[MIM:616973]: A form of mental retardation, a disordercharacterized by significantly below average general intellectualfunctioning associated with impairments in adaptive behavior andmanifested during the developmental period. MRD42 patientsmanifest global developmental delay commonly accompanied byhypotonia, seizures of various types, ophthalmologicalmanifestations, and poor growth. {ECO:0000269|PubMed:25485910,ECO:0000269|PubMed:27108799, ECO:0000269|PubMed:27668284,ECO:0000269|PubMed:28087732}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the WD repeat G protein beta family.{ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2782"],["bp:comment","REPLACED http://identifiers.org/uniprot/B1AKQ8"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_786971"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_002065"],["bp:comment","GBB1_HUMAN Reviewed; 340 AA."],["bp:comment","REPLACED http://identifiers.org/refseq/XP_017175466"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_00766_identity"],["bp:comment","REPLACED http://identifiers.org/uniprot/P01946"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2782"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_dip_DIP-599N_identity"],["bp:comment","REPLACED http://identifiers.org/refseq/XP_016856548"],["bp:comment","REPLACED http://identifiers.org/uniprot/P04901"],["bp:comment","REPLACED http://identifiers.org/uniprot/P62874"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29537"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNB1"],["bp:entityReference_http://identifiers.org/uniprot/P62873",[["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylserine"],["bp:term","N-acetylserine"]]],["bp:comment","MOD_RES 2 2 N-acetylserine."],["bp:featureLocation",[["bp:sequencePosition","2"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphohistidine"],["bp:term","MOD_RES Phosphohistidine"]]],["bp:comment","MOD_RES 266 266 Phosphohistidine."],["bp:featureLocation","MOD_RES 266 266 Phosphohistidine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphohistidine"],["bp:term","MOD_RES Phosphohistidine"]]],["bp:comment","MOD_RES 266 266 Phosphohistidine."],["bp:featureLocation","MOD_RES 266 266 Phosphohistidine."]]],["bp:standardName","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:xref","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:organism","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1"],["bp:displayName","GBB1_HUMAN"],["bp:name","GNB1"],["bp:name","Transducin beta chain 1"],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as a modulator or transducer in various transmembranesignaling systems. The beta and gamma chains are required for theGTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction.SUBUNIT: G proteins are composed of 3 units, alpha, beta andgamma. Interacts with ARHGEF18 and RASD2 (PubMed:14512443,PubMed:19255495). The heterodimer formed by GNB1 and GNG2interacts with ARHGEF5 (PubMed:19713215).{ECO:0000269|PubMed:14512443, ECO:0000269|PubMed:19255495,ECO:0000269|PubMed:19713215}.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=2;Name=1;IsoId=P62873-1; Sequence=Displayed;Name=2;IsoId=P62873-2; Sequence=VSP_055232;Note=No experimental confirmation available.;PTM: Phosphorylation at His-266 by NDKB contributes to G proteinactivation by increasing the high energetic phosphate transferonto GDP. {ECO:0000250}.DISEASE: Mental retardation, autosomal dominant 42 (MRD42)[MIM:616973]: A form of mental retardation, a disordercharacterized by significantly below average general intellectualfunctioning associated with impairments in adaptive behavior andmanifested during the developmental period. MRD42 patientsmanifest global developmental delay commonly accompanied byhypotonia, seizures of various types, ophthalmologicalmanifestations, and poor growth. {ECO:0000269|PubMed:25485910,ECO:0000269|PubMed:27108799, ECO:0000269|PubMed:27668284,ECO:0000269|PubMed:28087732}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the WD repeat G protein beta family.{ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2782"],["bp:comment","REPLACED http://identifiers.org/uniprot/B1AKQ8"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_786971"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_002065"],["bp:comment","GBB1_HUMAN Reviewed; 340 AA."],["bp:comment","REPLACED http://identifiers.org/refseq/XP_017175466"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_00766_identity"],["bp:comment","REPLACED http://identifiers.org/uniprot/P01946"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2782"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_dip_DIP-599N_identity"],["bp:comment","REPLACED http://identifiers.org/refseq/XP_016856548"],["bp:comment","REPLACED http://identifiers.org/uniprot/P04901"],["bp:comment","REPLACED http://identifiers.org/uniprot/P62874"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_13487"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29537"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29532"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29532"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29548"],["bp:stoichiometricCoefficient","1.0"]]],["bp:spontaneous","true"],["bp:left","true"],["bp:left","true"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29521"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29521"]]}},{"data":{"id":"SmallMolecule_dd131cecec0400bece272a2060bd2b05","class":"simple chemical","label":"all-trans-retinylester","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":797.2405,"y":390.62766,"w":48,"h":20},"metadata":[["bp:displayName","all-trans-retinylester"],["bp:entityReference_#SmallMoleculeReference_ee9b3742a16b293296c9be0e66638385",[]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29625"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]}},{"data":{"id":"Complex_a1b72fa4f9a00f6ff36e834cef0fc4de","class":"complex","label":"PDE6","parent":"","clonemarker":false,"stateVariables":[{"id":"Complex_a1b72fa4f9a00f6ff36e834cef0fc4de.info.1","class":"state variable","state":{"variable":"","value":"Act"}}],"unitsOfInformation":[],"bbox":{"x":184.23901,"y":637.35443,"w":52,"h":99},"metadata":[["bp:displayName","PDE6"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","PDE6G"],["bp:entityReference_http://identifiers.org/uniprot/P18545",[["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P18545"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylmethionine"],["bp:term","N-acetylmethionine"]]],["bp:comment","MOD_RES 1 1 N-acetylmethionine."],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P18545"]]],["bp:standardName","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma"],["bp:xref","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma"],["bp:xref","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma"],["bp:organism","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma"],["bp:displayName","CNRG_HUMAN"],["bp:name","3.1.4.35"],["bp:name","PDE6G"],["bp:name","PDEG"],["bp:name","GMP-PDE gamma"],["bp:comment","FUNCTION: Participates in processes of transmission andamplification of the visual signal. cGMP-PDEs are the effectormolecules in G-protein-mediated phototransduction in vertebraterods and cones.CATALYTIC ACTIVITY: Guanosine 3',5'-cyclic phosphate + H(2)O =guanosine 5'-phosphate.SUBUNIT: Oligomer composed of two catalytic chains (alpha andbeta), an inhibitory chain (gamma) and the delta chain.DISEASE: Retinitis pigmentosa 57 (RP57) [MIM:613582]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:20655036}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the rod/cone cGMP-PDE gamma subunit family.{ECO:0000305}.SEQUENCE CAUTION:Sequence=CAD97656.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};Sequence=EAW89666.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the PDE6A/B/G genes; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/pdemut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_002593"],["bp:comment","REPLACED http://www.humanmetabolism.org/#ref_http://www.humanmetabolism.org/#protein_PDE6G"],["bp:comment","CNRG_HUMAN Reviewed; 87 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_5148"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29715"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29715"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29863"],["bp:stoichiometricCoefficient","2.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","PDE6G"],["bp:entityReference_http://identifiers.org/uniprot/P18545",[["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P18545"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylmethionine"],["bp:term","N-acetylmethionine"]]],["bp:comment","MOD_RES 1 1 N-acetylmethionine."],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P18545"]]],["bp:standardName","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma"],["bp:xref","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma"],["bp:xref","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma"],["bp:organism","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma"],["bp:displayName","CNRG_HUMAN"],["bp:name","3.1.4.35"],["bp:name","PDE6G"],["bp:name","PDEG"],["bp:name","GMP-PDE gamma"],["bp:comment","FUNCTION: Participates in processes of transmission andamplification of the visual signal. cGMP-PDEs are the effectormolecules in G-protein-mediated phototransduction in vertebraterods and cones.CATALYTIC ACTIVITY: Guanosine 3',5'-cyclic phosphate + H(2)O =guanosine 5'-phosphate.SUBUNIT: Oligomer composed of two catalytic chains (alpha andbeta), an inhibitory chain (gamma) and the delta chain.DISEASE: Retinitis pigmentosa 57 (RP57) [MIM:613582]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:20655036}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the rod/cone cGMP-PDE gamma subunit family.{ECO:0000305}.SEQUENCE CAUTION:Sequence=CAD97656.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};Sequence=EAW89666.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the PDE6A/B/G genes; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/pdemut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_002593"],["bp:comment","REPLACED http://www.humanmetabolism.org/#ref_http://www.humanmetabolism.org/#protein_PDE6G"],["bp:comment","CNRG_HUMAN Reviewed; 87 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_5148"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29715"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29715"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29863"],["bp:stoichiometricCoefficient","2.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","PDE6G"],["bp:entityReference_http://identifiers.org/uniprot/P18545",[["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P18545"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylmethionine"],["bp:term","N-acetylmethionine"]]],["bp:comment","MOD_RES 1 1 N-acetylmethionine."],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P18545"]]],["bp:standardName","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma"],["bp:xref","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma"],["bp:xref","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma"],["bp:organism","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma"],["bp:displayName","CNRG_HUMAN"],["bp:name","3.1.4.35"],["bp:name","PDE6G"],["bp:name","PDEG"],["bp:name","GMP-PDE gamma"],["bp:comment","FUNCTION: Participates in processes of transmission andamplification of the visual signal. cGMP-PDEs are the effectormolecules in G-protein-mediated phototransduction in vertebraterods and cones.CATALYTIC ACTIVITY: Guanosine 3',5'-cyclic phosphate + H(2)O =guanosine 5'-phosphate.SUBUNIT: Oligomer composed of two catalytic chains (alpha andbeta), an inhibitory chain (gamma) and the delta chain.DISEASE: Retinitis pigmentosa 57 (RP57) [MIM:613582]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:20655036}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the rod/cone cGMP-PDE gamma subunit family.{ECO:0000305}.SEQUENCE CAUTION:Sequence=CAD97656.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};Sequence=EAW89666.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the PDE6A/B/G genes; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/pdemut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_002593"],["bp:comment","REPLACED http://www.humanmetabolism.org/#ref_http://www.humanmetabolism.org/#protein_PDE6G"],["bp:comment","CNRG_HUMAN Reviewed; 87 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_5148"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29715"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29715"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29863"],["bp:stoichiometricCoefficient","2.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","PDE6G"],["bp:entityReference_http://identifiers.org/uniprot/P18545",[["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P18545"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylmethionine"],["bp:term","N-acetylmethionine"]]],["bp:comment","MOD_RES 1 1 N-acetylmethionine."],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P18545"]]],["bp:standardName","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma"],["bp:xref","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma"],["bp:xref","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma"],["bp:organism","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma"],["bp:displayName","CNRG_HUMAN"],["bp:name","3.1.4.35"],["bp:name","PDE6G"],["bp:name","PDEG"],["bp:name","GMP-PDE gamma"],["bp:comment","FUNCTION: Participates in processes of transmission andamplification of the visual signal. cGMP-PDEs are the effectormolecules in G-protein-mediated phototransduction in vertebraterods and cones.CATALYTIC ACTIVITY: Guanosine 3',5'-cyclic phosphate + H(2)O =guanosine 5'-phosphate.SUBUNIT: Oligomer composed of two catalytic chains (alpha andbeta), an inhibitory chain (gamma) and the delta chain.DISEASE: Retinitis pigmentosa 57 (RP57) [MIM:613582]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:20655036}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the rod/cone cGMP-PDE gamma subunit family.{ECO:0000305}.SEQUENCE CAUTION:Sequence=CAD97656.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};Sequence=EAW89666.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the PDE6A/B/G genes; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/pdemut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_002593"],["bp:comment","REPLACED http://www.humanmetabolism.org/#ref_http://www.humanmetabolism.org/#protein_PDE6G"],["bp:comment","CNRG_HUMAN Reviewed; 87 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_5148"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29715"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29715"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29863"],["bp:stoichiometricCoefficient","2.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","PDE6G"],["bp:entityReference_http://identifiers.org/uniprot/P18545",[["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P18545"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylmethionine"],["bp:term","N-acetylmethionine"]]],["bp:comment","MOD_RES 1 1 N-acetylmethionine."],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P18545"]]],["bp:standardName","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma"],["bp:xref","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma"],["bp:xref","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma"],["bp:organism","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma"],["bp:displayName","CNRG_HUMAN"],["bp:name","3.1.4.35"],["bp:name","PDE6G"],["bp:name","PDEG"],["bp:name","GMP-PDE gamma"],["bp:comment","FUNCTION: Participates in processes of transmission andamplification of the visual signal. cGMP-PDEs are the effectormolecules in G-protein-mediated phototransduction in vertebraterods and cones.CATALYTIC ACTIVITY: Guanosine 3',5'-cyclic phosphate + H(2)O =guanosine 5'-phosphate.SUBUNIT: Oligomer composed of two catalytic chains (alpha andbeta), an inhibitory chain (gamma) and the delta chain.DISEASE: Retinitis pigmentosa 57 (RP57) [MIM:613582]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:20655036}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the rod/cone cGMP-PDE gamma subunit family.{ECO:0000305}.SEQUENCE CAUTION:Sequence=CAD97656.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};Sequence=EAW89666.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the PDE6A/B/G genes; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/pdemut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_002593"],["bp:comment","REPLACED http://www.humanmetabolism.org/#ref_http://www.humanmetabolism.org/#protein_PDE6G"],["bp:comment","CNRG_HUMAN Reviewed; 87 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_5148"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29715"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29715"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29863"],["bp:stoichiometricCoefficient","2.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","PDE6G"],["bp:entityReference_http://identifiers.org/uniprot/P18545",[["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P18545"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylmethionine"],["bp:term","N-acetylmethionine"]]],["bp:comment","MOD_RES 1 1 N-acetylmethionine."],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P18545"]]],["bp:standardName","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma"],["bp:xref","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma"],["bp:xref","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma"],["bp:organism","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma"],["bp:displayName","CNRG_HUMAN"],["bp:name","3.1.4.35"],["bp:name","PDE6G"],["bp:name","PDEG"],["bp:name","GMP-PDE gamma"],["bp:comment","FUNCTION: Participates in processes of transmission andamplification of the visual signal. cGMP-PDEs are the effectormolecules in G-protein-mediated phototransduction in vertebraterods and cones.CATALYTIC ACTIVITY: Guanosine 3',5'-cyclic phosphate + H(2)O =guanosine 5'-phosphate.SUBUNIT: Oligomer composed of two catalytic chains (alpha andbeta), an inhibitory chain (gamma) and the delta chain.DISEASE: Retinitis pigmentosa 57 (RP57) [MIM:613582]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:20655036}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the rod/cone cGMP-PDE gamma subunit family.{ECO:0000305}.SEQUENCE CAUTION:Sequence=CAD97656.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};Sequence=EAW89666.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the PDE6A/B/G genes; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/pdemut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_002593"],["bp:comment","REPLACED http://www.humanmetabolism.org/#ref_http://www.humanmetabolism.org/#protein_PDE6G"],["bp:comment","CNRG_HUMAN Reviewed; 87 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_5148"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29715"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29715"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29863"],["bp:stoichiometricCoefficient","2.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","PDE6G"],["bp:entityReference_http://identifiers.org/uniprot/P18545",[["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P18545"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylmethionine"],["bp:term","N-acetylmethionine"]]],["bp:comment","MOD_RES 1 1 N-acetylmethionine."],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P18545"]]],["bp:standardName","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma"],["bp:xref","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma"],["bp:xref","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma"],["bp:organism","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma"],["bp:displayName","CNRG_HUMAN"],["bp:name","3.1.4.35"],["bp:name","PDE6G"],["bp:name","PDEG"],["bp:name","GMP-PDE gamma"],["bp:comment","FUNCTION: Participates in processes of transmission andamplification of the visual signal. cGMP-PDEs are the effectormolecules in G-protein-mediated phototransduction in vertebraterods and cones.CATALYTIC ACTIVITY: Guanosine 3',5'-cyclic phosphate + H(2)O =guanosine 5'-phosphate.SUBUNIT: Oligomer composed of two catalytic chains (alpha andbeta), an inhibitory chain (gamma) and the delta chain.DISEASE: Retinitis pigmentosa 57 (RP57) [MIM:613582]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:20655036}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the rod/cone cGMP-PDE gamma subunit family.{ECO:0000305}.SEQUENCE CAUTION:Sequence=CAD97656.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};Sequence=EAW89666.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the PDE6A/B/G genes; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/pdemut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_002593"],["bp:comment","REPLACED http://www.humanmetabolism.org/#ref_http://www.humanmetabolism.org/#protein_PDE6G"],["bp:comment","CNRG_HUMAN Reviewed; 87 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_5148"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29715"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29715"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29863"],["bp:stoichiometricCoefficient","2.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29854"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29854"]]}},{"data":{"id":"Protein_83df3ed854aac8299449f5b80091d2b8_Complex_a1b72fa4f9a00f6ff36e834cef0fc4de","class":"macromolecule","label":"PDE6G","parent":"Complex_a1b72fa4f9a00f6ff36e834cef0fc4de","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":184.23901,"y":672.35443,"w":48,"h":25},"metadata":[["bp:displayName","PDE6G"],["bp:entityReference_http://identifiers.org/uniprot/P18545",[["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P18545"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylmethionine"],["bp:term","N-acetylmethionine"]]],["bp:comment","MOD_RES 1 1 N-acetylmethionine."],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P18545"]]],["bp:standardName","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma"],["bp:xref",[["bp:id","P18545"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","PDE6G"],["bp:db","hgnc symbol"]]],["bp:organism",[["bp:relationshipType",null],["bp:id","PDE6G"],["bp:db","hgnc symbol"]]],["bp:displayName","CNRG_HUMAN"],["bp:name","3.1.4.35"],["bp:name","PDE6G"],["bp:name","PDEG"],["bp:name","GMP-PDE gamma"],["bp:comment","FUNCTION: Participates in processes of transmission andamplification of the visual signal. cGMP-PDEs are the effectormolecules in G-protein-mediated phototransduction in vertebraterods and cones.CATALYTIC ACTIVITY: Guanosine 3',5'-cyclic phosphate + H(2)O =guanosine 5'-phosphate.SUBUNIT: Oligomer composed of two catalytic chains (alpha andbeta), an inhibitory chain (gamma) and the delta chain.DISEASE: Retinitis pigmentosa 57 (RP57) [MIM:613582]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:20655036}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the rod/cone cGMP-PDE gamma subunit family.{ECO:0000305}.SEQUENCE CAUTION:Sequence=CAD97656.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};Sequence=EAW89666.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the PDE6A/B/G genes; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/pdemut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_002593"],["bp:comment","REPLACED http://www.humanmetabolism.org/#ref_http://www.humanmetabolism.org/#protein_PDE6G"],["bp:comment","CNRG_HUMAN Reviewed; 87 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_5148"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29715"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29715"]]}},{"data":{"id":"Protein_2db3e84373d5bf06cbb82fc9e57e3ff4_Complex_a1b72fa4f9a00f6ff36e834cef0fc4de","class":"macromolecule","label":"PDE6B","parent":"Complex_a1b72fa4f9a00f6ff36e834cef0fc4de","clonemarker":false,"stateVariables":[{"id":"Protein_2db3e84373d5bf06cbb82fc9e57e3ff4_Complex_a1b72fa4f9a00f6ff36e834cef0fc4de.info.1","class":"state variable","state":{"variable":"","value":"sgergercys"}}],"unitsOfInformation":[],"bbox":{"x":184.23901,"y":637.35443,"w":48,"h":25},"metadata":[["bp:displayName","PDE6B"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00113"],["bp:db","protein modification ontology"]]],["bp:term","sgergercys"],["bp:term","S-geranylgeranyl-L-cysteine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29860"]]],["bp:entityReference_http://identifiers.org/uniprot/P35913",[["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P35913"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P35913"]]],["bp:standardName","Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta"],["bp:xref",[["bp:id","P35913"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","PDE6B"],["bp:db","hgnc symbol"]]],["bp:organism",[["bp:relationshipType",null],["bp:id","PDE6B"],["bp:db","hgnc symbol"]]],["bp:displayName","PDE6B_HUMAN"],["bp:name","PDEB"],["bp:name","3.1.4.35"],["bp:name","PDE6B"],["bp:name","GMP-PDE beta"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_5158"],["bp:comment","PDE6B_HUMAN Reviewed; 854 AA."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01571_identity"],["bp:comment","REPLACED http://www.humanmetabolism.org/#ref_http://www.humanmetabolism.org/#protein_PDE6B"],["bp:comment","FUNCTION: This protein participates in processes of transmissionand amplification of the visual signal. Necessary for theformation of a functional phosphodiesterase holoenzyme.CATALYTIC ACTIVITY: Guanosine 3',5'-cyclic phosphate + H(2)O =guanosine 5'-phosphate.COFACTOR:Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240;Evidence={ECO:0000250};Note=Binds 2 divalent metal cations per subunit. Site 1 maypreferentially bind zinc ions, while site 2 has a preference formagnesium and/or manganese ions. {ECO:0000250};SUBUNIT: Oligomer composed of two catalytic chains (alpha andbeta), an inhibitory chain (gamma) and the delta chain.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=3;Name=1;IsoId=P35913-1; Sequence=Displayed;Name=2;IsoId=P35913-2; Sequence=VSP_036884;Name=3;IsoId=P35913-3; Sequence=VSP_044919;Note=No experimental confirmation available.;DISEASE: Retinitis pigmentosa 40 (RP40) [MIM:613801]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:22334370,ECO:0000269|PubMed:8394174, ECO:0000269|PubMed:8557257,ECO:0000269|PubMed:8595886, ECO:0000269|PubMed:8698075,ECO:0000269|PubMed:8956055, ECO:0000269|PubMed:9543643}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Night blindness, congenital stationary, autosomaldominant 2 (CSNBAD2) [MIM:163500]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:8075643}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the cyclic nucleotide phosphodiesterasefamily. {ECO:0000305}.WEB RESOURCE: Name=Mutations of the PDE6A/B/G genes; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/pdemut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29857"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29857"]]}},{"data":{"id":"Protein_935b028833b5fe19f5445e2eb5dc9cd8_Complex_a1b72fa4f9a00f6ff36e834cef0fc4de","class":"macromolecule","label":"PDE6A","parent":"Complex_a1b72fa4f9a00f6ff36e834cef0fc4de","clonemarker":false,"stateVariables":[{"id":"Protein_935b028833b5fe19f5445e2eb5dc9cd8_Complex_a1b72fa4f9a00f6ff36e834cef0fc4de.info.1","class":"state variable","state":{"variable":"","value":"S-farnesyl-L-cysteine"}}],"unitsOfInformation":[],"bbox":{"x":184.23901,"y":602.35443,"w":48,"h":25},"metadata":[["bp:displayName","PDE6A"],["bp:feature",[["bp:modificationType",[["bp:xref",[["bp:id","MOD:00111"],["bp:db","protein modification ontology"]]],["bp:term","S-farnesyl-L-cysteine"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29856"]]],["bp:entityReference_http://identifiers.org/uniprot/P16499",[["bp:entityFeature",[["bp:modificationType",[["bp:term","N-acetylglycine"],["bp:term","MOD_RES N-acetylglycine"]]],["bp:comment","MOD_RES 2 2 N-acetylglycine."],["bp:featureLocation",[["bp:sequencePosition","2"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Cysteine methyl ester"],["bp:term","MOD_RES Cysteine methyl ester"]]],["bp:comment","MOD_RES 857 857 Cysteine methyl ester."],["bp:featureLocation",[["bp:sequencePosition","857"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Cysteine methyl ester"],["bp:term","MOD_RES Cysteine methyl ester"]]],["bp:comment","MOD_RES 857 857 Cysteine methyl ester."],["bp:featureLocation",[["bp:sequencePosition","857"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Cysteine methyl ester"],["bp:term","MOD_RES Cysteine methyl ester"]]],["bp:comment","MOD_RES 857 857 Cysteine methyl ester."],["bp:featureLocation",[["bp:sequencePosition","857"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha"],["bp:xref","Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha"],["bp:xref","Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha"],["bp:organism","Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha"],["bp:displayName","PDE6A_HUMAN"],["bp:name","PDEA"],["bp:name","3.1.4.35"],["bp:name","PDE6A"],["bp:name","PDE V-B1"],["bp:name","GMP-PDE alpha"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01570_identity"],["bp:comment","FUNCTION: This protein participates in processes of transmissionand amplification of the visual signal.CATALYTIC ACTIVITY: Guanosine 3',5'-cyclic phosphate + H(2)O =guanosine 5'-phosphate.COFACTOR:Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240;Evidence={ECO:0000250};Note=Binds 2 divalent metal cations per subunit. Site 1 maypreferentially bind zinc ions, while site 2 has a preference formagnesium and/or manganese ions. {ECO:0000250};SUBUNIT: Oligomer composed of two catalytic chains (alpha andbeta), an inhibitory chain (gamma) and the delta chain.SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Lipid-anchor{ECO:0000305}; Cytoplasmic side {ECO:0000305}.DISEASE: Retinitis pigmentosa 43 (RP43) [MIM:613810]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:10393062,ECO:0000269|PubMed:7493036}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the cyclic nucleotide phosphodiesterasefamily. {ECO:0000305}.WEB RESOURCE: Name=Mutations of the PDE6A/B/G genes; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/pdemut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","PDE6A_HUMAN Reviewed; 860 AA."],["bp:comment","REPLACED http://www.humanmetabolism.org/#ref_http://www.humanmetabolism.org/#protein_PDE6A"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_5145"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000431"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29855"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29855"]]}},{"data":{"id":"BiochemicalReaction_0d9463421db68fb6b6ec59faeba18c48_LEFT_TO_RIGHT","class":"process","label":"","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":1001.7432,"y":227.77972,"w":15,"h":15},"metadata":[["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","11-cis-retinol"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16302",[["bp:standardName","11-cis-retinol"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11310"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:19120"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:728"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:728"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H30O"],["bp:displayName","11-cis-retinol"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\CO"],["bp:name","11-cis-Retinol"],["bp:name","C20H30O"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol"],["bp:molecularWeight","286.23"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00899.eref"],["bp:comment","has_role CHEBI:75771"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMoleculeReference75454"],["bp:comment","is_a CHEBI:50211"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29628"],["bp:structure","REPLACED http://pid.nci.nih.gov/biopax#pid_29628"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29627"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29627"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29897"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","11-cis-retinol"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16302",[["bp:standardName","11-cis-retinol"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11310"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:19120"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:728"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:728"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H30O"],["bp:displayName","11-cis-retinol"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\CO"],["bp:name","11-cis-Retinol"],["bp:name","C20H30O"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol"],["bp:molecularWeight","286.23"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00899.eref"],["bp:comment","has_role CHEBI:75771"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMoleculeReference75454"],["bp:comment","is_a CHEBI:50211"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29628"],["bp:structure","REPLACED http://pid.nci.nih.gov/biopax#pid_29628"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29627"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29627"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29897"],["bp:stoichiometricCoefficient","1.0"]]],["bp:xref",[["bp:physicalEntity",[["bp:displayName","11-cis-retinol"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16302",[["bp:standardName","11-cis-retinol"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11310"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:19120"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:728"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:728"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H30O"],["bp:displayName","11-cis-retinol"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\CO"],["bp:name","11-cis-Retinol"],["bp:name","C20H30O"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol"],["bp:molecularWeight","286.23"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00899.eref"],["bp:comment","has_role CHEBI:75771"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMoleculeReference75454"],["bp:comment","is_a CHEBI:50211"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29628"],["bp:structure","REPLACED http://pid.nci.nih.gov/biopax#pid_29628"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29627"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29627"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29897"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","11-cis-retinol"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16302",[["bp:standardName","11-cis-retinol"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11310"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:19120"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:728"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:728"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H30O"],["bp:displayName","11-cis-retinol"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\CO"],["bp:name","11-cis-Retinol"],["bp:name","C20H30O"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol"],["bp:molecularWeight","286.23"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00899.eref"],["bp:comment","has_role CHEBI:75771"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMoleculeReference75454"],["bp:comment","is_a CHEBI:50211"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29628"],["bp:structure","REPLACED http://pid.nci.nih.gov/biopax#pid_29628"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29627"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29627"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29897"],["bp:stoichiometricCoefficient","1.0"]]],["bp:evidence",[["bp:physicalEntity",[["bp:displayName","11-cis-retinol"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16302",[["bp:standardName","11-cis-retinol"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11310"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:19120"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:728"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:728"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H30O"],["bp:displayName","11-cis-retinol"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\CO"],["bp:name","11-cis-Retinol"],["bp:name","C20H30O"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol"],["bp:molecularWeight","286.23"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00899.eref"],["bp:comment","has_role CHEBI:75771"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMoleculeReference75454"],["bp:comment","is_a CHEBI:50211"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29628"],["bp:structure","REPLACED http://pid.nci.nih.gov/biopax#pid_29628"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29627"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29627"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29897"],["bp:stoichiometricCoefficient","1.0"]]],["bp:right",[["bp:physicalEntity",[["bp:displayName","11-cis-retinol"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16302",[["bp:standardName","11-cis-retinol"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11310"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:19120"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:728"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:728"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H30O"],["bp:displayName","11-cis-retinol"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\CO"],["bp:name","11-cis-Retinol"],["bp:name","C20H30O"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol"],["bp:molecularWeight","286.23"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00899.eref"],["bp:comment","has_role CHEBI:75771"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMoleculeReference75454"],["bp:comment","is_a CHEBI:50211"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29628"],["bp:structure","REPLACED http://pid.nci.nih.gov/biopax#pid_29628"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29627"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29627"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29897"],["bp:stoichiometricCoefficient","1.0"]]],["bp:left",[["bp:physicalEntity",[["bp:displayName","11-cis-retinol"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16302",[["bp:standardName","11-cis-retinol"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:50211"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11310"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16302"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:19120"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:728"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:728"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H30O"],["bp:displayName","11-cis-retinol"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\CO"],["bp:name","11-cis-Retinol"],["bp:name","C20H30O"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol"],["bp:molecularWeight","286.23"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00899.eref"],["bp:comment","has_role CHEBI:75771"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMoleculeReference75454"],["bp:comment","is_a CHEBI:50211"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29628"],["bp:structure","REPLACED http://pid.nci.nih.gov/biopax#pid_29628"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29627"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29627"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29897"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29896"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29896"]]}},{"data":{"id":"Complex_38e35536ddcf52e8d0df5477aa66734b","class":"complex","label":"GC2/GCAP Family","parent":"","clonemarker":false,"stateVariables":[{"id":"Complex_38e35536ddcf52e8d0df5477aa66734b.info.1","class":"state variable","state":{"variable":"","value":"Act"}}],"unitsOfInformation":[],"bbox":{"x":790.2281,"y":932.09045,"w":52,"h":59},"metadata":[["bp:displayName","GC2/GCAP Family"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GC2"],["bp:entityReference_http://identifiers.org/uniprot/P51841",[["bp:standardName","Retinal guanylyl cyclase 2"],["bp:xref",[["bp:relationshipType",null],["bp:id","GUCY2F"],["bp:db","hgnc symbol"]]],["bp:xref",[["bp:id","P51841"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","P51841"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","GUC2F_HUMAN"],["bp:name","RETGC2"],["bp:name","GUC2F"],["bp:name","RETGC-2"],["bp:name","GUCY2F"],["bp:name","4.6.1.2"],["bp:name","Guanylate cyclase F"],["bp:name","GC-F"],["bp:name","Rod outer segment membrane guanylate cyclase 2"],["bp:name","ROS-GC2"],["bp:name","Guanylate cyclase 2F, retinal"],["bp:comment","GUC2F_HUMAN Reviewed; 1108 AA."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02078_identity"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_001513"],["bp:comment","FUNCTION: Probably plays a specific functional role in the rodsand/or cones of photoreceptors. It may be the enzyme involved inthe resynthesis of cGMP required for recovery of the dark stateafter phototransduction.CATALYTIC ACTIVITY: GTP = 3',5'-cyclic GMP + diphosphate.ENZYME REGULATION: Activated by GCAP-1; inhibited by calcium.SUBCELLULAR LOCATION: Membrane; Single-pass type I membraneprotein.TISSUE SPECIFICITY: Retina. Localized exclusively in the outernuclear layer and inner segments of the rod and cone photoreceptorcells.DOMAIN: The protein kinase domain is predicted to be catalyticallyinactive.PTM: There are 9 conserved cysteine residues in sensory guanylatecyclases, 6 in the extracellular domain, which may be involved inintra- or interchain disulfide bonds.SIMILARITY: Belongs to the adenylyl cyclase class-4/guanylylcyclase family. {ECO:0000255|PROSITE-ProRule:PRU00099}.WEB RESOURCE: Name=Mutations of the GUCY2F gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29759"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29761"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29760"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29760"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29760"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",null],["bp:entityFeature",null],["bp:entityFeature",null],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:xref","Guanylyl cyclase-activating protein 1"],["bp:organism","Guanylyl cyclase-activating protein 1"],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29760"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29758"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29758"]]}},{"data":{"id":"Protein_58a1f719f8c2ed9b0882f7798a8df554_Complex_38e35536ddcf52e8d0df5477aa66734b","class":"macromolecule","label":"GUCY2F","parent":"Complex_38e35536ddcf52e8d0df5477aa66734b","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":790.2281,"y":947.09045,"w":48,"h":25},"metadata":[["bp:displayName","GC2"],["bp:entityReference_http://identifiers.org/uniprot/P51841",[["bp:standardName","Retinal guanylyl cyclase 2"],["bp:xref",[["bp:relationshipType",null],["bp:id","GUCY2F"],["bp:db","hgnc symbol"]]],["bp:xref",[["bp:id","P51841"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","P51841"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","GUC2F_HUMAN"],["bp:name","RETGC2"],["bp:name","GUC2F"],["bp:name","RETGC-2"],["bp:name","GUCY2F"],["bp:name","4.6.1.2"],["bp:name","Guanylate cyclase F"],["bp:name","GC-F"],["bp:name","Rod outer segment membrane guanylate cyclase 2"],["bp:name","ROS-GC2"],["bp:name","Guanylate cyclase 2F, retinal"],["bp:comment","GUC2F_HUMAN Reviewed; 1108 AA."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02078_identity"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_001513"],["bp:comment","FUNCTION: Probably plays a specific functional role in the rodsand/or cones of photoreceptors. It may be the enzyme involved inthe resynthesis of cGMP required for recovery of the dark stateafter phototransduction.CATALYTIC ACTIVITY: GTP = 3',5'-cyclic GMP + diphosphate.ENZYME REGULATION: Activated by GCAP-1; inhibited by calcium.SUBCELLULAR LOCATION: Membrane; Single-pass type I membraneprotein.TISSUE SPECIFICITY: Retina. Localized exclusively in the outernuclear layer and inner segments of the rod and cone photoreceptorcells.DOMAIN: The protein kinase domain is predicted to be catalyticallyinactive.PTM: There are 9 conserved cysteine residues in sensory guanylatecyclases, 6 in the extracellular domain, which may be involved inintra- or interchain disulfide bonds.SIMILARITY: Belongs to the adenylyl cyclase class-4/guanylylcyclase family. {ECO:0000255|PROSITE-ProRule:PRU00099}.WEB RESOURCE: Name=Mutations of the GUCY2F gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29759"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]}},{"data":{"id":"Protein_d95c616d16b1d43598d8ef7c56c2075d_Complex_38e35536ddcf52e8d0df5477aa66734b","class":"macromolecule","label":"GCAP Family","parent":"Complex_38e35536ddcf52e8d0df5477aa66734b","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":790.2281,"y":917.09045,"w":48,"h":25},"metadata":[["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation",[["bp:sequencePosition","3"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation",[["bp:sequencePosition","3"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:memberPhysicalEntity",[["bp:displayName","GUCA1A"],["bp:entityReference_http://identifiers.org/uniprot/P43080",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P43080"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES Deamidated asparagine"],["bp:term","Deamidated asparagine"]]],["bp:comment","MOD_RES 3 3 Deamidated asparagine."],["bp:featureLocation",[["bp:sequencePosition","3"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanylyl cyclase-activating protein 1"],["bp:xref",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:organism",[["bp:id","P43080"],["bp:db","uniprot knowledgebase"]]],["bp:displayName","GUC1A_HUMAN"],["bp:name","Guanylate cyclase activator 1A"],["bp:name","GUCA1"],["bp:name","GCAP1"],["bp:name","C6orf131"],["bp:name","GCAP 1"],["bp:name","GCAP"],["bp:name","GUCA1A"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2978"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02648_identity"],["bp:comment","FUNCTION: Stimulates retinal guanylyl cyclase when free calciumions concentration is low and inhibits guanylyl cyclase when freecalcium ions concentration is elevated (PubMed:19459154). ThisCa(2+)-sensitive regulation of retinal guanylyl cyclase is a keyevent in recovery of the dark state of rod photoreceptorsfollowing light exposure. {ECO:0000269|PubMed:19459154,ECO:0000305}.SUBCELLULAR LOCATION: Membrane; Lipid-anchor.TISSUE SPECIFICITY: Retina; cone outer and inner segments, inparticular, in disk membrane regions, and to a lesser extent rodinner and outer segments.DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) whencalcium levels are high. Binds Mg(2+) when calcium levels are low.{ECO:0000250|UniProtKB:P46065}.DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomaldominant cone dystrophy. Cone dystrophies are retinal dystrophiescharacterized by progressive degeneration of the conephotoreceptors with preservation of rod function, as indicated byelectroretinogram. However, some rod involvement may be present insome cone dystrophies, particularly at late stage. Affectedindividuals suffer from photophobia, loss of visual acuity, colorvision and central visual field. Another sign is the absence ofmacular lesions for many years. Cone dystrophies are distinguishedfrom the cone-rod dystrophies in which some loss of peripheralvision also occurs. {ECO:0000269|PubMed:11108966,ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,ECO:0000269|PubMed:9425234}. Note=The disease is caused bymutations affecting the gene represented in this entry.SEQUENCE CAUTION:Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gcmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000400"],["bp:comment","GUC1A_HUMAN Reviewed; 201 AA."]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29603"]]],["bp:displayName","GCAP Family"],["bp:entityReference_#ProteinReference_68cc2efe2b85b654c494c99923d8b1cd","GCAP Family"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29595"]]}},{"data":{"id":"SmallMolecule_7414b0b55879a305bd7ba983351edd98","class":"simple chemical","label":"11-cis-retinal","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":893.014,"y":274.38266,"w":48,"h":20},"metadata":[["bp:displayName","11-cis-retinal"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:16066",[["bp:standardName","11-cis-retinal"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:11311"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:23240"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:727"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:16066"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:15035"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:19119"],["bp:db","chebi"]]],["bp:chemicalFormula","C20H28O"],["bp:displayName","11-cis-retinal"],["bp:name","11-cis-retinene"],["bp:name","11-cis-vitamin A aldehyde"],["bp:name","(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal"],["bp:name","11-cis-Retinal"],["bp:name","11-cis-Vitamin A aldehyde"],["bp:name","CC(/C=C\\\\C=C(C)\\\\C=C\\\\C1=C(C)CCCC1(C)C)=C\\\\C=O"],["bp:name","C20H28O"],["bp:name","11-cis-Retinene"],["bp:molecularWeight","284.214"],["bp:comment","A retinal having 2E,4Z,6E,8E-double bond geometry."],["bp:comment","has_role CHEBI:23240"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB02152"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29746"],["bp:comment","is_a CHEBI:15035"],["bp:comment","has_role CHEBI:77746"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC02110.eref"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6-,12-11+,16-8+,17-13+"]]]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29745"]]}},{"data":{"id":"Complex_6a0c3a0c50969ce329823fd32890fa61","class":"complex","label":"PDE6G/GNAT1/GTP","parent":"","clonemarker":false,"stateVariables":[{"id":"Complex_6a0c3a0c50969ce329823fd32890fa61.info.1","class":"state variable","state":{"variable":"","value":"Act"}}],"unitsOfInformation":[],"bbox":{"x":444.46213,"y":715.4839,"w":52,"h":84},"metadata":[["bp:displayName","PDE6G/GNAT1/GTP"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29719"],["bp:stoichiometricCoefficient","2.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29719"],["bp:stoichiometricCoefficient","2.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29719"],["bp:stoichiometricCoefficient","2.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29719"],["bp:stoichiometricCoefficient","2.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29719"],["bp:stoichiometricCoefficient","2.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29719"],["bp:stoichiometricCoefficient","2.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29719"],["bp:stoichiometricCoefficient","2.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29714"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29714"]]}},{"data":{"id":"SmallMolecule_4f4ea8c9f46fdd97ff867fe7c8860bda_Complex_6a0c3a0c50969ce329823fd32890fa61","class":"simple chemical","label":"GTP","parent":"Complex_6a0c3a0c50969ce329823fd32890fa61","clonemarker":true,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":442.96213,"y":747.9839,"w":45,"h":15},"metadata":[["bp:displayName","GTP"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:15996",[["bp:standardName","guanosine 5'-(tetrahydrogen triphosphate)"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37121"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:5234"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13342"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:37045"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:24451"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:15996"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:42934"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:76971"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57600"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57600"],["bp:db","chebi"]]],["bp:chemicalFormula","C10H16N5O14P3"],["bp:displayName","GTP"],["bp:name","Guanosine 5'-triphosphate"],["bp:name","guanosine triphosphate"],["bp:name","H4gtp"],["bp:name","Nc1nc2n(cnc2c(=O)[nH]1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O"],["bp:name","guanosine 5'-triphosphoric acid"],["bp:name","GUANOSINE-5'-TRIPHOSPHATE"],["bp:name","C10H16N5O14P3"],["bp:name","5'-GTP"],["bp:molecularWeight","523.1806"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/SmallMoleculeReference_bind_212_identity"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB04137"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_310"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://www.inoh.org/biopax/IMR_0001354_GTP"],["bp:comment","has_role CHEBI:76971"],["bp:comment","is_a CHEBI:37045"],["bp:comment","is_a CHEBI:37121"],["bp:comment","is_conjugate_acid_of CHEBI:57600"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00044.eref"],["bp:structure","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC00044.eref"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_309"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_309"]]}},{"data":{"id":"Protein_83df3ed854aac8299449f5b80091d2b8_Complex_6a0c3a0c50969ce329823fd32890fa61","class":"macromolecule","label":"PDE6G","parent":"Complex_6a0c3a0c50969ce329823fd32890fa61","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":444.46213,"y":722.9839,"w":48,"h":25},"metadata":[["bp:displayName","PDE6G"],["bp:entityReference_http://identifiers.org/uniprot/P18545",[["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P18545"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylmethionine"],["bp:term","N-acetylmethionine"]]],["bp:comment","MOD_RES 1 1 N-acetylmethionine."],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P18545"]]],["bp:standardName","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma"],["bp:xref",[["bp:id","P18545"],["bp:db","uniprot knowledgebase"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","PDE6G"],["bp:db","hgnc symbol"]]],["bp:organism",[["bp:relationshipType",null],["bp:id","PDE6G"],["bp:db","hgnc symbol"]]],["bp:displayName","CNRG_HUMAN"],["bp:name","3.1.4.35"],["bp:name","PDE6G"],["bp:name","PDEG"],["bp:name","GMP-PDE gamma"],["bp:comment","FUNCTION: Participates in processes of transmission andamplification of the visual signal. cGMP-PDEs are the effectormolecules in G-protein-mediated phototransduction in vertebraterods and cones.CATALYTIC ACTIVITY: Guanosine 3',5'-cyclic phosphate + H(2)O =guanosine 5'-phosphate.SUBUNIT: Oligomer composed of two catalytic chains (alpha andbeta), an inhibitory chain (gamma) and the delta chain.DISEASE: Retinitis pigmentosa 57 (RP57) [MIM:613582]: A retinaldystrophy belonging to the group of pigmentary retinopathies.Retinitis pigmentosa is characterized by retinal pigment depositsvisible on fundus examination and primary loss of rodphotoreceptor cells followed by secondary loss of conephotoreceptors. Patients typically have night vision blindness andloss of midperipheral visual field. As their condition progresses,they lose their far peripheral visual field and eventually centralvision as well. {ECO:0000269|PubMed:20655036}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the rod/cone cGMP-PDE gamma subunit family.{ECO:0000305}.SEQUENCE CAUTION:Sequence=CAD97656.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};Sequence=EAW89666.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};WEB RESOURCE: Name=Mutations of the PDE6A/B/G genes; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/pdemut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_002593"],["bp:comment","REPLACED http://www.humanmetabolism.org/#ref_http://www.humanmetabolism.org/#protein_PDE6G"],["bp:comment","CNRG_HUMAN Reviewed; 87 AA."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_5148"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29715"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29715"]]}},{"data":{"id":"Protein_5d6c1415855226905a79c603d64a3009_Complex_6a0c3a0c50969ce329823fd32890fa61","class":"macromolecule","label":"GNAT1","parent":"Complex_6a0c3a0c50969ce329823fd32890fa61","clonemarker":false,"stateVariables":[{"id":"Protein_5d6c1415855226905a79c603d64a3009_Complex_6a0c3a0c50969ce329823fd32890fa61.info.1","class":"state variable","state":{"variable":"","value":"Act"}}],"unitsOfInformation":[],"bbox":{"x":444.46213,"y":687.9839,"w":48,"h":25},"metadata":[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES ADP-ribosylarginine"],["bp:term","ADP-ribosylarginine"]]],["bp:comment","MOD_RES 174 174 ADP-ribosylarginine; by cholera toxin."],["bp:featureLocation",[["bp:sequencePosition","174"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P11488"]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P11488"]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P11488"]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]}},{"data":{"id":"SmallMolecule_649df39bf717e2d236e0bfbb23a7e9f4","class":"simple chemical","label":"Lecithin","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":632.73584,"y":451.3177,"w":48,"h":20},"metadata":[["bp:displayName","Lecithin"],["bp:entityReference_#SmallMoleculeReference_bb45d6d43d922df3ec0c991ad1e9c8de",[]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29767"],["bp:dataSource",[["bp:standardName","NCI Pathway Interaction Database: Pathway"],["bp:displayName","pid"],["bp:comment","Source type: BIOPAX, NCI Curated Human Pathways from PID (final); 27-Jul-2015"]]]]}},{"data":{"id":"ComplexAssembly_a4e1b5ff2b43ed93bd65a3d3a9da6353_LEFT_TO_RIGHT","class":"process","label":"","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":213.58823,"y":387.70358,"w":15,"h":15},"metadata":[["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1/GTP"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29653"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29653"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29661"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1/GTP"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29653"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29653"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29661"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1/GTP"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29653"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29653"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29661"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1/GTP"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29653"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29653"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29661"],["bp:stoichiometricCoefficient","1.0"]]],["bp:right",[["bp:physicalEntity",[["bp:displayName","GNAT1/GTP"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29653"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29653"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29661"],["bp:stoichiometricCoefficient","1.0"]]],["bp:right",[["bp:physicalEntity",[["bp:displayName","GNAT1/GTP"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29653"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29653"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29661"],["bp:stoichiometricCoefficient","1.0"]]],["bp:right",[["bp:physicalEntity",[["bp:displayName","GNAT1/GTP"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:component",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:feature",[["bp:physicalEntity",[["bp:displayName","GNAT1"],["bp:feature",[["bp:modificationType",[["bp:term","residue modification, active"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29655"]]],["bp:entityReference_http://identifiers.org/uniprot/P11488",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphotyrosine"],["bp:term","MOD_RES Phosphotyrosine"]]],["bp:comment","MOD_RES 142 142 Phosphotyrosine; by SRC."],["bp:featureLocation",[["bp:sequencePosition","142"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:xref","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:organism","Guanine nucleotide-binding protein G(t) subunit alpha-1"],["bp:displayName","GNAT1_HUMAN"],["bp:name","GNAT1"],["bp:name","GNATR"],["bp:name","Transducin alpha-1 chain"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_08850_identity"],["bp:comment","GNAT1_HUMAN Reviewed; 350 AA."],["bp:comment","FUNCTION: Guanine nucleotide-binding proteins (G proteins) areinvolved as modulators or transducers in various transmembranesignaling systems. Transducin is an amplifier and one of thetransducers of a visual impulse that performs the coupling betweenrhodopsin and cGMP-phosphodiesterase.SUBUNIT: G proteins are composed of 3 units; alpha, beta andgamma. The alpha chain contains the guanine nucleotide bindingsite. Interacts (when myristoylated) with UNC119; interaction isrequired for localization in sensory neurons.{ECO:0000269|PubMed:21642972}.TISSUE SPECIFICITY: Rod. Predominantly expressed in the retinafollowed by the ciliary body, iris and retinal pigment epithelium.{ECO:0000269|PubMed:22190596}.DEVELOPMENTAL STAGE: Expressed at approximately postnatal day 7.{ECO:0000269|PubMed:22190596}.DISEASE: Night blindness, congenital stationary, autosomaldominant 3 (CSNBAD3) [MIM:610444]: A non-progressive retinaldisorder characterized by impaired night vision, often associatedwith nystagmus and myopia. {ECO:0000269|PubMed:17584859,ECO:0000269|PubMed:8673138}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Night blindness, congenital stationary, 1G (CSNB1G)[MIM:616389]: An autosomal recessive form of congenital stationarynight blindness, a non-progressive retinal disorder characterizedby impaired night vision or in dim light, with good vision only onbright days. {ECO:0000269|PubMed:22190596}. Note=The disease iscaused by mutations affecting the gene represented in this entry.SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.{ECO:0000305}.WEB RESOURCE: Name=Mutations of the GNAT1 gene; Note=RetinaInternational's Scientific Newsletter;URL=\"http://www.retina-international.org/files/sci-news/gntmut.htm\"; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2779"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2779"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29654"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29656"],["bp:stoichiometricCoefficient","1.0"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29653"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29653"]]],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29661"],["bp:stoichiometricCoefficient","1.0"]]],["bp:spontaneous","true"],["bp:left","true"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_29644"],["bp:dataSource","REPLACED http://pid.nci.nih.gov/biopax#pid_29644"]]}}],"edges":[{"data":{"id":"ComplexAssembly_1a5f5156b2fa0b7d4490803d5803210d_LEFT_TO_RIGHT-output--to--Complex_5884d043b0305ba6dc7cc2dda0e90bba","class":"production","cardinality":0,"source":"ComplexAssembly_1a5f5156b2fa0b7d4490803d5803210d_LEFT_TO_RIGHT","target":"Complex_5884d043b0305ba6dc7cc2dda0e90bba","bendPointPositions":[],"portSource":"OutputPort_ComplexAssembly_1a5f5156b2fa0b7d4490803d5803210d_LEFT_TO_RIGHT","portTarget":"Complex_5884d043b0305ba6dc7cc2dda0e90bba"}},{"data":{"id":"ComplexAssembly_ffc0fd905747da36e9042f7bced9650a_LEFT_TO_RIGHT-output--to--Protein_5e6544b9ca2610522930422e887fd7f1","class":"production","cardinality":0,"source":"ComplexAssembly_ffc0fd905747da36e9042f7bced9650a_LEFT_TO_RIGHT","target":"Protein_5e6544b9ca2610522930422e887fd7f1","bendPointPositions":[],"portSource":"OutputPort_ComplexAssembly_ffc0fd905747da36e9042f7bced9650a_LEFT_TO_RIGHT","portTarget":"Protein_5e6544b9ca2610522930422e887fd7f1"}},{"data":{"id":"BiochemicalReaction_0d9463421db68fb6b6ec59faeba18c48_LEFT_TO_RIGHT-output--to--SmallMolecule_7414b0b55879a305bd7ba983351edd98","class":"production","cardinality":0,"source":"BiochemicalReaction_0d9463421db68fb6b6ec59faeba18c48_LEFT_TO_RIGHT","target":"SmallMolecule_7414b0b55879a305bd7ba983351edd98","bendPointPositions":[],"portSource":"OutputPort_BiochemicalReaction_0d9463421db68fb6b6ec59faeba18c48_LEFT_TO_RIGHT","portTarget":"SmallMolecule_7414b0b55879a305bd7ba983351edd98"}},{"data":{"id":"Complex_0474d84a6ffcbc5067d637d13cb69efa--to--BiochemicalReaction_033023272a65b72d1b378b0e31385d69_LEFT_TO_RIGHT","class":"catalysis","cardinality":0,"source":"Complex_0474d84a6ffcbc5067d637d13cb69efa","target":"BiochemicalReaction_033023272a65b72d1b378b0e31385d69_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Complex_0474d84a6ffcbc5067d637d13cb69efa","portTarget":"BiochemicalReaction_033023272a65b72d1b378b0e31385d69_LEFT_TO_RIGHT"}},{"data":{"id":"ComplexAssembly_e25341187875d5db0c67decbbd98c874_LEFT_TO_RIGHT-output--to--Complex_681c549d7df39ee36faec933344df711","class":"production","cardinality":2,"source":"ComplexAssembly_e25341187875d5db0c67decbbd98c874_LEFT_TO_RIGHT","target":"Complex_681c549d7df39ee36faec933344df711","bendPointPositions":[],"portSource":"OutputPort_ComplexAssembly_e25341187875d5db0c67decbbd98c874_LEFT_TO_RIGHT","portTarget":"Complex_681c549d7df39ee36faec933344df711"}},{"data":{"id":"Transport_607b1da044a923e5881717ffa2bf5e3f_LEFT_TO_RIGHT-output--to--SmallMolecule_0caf25f6eb33df1ed0f36474e15b1ef1","class":"production","cardinality":0,"source":"Transport_607b1da044a923e5881717ffa2bf5e3f_LEFT_TO_RIGHT","target":"SmallMolecule_0caf25f6eb33df1ed0f36474e15b1ef1","bendPointPositions":[],"portSource":"OutputPort_Transport_607b1da044a923e5881717ffa2bf5e3f_LEFT_TO_RIGHT","portTarget":"SmallMolecule_0caf25f6eb33df1ed0f36474e15b1ef1"}},{"data":{"id":"Transport_7492807daea2b2ce89e699ac17445326_LEFT_TO_RIGHT-output--to--SmallMolecule_6c83cd8ccb4d9cb825f76253908306fa","class":"production","cardinality":0,"source":"Transport_7492807daea2b2ce89e699ac17445326_LEFT_TO_RIGHT","target":"SmallMolecule_6c83cd8ccb4d9cb825f76253908306fa","bendPointPositions":[],"portSource":"OutputPort_Transport_7492807daea2b2ce89e699ac17445326_LEFT_TO_RIGHT","portTarget":"SmallMolecule_6c83cd8ccb4d9cb825f76253908306fa"}},{"data":{"id":"Protein_f67dbfea94353a8979ca197d59be5795--to--ComplexAssembly_1a5f5156b2fa0b7d4490803d5803210d_LEFT_TO_RIGHT-input","class":"consumption","cardinality":0,"source":"Protein_f67dbfea94353a8979ca197d59be5795","target":"ComplexAssembly_1a5f5156b2fa0b7d4490803d5803210d_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Protein_f67dbfea94353a8979ca197d59be5795","portTarget":"InputPort_ComplexAssembly_1a5f5156b2fa0b7d4490803d5803210d_LEFT_TO_RIGHT"}},{"data":{"id":"Complex_7fba29591c0d3e0267091aedc2769edc--to--ComplexAssembly_d58b2e2cc5a8a1777140105132b2a01e_LEFT_TO_RIGHT-input","class":"consumption","cardinality":0,"source":"Complex_7fba29591c0d3e0267091aedc2769edc","target":"ComplexAssembly_d58b2e2cc5a8a1777140105132b2a01e_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Complex_7fba29591c0d3e0267091aedc2769edc","portTarget":"InputPort_ComplexAssembly_d58b2e2cc5a8a1777140105132b2a01e_LEFT_TO_RIGHT"}},{"data":{"id":"Complex_839bbfb17f833b9521c6a6ea96aa610a--to--BiochemicalReaction_003a892501df9e94fa8f085fc17cdc2d_LEFT_TO_RIGHT-input","class":"consumption","cardinality":0,"source":"Complex_839bbfb17f833b9521c6a6ea96aa610a","target":"BiochemicalReaction_003a892501df9e94fa8f085fc17cdc2d_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Complex_839bbfb17f833b9521c6a6ea96aa610a","portTarget":"InputPort_BiochemicalReaction_003a892501df9e94fa8f085fc17cdc2d_LEFT_TO_RIGHT"}},{"data":{"id":"SmallMolecule_3be66134bf02bbe333791a9380f11481--to--BiochemicalReaction_39a2cf1134121f166f1af8fc476d59b6_LEFT_TO_RIGHT-input","class":"consumption","cardinality":0,"source":"SmallMolecule_3be66134bf02bbe333791a9380f11481","target":"BiochemicalReaction_39a2cf1134121f166f1af8fc476d59b6_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"SmallMolecule_3be66134bf02bbe333791a9380f11481","portTarget":"InputPort_BiochemicalReaction_39a2cf1134121f166f1af8fc476d59b6_LEFT_TO_RIGHT"}},{"data":{"id":"ComplexAssembly_2b3b817d306cb30db5b3e6f7ef58e9dc_LEFT_TO_RIGHT-output--to--SmallMolecule_e630bbcee8096e9e453f64506e7b8b7f","class":"production","cardinality":0,"source":"ComplexAssembly_2b3b817d306cb30db5b3e6f7ef58e9dc_LEFT_TO_RIGHT","target":"SmallMolecule_e630bbcee8096e9e453f64506e7b8b7f","bendPointPositions":[],"portSource":"OutputPort_ComplexAssembly_2b3b817d306cb30db5b3e6f7ef58e9dc_LEFT_TO_RIGHT","portTarget":"SmallMolecule_e630bbcee8096e9e453f64506e7b8b7f"}},{"data":{"id":"SmallMolecule_4f4ea8c9f46fdd97ff867fe7c8860bda_BiochemicalReaction_ebe2587eee20076625365bcbf196a091_LEFT_TO_RIGHT--to--BiochemicalReaction_ebe2587eee20076625365bcbf196a091_LEFT_TO_RIGHT-input","class":"consumption","cardinality":0,"source":"SmallMolecule_4f4ea8c9f46fdd97ff867fe7c8860bda_BiochemicalReaction_ebe2587eee20076625365bcbf196a091_LEFT_TO_RIGHT","target":"BiochemicalReaction_ebe2587eee20076625365bcbf196a091_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"SmallMolecule_4f4ea8c9f46fdd97ff867fe7c8860bda_BiochemicalReaction_ebe2587eee20076625365bcbf196a091_LEFT_TO_RIGHT","portTarget":"InputPort_BiochemicalReaction_ebe2587eee20076625365bcbf196a091_LEFT_TO_RIGHT"}},{"data":{"id":"Complex_6a0c3a0c50969ce329823fd32890fa61--to--ComplexAssembly_e25341187875d5db0c67decbbd98c874_LEFT_TO_RIGHT-input","class":"consumption","cardinality":0,"source":"Complex_6a0c3a0c50969ce329823fd32890fa61","target":"ComplexAssembly_e25341187875d5db0c67decbbd98c874_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Complex_6a0c3a0c50969ce329823fd32890fa61","portTarget":"InputPort_ComplexAssembly_e25341187875d5db0c67decbbd98c874_LEFT_TO_RIGHT"}},{"data":{"id":"ComplexAssembly_a4e1b5ff2b43ed93bd65a3d3a9da6353_LEFT_TO_RIGHT-output--to--Complex_c4e02fccdf29968aa1e9e599de8ca892","class":"production","cardinality":0,"source":"ComplexAssembly_a4e1b5ff2b43ed93bd65a3d3a9da6353_LEFT_TO_RIGHT","target":"Complex_c4e02fccdf29968aa1e9e599de8ca892","bendPointPositions":[],"portSource":"OutputPort_ComplexAssembly_a4e1b5ff2b43ed93bd65a3d3a9da6353_LEFT_TO_RIGHT","portTarget":"Complex_c4e02fccdf29968aa1e9e599de8ca892"}},{"data":{"id":"BiochemicalReaction_033023272a65b72d1b378b0e31385d69_LEFT_TO_RIGHT-output--to--SmallMolecule_5edfcfcaa4b53c1c3e305c425b8b94ca","class":"production","cardinality":0,"source":"BiochemicalReaction_033023272a65b72d1b378b0e31385d69_LEFT_TO_RIGHT","target":"SmallMolecule_5edfcfcaa4b53c1c3e305c425b8b94ca","bendPointPositions":[],"portSource":"OutputPort_BiochemicalReaction_033023272a65b72d1b378b0e31385d69_LEFT_TO_RIGHT","portTarget":"SmallMolecule_5edfcfcaa4b53c1c3e305c425b8b94ca"}},{"data":{"id":"BiochemicalReaction_51f2b95182998dbe0cbfc10905f3feca_LEFT_TO_RIGHT-output--to--Complex_06656978d62db153fd8034cbecaae575","class":"production","cardinality":0,"source":"BiochemicalReaction_51f2b95182998dbe0cbfc10905f3feca_LEFT_TO_RIGHT","target":"Complex_06656978d62db153fd8034cbecaae575","bendPointPositions":[],"portSource":"OutputPort_BiochemicalReaction_51f2b95182998dbe0cbfc10905f3feca_LEFT_TO_RIGHT","portTarget":"Complex_06656978d62db153fd8034cbecaae575"}},{"data":{"id":"ComplexAssembly_2b3b817d306cb30db5b3e6f7ef58e9dc_LEFT_TO_RIGHT-output--to--Protein_f67dbfea94353a8979ca197d59be5795","class":"production","cardinality":0,"source":"ComplexAssembly_2b3b817d306cb30db5b3e6f7ef58e9dc_LEFT_TO_RIGHT","target":"Protein_f67dbfea94353a8979ca197d59be5795","bendPointPositions":[],"portSource":"OutputPort_ComplexAssembly_2b3b817d306cb30db5b3e6f7ef58e9dc_LEFT_TO_RIGHT","portTarget":"Protein_f67dbfea94353a8979ca197d59be5795"}},{"data":{"id":"ComplexAssembly_3bc924c5cd39f7ee06d898b63d989d08_LEFT_TO_RIGHT-output--to--Protein_5e6544b9ca2610522930422e887fd7f1","class":"production","cardinality":0,"source":"ComplexAssembly_3bc924c5cd39f7ee06d898b63d989d08_LEFT_TO_RIGHT","target":"Protein_5e6544b9ca2610522930422e887fd7f1","bendPointPositions":[],"portSource":"OutputPort_ComplexAssembly_3bc924c5cd39f7ee06d898b63d989d08_LEFT_TO_RIGHT","portTarget":"Protein_5e6544b9ca2610522930422e887fd7f1"}},{"data":{"id":"ComplexAssembly_e25341187875d5db0c67decbbd98c874_LEFT_TO_RIGHT-output--to--Complex_7ffe09f1835e4d2f8483e067d5f712ff","class":"production","cardinality":0,"source":"ComplexAssembly_e25341187875d5db0c67decbbd98c874_LEFT_TO_RIGHT","target":"Complex_7ffe09f1835e4d2f8483e067d5f712ff","bendPointPositions":[],"portSource":"OutputPort_ComplexAssembly_e25341187875d5db0c67decbbd98c874_LEFT_TO_RIGHT","portTarget":"Complex_7ffe09f1835e4d2f8483e067d5f712ff"}},{"data":{"id":"SmallMolecule_6658a8720996f04f3b8cd03be7a2ec3e--to--Transport_7492807daea2b2ce89e699ac17445326_LEFT_TO_RIGHT-input","class":"consumption","cardinality":0,"source":"SmallMolecule_6658a8720996f04f3b8cd03be7a2ec3e","target":"Transport_7492807daea2b2ce89e699ac17445326_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"SmallMolecule_6658a8720996f04f3b8cd03be7a2ec3e","portTarget":"InputPort_Transport_7492807daea2b2ce89e699ac17445326_LEFT_TO_RIGHT"}},{"data":{"id":"Complex_1edcbd716fcdb6653d759a6e49903878--to--ComplexAssembly_3bc924c5cd39f7ee06d898b63d989d08_LEFT_TO_RIGHT-input","class":"consumption","cardinality":0,"source":"Complex_1edcbd716fcdb6653d759a6e49903878","target":"ComplexAssembly_3bc924c5cd39f7ee06d898b63d989d08_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Complex_1edcbd716fcdb6653d759a6e49903878","portTarget":"InputPort_ComplexAssembly_3bc924c5cd39f7ee06d898b63d989d08_LEFT_TO_RIGHT"}},{"data":{"id":"Complex_273e090a34386a1ba38ce7060ea62c91--to--Transport_7492807daea2b2ce89e699ac17445326_LEFT_TO_RIGHT","class":"catalysis","cardinality":0,"source":"Complex_273e090a34386a1ba38ce7060ea62c91","target":"Transport_7492807daea2b2ce89e699ac17445326_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Complex_273e090a34386a1ba38ce7060ea62c91","portTarget":"Transport_7492807daea2b2ce89e699ac17445326_LEFT_TO_RIGHT"}},{"data":{"id":"BiochemicalReaction_39a2cf1134121f166f1af8fc476d59b6_LEFT_TO_RIGHT-output--to--SmallMolecule_cf976f077ef4202f9148a7f67399a6c9","class":"production","cardinality":0,"source":"BiochemicalReaction_39a2cf1134121f166f1af8fc476d59b6_LEFT_TO_RIGHT","target":"SmallMolecule_cf976f077ef4202f9148a7f67399a6c9","bendPointPositions":[],"portSource":"OutputPort_BiochemicalReaction_39a2cf1134121f166f1af8fc476d59b6_LEFT_TO_RIGHT","portTarget":"SmallMolecule_cf976f077ef4202f9148a7f67399a6c9"}},{"data":{"id":"Transport_fbd1a94ea3d89a1f5eee593d21370775_LEFT_TO_RIGHT-output--to--Complex_e3341bc18ae87f348a3784bb57f7d7ec","class":"production","cardinality":0,"source":"Transport_fbd1a94ea3d89a1f5eee593d21370775_LEFT_TO_RIGHT","target":"Complex_e3341bc18ae87f348a3784bb57f7d7ec","bendPointPositions":[],"portSource":"OutputPort_Transport_fbd1a94ea3d89a1f5eee593d21370775_LEFT_TO_RIGHT","portTarget":"Complex_e3341bc18ae87f348a3784bb57f7d7ec"}},{"data":{"id":"Transport_607b1da044a923e5881717ffa2bf5e3f_LEFT_TO_RIGHT-output--to--SmallMolecule_3e76e616ad0dd87d938b5196e8753edf","class":"production","cardinality":0,"source":"Transport_607b1da044a923e5881717ffa2bf5e3f_LEFT_TO_RIGHT","target":"SmallMolecule_3e76e616ad0dd87d938b5196e8753edf","bendPointPositions":[],"portSource":"OutputPort_Transport_607b1da044a923e5881717ffa2bf5e3f_LEFT_TO_RIGHT","portTarget":"SmallMolecule_3e76e616ad0dd87d938b5196e8753edf"}},{"data":{"id":"ComplexAssembly_ffc0fd905747da36e9042f7bced9650a_LEFT_TO_RIGHT-output--to--SmallMolecule_3be66134bf02bbe333791a9380f11481","class":"production","cardinality":0,"source":"ComplexAssembly_ffc0fd905747da36e9042f7bced9650a_LEFT_TO_RIGHT","target":"SmallMolecule_3be66134bf02bbe333791a9380f11481","bendPointPositions":[],"portSource":"OutputPort_ComplexAssembly_ffc0fd905747da36e9042f7bced9650a_LEFT_TO_RIGHT","portTarget":"SmallMolecule_3be66134bf02bbe333791a9380f11481"}},{"data":{"id":"SmallMolecule_cf976f077ef4202f9148a7f67399a6c9--to--BiochemicalReaction_3c445c3f24014e21fe546aa259e68e5c_LEFT_TO_RIGHT-input","class":"consumption","cardinality":0,"source":"SmallMolecule_cf976f077ef4202f9148a7f67399a6c9","target":"BiochemicalReaction_3c445c3f24014e21fe546aa259e68e5c_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"SmallMolecule_cf976f077ef4202f9148a7f67399a6c9","portTarget":"InputPort_BiochemicalReaction_3c445c3f24014e21fe546aa259e68e5c_LEFT_TO_RIGHT"}},{"data":{"id":"Complex_bfe4c390a209f35f4c9f85fc26a08004--to--ComplexAssembly_ffc0fd905747da36e9042f7bced9650a_LEFT_TO_RIGHT-input","class":"consumption","cardinality":0,"source":"Complex_bfe4c390a209f35f4c9f85fc26a08004","target":"ComplexAssembly_ffc0fd905747da36e9042f7bced9650a_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Complex_bfe4c390a209f35f4c9f85fc26a08004","portTarget":"InputPort_ComplexAssembly_ffc0fd905747da36e9042f7bced9650a_LEFT_TO_RIGHT"}},{"data":{"id":"Complex_681c549d7df39ee36faec933344df711--to--ComplexAssembly_d58b2e2cc5a8a1777140105132b2a01e_LEFT_TO_RIGHT-input","class":"consumption","cardinality":0,"source":"Complex_681c549d7df39ee36faec933344df711","target":"ComplexAssembly_d58b2e2cc5a8a1777140105132b2a01e_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Complex_681c549d7df39ee36faec933344df711","portTarget":"InputPort_ComplexAssembly_d58b2e2cc5a8a1777140105132b2a01e_LEFT_TO_RIGHT"}},{"data":{"id":"Complex_6a0c3a0c50969ce329823fd32890fa61--to--BiochemicalReaction_033023272a65b72d1b378b0e31385d69_LEFT_TO_RIGHT","class":"catalysis","cardinality":0,"source":"Complex_6a0c3a0c50969ce329823fd32890fa61","target":"BiochemicalReaction_033023272a65b72d1b378b0e31385d69_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Complex_6a0c3a0c50969ce329823fd32890fa61","portTarget":"BiochemicalReaction_033023272a65b72d1b378b0e31385d69_LEFT_TO_RIGHT"}},{"data":{"id":"Protein_42540b2c5224aad9e9d215624eb93672--to--BiochemicalReaction_3c445c3f24014e21fe546aa259e68e5c_LEFT_TO_RIGHT","class":"catalysis","cardinality":0,"source":"Protein_42540b2c5224aad9e9d215624eb93672","target":"BiochemicalReaction_3c445c3f24014e21fe546aa259e68e5c_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Protein_42540b2c5224aad9e9d215624eb93672","portTarget":"BiochemicalReaction_3c445c3f24014e21fe546aa259e68e5c_LEFT_TO_RIGHT"}},{"data":{"id":"Protein_4ff4878e3bfef76a8eb2e70eb877ae31--to--BiochemicalReaction_51f2b95182998dbe0cbfc10905f3feca_LEFT_TO_RIGHT","class":"catalysis","cardinality":0,"source":"Protein_4ff4878e3bfef76a8eb2e70eb877ae31","target":"BiochemicalReaction_51f2b95182998dbe0cbfc10905f3feca_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Protein_4ff4878e3bfef76a8eb2e70eb877ae31","portTarget":"BiochemicalReaction_51f2b95182998dbe0cbfc10905f3feca_LEFT_TO_RIGHT"}},{"data":{"id":"ComplexAssembly_6593325a4d9e7048801c4f61cb410015_LEFT_TO_RIGHT-output--to--Complex_6f5987bf8a98e642454a66b4fc7108b4","class":"production","cardinality":0,"source":"ComplexAssembly_6593325a4d9e7048801c4f61cb410015_LEFT_TO_RIGHT","target":"Complex_6f5987bf8a98e642454a66b4fc7108b4","bendPointPositions":[],"portSource":"OutputPort_ComplexAssembly_6593325a4d9e7048801c4f61cb410015_LEFT_TO_RIGHT","portTarget":"Complex_6f5987bf8a98e642454a66b4fc7108b4"}},{"data":{"id":"SmallMolecule_bccee74407d2f7a76e0e86b318622e2b_BiochemicalReaction_51f2b95182998dbe0cbfc10905f3feca_LEFT_TO_RIGHT--to--BiochemicalReaction_51f2b95182998dbe0cbfc10905f3feca_LEFT_TO_RIGHT-input","class":"consumption","cardinality":0,"source":"SmallMolecule_bccee74407d2f7a76e0e86b318622e2b_BiochemicalReaction_51f2b95182998dbe0cbfc10905f3feca_LEFT_TO_RIGHT","target":"BiochemicalReaction_51f2b95182998dbe0cbfc10905f3feca_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"SmallMolecule_bccee74407d2f7a76e0e86b318622e2b_BiochemicalReaction_51f2b95182998dbe0cbfc10905f3feca_LEFT_TO_RIGHT","portTarget":"InputPort_BiochemicalReaction_51f2b95182998dbe0cbfc10905f3feca_LEFT_TO_RIGHT"}},{"data":{"id":"Complex_a8839e630eb701d733e0eb95a4de7522--to--BiochemicalReaction_ebe2587eee20076625365bcbf196a091_LEFT_TO_RIGHT","class":"catalysis","cardinality":0,"source":"Complex_a8839e630eb701d733e0eb95a4de7522","target":"BiochemicalReaction_ebe2587eee20076625365bcbf196a091_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Complex_a8839e630eb701d733e0eb95a4de7522","portTarget":"BiochemicalReaction_ebe2587eee20076625365bcbf196a091_LEFT_TO_RIGHT"}},{"data":{"id":"Protein_0014fe7e9fa90edadb4857f80a0eb091--to--ComplexAssembly_3bc924c5cd39f7ee06d898b63d989d08_LEFT_TO_RIGHT","class":"catalysis","cardinality":0,"source":"Protein_0014fe7e9fa90edadb4857f80a0eb091","target":"ComplexAssembly_3bc924c5cd39f7ee06d898b63d989d08_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Protein_0014fe7e9fa90edadb4857f80a0eb091","portTarget":"ComplexAssembly_3bc924c5cd39f7ee06d898b63d989d08_LEFT_TO_RIGHT"}},{"data":{"id":"Complex_bfe4c390a209f35f4c9f85fc26a08004--to--ComplexAssembly_6593325a4d9e7048801c4f61cb410015_LEFT_TO_RIGHT-input","class":"consumption","cardinality":0,"source":"Complex_bfe4c390a209f35f4c9f85fc26a08004","target":"ComplexAssembly_6593325a4d9e7048801c4f61cb410015_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Complex_bfe4c390a209f35f4c9f85fc26a08004","portTarget":"InputPort_ComplexAssembly_6593325a4d9e7048801c4f61cb410015_LEFT_TO_RIGHT"}},{"data":{"id":"Protein_bb03ec1e2744ad7c66fc37d4ec02ee5f--to--BiochemicalReaction_3122526332e38d855b69ebef2bc40068_LEFT_TO_RIGHT","class":"catalysis","cardinality":0,"source":"Protein_bb03ec1e2744ad7c66fc37d4ec02ee5f","target":"BiochemicalReaction_3122526332e38d855b69ebef2bc40068_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Protein_bb03ec1e2744ad7c66fc37d4ec02ee5f","portTarget":"BiochemicalReaction_3122526332e38d855b69ebef2bc40068_LEFT_TO_RIGHT"}},{"data":{"id":"BiochemicalReaction_3c445c3f24014e21fe546aa259e68e5c_LEFT_TO_RIGHT-output--to--SmallMolecule_dd131cecec0400bece272a2060bd2b05","class":"production","cardinality":0,"source":"BiochemicalReaction_3c445c3f24014e21fe546aa259e68e5c_LEFT_TO_RIGHT","target":"SmallMolecule_dd131cecec0400bece272a2060bd2b05","bendPointPositions":[],"portSource":"OutputPort_BiochemicalReaction_3c445c3f24014e21fe546aa259e68e5c_LEFT_TO_RIGHT","portTarget":"SmallMolecule_dd131cecec0400bece272a2060bd2b05"}},{"data":{"id":"Protein_3e7d00184038f5fbc042e46fe22f53ec--to--ComplexAssembly_8cdd666c217309a6e1c376231760e8ed_LEFT_TO_RIGHT-input","class":"consumption","cardinality":0,"source":"Protein_3e7d00184038f5fbc042e46fe22f53ec","target":"ComplexAssembly_8cdd666c217309a6e1c376231760e8ed_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Protein_3e7d00184038f5fbc042e46fe22f53ec","portTarget":"InputPort_ComplexAssembly_8cdd666c217309a6e1c376231760e8ed_LEFT_TO_RIGHT"}},{"data":{"id":"Protein_db5d1a64ad1654f31ca849da8e9b326d--to--Transport_607b1da044a923e5881717ffa2bf5e3f_LEFT_TO_RIGHT","class":"catalysis","cardinality":0,"source":"Protein_db5d1a64ad1654f31ca849da8e9b326d","target":"Transport_607b1da044a923e5881717ffa2bf5e3f_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Protein_db5d1a64ad1654f31ca849da8e9b326d","portTarget":"Transport_607b1da044a923e5881717ffa2bf5e3f_LEFT_TO_RIGHT"}},{"data":{"id":"ComplexAssembly_3bc924c5cd39f7ee06d898b63d989d08_LEFT_TO_RIGHT-output--to--Protein_2357f4b5860837413497201285410149","class":"production","cardinality":0,"source":"ComplexAssembly_3bc924c5cd39f7ee06d898b63d989d08_LEFT_TO_RIGHT","target":"Protein_2357f4b5860837413497201285410149","bendPointPositions":[],"portSource":"OutputPort_ComplexAssembly_3bc924c5cd39f7ee06d898b63d989d08_LEFT_TO_RIGHT","portTarget":"Protein_2357f4b5860837413497201285410149"}},{"data":{"id":"Transport_70c6d41ad671622a441a872527127014_LEFT_TO_RIGHT-output--to--SmallMolecule_e630bbcee8096e9e453f64506e7b8b7f","class":"production","cardinality":0,"source":"Transport_70c6d41ad671622a441a872527127014_LEFT_TO_RIGHT","target":"SmallMolecule_e630bbcee8096e9e453f64506e7b8b7f","bendPointPositions":[],"portSource":"OutputPort_Transport_70c6d41ad671622a441a872527127014_LEFT_TO_RIGHT","portTarget":"SmallMolecule_e630bbcee8096e9e453f64506e7b8b7f"}},{"data":{"id":"Complex_38e35536ddcf52e8d0df5477aa66734b--to--BiochemicalReaction_ebe2587eee20076625365bcbf196a091_LEFT_TO_RIGHT","class":"catalysis","cardinality":0,"source":"Complex_38e35536ddcf52e8d0df5477aa66734b","target":"BiochemicalReaction_ebe2587eee20076625365bcbf196a091_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Complex_38e35536ddcf52e8d0df5477aa66734b","portTarget":"BiochemicalReaction_ebe2587eee20076625365bcbf196a091_LEFT_TO_RIGHT"}},{"data":{"id":"Protein_85331f89b392effc75c17fa2a1817c39--to--ComplexAssembly_1a5f5156b2fa0b7d4490803d5803210d_LEFT_TO_RIGHT-input","class":"consumption","cardinality":0,"source":"Protein_85331f89b392effc75c17fa2a1817c39","target":"ComplexAssembly_1a5f5156b2fa0b7d4490803d5803210d_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Protein_85331f89b392effc75c17fa2a1817c39","portTarget":"InputPort_ComplexAssembly_1a5f5156b2fa0b7d4490803d5803210d_LEFT_TO_RIGHT"}},{"data":{"id":"Complex_c11edd9737faa91eb365922aa30c5be4--to--ComplexAssembly_6593325a4d9e7048801c4f61cb410015_LEFT_TO_RIGHT-input","class":"consumption","cardinality":0,"source":"Complex_c11edd9737faa91eb365922aa30c5be4","target":"ComplexAssembly_6593325a4d9e7048801c4f61cb410015_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Complex_c11edd9737faa91eb365922aa30c5be4","portTarget":"InputPort_ComplexAssembly_6593325a4d9e7048801c4f61cb410015_LEFT_TO_RIGHT"}},{"data":{"id":"SmallMolecule_e630bbcee8096e9e453f64506e7b8b7f--to--Transport_607b1da044a923e5881717ffa2bf5e3f_LEFT_TO_RIGHT-input","class":"consumption","cardinality":0,"source":"SmallMolecule_e630bbcee8096e9e453f64506e7b8b7f","target":"Transport_607b1da044a923e5881717ffa2bf5e3f_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"SmallMolecule_e630bbcee8096e9e453f64506e7b8b7f","portTarget":"InputPort_Transport_607b1da044a923e5881717ffa2bf5e3f_LEFT_TO_RIGHT"}},{"data":{"id":"Complex_0474d84a6ffcbc5067d637d13cb69efa--to--ComplexAssembly_e25341187875d5db0c67decbbd98c874_LEFT_TO_RIGHT-input","class":"consumption","cardinality":0,"source":"Complex_0474d84a6ffcbc5067d637d13cb69efa","target":"ComplexAssembly_e25341187875d5db0c67decbbd98c874_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Complex_0474d84a6ffcbc5067d637d13cb69efa","portTarget":"InputPort_ComplexAssembly_e25341187875d5db0c67decbbd98c874_LEFT_TO_RIGHT"}},{"data":{"id":"SmallMolecule_0c81f39e6cd6aea223184468ac17f368--to--Transport_607b1da044a923e5881717ffa2bf5e3f_LEFT_TO_RIGHT-input","class":"consumption","cardinality":0,"source":"SmallMolecule_0c81f39e6cd6aea223184468ac17f368","target":"Transport_607b1da044a923e5881717ffa2bf5e3f_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"SmallMolecule_0c81f39e6cd6aea223184468ac17f368","portTarget":"InputPort_Transport_607b1da044a923e5881717ffa2bf5e3f_LEFT_TO_RIGHT"}},{"data":{"id":"Complex_df144db5664a3420707d4ed04b7742e9--to--Transport_fbd1a94ea3d89a1f5eee593d21370775_LEFT_TO_RIGHT-input","class":"consumption","cardinality":0,"source":"Complex_df144db5664a3420707d4ed04b7742e9","target":"Transport_fbd1a94ea3d89a1f5eee593d21370775_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Complex_df144db5664a3420707d4ed04b7742e9","portTarget":"InputPort_Transport_fbd1a94ea3d89a1f5eee593d21370775_LEFT_TO_RIGHT"}},{"data":{"id":"Complex_8427e7fa54571a2521093660159fa15a--to--ComplexAssembly_e25341187875d5db0c67decbbd98c874_LEFT_TO_RIGHT","class":"catalysis","cardinality":0,"source":"Complex_8427e7fa54571a2521093660159fa15a","target":"ComplexAssembly_e25341187875d5db0c67decbbd98c874_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Complex_8427e7fa54571a2521093660159fa15a","portTarget":"ComplexAssembly_e25341187875d5db0c67decbbd98c874_LEFT_TO_RIGHT"}},{"data":{"id":"SmallMolecule_dd131cecec0400bece272a2060bd2b05--to--BiochemicalReaction_3122526332e38d855b69ebef2bc40068_LEFT_TO_RIGHT-input","class":"consumption","cardinality":0,"source":"SmallMolecule_dd131cecec0400bece272a2060bd2b05","target":"BiochemicalReaction_3122526332e38d855b69ebef2bc40068_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"SmallMolecule_dd131cecec0400bece272a2060bd2b05","portTarget":"InputPort_BiochemicalReaction_3122526332e38d855b69ebef2bc40068_LEFT_TO_RIGHT"}},{"data":{"id":"BiochemicalReaction_51f2b95182998dbe0cbfc10905f3feca_LEFT_TO_RIGHT-output--to--SmallMolecule_ad47b0bd5d53b98f714d186fd4ade87a_BiochemicalReaction_51f2b95182998dbe0cbfc10905f3feca_LEFT_TO_RIGHT","class":"production","cardinality":0,"source":"BiochemicalReaction_51f2b95182998dbe0cbfc10905f3feca_LEFT_TO_RIGHT","target":"SmallMolecule_ad47b0bd5d53b98f714d186fd4ade87a_BiochemicalReaction_51f2b95182998dbe0cbfc10905f3feca_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"OutputPort_BiochemicalReaction_51f2b95182998dbe0cbfc10905f3feca_LEFT_TO_RIGHT","portTarget":"SmallMolecule_ad47b0bd5d53b98f714d186fd4ade87a_BiochemicalReaction_51f2b95182998dbe0cbfc10905f3feca_LEFT_TO_RIGHT"}},{"data":{"id":"Complex_273e090a34386a1ba38ce7060ea62c91--to--Transport_70c6d41ad671622a441a872527127014_LEFT_TO_RIGHT","class":"catalysis","cardinality":0,"source":"Complex_273e090a34386a1ba38ce7060ea62c91","target":"Transport_70c6d41ad671622a441a872527127014_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Complex_273e090a34386a1ba38ce7060ea62c91","portTarget":"Transport_70c6d41ad671622a441a872527127014_LEFT_TO_RIGHT"}},{"data":{"id":"Protein_f67dbfea94353a8979ca197d59be5795--to--ComplexAssembly_a49775b5bf5a7b4bc9c3fee882a528e5_LEFT_TO_RIGHT-input","class":"consumption","cardinality":0,"source":"Protein_f67dbfea94353a8979ca197d59be5795","target":"ComplexAssembly_a49775b5bf5a7b4bc9c3fee882a528e5_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Protein_f67dbfea94353a8979ca197d59be5795","portTarget":"InputPort_ComplexAssembly_a49775b5bf5a7b4bc9c3fee882a528e5_LEFT_TO_RIGHT"}},{"data":{"id":"Complex_a1b72fa4f9a00f6ff36e834cef0fc4de--to--ComplexAssembly_d15ded55f902648b3b2f9ad1aebe99d7_LEFT_TO_RIGHT-input","class":"consumption","cardinality":0,"source":"Complex_a1b72fa4f9a00f6ff36e834cef0fc4de","target":"ComplexAssembly_d15ded55f902648b3b2f9ad1aebe99d7_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Complex_a1b72fa4f9a00f6ff36e834cef0fc4de","portTarget":"InputPort_ComplexAssembly_d15ded55f902648b3b2f9ad1aebe99d7_LEFT_TO_RIGHT"}},{"data":{"id":"Complex_2ce3afb19b8a69249e0ba29acea9e2bf--to--ComplexAssembly_2b3b817d306cb30db5b3e6f7ef58e9dc_LEFT_TO_RIGHT-input","class":"consumption","cardinality":0,"source":"Complex_2ce3afb19b8a69249e0ba29acea9e2bf","target":"ComplexAssembly_2b3b817d306cb30db5b3e6f7ef58e9dc_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Complex_2ce3afb19b8a69249e0ba29acea9e2bf","portTarget":"InputPort_ComplexAssembly_2b3b817d306cb30db5b3e6f7ef58e9dc_LEFT_TO_RIGHT"}},{"data":{"id":"SmallMolecule_7414b0b55879a305bd7ba983351edd98--to--ComplexAssembly_8cdd666c217309a6e1c376231760e8ed_LEFT_TO_RIGHT-input","class":"consumption","cardinality":0,"source":"SmallMolecule_7414b0b55879a305bd7ba983351edd98","target":"ComplexAssembly_8cdd666c217309a6e1c376231760e8ed_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"SmallMolecule_7414b0b55879a305bd7ba983351edd98","portTarget":"InputPort_ComplexAssembly_8cdd666c217309a6e1c376231760e8ed_LEFT_TO_RIGHT"}},{"data":{"id":"SmallMolecule_649df39bf717e2d236e0bfbb23a7e9f4--to--BiochemicalReaction_3c445c3f24014e21fe546aa259e68e5c_LEFT_TO_RIGHT-input","class":"consumption","cardinality":0,"source":"SmallMolecule_649df39bf717e2d236e0bfbb23a7e9f4","target":"BiochemicalReaction_3c445c3f24014e21fe546aa259e68e5c_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"SmallMolecule_649df39bf717e2d236e0bfbb23a7e9f4","portTarget":"InputPort_BiochemicalReaction_3c445c3f24014e21fe546aa259e68e5c_LEFT_TO_RIGHT"}},{"data":{"id":"Protein_8efc562e8cef905bbaae9997cd3d4eb4--to--BiochemicalReaction_0d9463421db68fb6b6ec59faeba18c48_LEFT_TO_RIGHT","class":"catalysis","cardinality":0,"source":"Protein_8efc562e8cef905bbaae9997cd3d4eb4","target":"BiochemicalReaction_0d9463421db68fb6b6ec59faeba18c48_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Protein_8efc562e8cef905bbaae9997cd3d4eb4","portTarget":"BiochemicalReaction_0d9463421db68fb6b6ec59faeba18c48_LEFT_TO_RIGHT"}},{"data":{"id":"ComplexAssembly_e25341187875d5db0c67decbbd98c874_LEFT_TO_RIGHT-output--to--SmallMolecule_56e3033dde8d0eb1e072e60c6df6c966_ComplexAssembly_e25341187875d5db0c67decbbd98c874_LEFT_TO_RIGHT","class":"production","cardinality":0,"source":"ComplexAssembly_e25341187875d5db0c67decbbd98c874_LEFT_TO_RIGHT","target":"SmallMolecule_56e3033dde8d0eb1e072e60c6df6c966_ComplexAssembly_e25341187875d5db0c67decbbd98c874_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"OutputPort_ComplexAssembly_e25341187875d5db0c67decbbd98c874_LEFT_TO_RIGHT","portTarget":"SmallMolecule_56e3033dde8d0eb1e072e60c6df6c966_ComplexAssembly_e25341187875d5db0c67decbbd98c874_LEFT_TO_RIGHT"}},{"data":{"id":"ComplexAssembly_a49775b5bf5a7b4bc9c3fee882a528e5_LEFT_TO_RIGHT-output--to--Complex_38e35536ddcf52e8d0df5477aa66734b","class":"production","cardinality":0,"source":"ComplexAssembly_a49775b5bf5a7b4bc9c3fee882a528e5_LEFT_TO_RIGHT","target":"Complex_38e35536ddcf52e8d0df5477aa66734b","bendPointPositions":[],"portSource":"OutputPort_ComplexAssembly_a49775b5bf5a7b4bc9c3fee882a528e5_LEFT_TO_RIGHT","portTarget":"Complex_38e35536ddcf52e8d0df5477aa66734b"}},{"data":{"id":"ComplexAssembly_d15ded55f902648b3b2f9ad1aebe99d7_LEFT_TO_RIGHT-output--to--Complex_0474d84a6ffcbc5067d637d13cb69efa","class":"production","cardinality":0,"source":"ComplexAssembly_d15ded55f902648b3b2f9ad1aebe99d7_LEFT_TO_RIGHT","target":"Complex_0474d84a6ffcbc5067d637d13cb69efa","bendPointPositions":[],"portSource":"OutputPort_ComplexAssembly_d15ded55f902648b3b2f9ad1aebe99d7_LEFT_TO_RIGHT","portTarget":"Complex_0474d84a6ffcbc5067d637d13cb69efa"}},{"data":{"id":"Protein_db5d1a64ad1654f31ca849da8e9b326d--to--Transport_fbd1a94ea3d89a1f5eee593d21370775_LEFT_TO_RIGHT","class":"catalysis","cardinality":0,"source":"Protein_db5d1a64ad1654f31ca849da8e9b326d","target":"Transport_fbd1a94ea3d89a1f5eee593d21370775_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Protein_db5d1a64ad1654f31ca849da8e9b326d","portTarget":"Transport_fbd1a94ea3d89a1f5eee593d21370775_LEFT_TO_RIGHT"}},{"data":{"id":"Complex_bfe4c390a209f35f4c9f85fc26a08004--to--BiochemicalReaction_51f2b95182998dbe0cbfc10905f3feca_LEFT_TO_RIGHT-input","class":"consumption","cardinality":0,"source":"Complex_bfe4c390a209f35f4c9f85fc26a08004","target":"BiochemicalReaction_51f2b95182998dbe0cbfc10905f3feca_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Complex_bfe4c390a209f35f4c9f85fc26a08004","portTarget":"InputPort_BiochemicalReaction_51f2b95182998dbe0cbfc10905f3feca_LEFT_TO_RIGHT"}},{"data":{"id":"ComplexAssembly_d58b2e2cc5a8a1777140105132b2a01e_LEFT_TO_RIGHT-output--to--Complex_c11edd9737faa91eb365922aa30c5be4","class":"production","cardinality":0,"source":"ComplexAssembly_d58b2e2cc5a8a1777140105132b2a01e_LEFT_TO_RIGHT","target":"Complex_c11edd9737faa91eb365922aa30c5be4","bendPointPositions":[],"portSource":"OutputPort_ComplexAssembly_d58b2e2cc5a8a1777140105132b2a01e_LEFT_TO_RIGHT","portTarget":"Complex_c11edd9737faa91eb365922aa30c5be4"}},{"data":{"id":"ComplexAssembly_d15ded55f902648b3b2f9ad1aebe99d7_LEFT_TO_RIGHT-output--to--Complex_6a0c3a0c50969ce329823fd32890fa61","class":"production","cardinality":0,"source":"ComplexAssembly_d15ded55f902648b3b2f9ad1aebe99d7_LEFT_TO_RIGHT","target":"Complex_6a0c3a0c50969ce329823fd32890fa61","bendPointPositions":[],"portSource":"OutputPort_ComplexAssembly_d15ded55f902648b3b2f9ad1aebe99d7_LEFT_TO_RIGHT","portTarget":"Complex_6a0c3a0c50969ce329823fd32890fa61"}},{"data":{"id":"Complex_6f5987bf8a98e642454a66b4fc7108b4--to--ComplexAssembly_a4e1b5ff2b43ed93bd65a3d3a9da6353_LEFT_TO_RIGHT-input","class":"consumption","cardinality":0,"source":"Complex_6f5987bf8a98e642454a66b4fc7108b4","target":"ComplexAssembly_a4e1b5ff2b43ed93bd65a3d3a9da6353_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Complex_6f5987bf8a98e642454a66b4fc7108b4","portTarget":"InputPort_ComplexAssembly_a4e1b5ff2b43ed93bd65a3d3a9da6353_LEFT_TO_RIGHT"}},{"data":{"id":"BiochemicalReaction_ebe2587eee20076625365bcbf196a091_LEFT_TO_RIGHT-output--to--SmallMolecule_0410492d790c65d4bd97585d42aabbd5","class":"production","cardinality":0,"source":"BiochemicalReaction_ebe2587eee20076625365bcbf196a091_LEFT_TO_RIGHT","target":"SmallMolecule_0410492d790c65d4bd97585d42aabbd5","bendPointPositions":[],"portSource":"OutputPort_BiochemicalReaction_ebe2587eee20076625365bcbf196a091_LEFT_TO_RIGHT","portTarget":"SmallMolecule_0410492d790c65d4bd97585d42aabbd5"}},{"data":{"id":"Complex_273e090a34386a1ba38ce7060ea62c91--to--BiochemicalReaction_033023272a65b72d1b378b0e31385d69_LEFT_TO_RIGHT-input","class":"consumption","cardinality":0,"source":"Complex_273e090a34386a1ba38ce7060ea62c91","target":"BiochemicalReaction_033023272a65b72d1b378b0e31385d69_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Complex_273e090a34386a1ba38ce7060ea62c91","portTarget":"InputPort_BiochemicalReaction_033023272a65b72d1b378b0e31385d69_LEFT_TO_RIGHT"}},{"data":{"id":"ComplexAssembly_8cdd666c217309a6e1c376231760e8ed_LEFT_TO_RIGHT-output--to--Complex_839bbfb17f833b9521c6a6ea96aa610a","class":"production","cardinality":0,"source":"ComplexAssembly_8cdd666c217309a6e1c376231760e8ed_LEFT_TO_RIGHT","target":"Complex_839bbfb17f833b9521c6a6ea96aa610a","bendPointPositions":[],"portSource":"OutputPort_ComplexAssembly_8cdd666c217309a6e1c376231760e8ed_LEFT_TO_RIGHT","portTarget":"Complex_839bbfb17f833b9521c6a6ea96aa610a"}},{"data":{"id":"Protein_2357f4b5860837413497201285410149--to--ComplexAssembly_2a75f0ef389321d172c1969c8bfe7d63_LEFT_TO_RIGHT-input","class":"consumption","cardinality":0,"source":"Protein_2357f4b5860837413497201285410149","target":"ComplexAssembly_2a75f0ef389321d172c1969c8bfe7d63_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Protein_2357f4b5860837413497201285410149","portTarget":"InputPort_ComplexAssembly_2a75f0ef389321d172c1969c8bfe7d63_LEFT_TO_RIGHT"}},{"data":{"id":"ComplexAssembly_a4e1b5ff2b43ed93bd65a3d3a9da6353_LEFT_TO_RIGHT-output--to--Complex_7fba29591c0d3e0267091aedc2769edc","class":"production","cardinality":0,"source":"ComplexAssembly_a4e1b5ff2b43ed93bd65a3d3a9da6353_LEFT_TO_RIGHT","target":"Complex_7fba29591c0d3e0267091aedc2769edc","bendPointPositions":[],"portSource":"OutputPort_ComplexAssembly_a4e1b5ff2b43ed93bd65a3d3a9da6353_LEFT_TO_RIGHT","portTarget":"Complex_7fba29591c0d3e0267091aedc2769edc"}},{"data":{"id":"SmallMolecule_591e0b6209251306d628e16e6156d216--to--BiochemicalReaction_0d9463421db68fb6b6ec59faeba18c48_LEFT_TO_RIGHT-input","class":"consumption","cardinality":0,"source":"SmallMolecule_591e0b6209251306d628e16e6156d216","target":"BiochemicalReaction_0d9463421db68fb6b6ec59faeba18c48_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"SmallMolecule_591e0b6209251306d628e16e6156d216","portTarget":"InputPort_BiochemicalReaction_0d9463421db68fb6b6ec59faeba18c48_LEFT_TO_RIGHT"}},{"data":{"id":"BiochemicalReaction_3122526332e38d855b69ebef2bc40068_LEFT_TO_RIGHT-output--to--SmallMolecule_591e0b6209251306d628e16e6156d216","class":"production","cardinality":0,"source":"BiochemicalReaction_3122526332e38d855b69ebef2bc40068_LEFT_TO_RIGHT","target":"SmallMolecule_591e0b6209251306d628e16e6156d216","bendPointPositions":[],"portSource":"OutputPort_BiochemicalReaction_3122526332e38d855b69ebef2bc40068_LEFT_TO_RIGHT","portTarget":"SmallMolecule_591e0b6209251306d628e16e6156d216"}},{"data":{"id":"ComplexAssembly_3bc924c5cd39f7ee06d898b63d989d08_LEFT_TO_RIGHT-output--to--SmallMolecule_3be66134bf02bbe333791a9380f11481","class":"production","cardinality":0,"source":"ComplexAssembly_3bc924c5cd39f7ee06d898b63d989d08_LEFT_TO_RIGHT","target":"SmallMolecule_3be66134bf02bbe333791a9380f11481","bendPointPositions":[],"portSource":"OutputPort_ComplexAssembly_3bc924c5cd39f7ee06d898b63d989d08_LEFT_TO_RIGHT","portTarget":"SmallMolecule_3be66134bf02bbe333791a9380f11481"}},{"data":{"id":"Protein_c88bfbd9fb33de98774d62d2ffe2dfb5--to--BiochemicalReaction_39a2cf1134121f166f1af8fc476d59b6_LEFT_TO_RIGHT","class":"catalysis","cardinality":0,"source":"Protein_c88bfbd9fb33de98774d62d2ffe2dfb5","target":"BiochemicalReaction_39a2cf1134121f166f1af8fc476d59b6_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Protein_c88bfbd9fb33de98774d62d2ffe2dfb5","portTarget":"BiochemicalReaction_39a2cf1134121f166f1af8fc476d59b6_LEFT_TO_RIGHT"}},{"data":{"id":"SmallMolecule_0caf25f6eb33df1ed0f36474e15b1ef1--to--Transport_70c6d41ad671622a441a872527127014_LEFT_TO_RIGHT-input","class":"consumption","cardinality":0,"source":"SmallMolecule_0caf25f6eb33df1ed0f36474e15b1ef1","target":"Transport_70c6d41ad671622a441a872527127014_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"SmallMolecule_0caf25f6eb33df1ed0f36474e15b1ef1","portTarget":"InputPort_Transport_70c6d41ad671622a441a872527127014_LEFT_TO_RIGHT"}},{"data":{"id":"BiochemicalReaction_3c445c3f24014e21fe546aa259e68e5c_LEFT_TO_RIGHT-output--to--SmallMolecule_a33aac33a3d8a89ead56da53b388c23c","class":"production","cardinality":0,"source":"BiochemicalReaction_3c445c3f24014e21fe546aa259e68e5c_LEFT_TO_RIGHT","target":"SmallMolecule_a33aac33a3d8a89ead56da53b388c23c","bendPointPositions":[],"portSource":"OutputPort_BiochemicalReaction_3c445c3f24014e21fe546aa259e68e5c_LEFT_TO_RIGHT","portTarget":"SmallMolecule_a33aac33a3d8a89ead56da53b388c23c"}},{"data":{"id":"BiochemicalReaction_033023272a65b72d1b378b0e31385d69_LEFT_TO_RIGHT-output--to--Complex_0bb5c23dbe663791dc41f100b9a03e6d","class":"production","cardinality":0,"source":"BiochemicalReaction_033023272a65b72d1b378b0e31385d69_LEFT_TO_RIGHT","target":"Complex_0bb5c23dbe663791dc41f100b9a03e6d","bendPointPositions":[],"portSource":"OutputPort_BiochemicalReaction_033023272a65b72d1b378b0e31385d69_LEFT_TO_RIGHT","portTarget":"Complex_0bb5c23dbe663791dc41f100b9a03e6d"}},{"data":{"id":"ComplexAssembly_a4e1b5ff2b43ed93bd65a3d3a9da6353_LEFT_TO_RIGHT-output--to--Complex_bfe4c390a209f35f4c9f85fc26a08004","class":"production","cardinality":0,"source":"ComplexAssembly_a4e1b5ff2b43ed93bd65a3d3a9da6353_LEFT_TO_RIGHT","target":"Complex_bfe4c390a209f35f4c9f85fc26a08004","bendPointPositions":[],"portSource":"OutputPort_ComplexAssembly_a4e1b5ff2b43ed93bd65a3d3a9da6353_LEFT_TO_RIGHT","portTarget":"Complex_bfe4c390a209f35f4c9f85fc26a08004"}},{"data":{"id":"Complex_06656978d62db153fd8034cbecaae575--to--ComplexAssembly_2a75f0ef389321d172c1969c8bfe7d63_LEFT_TO_RIGHT-input","class":"consumption","cardinality":0,"source":"Complex_06656978d62db153fd8034cbecaae575","target":"ComplexAssembly_2a75f0ef389321d172c1969c8bfe7d63_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Complex_06656978d62db153fd8034cbecaae575","portTarget":"InputPort_ComplexAssembly_2a75f0ef389321d172c1969c8bfe7d63_LEFT_TO_RIGHT"}},{"data":{"id":"Protein_58a1f719f8c2ed9b0882f7798a8df554--to--ComplexAssembly_a49775b5bf5a7b4bc9c3fee882a528e5_LEFT_TO_RIGHT-input","class":"consumption","cardinality":0,"source":"Protein_58a1f719f8c2ed9b0882f7798a8df554","target":"ComplexAssembly_a49775b5bf5a7b4bc9c3fee882a528e5_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Protein_58a1f719f8c2ed9b0882f7798a8df554","portTarget":"InputPort_ComplexAssembly_a49775b5bf5a7b4bc9c3fee882a528e5_LEFT_TO_RIGHT"}},{"data":{"id":"Complex_c4e02fccdf29968aa1e9e599de8ca892--to--ComplexAssembly_d15ded55f902648b3b2f9ad1aebe99d7_LEFT_TO_RIGHT-input","class":"consumption","cardinality":2,"source":"Complex_c4e02fccdf29968aa1e9e599de8ca892","target":"ComplexAssembly_d15ded55f902648b3b2f9ad1aebe99d7_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Complex_c4e02fccdf29968aa1e9e599de8ca892","portTarget":"InputPort_ComplexAssembly_d15ded55f902648b3b2f9ad1aebe99d7_LEFT_TO_RIGHT"}},{"data":{"id":"ComplexAssembly_2a75f0ef389321d172c1969c8bfe7d63_LEFT_TO_RIGHT-output--to--Complex_1edcbd716fcdb6653d759a6e49903878","class":"production","cardinality":0,"source":"ComplexAssembly_2a75f0ef389321d172c1969c8bfe7d63_LEFT_TO_RIGHT","target":"Complex_1edcbd716fcdb6653d759a6e49903878","bendPointPositions":[],"portSource":"OutputPort_ComplexAssembly_2a75f0ef389321d172c1969c8bfe7d63_LEFT_TO_RIGHT","portTarget":"Complex_1edcbd716fcdb6653d759a6e49903878"}},{"data":{"id":"BiochemicalReaction_003a892501df9e94fa8f085fc17cdc2d_LEFT_TO_RIGHT-output--to--Complex_bfe4c390a209f35f4c9f85fc26a08004","class":"production","cardinality":0,"source":"BiochemicalReaction_003a892501df9e94fa8f085fc17cdc2d_LEFT_TO_RIGHT","target":"Complex_bfe4c390a209f35f4c9f85fc26a08004","bendPointPositions":[],"portSource":"OutputPort_BiochemicalReaction_003a892501df9e94fa8f085fc17cdc2d_LEFT_TO_RIGHT","portTarget":"Complex_bfe4c390a209f35f4c9f85fc26a08004"}}],"pathwayMetadata":{"comments":["REPLACED http://pid.nci.nih.gov/biopax#pid_29520"],"dataSource":["pid"],"title":["Visual signal transduction: Rods"]}}